<!DOCTYPE html>
<html>
<head><meta charset="utf-8" />

<title>DATA VISUALIZATION</title>

<script src="https://cdnjs.cloudflare.com/ajax/libs/require.js/2.1.10/require.min.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/2.0.3/jquery.min.js"></script>



<style type="text/css">
    /*!
*
* Twitter Bootstrap
*
*/
/*!
 * Bootstrap v3.3.7 (http://getbootstrap.com)
 * Copyright 2011-2016 Twitter, Inc.
 * Licensed under MIT (https://github.com/twbs/bootstrap/blob/master/LICENSE)
 */
/*! normalize.css v3.0.3 | MIT License | github.com/necolas/normalize.css */
html {
  font-family: sans-serif;
  -ms-text-size-adjust: 100%;
  -webkit-text-size-adjust: 100%;
}
body {
  margin: 0;
}
article,
aside,
details,
figcaption,
figure,
footer,
header,
hgroup,
main,
menu,
nav,
section,
summary {
  display: block;
}
audio,
canvas,
progress,
video {
  display: inline-block;
  vertical-align: baseline;
}
audio:not([controls]) {
  display: none;
  height: 0;
}
[hidden],
template {
  display: none;
}
a {
  background-color: transparent;
}
a:active,
a:hover {
  outline: 0;
}
abbr[title] {
  border-bottom: 1px dotted;
}
b,
strong {
  font-weight: bold;
}
dfn {
  font-style: italic;
}
h1 {
  font-size: 2em;
  margin: 0.67em 0;
}
mark {
  background: #ff0;
  color: #000;
}
small {
  font-size: 80%;
}
sub,
sup {
  font-size: 75%;
  line-height: 0;
  position: relative;
  vertical-align: baseline;
}
sup {
  top: -0.5em;
}
sub {
  bottom: -0.25em;
}
img {
  border: 0;
}
svg:not(:root) {
  overflow: hidden;
}
figure {
  margin: 1em 40px;
}
hr {
  box-sizing: content-box;
  height: 0;
}
pre {
  overflow: auto;
}
code,
kbd,
pre,
samp {
  font-family: monospace, monospace;
  font-size: 1em;
}
button,
input,
optgroup,
select,
textarea {
  color: inherit;
  font: inherit;
  margin: 0;
}
button {
  overflow: visible;
}
button,
select {
  text-transform: none;
}
button,
html input[type="button"],
input[type="reset"],
input[type="submit"] {
  -webkit-appearance: button;
  cursor: pointer;
}
button[disabled],
html input[disabled] {
  cursor: default;
}
button::-moz-focus-inner,
input::-moz-focus-inner {
  border: 0;
  padding: 0;
}
input {
  line-height: normal;
}
input[type="checkbox"],
input[type="radio"] {
  box-sizing: border-box;
  padding: 0;
}
input[type="number"]::-webkit-inner-spin-button,
input[type="number"]::-webkit-outer-spin-button {
  height: auto;
}
input[type="search"] {
  -webkit-appearance: textfield;
  box-sizing: content-box;
}
input[type="search"]::-webkit-search-cancel-button,
input[type="search"]::-webkit-search-decoration {
  -webkit-appearance: none;
}
fieldset {
  border: 1px solid #c0c0c0;
  margin: 0 2px;
  padding: 0.35em 0.625em 0.75em;
}
legend {
  border: 0;
  padding: 0;
}
textarea {
  overflow: auto;
}
optgroup {
  font-weight: bold;
}
table {
  border-collapse: collapse;
  border-spacing: 0;
}
td,
th {
  padding: 0;
}
/*! Source: https://github.com/h5bp/html5-boilerplate/blob/master/src/css/main.css */
@media print {
  *,
  *:before,
  *:after {
    background: transparent !important;
    box-shadow: none !important;
    text-shadow: none !important;
  }
  a,
  a:visited {
    text-decoration: underline;
  }
  a[href]:after {
    content: " (" attr(href) ")";
  }
  abbr[title]:after {
    content: " (" attr(title) ")";
  }
  a[href^="#"]:after,
  a[href^="javascript:"]:after {
    content: "";
  }
  pre,
  blockquote {
    border: 1px solid #999;
    page-break-inside: avoid;
  }
  thead {
    display: table-header-group;
  }
  tr,
  img {
    page-break-inside: avoid;
  }
  img {
    max-width: 100% !important;
  }
  p,
  h2,
  h3 {
    orphans: 3;
    widows: 3;
  }
  h2,
  h3 {
    page-break-after: avoid;
  }
  .navbar {
    display: none;
  }
  .btn > .caret,
  .dropup > .btn > .caret {
    border-top-color: #000 !important;
  }
  .label {
    border: 1px solid #000;
  }
  .table {
    border-collapse: collapse !important;
  }
  .table td,
  .table th {
    background-color: #fff !important;
  }
  .table-bordered th,
  .table-bordered td {
    border: 1px solid #ddd !important;
  }
}
@font-face {
  font-family: 'Glyphicons Halflings';
  src: url('../components/bootstrap/fonts/glyphicons-halflings-regular.eot');
  src: url('../components/bootstrap/fonts/glyphicons-halflings-regular.eot?#iefix') format('embedded-opentype'), url('../components/bootstrap/fonts/glyphicons-halflings-regular.woff2') format('woff2'), url('../components/bootstrap/fonts/glyphicons-halflings-regular.woff') format('woff'), url('../components/bootstrap/fonts/glyphicons-halflings-regular.ttf') format('truetype'), url('../components/bootstrap/fonts/glyphicons-halflings-regular.svg#glyphicons_halflingsregular') format('svg');
}
.glyphicon {
  position: relative;
  top: 1px;
  display: inline-block;
  font-family: 'Glyphicons Halflings';
  font-style: normal;
  font-weight: normal;
  line-height: 1;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
}
.glyphicon-asterisk:before {
  content: "\002a";
}
.glyphicon-plus:before {
  content: "\002b";
}
.glyphicon-euro:before,
.glyphicon-eur:before {
  content: "\20ac";
}
.glyphicon-minus:before {
  content: "\2212";
}
.glyphicon-cloud:before {
  content: "\2601";
}
.glyphicon-envelope:before {
  content: "\2709";
}
.glyphicon-pencil:before {
  content: "\270f";
}
.glyphicon-glass:before {
  content: "\e001";
}
.glyphicon-music:before {
  content: "\e002";
}
.glyphicon-search:before {
  content: "\e003";
}
.glyphicon-heart:before {
  content: "\e005";
}
.glyphicon-star:before {
  content: "\e006";
}
.glyphicon-star-empty:before {
  content: "\e007";
}
.glyphicon-user:before {
  content: "\e008";
}
.glyphicon-film:before {
  content: "\e009";
}
.glyphicon-th-large:before {
  content: "\e010";
}
.glyphicon-th:before {
  content: "\e011";
}
.glyphicon-th-list:before {
  content: "\e012";
}
.glyphicon-ok:before {
  content: "\e013";
}
.glyphicon-remove:before {
  content: "\e014";
}
.glyphicon-zoom-in:before {
  content: "\e015";
}
.glyphicon-zoom-out:before {
  content: "\e016";
}
.glyphicon-off:before {
  content: "\e017";
}
.glyphicon-signal:before {
  content: "\e018";
}
.glyphicon-cog:before {
  content: "\e019";
}
.glyphicon-trash:before {
  content: "\e020";
}
.glyphicon-home:before {
  content: "\e021";
}
.glyphicon-file:before {
  content: "\e022";
}
.glyphicon-time:before {
  content: "\e023";
}
.glyphicon-road:before {
  content: "\e024";
}
.glyphicon-download-alt:before {
  content: "\e025";
}
.glyphicon-download:before {
  content: "\e026";
}
.glyphicon-upload:before {
  content: "\e027";
}
.glyphicon-inbox:before {
  content: "\e028";
}
.glyphicon-play-circle:before {
  content: "\e029";
}
.glyphicon-repeat:before {
  content: "\e030";
}
.glyphicon-refresh:before {
  content: "\e031";
}
.glyphicon-list-alt:before {
  content: "\e032";
}
.glyphicon-lock:before {
  content: "\e033";
}
.glyphicon-flag:before {
  content: "\e034";
}
.glyphicon-headphones:before {
  content: "\e035";
}
.glyphicon-volume-off:before {
  content: "\e036";
}
.glyphicon-volume-down:before {
  content: "\e037";
}
.glyphicon-volume-up:before {
  content: "\e038";
}
.glyphicon-qrcode:before {
  content: "\e039";
}
.glyphicon-barcode:before {
  content: "\e040";
}
.glyphicon-tag:before {
  content: "\e041";
}
.glyphicon-tags:before {
  content: "\e042";
}
.glyphicon-book:before {
  content: "\e043";
}
.glyphicon-bookmark:before {
  content: "\e044";
}
.glyphicon-print:before {
  content: "\e045";
}
.glyphicon-camera:before {
  content: "\e046";
}
.glyphicon-font:before {
  content: "\e047";
}
.glyphicon-bold:before {
  content: "\e048";
}
.glyphicon-italic:before {
  content: "\e049";
}
.glyphicon-text-height:before {
  content: "\e050";
}
.glyphicon-text-width:before {
  content: "\e051";
}
.glyphicon-align-left:before {
  content: "\e052";
}
.glyphicon-align-center:before {
  content: "\e053";
}
.glyphicon-align-right:before {
  content: "\e054";
}
.glyphicon-align-justify:before {
  content: "\e055";
}
.glyphicon-list:before {
  content: "\e056";
}
.glyphicon-indent-left:before {
  content: "\e057";
}
.glyphicon-indent-right:before {
  content: "\e058";
}
.glyphicon-facetime-video:before {
  content: "\e059";
}
.glyphicon-picture:before {
  content: "\e060";
}
.glyphicon-map-marker:before {
  content: "\e062";
}
.glyphicon-adjust:before {
  content: "\e063";
}
.glyphicon-tint:before {
  content: "\e064";
}
.glyphicon-edit:before {
  content: "\e065";
}
.glyphicon-share:before {
  content: "\e066";
}
.glyphicon-check:before {
  content: "\e067";
}
.glyphicon-move:before {
  content: "\e068";
}
.glyphicon-step-backward:before {
  content: "\e069";
}
.glyphicon-fast-backward:before {
  content: "\e070";
}
.glyphicon-backward:before {
  content: "\e071";
}
.glyphicon-play:before {
  content: "\e072";
}
.glyphicon-pause:before {
  content: "\e073";
}
.glyphicon-stop:before {
  content: "\e074";
}
.glyphicon-forward:before {
  content: "\e075";
}
.glyphicon-fast-forward:before {
  content: "\e076";
}
.glyphicon-step-forward:before {
  content: "\e077";
}
.glyphicon-eject:before {
  content: "\e078";
}
.glyphicon-chevron-left:before {
  content: "\e079";
}
.glyphicon-chevron-right:before {
  content: "\e080";
}
.glyphicon-plus-sign:before {
  content: "\e081";
}
.glyphicon-minus-sign:before {
  content: "\e082";
}
.glyphicon-remove-sign:before {
  content: "\e083";
}
.glyphicon-ok-sign:before {
  content: "\e084";
}
.glyphicon-question-sign:before {
  content: "\e085";
}
.glyphicon-info-sign:before {
  content: "\e086";
}
.glyphicon-screenshot:before {
  content: "\e087";
}
.glyphicon-remove-circle:before {
  content: "\e088";
}
.glyphicon-ok-circle:before {
  content: "\e089";
}
.glyphicon-ban-circle:before {
  content: "\e090";
}
.glyphicon-arrow-left:before {
  content: "\e091";
}
.glyphicon-arrow-right:before {
  content: "\e092";
}
.glyphicon-arrow-up:before {
  content: "\e093";
}
.glyphicon-arrow-down:before {
  content: "\e094";
}
.glyphicon-share-alt:before {
  content: "\e095";
}
.glyphicon-resize-full:before {
  content: "\e096";
}
.glyphicon-resize-small:before {
  content: "\e097";
}
.glyphicon-exclamation-sign:before {
  content: "\e101";
}
.glyphicon-gift:before {
  content: "\e102";
}
.glyphicon-leaf:before {
  content: "\e103";
}
.glyphicon-fire:before {
  content: "\e104";
}
.glyphicon-eye-open:before {
  content: "\e105";
}
.glyphicon-eye-close:before {
  content: "\e106";
}
.glyphicon-warning-sign:before {
  content: "\e107";
}
.glyphicon-plane:before {
  content: "\e108";
}
.glyphicon-calendar:before {
  content: "\e109";
}
.glyphicon-random:before {
  content: "\e110";
}
.glyphicon-comment:before {
  content: "\e111";
}
.glyphicon-magnet:before {
  content: "\e112";
}
.glyphicon-chevron-up:before {
  content: "\e113";
}
.glyphicon-chevron-down:before {
  content: "\e114";
}
.glyphicon-retweet:before {
  content: "\e115";
}
.glyphicon-shopping-cart:before {
  content: "\e116";
}
.glyphicon-folder-close:before {
  content: "\e117";
}
.glyphicon-folder-open:before {
  content: "\e118";
}
.glyphicon-resize-vertical:before {
  content: "\e119";
}
.glyphicon-resize-horizontal:before {
  content: "\e120";
}
.glyphicon-hdd:before {
  content: "\e121";
}
.glyphicon-bullhorn:before {
  content: "\e122";
}
.glyphicon-bell:before {
  content: "\e123";
}
.glyphicon-certificate:before {
  content: "\e124";
}
.glyphicon-thumbs-up:before {
  content: "\e125";
}
.glyphicon-thumbs-down:before {
  content: "\e126";
}
.glyphicon-hand-right:before {
  content: "\e127";
}
.glyphicon-hand-left:before {
  content: "\e128";
}
.glyphicon-hand-up:before {
  content: "\e129";
}
.glyphicon-hand-down:before {
  content: "\e130";
}
.glyphicon-circle-arrow-right:before {
  content: "\e131";
}
.glyphicon-circle-arrow-left:before {
  content: "\e132";
}
.glyphicon-circle-arrow-up:before {
  content: "\e133";
}
.glyphicon-circle-arrow-down:before {
  content: "\e134";
}
.glyphicon-globe:before {
  content: "\e135";
}
.glyphicon-wrench:before {
  content: "\e136";
}
.glyphicon-tasks:before {
  content: "\e137";
}
.glyphicon-filter:before {
  content: "\e138";
}
.glyphicon-briefcase:before {
  content: "\e139";
}
.glyphicon-fullscreen:before {
  content: "\e140";
}
.glyphicon-dashboard:before {
  content: "\e141";
}
.glyphicon-paperclip:before {
  content: "\e142";
}
.glyphicon-heart-empty:before {
  content: "\e143";
}
.glyphicon-link:before {
  content: "\e144";
}
.glyphicon-phone:before {
  content: "\e145";
}
.glyphicon-pushpin:before {
  content: "\e146";
}
.glyphicon-usd:before {
  content: "\e148";
}
.glyphicon-gbp:before {
  content: "\e149";
}
.glyphicon-sort:before {
  content: "\e150";
}
.glyphicon-sort-by-alphabet:before {
  content: "\e151";
}
.glyphicon-sort-by-alphabet-alt:before {
  content: "\e152";
}
.glyphicon-sort-by-order:before {
  content: "\e153";
}
.glyphicon-sort-by-order-alt:before {
  content: "\e154";
}
.glyphicon-sort-by-attributes:before {
  content: "\e155";
}
.glyphicon-sort-by-attributes-alt:before {
  content: "\e156";
}
.glyphicon-unchecked:before {
  content: "\e157";
}
.glyphicon-expand:before {
  content: "\e158";
}
.glyphicon-collapse-down:before {
  content: "\e159";
}
.glyphicon-collapse-up:before {
  content: "\e160";
}
.glyphicon-log-in:before {
  content: "\e161";
}
.glyphicon-flash:before {
  content: "\e162";
}
.glyphicon-log-out:before {
  content: "\e163";
}
.glyphicon-new-window:before {
  content: "\e164";
}
.glyphicon-record:before {
  content: "\e165";
}
.glyphicon-save:before {
  content: "\e166";
}
.glyphicon-open:before {
  content: "\e167";
}
.glyphicon-saved:before {
  content: "\e168";
}
.glyphicon-import:before {
  content: "\e169";
}
.glyphicon-export:before {
  content: "\e170";
}
.glyphicon-send:before {
  content: "\e171";
}
.glyphicon-floppy-disk:before {
  content: "\e172";
}
.glyphicon-floppy-saved:before {
  content: "\e173";
}
.glyphicon-floppy-remove:before {
  content: "\e174";
}
.glyphicon-floppy-save:before {
  content: "\e175";
}
.glyphicon-floppy-open:before {
  content: "\e176";
}
.glyphicon-credit-card:before {
  content: "\e177";
}
.glyphicon-transfer:before {
  content: "\e178";
}
.glyphicon-cutlery:before {
  content: "\e179";
}
.glyphicon-header:before {
  content: "\e180";
}
.glyphicon-compressed:before {
  content: "\e181";
}
.glyphicon-earphone:before {
  content: "\e182";
}
.glyphicon-phone-alt:before {
  content: "\e183";
}
.glyphicon-tower:before {
  content: "\e184";
}
.glyphicon-stats:before {
  content: "\e185";
}
.glyphicon-sd-video:before {
  content: "\e186";
}
.glyphicon-hd-video:before {
  content: "\e187";
}
.glyphicon-subtitles:before {
  content: "\e188";
}
.glyphicon-sound-stereo:before {
  content: "\e189";
}
.glyphicon-sound-dolby:before {
  content: "\e190";
}
.glyphicon-sound-5-1:before {
  content: "\e191";
}
.glyphicon-sound-6-1:before {
  content: "\e192";
}
.glyphicon-sound-7-1:before {
  content: "\e193";
}
.glyphicon-copyright-mark:before {
  content: "\e194";
}
.glyphicon-registration-mark:before {
  content: "\e195";
}
.glyphicon-cloud-download:before {
  content: "\e197";
}
.glyphicon-cloud-upload:before {
  content: "\e198";
}
.glyphicon-tree-conifer:before {
  content: "\e199";
}
.glyphicon-tree-deciduous:before {
  content: "\e200";
}
.glyphicon-cd:before {
  content: "\e201";
}
.glyphicon-save-file:before {
  content: "\e202";
}
.glyphicon-open-file:before {
  content: "\e203";
}
.glyphicon-level-up:before {
  content: "\e204";
}
.glyphicon-copy:before {
  content: "\e205";
}
.glyphicon-paste:before {
  content: "\e206";
}
.glyphicon-alert:before {
  content: "\e209";
}
.glyphicon-equalizer:before {
  content: "\e210";
}
.glyphicon-king:before {
  content: "\e211";
}
.glyphicon-queen:before {
  content: "\e212";
}
.glyphicon-pawn:before {
  content: "\e213";
}
.glyphicon-bishop:before {
  content: "\e214";
}
.glyphicon-knight:before {
  content: "\e215";
}
.glyphicon-baby-formula:before {
  content: "\e216";
}
.glyphicon-tent:before {
  content: "\26fa";
}
.glyphicon-blackboard:before {
  content: "\e218";
}
.glyphicon-bed:before {
  content: "\e219";
}
.glyphicon-apple:before {
  content: "\f8ff";
}
.glyphicon-erase:before {
  content: "\e221";
}
.glyphicon-hourglass:before {
  content: "\231b";
}
.glyphicon-lamp:before {
  content: "\e223";
}
.glyphicon-duplicate:before {
  content: "\e224";
}
.glyphicon-piggy-bank:before {
  content: "\e225";
}
.glyphicon-scissors:before {
  content: "\e226";
}
.glyphicon-bitcoin:before {
  content: "\e227";
}
.glyphicon-btc:before {
  content: "\e227";
}
.glyphicon-xbt:before {
  content: "\e227";
}
.glyphicon-yen:before {
  content: "\00a5";
}
.glyphicon-jpy:before {
  content: "\00a5";
}
.glyphicon-ruble:before {
  content: "\20bd";
}
.glyphicon-rub:before {
  content: "\20bd";
}
.glyphicon-scale:before {
  content: "\e230";
}
.glyphicon-ice-lolly:before {
  content: "\e231";
}
.glyphicon-ice-lolly-tasted:before {
  content: "\e232";
}
.glyphicon-education:before {
  content: "\e233";
}
.glyphicon-option-horizontal:before {
  content: "\e234";
}
.glyphicon-option-vertical:before {
  content: "\e235";
}
.glyphicon-menu-hamburger:before {
  content: "\e236";
}
.glyphicon-modal-window:before {
  content: "\e237";
}
.glyphicon-oil:before {
  content: "\e238";
}
.glyphicon-grain:before {
  content: "\e239";
}
.glyphicon-sunglasses:before {
  content: "\e240";
}
.glyphicon-text-size:before {
  content: "\e241";
}
.glyphicon-text-color:before {
  content: "\e242";
}
.glyphicon-text-background:before {
  content: "\e243";
}
.glyphicon-object-align-top:before {
  content: "\e244";
}
.glyphicon-object-align-bottom:before {
  content: "\e245";
}
.glyphicon-object-align-horizontal:before {
  content: "\e246";
}
.glyphicon-object-align-left:before {
  content: "\e247";
}
.glyphicon-object-align-vertical:before {
  content: "\e248";
}
.glyphicon-object-align-right:before {
  content: "\e249";
}
.glyphicon-triangle-right:before {
  content: "\e250";
}
.glyphicon-triangle-left:before {
  content: "\e251";
}
.glyphicon-triangle-bottom:before {
  content: "\e252";
}
.glyphicon-triangle-top:before {
  content: "\e253";
}
.glyphicon-console:before {
  content: "\e254";
}
.glyphicon-superscript:before {
  content: "\e255";
}
.glyphicon-subscript:before {
  content: "\e256";
}
.glyphicon-menu-left:before {
  content: "\e257";
}
.glyphicon-menu-right:before {
  content: "\e258";
}
.glyphicon-menu-down:before {
  content: "\e259";
}
.glyphicon-menu-up:before {
  content: "\e260";
}
* {
  -webkit-box-sizing: border-box;
  -moz-box-sizing: border-box;
  box-sizing: border-box;
}
*:before,
*:after {
  -webkit-box-sizing: border-box;
  -moz-box-sizing: border-box;
  box-sizing: border-box;
}
html {
  font-size: 10px;
  -webkit-tap-highlight-color: rgba(0, 0, 0, 0);
}
body {
  font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
  font-size: 13px;
  line-height: 1.42857143;
  color: #000;
  background-color: #fff;
}
input,
button,
select,
textarea {
  font-family: inherit;
  font-size: inherit;
  line-height: inherit;
}
a {
  color: #337ab7;
  text-decoration: none;
}
a:hover,
a:focus {
  color: #23527c;
  text-decoration: underline;
}
a:focus {
  outline: 5px auto -webkit-focus-ring-color;
  outline-offset: -2px;
}
figure {
  margin: 0;
}
img {
  vertical-align: middle;
}
.img-responsive,
.thumbnail > img,
.thumbnail a > img,
.carousel-inner > .item > img,
.carousel-inner > .item > a > img {
  display: block;
  max-width: 100%;
  height: auto;
}
.img-rounded {
  border-radius: 3px;
}
.img-thumbnail {
  padding: 4px;
  line-height: 1.42857143;
  background-color: #fff;
  border: 1px solid #ddd;
  border-radius: 2px;
  -webkit-transition: all 0.2s ease-in-out;
  -o-transition: all 0.2s ease-in-out;
  transition: all 0.2s ease-in-out;
  display: inline-block;
  max-width: 100%;
  height: auto;
}
.img-circle {
  border-radius: 50%;
}
hr {
  margin-top: 18px;
  margin-bottom: 18px;
  border: 0;
  border-top: 1px solid #eeeeee;
}
.sr-only {
  position: absolute;
  width: 1px;
  height: 1px;
  margin: -1px;
  padding: 0;
  overflow: hidden;
  clip: rect(0, 0, 0, 0);
  border: 0;
}
.sr-only-focusable:active,
.sr-only-focusable:focus {
  position: static;
  width: auto;
  height: auto;
  margin: 0;
  overflow: visible;
  clip: auto;
}
[role="button"] {
  cursor: pointer;
}
h1,
h2,
h3,
h4,
h5,
h6,
.h1,
.h2,
.h3,
.h4,
.h5,
.h6 {
  font-family: inherit;
  font-weight: 500;
  line-height: 1.1;
  color: inherit;
}
h1 small,
h2 small,
h3 small,
h4 small,
h5 small,
h6 small,
.h1 small,
.h2 small,
.h3 small,
.h4 small,
.h5 small,
.h6 small,
h1 .small,
h2 .small,
h3 .small,
h4 .small,
h5 .small,
h6 .small,
.h1 .small,
.h2 .small,
.h3 .small,
.h4 .small,
.h5 .small,
.h6 .small {
  font-weight: normal;
  line-height: 1;
  color: #777777;
}
h1,
.h1,
h2,
.h2,
h3,
.h3 {
  margin-top: 18px;
  margin-bottom: 9px;
}
h1 small,
.h1 small,
h2 small,
.h2 small,
h3 small,
.h3 small,
h1 .small,
.h1 .small,
h2 .small,
.h2 .small,
h3 .small,
.h3 .small {
  font-size: 65%;
}
h4,
.h4,
h5,
.h5,
h6,
.h6 {
  margin-top: 9px;
  margin-bottom: 9px;
}
h4 small,
.h4 small,
h5 small,
.h5 small,
h6 small,
.h6 small,
h4 .small,
.h4 .small,
h5 .small,
.h5 .small,
h6 .small,
.h6 .small {
  font-size: 75%;
}
h1,
.h1 {
  font-size: 33px;
}
h2,
.h2 {
  font-size: 27px;
}
h3,
.h3 {
  font-size: 23px;
}
h4,
.h4 {
  font-size: 17px;
}
h5,
.h5 {
  font-size: 13px;
}
h6,
.h6 {
  font-size: 12px;
}
p {
  margin: 0 0 9px;
}
.lead {
  margin-bottom: 18px;
  font-size: 14px;
  font-weight: 300;
  line-height: 1.4;
}
@media (min-width: 768px) {
  .lead {
    font-size: 19.5px;
  }
}
small,
.small {
  font-size: 92%;
}
mark,
.mark {
  background-color: #fcf8e3;
  padding: .2em;
}
.text-left {
  text-align: left;
}
.text-right {
  text-align: right;
}
.text-center {
  text-align: center;
}
.text-justify {
  text-align: justify;
}
.text-nowrap {
  white-space: nowrap;
}
.text-lowercase {
  text-transform: lowercase;
}
.text-uppercase {
  text-transform: uppercase;
}
.text-capitalize {
  text-transform: capitalize;
}
.text-muted {
  color: #777777;
}
.text-primary {
  color: #337ab7;
}
a.text-primary:hover,
a.text-primary:focus {
  color: #286090;
}
.text-success {
  color: #3c763d;
}
a.text-success:hover,
a.text-success:focus {
  color: #2b542c;
}
.text-info {
  color: #31708f;
}
a.text-info:hover,
a.text-info:focus {
  color: #245269;
}
.text-warning {
  color: #8a6d3b;
}
a.text-warning:hover,
a.text-warning:focus {
  color: #66512c;
}
.text-danger {
  color: #a94442;
}
a.text-danger:hover,
a.text-danger:focus {
  color: #843534;
}
.bg-primary {
  color: #fff;
  background-color: #337ab7;
}
a.bg-primary:hover,
a.bg-primary:focus {
  background-color: #286090;
}
.bg-success {
  background-color: #dff0d8;
}
a.bg-success:hover,
a.bg-success:focus {
  background-color: #c1e2b3;
}
.bg-info {
  background-color: #d9edf7;
}
a.bg-info:hover,
a.bg-info:focus {
  background-color: #afd9ee;
}
.bg-warning {
  background-color: #fcf8e3;
}
a.bg-warning:hover,
a.bg-warning:focus {
  background-color: #f7ecb5;
}
.bg-danger {
  background-color: #f2dede;
}
a.bg-danger:hover,
a.bg-danger:focus {
  background-color: #e4b9b9;
}
.page-header {
  padding-bottom: 8px;
  margin: 36px 0 18px;
  border-bottom: 1px solid #eeeeee;
}
ul,
ol {
  margin-top: 0;
  margin-bottom: 9px;
}
ul ul,
ol ul,
ul ol,
ol ol {
  margin-bottom: 0;
}
.list-unstyled {
  padding-left: 0;
  list-style: none;
}
.list-inline {
  padding-left: 0;
  list-style: none;
  margin-left: -5px;
}
.list-inline > li {
  display: inline-block;
  padding-left: 5px;
  padding-right: 5px;
}
dl {
  margin-top: 0;
  margin-bottom: 18px;
}
dt,
dd {
  line-height: 1.42857143;
}
dt {
  font-weight: bold;
}
dd {
  margin-left: 0;
}
@media (min-width: 541px) {
  .dl-horizontal dt {
    float: left;
    width: 160px;
    clear: left;
    text-align: right;
    overflow: hidden;
    text-overflow: ellipsis;
    white-space: nowrap;
  }
  .dl-horizontal dd {
    margin-left: 180px;
  }
}
abbr[title],
abbr[data-original-title] {
  cursor: help;
  border-bottom: 1px dotted #777777;
}
.initialism {
  font-size: 90%;
  text-transform: uppercase;
}
blockquote {
  padding: 9px 18px;
  margin: 0 0 18px;
  font-size: inherit;
  border-left: 5px solid #eeeeee;
}
blockquote p:last-child,
blockquote ul:last-child,
blockquote ol:last-child {
  margin-bottom: 0;
}
blockquote footer,
blockquote small,
blockquote .small {
  display: block;
  font-size: 80%;
  line-height: 1.42857143;
  color: #777777;
}
blockquote footer:before,
blockquote small:before,
blockquote .small:before {
  content: '\2014 \00A0';
}
.blockquote-reverse,
blockquote.pull-right {
  padding-right: 15px;
  padding-left: 0;
  border-right: 5px solid #eeeeee;
  border-left: 0;
  text-align: right;
}
.blockquote-reverse footer:before,
blockquote.pull-right footer:before,
.blockquote-reverse small:before,
blockquote.pull-right small:before,
.blockquote-reverse .small:before,
blockquote.pull-right .small:before {
  content: '';
}
.blockquote-reverse footer:after,
blockquote.pull-right footer:after,
.blockquote-reverse small:after,
blockquote.pull-right small:after,
.blockquote-reverse .small:after,
blockquote.pull-right .small:after {
  content: '\00A0 \2014';
}
address {
  margin-bottom: 18px;
  font-style: normal;
  line-height: 1.42857143;
}
code,
kbd,
pre,
samp {
  font-family: monospace;
}
code {
  padding: 2px 4px;
  font-size: 90%;
  color: #c7254e;
  background-color: #f9f2f4;
  border-radius: 2px;
}
kbd {
  padding: 2px 4px;
  font-size: 90%;
  color: #888;
  background-color: transparent;
  border-radius: 1px;
  box-shadow: inset 0 -1px 0 rgba(0, 0, 0, 0.25);
}
kbd kbd {
  padding: 0;
  font-size: 100%;
  font-weight: bold;
  box-shadow: none;
}
pre {
  display: block;
  padding: 8.5px;
  margin: 0 0 9px;
  font-size: 12px;
  line-height: 1.42857143;
  word-break: break-all;
  word-wrap: break-word;
  color: #333333;
  background-color: #f5f5f5;
  border: 1px solid #ccc;
  border-radius: 2px;
}
pre code {
  padding: 0;
  font-size: inherit;
  color: inherit;
  white-space: pre-wrap;
  background-color: transparent;
  border-radius: 0;
}
.pre-scrollable {
  max-height: 340px;
  overflow-y: scroll;
}
.container {
  margin-right: auto;
  margin-left: auto;
  padding-left: 0px;
  padding-right: 0px;
}
@media (min-width: 768px) {
  .container {
    width: 768px;
  }
}
@media (min-width: 992px) {
  .container {
    width: 940px;
  }
}
@media (min-width: 1200px) {
  .container {
    width: 1140px;
  }
}
.container-fluid {
  margin-right: auto;
  margin-left: auto;
  padding-left: 0px;
  padding-right: 0px;
}
.row {
  margin-left: 0px;
  margin-right: 0px;
}
.col-xs-1, .col-sm-1, .col-md-1, .col-lg-1, .col-xs-2, .col-sm-2, .col-md-2, .col-lg-2, .col-xs-3, .col-sm-3, .col-md-3, .col-lg-3, .col-xs-4, .col-sm-4, .col-md-4, .col-lg-4, .col-xs-5, .col-sm-5, .col-md-5, .col-lg-5, .col-xs-6, .col-sm-6, .col-md-6, .col-lg-6, .col-xs-7, .col-sm-7, .col-md-7, .col-lg-7, .col-xs-8, .col-sm-8, .col-md-8, .col-lg-8, .col-xs-9, .col-sm-9, .col-md-9, .col-lg-9, .col-xs-10, .col-sm-10, .col-md-10, .col-lg-10, .col-xs-11, .col-sm-11, .col-md-11, .col-lg-11, .col-xs-12, .col-sm-12, .col-md-12, .col-lg-12 {
  position: relative;
  min-height: 1px;
  padding-left: 0px;
  padding-right: 0px;
}
.col-xs-1, .col-xs-2, .col-xs-3, .col-xs-4, .col-xs-5, .col-xs-6, .col-xs-7, .col-xs-8, .col-xs-9, .col-xs-10, .col-xs-11, .col-xs-12 {
  float: left;
}
.col-xs-12 {
  width: 100%;
}
.col-xs-11 {
  width: 91.66666667%;
}
.col-xs-10 {
  width: 83.33333333%;
}
.col-xs-9 {
  width: 75%;
}
.col-xs-8 {
  width: 66.66666667%;
}
.col-xs-7 {
  width: 58.33333333%;
}
.col-xs-6 {
  width: 50%;
}
.col-xs-5 {
  width: 41.66666667%;
}
.col-xs-4 {
  width: 33.33333333%;
}
.col-xs-3 {
  width: 25%;
}
.col-xs-2 {
  width: 16.66666667%;
}
.col-xs-1 {
  width: 8.33333333%;
}
.col-xs-pull-12 {
  right: 100%;
}
.col-xs-pull-11 {
  right: 91.66666667%;
}
.col-xs-pull-10 {
  right: 83.33333333%;
}
.col-xs-pull-9 {
  right: 75%;
}
.col-xs-pull-8 {
  right: 66.66666667%;
}
.col-xs-pull-7 {
  right: 58.33333333%;
}
.col-xs-pull-6 {
  right: 50%;
}
.col-xs-pull-5 {
  right: 41.66666667%;
}
.col-xs-pull-4 {
  right: 33.33333333%;
}
.col-xs-pull-3 {
  right: 25%;
}
.col-xs-pull-2 {
  right: 16.66666667%;
}
.col-xs-pull-1 {
  right: 8.33333333%;
}
.col-xs-pull-0 {
  right: auto;
}
.col-xs-push-12 {
  left: 100%;
}
.col-xs-push-11 {
  left: 91.66666667%;
}
.col-xs-push-10 {
  left: 83.33333333%;
}
.col-xs-push-9 {
  left: 75%;
}
.col-xs-push-8 {
  left: 66.66666667%;
}
.col-xs-push-7 {
  left: 58.33333333%;
}
.col-xs-push-6 {
  left: 50%;
}
.col-xs-push-5 {
  left: 41.66666667%;
}
.col-xs-push-4 {
  left: 33.33333333%;
}
.col-xs-push-3 {
  left: 25%;
}
.col-xs-push-2 {
  left: 16.66666667%;
}
.col-xs-push-1 {
  left: 8.33333333%;
}
.col-xs-push-0 {
  left: auto;
}
.col-xs-offset-12 {
  margin-left: 100%;
}
.col-xs-offset-11 {
  margin-left: 91.66666667%;
}
.col-xs-offset-10 {
  margin-left: 83.33333333%;
}
.col-xs-offset-9 {
  margin-left: 75%;
}
.col-xs-offset-8 {
  margin-left: 66.66666667%;
}
.col-xs-offset-7 {
  margin-left: 58.33333333%;
}
.col-xs-offset-6 {
  margin-left: 50%;
}
.col-xs-offset-5 {
  margin-left: 41.66666667%;
}
.col-xs-offset-4 {
  margin-left: 33.33333333%;
}
.col-xs-offset-3 {
  margin-left: 25%;
}
.col-xs-offset-2 {
  margin-left: 16.66666667%;
}
.col-xs-offset-1 {
  margin-left: 8.33333333%;
}
.col-xs-offset-0 {
  margin-left: 0%;
}
@media (min-width: 768px) {
  .col-sm-1, .col-sm-2, .col-sm-3, .col-sm-4, .col-sm-5, .col-sm-6, .col-sm-7, .col-sm-8, .col-sm-9, .col-sm-10, .col-sm-11, .col-sm-12 {
    float: left;
  }
  .col-sm-12 {
    width: 100%;
  }
  .col-sm-11 {
    width: 91.66666667%;
  }
  .col-sm-10 {
    width: 83.33333333%;
  }
  .col-sm-9 {
    width: 75%;
  }
  .col-sm-8 {
    width: 66.66666667%;
  }
  .col-sm-7 {
    width: 58.33333333%;
  }
  .col-sm-6 {
    width: 50%;
  }
  .col-sm-5 {
    width: 41.66666667%;
  }
  .col-sm-4 {
    width: 33.33333333%;
  }
  .col-sm-3 {
    width: 25%;
  }
  .col-sm-2 {
    width: 16.66666667%;
  }
  .col-sm-1 {
    width: 8.33333333%;
  }
  .col-sm-pull-12 {
    right: 100%;
  }
  .col-sm-pull-11 {
    right: 91.66666667%;
  }
  .col-sm-pull-10 {
    right: 83.33333333%;
  }
  .col-sm-pull-9 {
    right: 75%;
  }
  .col-sm-pull-8 {
    right: 66.66666667%;
  }
  .col-sm-pull-7 {
    right: 58.33333333%;
  }
  .col-sm-pull-6 {
    right: 50%;
  }
  .col-sm-pull-5 {
    right: 41.66666667%;
  }
  .col-sm-pull-4 {
    right: 33.33333333%;
  }
  .col-sm-pull-3 {
    right: 25%;
  }
  .col-sm-pull-2 {
    right: 16.66666667%;
  }
  .col-sm-pull-1 {
    right: 8.33333333%;
  }
  .col-sm-pull-0 {
    right: auto;
  }
  .col-sm-push-12 {
    left: 100%;
  }
  .col-sm-push-11 {
    left: 91.66666667%;
  }
  .col-sm-push-10 {
    left: 83.33333333%;
  }
  .col-sm-push-9 {
    left: 75%;
  }
  .col-sm-push-8 {
    left: 66.66666667%;
  }
  .col-sm-push-7 {
    left: 58.33333333%;
  }
  .col-sm-push-6 {
    left: 50%;
  }
  .col-sm-push-5 {
    left: 41.66666667%;
  }
  .col-sm-push-4 {
    left: 33.33333333%;
  }
  .col-sm-push-3 {
    left: 25%;
  }
  .col-sm-push-2 {
    left: 16.66666667%;
  }
  .col-sm-push-1 {
    left: 8.33333333%;
  }
  .col-sm-push-0 {
    left: auto;
  }
  .col-sm-offset-12 {
    margin-left: 100%;
  }
  .col-sm-offset-11 {
    margin-left: 91.66666667%;
  }
  .col-sm-offset-10 {
    margin-left: 83.33333333%;
  }
  .col-sm-offset-9 {
    margin-left: 75%;
  }
  .col-sm-offset-8 {
    margin-left: 66.66666667%;
  }
  .col-sm-offset-7 {
    margin-left: 58.33333333%;
  }
  .col-sm-offset-6 {
    margin-left: 50%;
  }
  .col-sm-offset-5 {
    margin-left: 41.66666667%;
  }
  .col-sm-offset-4 {
    margin-left: 33.33333333%;
  }
  .col-sm-offset-3 {
    margin-left: 25%;
  }
  .col-sm-offset-2 {
    margin-left: 16.66666667%;
  }
  .col-sm-offset-1 {
    margin-left: 8.33333333%;
  }
  .col-sm-offset-0 {
    margin-left: 0%;
  }
}
@media (min-width: 992px) {
  .col-md-1, .col-md-2, .col-md-3, .col-md-4, .col-md-5, .col-md-6, .col-md-7, .col-md-8, .col-md-9, .col-md-10, .col-md-11, .col-md-12 {
    float: left;
  }
  .col-md-12 {
    width: 100%;
  }
  .col-md-11 {
    width: 91.66666667%;
  }
  .col-md-10 {
    width: 83.33333333%;
  }
  .col-md-9 {
    width: 75%;
  }
  .col-md-8 {
    width: 66.66666667%;
  }
  .col-md-7 {
    width: 58.33333333%;
  }
  .col-md-6 {
    width: 50%;
  }
  .col-md-5 {
    width: 41.66666667%;
  }
  .col-md-4 {
    width: 33.33333333%;
  }
  .col-md-3 {
    width: 25%;
  }
  .col-md-2 {
    width: 16.66666667%;
  }
  .col-md-1 {
    width: 8.33333333%;
  }
  .col-md-pull-12 {
    right: 100%;
  }
  .col-md-pull-11 {
    right: 91.66666667%;
  }
  .col-md-pull-10 {
    right: 83.33333333%;
  }
  .col-md-pull-9 {
    right: 75%;
  }
  .col-md-pull-8 {
    right: 66.66666667%;
  }
  .col-md-pull-7 {
    right: 58.33333333%;
  }
  .col-md-pull-6 {
    right: 50%;
  }
  .col-md-pull-5 {
    right: 41.66666667%;
  }
  .col-md-pull-4 {
    right: 33.33333333%;
  }
  .col-md-pull-3 {
    right: 25%;
  }
  .col-md-pull-2 {
    right: 16.66666667%;
  }
  .col-md-pull-1 {
    right: 8.33333333%;
  }
  .col-md-pull-0 {
    right: auto;
  }
  .col-md-push-12 {
    left: 100%;
  }
  .col-md-push-11 {
    left: 91.66666667%;
  }
  .col-md-push-10 {
    left: 83.33333333%;
  }
  .col-md-push-9 {
    left: 75%;
  }
  .col-md-push-8 {
    left: 66.66666667%;
  }
  .col-md-push-7 {
    left: 58.33333333%;
  }
  .col-md-push-6 {
    left: 50%;
  }
  .col-md-push-5 {
    left: 41.66666667%;
  }
  .col-md-push-4 {
    left: 33.33333333%;
  }
  .col-md-push-3 {
    left: 25%;
  }
  .col-md-push-2 {
    left: 16.66666667%;
  }
  .col-md-push-1 {
    left: 8.33333333%;
  }
  .col-md-push-0 {
    left: auto;
  }
  .col-md-offset-12 {
    margin-left: 100%;
  }
  .col-md-offset-11 {
    margin-left: 91.66666667%;
  }
  .col-md-offset-10 {
    margin-left: 83.33333333%;
  }
  .col-md-offset-9 {
    margin-left: 75%;
  }
  .col-md-offset-8 {
    margin-left: 66.66666667%;
  }
  .col-md-offset-7 {
    margin-left: 58.33333333%;
  }
  .col-md-offset-6 {
    margin-left: 50%;
  }
  .col-md-offset-5 {
    margin-left: 41.66666667%;
  }
  .col-md-offset-4 {
    margin-left: 33.33333333%;
  }
  .col-md-offset-3 {
    margin-left: 25%;
  }
  .col-md-offset-2 {
    margin-left: 16.66666667%;
  }
  .col-md-offset-1 {
    margin-left: 8.33333333%;
  }
  .col-md-offset-0 {
    margin-left: 0%;
  }
}
@media (min-width: 1200px) {
  .col-lg-1, .col-lg-2, .col-lg-3, .col-lg-4, .col-lg-5, .col-lg-6, .col-lg-7, .col-lg-8, .col-lg-9, .col-lg-10, .col-lg-11, .col-lg-12 {
    float: left;
  }
  .col-lg-12 {
    width: 100%;
  }
  .col-lg-11 {
    width: 91.66666667%;
  }
  .col-lg-10 {
    width: 83.33333333%;
  }
  .col-lg-9 {
    width: 75%;
  }
  .col-lg-8 {
    width: 66.66666667%;
  }
  .col-lg-7 {
    width: 58.33333333%;
  }
  .col-lg-6 {
    width: 50%;
  }
  .col-lg-5 {
    width: 41.66666667%;
  }
  .col-lg-4 {
    width: 33.33333333%;
  }
  .col-lg-3 {
    width: 25%;
  }
  .col-lg-2 {
    width: 16.66666667%;
  }
  .col-lg-1 {
    width: 8.33333333%;
  }
  .col-lg-pull-12 {
    right: 100%;
  }
  .col-lg-pull-11 {
    right: 91.66666667%;
  }
  .col-lg-pull-10 {
    right: 83.33333333%;
  }
  .col-lg-pull-9 {
    right: 75%;
  }
  .col-lg-pull-8 {
    right: 66.66666667%;
  }
  .col-lg-pull-7 {
    right: 58.33333333%;
  }
  .col-lg-pull-6 {
    right: 50%;
  }
  .col-lg-pull-5 {
    right: 41.66666667%;
  }
  .col-lg-pull-4 {
    right: 33.33333333%;
  }
  .col-lg-pull-3 {
    right: 25%;
  }
  .col-lg-pull-2 {
    right: 16.66666667%;
  }
  .col-lg-pull-1 {
    right: 8.33333333%;
  }
  .col-lg-pull-0 {
    right: auto;
  }
  .col-lg-push-12 {
    left: 100%;
  }
  .col-lg-push-11 {
    left: 91.66666667%;
  }
  .col-lg-push-10 {
    left: 83.33333333%;
  }
  .col-lg-push-9 {
    left: 75%;
  }
  .col-lg-push-8 {
    left: 66.66666667%;
  }
  .col-lg-push-7 {
    left: 58.33333333%;
  }
  .col-lg-push-6 {
    left: 50%;
  }
  .col-lg-push-5 {
    left: 41.66666667%;
  }
  .col-lg-push-4 {
    left: 33.33333333%;
  }
  .col-lg-push-3 {
    left: 25%;
  }
  .col-lg-push-2 {
    left: 16.66666667%;
  }
  .col-lg-push-1 {
    left: 8.33333333%;
  }
  .col-lg-push-0 {
    left: auto;
  }
  .col-lg-offset-12 {
    margin-left: 100%;
  }
  .col-lg-offset-11 {
    margin-left: 91.66666667%;
  }
  .col-lg-offset-10 {
    margin-left: 83.33333333%;
  }
  .col-lg-offset-9 {
    margin-left: 75%;
  }
  .col-lg-offset-8 {
    margin-left: 66.66666667%;
  }
  .col-lg-offset-7 {
    margin-left: 58.33333333%;
  }
  .col-lg-offset-6 {
    margin-left: 50%;
  }
  .col-lg-offset-5 {
    margin-left: 41.66666667%;
  }
  .col-lg-offset-4 {
    margin-left: 33.33333333%;
  }
  .col-lg-offset-3 {
    margin-left: 25%;
  }
  .col-lg-offset-2 {
    margin-left: 16.66666667%;
  }
  .col-lg-offset-1 {
    margin-left: 8.33333333%;
  }
  .col-lg-offset-0 {
    margin-left: 0%;
  }
}
table {
  background-color: transparent;
}
caption {
  padding-top: 8px;
  padding-bottom: 8px;
  color: #777777;
  text-align: left;
}
th {
  text-align: left;
}
.table {
  width: 100%;
  max-width: 100%;
  margin-bottom: 18px;
}
.table > thead > tr > th,
.table > tbody > tr > th,
.table > tfoot > tr > th,
.table > thead > tr > td,
.table > tbody > tr > td,
.table > tfoot > tr > td {
  padding: 8px;
  line-height: 1.42857143;
  vertical-align: top;
  border-top: 1px solid #ddd;
}
.table > thead > tr > th {
  vertical-align: bottom;
  border-bottom: 2px solid #ddd;
}
.table > caption + thead > tr:first-child > th,
.table > colgroup + thead > tr:first-child > th,
.table > thead:first-child > tr:first-child > th,
.table > caption + thead > tr:first-child > td,
.table > colgroup + thead > tr:first-child > td,
.table > thead:first-child > tr:first-child > td {
  border-top: 0;
}
.table > tbody + tbody {
  border-top: 2px solid #ddd;
}
.table .table {
  background-color: #fff;
}
.table-condensed > thead > tr > th,
.table-condensed > tbody > tr > th,
.table-condensed > tfoot > tr > th,
.table-condensed > thead > tr > td,
.table-condensed > tbody > tr > td,
.table-condensed > tfoot > tr > td {
  padding: 5px;
}
.table-bordered {
  border: 1px solid #ddd;
}
.table-bordered > thead > tr > th,
.table-bordered > tbody > tr > th,
.table-bordered > tfoot > tr > th,
.table-bordered > thead > tr > td,
.table-bordered > tbody > tr > td,
.table-bordered > tfoot > tr > td {
  border: 1px solid #ddd;
}
.table-bordered > thead > tr > th,
.table-bordered > thead > tr > td {
  border-bottom-width: 2px;
}
.table-striped > tbody > tr:nth-of-type(odd) {
  background-color: #f9f9f9;
}
.table-hover > tbody > tr:hover {
  background-color: #f5f5f5;
}
table col[class*="col-"] {
  position: static;
  float: none;
  display: table-column;
}
table td[class*="col-"],
table th[class*="col-"] {
  position: static;
  float: none;
  display: table-cell;
}
.table > thead > tr > td.active,
.table > tbody > tr > td.active,
.table > tfoot > tr > td.active,
.table > thead > tr > th.active,
.table > tbody > tr > th.active,
.table > tfoot > tr > th.active,
.table > thead > tr.active > td,
.table > tbody > tr.active > td,
.table > tfoot > tr.active > td,
.table > thead > tr.active > th,
.table > tbody > tr.active > th,
.table > tfoot > tr.active > th {
  background-color: #f5f5f5;
}
.table-hover > tbody > tr > td.active:hover,
.table-hover > tbody > tr > th.active:hover,
.table-hover > tbody > tr.active:hover > td,
.table-hover > tbody > tr:hover > .active,
.table-hover > tbody > tr.active:hover > th {
  background-color: #e8e8e8;
}
.table > thead > tr > td.success,
.table > tbody > tr > td.success,
.table > tfoot > tr > td.success,
.table > thead > tr > th.success,
.table > tbody > tr > th.success,
.table > tfoot > tr > th.success,
.table > thead > tr.success > td,
.table > tbody > tr.success > td,
.table > tfoot > tr.success > td,
.table > thead > tr.success > th,
.table > tbody > tr.success > th,
.table > tfoot > tr.success > th {
  background-color: #dff0d8;
}
.table-hover > tbody > tr > td.success:hover,
.table-hover > tbody > tr > th.success:hover,
.table-hover > tbody > tr.success:hover > td,
.table-hover > tbody > tr:hover > .success,
.table-hover > tbody > tr.success:hover > th {
  background-color: #d0e9c6;
}
.table > thead > tr > td.info,
.table > tbody > tr > td.info,
.table > tfoot > tr > td.info,
.table > thead > tr > th.info,
.table > tbody > tr > th.info,
.table > tfoot > tr > th.info,
.table > thead > tr.info > td,
.table > tbody > tr.info > td,
.table > tfoot > tr.info > td,
.table > thead > tr.info > th,
.table > tbody > tr.info > th,
.table > tfoot > tr.info > th {
  background-color: #d9edf7;
}
.table-hover > tbody > tr > td.info:hover,
.table-hover > tbody > tr > th.info:hover,
.table-hover > tbody > tr.info:hover > td,
.table-hover > tbody > tr:hover > .info,
.table-hover > tbody > tr.info:hover > th {
  background-color: #c4e3f3;
}
.table > thead > tr > td.warning,
.table > tbody > tr > td.warning,
.table > tfoot > tr > td.warning,
.table > thead > tr > th.warning,
.table > tbody > tr > th.warning,
.table > tfoot > tr > th.warning,
.table > thead > tr.warning > td,
.table > tbody > tr.warning > td,
.table > tfoot > tr.warning > td,
.table > thead > tr.warning > th,
.table > tbody > tr.warning > th,
.table > tfoot > tr.warning > th {
  background-color: #fcf8e3;
}
.table-hover > tbody > tr > td.warning:hover,
.table-hover > tbody > tr > th.warning:hover,
.table-hover > tbody > tr.warning:hover > td,
.table-hover > tbody > tr:hover > .warning,
.table-hover > tbody > tr.warning:hover > th {
  background-color: #faf2cc;
}
.table > thead > tr > td.danger,
.table > tbody > tr > td.danger,
.table > tfoot > tr > td.danger,
.table > thead > tr > th.danger,
.table > tbody > tr > th.danger,
.table > tfoot > tr > th.danger,
.table > thead > tr.danger > td,
.table > tbody > tr.danger > td,
.table > tfoot > tr.danger > td,
.table > thead > tr.danger > th,
.table > tbody > tr.danger > th,
.table > tfoot > tr.danger > th {
  background-color: #f2dede;
}
.table-hover > tbody > tr > td.danger:hover,
.table-hover > tbody > tr > th.danger:hover,
.table-hover > tbody > tr.danger:hover > td,
.table-hover > tbody > tr:hover > .danger,
.table-hover > tbody > tr.danger:hover > th {
  background-color: #ebcccc;
}
.table-responsive {
  overflow-x: auto;
  min-height: 0.01%;
}
@media screen and (max-width: 767px) {
  .table-responsive {
    width: 100%;
    margin-bottom: 13.5px;
    overflow-y: hidden;
    -ms-overflow-style: -ms-autohiding-scrollbar;
    border: 1px solid #ddd;
  }
  .table-responsive > .table {
    margin-bottom: 0;
  }
  .table-responsive > .table > thead > tr > th,
  .table-responsive > .table > tbody > tr > th,
  .table-responsive > .table > tfoot > tr > th,
  .table-responsive > .table > thead > tr > td,
  .table-responsive > .table > tbody > tr > td,
  .table-responsive > .table > tfoot > tr > td {
    white-space: nowrap;
  }
  .table-responsive > .table-bordered {
    border: 0;
  }
  .table-responsive > .table-bordered > thead > tr > th:first-child,
  .table-responsive > .table-bordered > tbody > tr > th:first-child,
  .table-responsive > .table-bordered > tfoot > tr > th:first-child,
  .table-responsive > .table-bordered > thead > tr > td:first-child,
  .table-responsive > .table-bordered > tbody > tr > td:first-child,
  .table-responsive > .table-bordered > tfoot > tr > td:first-child {
    border-left: 0;
  }
  .table-responsive > .table-bordered > thead > tr > th:last-child,
  .table-responsive > .table-bordered > tbody > tr > th:last-child,
  .table-responsive > .table-bordered > tfoot > tr > th:last-child,
  .table-responsive > .table-bordered > thead > tr > td:last-child,
  .table-responsive > .table-bordered > tbody > tr > td:last-child,
  .table-responsive > .table-bordered > tfoot > tr > td:last-child {
    border-right: 0;
  }
  .table-responsive > .table-bordered > tbody > tr:last-child > th,
  .table-responsive > .table-bordered > tfoot > tr:last-child > th,
  .table-responsive > .table-bordered > tbody > tr:last-child > td,
  .table-responsive > .table-bordered > tfoot > tr:last-child > td {
    border-bottom: 0;
  }
}
fieldset {
  padding: 0;
  margin: 0;
  border: 0;
  min-width: 0;
}
legend {
  display: block;
  width: 100%;
  padding: 0;
  margin-bottom: 18px;
  font-size: 19.5px;
  line-height: inherit;
  color: #333333;
  border: 0;
  border-bottom: 1px solid #e5e5e5;
}
label {
  display: inline-block;
  max-width: 100%;
  margin-bottom: 5px;
  font-weight: bold;
}
input[type="search"] {
  -webkit-box-sizing: border-box;
  -moz-box-sizing: border-box;
  box-sizing: border-box;
}
input[type="radio"],
input[type="checkbox"] {
  margin: 4px 0 0;
  margin-top: 1px \9;
  line-height: normal;
}
input[type="file"] {
  display: block;
}
input[type="range"] {
  display: block;
  width: 100%;
}
select[multiple],
select[size] {
  height: auto;
}
input[type="file"]:focus,
input[type="radio"]:focus,
input[type="checkbox"]:focus {
  outline: 5px auto -webkit-focus-ring-color;
  outline-offset: -2px;
}
output {
  display: block;
  padding-top: 7px;
  font-size: 13px;
  line-height: 1.42857143;
  color: #555555;
}
.form-control {
  display: block;
  width: 100%;
  height: 32px;
  padding: 6px 12px;
  font-size: 13px;
  line-height: 1.42857143;
  color: #555555;
  background-color: #fff;
  background-image: none;
  border: 1px solid #ccc;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  -webkit-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  -o-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
}
.form-control:focus {
  border-color: #66afe9;
  outline: 0;
  -webkit-box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
  box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
}
.form-control::-moz-placeholder {
  color: #999;
  opacity: 1;
}
.form-control:-ms-input-placeholder {
  color: #999;
}
.form-control::-webkit-input-placeholder {
  color: #999;
}
.form-control::-ms-expand {
  border: 0;
  background-color: transparent;
}
.form-control[disabled],
.form-control[readonly],
fieldset[disabled] .form-control {
  background-color: #eeeeee;
  opacity: 1;
}
.form-control[disabled],
fieldset[disabled] .form-control {
  cursor: not-allowed;
}
textarea.form-control {
  height: auto;
}
input[type="search"] {
  -webkit-appearance: none;
}
@media screen and (-webkit-min-device-pixel-ratio: 0) {
  input[type="date"].form-control,
  input[type="time"].form-control,
  input[type="datetime-local"].form-control,
  input[type="month"].form-control {
    line-height: 32px;
  }
  input[type="date"].input-sm,
  input[type="time"].input-sm,
  input[type="datetime-local"].input-sm,
  input[type="month"].input-sm,
  .input-group-sm input[type="date"],
  .input-group-sm input[type="time"],
  .input-group-sm input[type="datetime-local"],
  .input-group-sm input[type="month"] {
    line-height: 30px;
  }
  input[type="date"].input-lg,
  input[type="time"].input-lg,
  input[type="datetime-local"].input-lg,
  input[type="month"].input-lg,
  .input-group-lg input[type="date"],
  .input-group-lg input[type="time"],
  .input-group-lg input[type="datetime-local"],
  .input-group-lg input[type="month"] {
    line-height: 45px;
  }
}
.form-group {
  margin-bottom: 15px;
}
.radio,
.checkbox {
  position: relative;
  display: block;
  margin-top: 10px;
  margin-bottom: 10px;
}
.radio label,
.checkbox label {
  min-height: 18px;
  padding-left: 20px;
  margin-bottom: 0;
  font-weight: normal;
  cursor: pointer;
}
.radio input[type="radio"],
.radio-inline input[type="radio"],
.checkbox input[type="checkbox"],
.checkbox-inline input[type="checkbox"] {
  position: absolute;
  margin-left: -20px;
  margin-top: 4px \9;
}
.radio + .radio,
.checkbox + .checkbox {
  margin-top: -5px;
}
.radio-inline,
.checkbox-inline {
  position: relative;
  display: inline-block;
  padding-left: 20px;
  margin-bottom: 0;
  vertical-align: middle;
  font-weight: normal;
  cursor: pointer;
}
.radio-inline + .radio-inline,
.checkbox-inline + .checkbox-inline {
  margin-top: 0;
  margin-left: 10px;
}
input[type="radio"][disabled],
input[type="checkbox"][disabled],
input[type="radio"].disabled,
input[type="checkbox"].disabled,
fieldset[disabled] input[type="radio"],
fieldset[disabled] input[type="checkbox"] {
  cursor: not-allowed;
}
.radio-inline.disabled,
.checkbox-inline.disabled,
fieldset[disabled] .radio-inline,
fieldset[disabled] .checkbox-inline {
  cursor: not-allowed;
}
.radio.disabled label,
.checkbox.disabled label,
fieldset[disabled] .radio label,
fieldset[disabled] .checkbox label {
  cursor: not-allowed;
}
.form-control-static {
  padding-top: 7px;
  padding-bottom: 7px;
  margin-bottom: 0;
  min-height: 31px;
}
.form-control-static.input-lg,
.form-control-static.input-sm {
  padding-left: 0;
  padding-right: 0;
}
.input-sm {
  height: 30px;
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
}
select.input-sm {
  height: 30px;
  line-height: 30px;
}
textarea.input-sm,
select[multiple].input-sm {
  height: auto;
}
.form-group-sm .form-control {
  height: 30px;
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
}
.form-group-sm select.form-control {
  height: 30px;
  line-height: 30px;
}
.form-group-sm textarea.form-control,
.form-group-sm select[multiple].form-control {
  height: auto;
}
.form-group-sm .form-control-static {
  height: 30px;
  min-height: 30px;
  padding: 6px 10px;
  font-size: 12px;
  line-height: 1.5;
}
.input-lg {
  height: 45px;
  padding: 10px 16px;
  font-size: 17px;
  line-height: 1.3333333;
  border-radius: 3px;
}
select.input-lg {
  height: 45px;
  line-height: 45px;
}
textarea.input-lg,
select[multiple].input-lg {
  height: auto;
}
.form-group-lg .form-control {
  height: 45px;
  padding: 10px 16px;
  font-size: 17px;
  line-height: 1.3333333;
  border-radius: 3px;
}
.form-group-lg select.form-control {
  height: 45px;
  line-height: 45px;
}
.form-group-lg textarea.form-control,
.form-group-lg select[multiple].form-control {
  height: auto;
}
.form-group-lg .form-control-static {
  height: 45px;
  min-height: 35px;
  padding: 11px 16px;
  font-size: 17px;
  line-height: 1.3333333;
}
.has-feedback {
  position: relative;
}
.has-feedback .form-control {
  padding-right: 40px;
}
.form-control-feedback {
  position: absolute;
  top: 0;
  right: 0;
  z-index: 2;
  display: block;
  width: 32px;
  height: 32px;
  line-height: 32px;
  text-align: center;
  pointer-events: none;
}
.input-lg + .form-control-feedback,
.input-group-lg + .form-control-feedback,
.form-group-lg .form-control + .form-control-feedback {
  width: 45px;
  height: 45px;
  line-height: 45px;
}
.input-sm + .form-control-feedback,
.input-group-sm + .form-control-feedback,
.form-group-sm .form-control + .form-control-feedback {
  width: 30px;
  height: 30px;
  line-height: 30px;
}
.has-success .help-block,
.has-success .control-label,
.has-success .radio,
.has-success .checkbox,
.has-success .radio-inline,
.has-success .checkbox-inline,
.has-success.radio label,
.has-success.checkbox label,
.has-success.radio-inline label,
.has-success.checkbox-inline label {
  color: #3c763d;
}
.has-success .form-control {
  border-color: #3c763d;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
}
.has-success .form-control:focus {
  border-color: #2b542c;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #67b168;
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #67b168;
}
.has-success .input-group-addon {
  color: #3c763d;
  border-color: #3c763d;
  background-color: #dff0d8;
}
.has-success .form-control-feedback {
  color: #3c763d;
}
.has-warning .help-block,
.has-warning .control-label,
.has-warning .radio,
.has-warning .checkbox,
.has-warning .radio-inline,
.has-warning .checkbox-inline,
.has-warning.radio label,
.has-warning.checkbox label,
.has-warning.radio-inline label,
.has-warning.checkbox-inline label {
  color: #8a6d3b;
}
.has-warning .form-control {
  border-color: #8a6d3b;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
}
.has-warning .form-control:focus {
  border-color: #66512c;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #c0a16b;
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #c0a16b;
}
.has-warning .input-group-addon {
  color: #8a6d3b;
  border-color: #8a6d3b;
  background-color: #fcf8e3;
}
.has-warning .form-control-feedback {
  color: #8a6d3b;
}
.has-error .help-block,
.has-error .control-label,
.has-error .radio,
.has-error .checkbox,
.has-error .radio-inline,
.has-error .checkbox-inline,
.has-error.radio label,
.has-error.checkbox label,
.has-error.radio-inline label,
.has-error.checkbox-inline label {
  color: #a94442;
}
.has-error .form-control {
  border-color: #a94442;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
}
.has-error .form-control:focus {
  border-color: #843534;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #ce8483;
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #ce8483;
}
.has-error .input-group-addon {
  color: #a94442;
  border-color: #a94442;
  background-color: #f2dede;
}
.has-error .form-control-feedback {
  color: #a94442;
}
.has-feedback label ~ .form-control-feedback {
  top: 23px;
}
.has-feedback label.sr-only ~ .form-control-feedback {
  top: 0;
}
.help-block {
  display: block;
  margin-top: 5px;
  margin-bottom: 10px;
  color: #404040;
}
@media (min-width: 768px) {
  .form-inline .form-group {
    display: inline-block;
    margin-bottom: 0;
    vertical-align: middle;
  }
  .form-inline .form-control {
    display: inline-block;
    width: auto;
    vertical-align: middle;
  }
  .form-inline .form-control-static {
    display: inline-block;
  }
  .form-inline .input-group {
    display: inline-table;
    vertical-align: middle;
  }
  .form-inline .input-group .input-group-addon,
  .form-inline .input-group .input-group-btn,
  .form-inline .input-group .form-control {
    width: auto;
  }
  .form-inline .input-group > .form-control {
    width: 100%;
  }
  .form-inline .control-label {
    margin-bottom: 0;
    vertical-align: middle;
  }
  .form-inline .radio,
  .form-inline .checkbox {
    display: inline-block;
    margin-top: 0;
    margin-bottom: 0;
    vertical-align: middle;
  }
  .form-inline .radio label,
  .form-inline .checkbox label {
    padding-left: 0;
  }
  .form-inline .radio input[type="radio"],
  .form-inline .checkbox input[type="checkbox"] {
    position: relative;
    margin-left: 0;
  }
  .form-inline .has-feedback .form-control-feedback {
    top: 0;
  }
}
.form-horizontal .radio,
.form-horizontal .checkbox,
.form-horizontal .radio-inline,
.form-horizontal .checkbox-inline {
  margin-top: 0;
  margin-bottom: 0;
  padding-top: 7px;
}
.form-horizontal .radio,
.form-horizontal .checkbox {
  min-height: 25px;
}
.form-horizontal .form-group {
  margin-left: 0px;
  margin-right: 0px;
}
@media (min-width: 768px) {
  .form-horizontal .control-label {
    text-align: right;
    margin-bottom: 0;
    padding-top: 7px;
  }
}
.form-horizontal .has-feedback .form-control-feedback {
  right: 0px;
}
@media (min-width: 768px) {
  .form-horizontal .form-group-lg .control-label {
    padding-top: 11px;
    font-size: 17px;
  }
}
@media (min-width: 768px) {
  .form-horizontal .form-group-sm .control-label {
    padding-top: 6px;
    font-size: 12px;
  }
}
.btn {
  display: inline-block;
  margin-bottom: 0;
  font-weight: normal;
  text-align: center;
  vertical-align: middle;
  touch-action: manipulation;
  cursor: pointer;
  background-image: none;
  border: 1px solid transparent;
  white-space: nowrap;
  padding: 6px 12px;
  font-size: 13px;
  line-height: 1.42857143;
  border-radius: 2px;
  -webkit-user-select: none;
  -moz-user-select: none;
  -ms-user-select: none;
  user-select: none;
}
.btn:focus,
.btn:active:focus,
.btn.active:focus,
.btn.focus,
.btn:active.focus,
.btn.active.focus {
  outline: 5px auto -webkit-focus-ring-color;
  outline-offset: -2px;
}
.btn:hover,
.btn:focus,
.btn.focus {
  color: #333;
  text-decoration: none;
}
.btn:active,
.btn.active {
  outline: 0;
  background-image: none;
  -webkit-box-shadow: inset 0 3px 5px rgba(0, 0, 0, 0.125);
  box-shadow: inset 0 3px 5px rgba(0, 0, 0, 0.125);
}
.btn.disabled,
.btn[disabled],
fieldset[disabled] .btn {
  cursor: not-allowed;
  opacity: 0.65;
  filter: alpha(opacity=65);
  -webkit-box-shadow: none;
  box-shadow: none;
}
a.btn.disabled,
fieldset[disabled] a.btn {
  pointer-events: none;
}
.btn-default {
  color: #333;
  background-color: #fff;
  border-color: #ccc;
}
.btn-default:focus,
.btn-default.focus {
  color: #333;
  background-color: #e6e6e6;
  border-color: #8c8c8c;
}
.btn-default:hover {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
.btn-default:active,
.btn-default.active,
.open > .dropdown-toggle.btn-default {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
.btn-default:active:hover,
.btn-default.active:hover,
.open > .dropdown-toggle.btn-default:hover,
.btn-default:active:focus,
.btn-default.active:focus,
.open > .dropdown-toggle.btn-default:focus,
.btn-default:active.focus,
.btn-default.active.focus,
.open > .dropdown-toggle.btn-default.focus {
  color: #333;
  background-color: #d4d4d4;
  border-color: #8c8c8c;
}
.btn-default:active,
.btn-default.active,
.open > .dropdown-toggle.btn-default {
  background-image: none;
}
.btn-default.disabled:hover,
.btn-default[disabled]:hover,
fieldset[disabled] .btn-default:hover,
.btn-default.disabled:focus,
.btn-default[disabled]:focus,
fieldset[disabled] .btn-default:focus,
.btn-default.disabled.focus,
.btn-default[disabled].focus,
fieldset[disabled] .btn-default.focus {
  background-color: #fff;
  border-color: #ccc;
}
.btn-default .badge {
  color: #fff;
  background-color: #333;
}
.btn-primary {
  color: #fff;
  background-color: #337ab7;
  border-color: #2e6da4;
}
.btn-primary:focus,
.btn-primary.focus {
  color: #fff;
  background-color: #286090;
  border-color: #122b40;
}
.btn-primary:hover {
  color: #fff;
  background-color: #286090;
  border-color: #204d74;
}
.btn-primary:active,
.btn-primary.active,
.open > .dropdown-toggle.btn-primary {
  color: #fff;
  background-color: #286090;
  border-color: #204d74;
}
.btn-primary:active:hover,
.btn-primary.active:hover,
.open > .dropdown-toggle.btn-primary:hover,
.btn-primary:active:focus,
.btn-primary.active:focus,
.open > .dropdown-toggle.btn-primary:focus,
.btn-primary:active.focus,
.btn-primary.active.focus,
.open > .dropdown-toggle.btn-primary.focus {
  color: #fff;
  background-color: #204d74;
  border-color: #122b40;
}
.btn-primary:active,
.btn-primary.active,
.open > .dropdown-toggle.btn-primary {
  background-image: none;
}
.btn-primary.disabled:hover,
.btn-primary[disabled]:hover,
fieldset[disabled] .btn-primary:hover,
.btn-primary.disabled:focus,
.btn-primary[disabled]:focus,
fieldset[disabled] .btn-primary:focus,
.btn-primary.disabled.focus,
.btn-primary[disabled].focus,
fieldset[disabled] .btn-primary.focus {
  background-color: #337ab7;
  border-color: #2e6da4;
}
.btn-primary .badge {
  color: #337ab7;
  background-color: #fff;
}
.btn-success {
  color: #fff;
  background-color: #5cb85c;
  border-color: #4cae4c;
}
.btn-success:focus,
.btn-success.focus {
  color: #fff;
  background-color: #449d44;
  border-color: #255625;
}
.btn-success:hover {
  color: #fff;
  background-color: #449d44;
  border-color: #398439;
}
.btn-success:active,
.btn-success.active,
.open > .dropdown-toggle.btn-success {
  color: #fff;
  background-color: #449d44;
  border-color: #398439;
}
.btn-success:active:hover,
.btn-success.active:hover,
.open > .dropdown-toggle.btn-success:hover,
.btn-success:active:focus,
.btn-success.active:focus,
.open > .dropdown-toggle.btn-success:focus,
.btn-success:active.focus,
.btn-success.active.focus,
.open > .dropdown-toggle.btn-success.focus {
  color: #fff;
  background-color: #398439;
  border-color: #255625;
}
.btn-success:active,
.btn-success.active,
.open > .dropdown-toggle.btn-success {
  background-image: none;
}
.btn-success.disabled:hover,
.btn-success[disabled]:hover,
fieldset[disabled] .btn-success:hover,
.btn-success.disabled:focus,
.btn-success[disabled]:focus,
fieldset[disabled] .btn-success:focus,
.btn-success.disabled.focus,
.btn-success[disabled].focus,
fieldset[disabled] .btn-success.focus {
  background-color: #5cb85c;
  border-color: #4cae4c;
}
.btn-success .badge {
  color: #5cb85c;
  background-color: #fff;
}
.btn-info {
  color: #fff;
  background-color: #5bc0de;
  border-color: #46b8da;
}
.btn-info:focus,
.btn-info.focus {
  color: #fff;
  background-color: #31b0d5;
  border-color: #1b6d85;
}
.btn-info:hover {
  color: #fff;
  background-color: #31b0d5;
  border-color: #269abc;
}
.btn-info:active,
.btn-info.active,
.open > .dropdown-toggle.btn-info {
  color: #fff;
  background-color: #31b0d5;
  border-color: #269abc;
}
.btn-info:active:hover,
.btn-info.active:hover,
.open > .dropdown-toggle.btn-info:hover,
.btn-info:active:focus,
.btn-info.active:focus,
.open > .dropdown-toggle.btn-info:focus,
.btn-info:active.focus,
.btn-info.active.focus,
.open > .dropdown-toggle.btn-info.focus {
  color: #fff;
  background-color: #269abc;
  border-color: #1b6d85;
}
.btn-info:active,
.btn-info.active,
.open > .dropdown-toggle.btn-info {
  background-image: none;
}
.btn-info.disabled:hover,
.btn-info[disabled]:hover,
fieldset[disabled] .btn-info:hover,
.btn-info.disabled:focus,
.btn-info[disabled]:focus,
fieldset[disabled] .btn-info:focus,
.btn-info.disabled.focus,
.btn-info[disabled].focus,
fieldset[disabled] .btn-info.focus {
  background-color: #5bc0de;
  border-color: #46b8da;
}
.btn-info .badge {
  color: #5bc0de;
  background-color: #fff;
}
.btn-warning {
  color: #fff;
  background-color: #f0ad4e;
  border-color: #eea236;
}
.btn-warning:focus,
.btn-warning.focus {
  color: #fff;
  background-color: #ec971f;
  border-color: #985f0d;
}
.btn-warning:hover {
  color: #fff;
  background-color: #ec971f;
  border-color: #d58512;
}
.btn-warning:active,
.btn-warning.active,
.open > .dropdown-toggle.btn-warning {
  color: #fff;
  background-color: #ec971f;
  border-color: #d58512;
}
.btn-warning:active:hover,
.btn-warning.active:hover,
.open > .dropdown-toggle.btn-warning:hover,
.btn-warning:active:focus,
.btn-warning.active:focus,
.open > .dropdown-toggle.btn-warning:focus,
.btn-warning:active.focus,
.btn-warning.active.focus,
.open > .dropdown-toggle.btn-warning.focus {
  color: #fff;
  background-color: #d58512;
  border-color: #985f0d;
}
.btn-warning:active,
.btn-warning.active,
.open > .dropdown-toggle.btn-warning {
  background-image: none;
}
.btn-warning.disabled:hover,
.btn-warning[disabled]:hover,
fieldset[disabled] .btn-warning:hover,
.btn-warning.disabled:focus,
.btn-warning[disabled]:focus,
fieldset[disabled] .btn-warning:focus,
.btn-warning.disabled.focus,
.btn-warning[disabled].focus,
fieldset[disabled] .btn-warning.focus {
  background-color: #f0ad4e;
  border-color: #eea236;
}
.btn-warning .badge {
  color: #f0ad4e;
  background-color: #fff;
}
.btn-danger {
  color: #fff;
  background-color: #d9534f;
  border-color: #d43f3a;
}
.btn-danger:focus,
.btn-danger.focus {
  color: #fff;
  background-color: #c9302c;
  border-color: #761c19;
}
.btn-danger:hover {
  color: #fff;
  background-color: #c9302c;
  border-color: #ac2925;
}
.btn-danger:active,
.btn-danger.active,
.open > .dropdown-toggle.btn-danger {
  color: #fff;
  background-color: #c9302c;
  border-color: #ac2925;
}
.btn-danger:active:hover,
.btn-danger.active:hover,
.open > .dropdown-toggle.btn-danger:hover,
.btn-danger:active:focus,
.btn-danger.active:focus,
.open > .dropdown-toggle.btn-danger:focus,
.btn-danger:active.focus,
.btn-danger.active.focus,
.open > .dropdown-toggle.btn-danger.focus {
  color: #fff;
  background-color: #ac2925;
  border-color: #761c19;
}
.btn-danger:active,
.btn-danger.active,
.open > .dropdown-toggle.btn-danger {
  background-image: none;
}
.btn-danger.disabled:hover,
.btn-danger[disabled]:hover,
fieldset[disabled] .btn-danger:hover,
.btn-danger.disabled:focus,
.btn-danger[disabled]:focus,
fieldset[disabled] .btn-danger:focus,
.btn-danger.disabled.focus,
.btn-danger[disabled].focus,
fieldset[disabled] .btn-danger.focus {
  background-color: #d9534f;
  border-color: #d43f3a;
}
.btn-danger .badge {
  color: #d9534f;
  background-color: #fff;
}
.btn-link {
  color: #337ab7;
  font-weight: normal;
  border-radius: 0;
}
.btn-link,
.btn-link:active,
.btn-link.active,
.btn-link[disabled],
fieldset[disabled] .btn-link {
  background-color: transparent;
  -webkit-box-shadow: none;
  box-shadow: none;
}
.btn-link,
.btn-link:hover,
.btn-link:focus,
.btn-link:active {
  border-color: transparent;
}
.btn-link:hover,
.btn-link:focus {
  color: #23527c;
  text-decoration: underline;
  background-color: transparent;
}
.btn-link[disabled]:hover,
fieldset[disabled] .btn-link:hover,
.btn-link[disabled]:focus,
fieldset[disabled] .btn-link:focus {
  color: #777777;
  text-decoration: none;
}
.btn-lg,
.btn-group-lg > .btn {
  padding: 10px 16px;
  font-size: 17px;
  line-height: 1.3333333;
  border-radius: 3px;
}
.btn-sm,
.btn-group-sm > .btn {
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
}
.btn-xs,
.btn-group-xs > .btn {
  padding: 1px 5px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
}
.btn-block {
  display: block;
  width: 100%;
}
.btn-block + .btn-block {
  margin-top: 5px;
}
input[type="submit"].btn-block,
input[type="reset"].btn-block,
input[type="button"].btn-block {
  width: 100%;
}
.fade {
  opacity: 0;
  -webkit-transition: opacity 0.15s linear;
  -o-transition: opacity 0.15s linear;
  transition: opacity 0.15s linear;
}
.fade.in {
  opacity: 1;
}
.collapse {
  display: none;
}
.collapse.in {
  display: block;
}
tr.collapse.in {
  display: table-row;
}
tbody.collapse.in {
  display: table-row-group;
}
.collapsing {
  position: relative;
  height: 0;
  overflow: hidden;
  -webkit-transition-property: height, visibility;
  transition-property: height, visibility;
  -webkit-transition-duration: 0.35s;
  transition-duration: 0.35s;
  -webkit-transition-timing-function: ease;
  transition-timing-function: ease;
}
.caret {
  display: inline-block;
  width: 0;
  height: 0;
  margin-left: 2px;
  vertical-align: middle;
  border-top: 4px dashed;
  border-top: 4px solid \9;
  border-right: 4px solid transparent;
  border-left: 4px solid transparent;
}
.dropup,
.dropdown {
  position: relative;
}
.dropdown-toggle:focus {
  outline: 0;
}
.dropdown-menu {
  position: absolute;
  top: 100%;
  left: 0;
  z-index: 1000;
  display: none;
  float: left;
  min-width: 160px;
  padding: 5px 0;
  margin: 2px 0 0;
  list-style: none;
  font-size: 13px;
  text-align: left;
  background-color: #fff;
  border: 1px solid #ccc;
  border: 1px solid rgba(0, 0, 0, 0.15);
  border-radius: 2px;
  -webkit-box-shadow: 0 6px 12px rgba(0, 0, 0, 0.175);
  box-shadow: 0 6px 12px rgba(0, 0, 0, 0.175);
  background-clip: padding-box;
}
.dropdown-menu.pull-right {
  right: 0;
  left: auto;
}
.dropdown-menu .divider {
  height: 1px;
  margin: 8px 0;
  overflow: hidden;
  background-color: #e5e5e5;
}
.dropdown-menu > li > a {
  display: block;
  padding: 3px 20px;
  clear: both;
  font-weight: normal;
  line-height: 1.42857143;
  color: #333333;
  white-space: nowrap;
}
.dropdown-menu > li > a:hover,
.dropdown-menu > li > a:focus {
  text-decoration: none;
  color: #262626;
  background-color: #f5f5f5;
}
.dropdown-menu > .active > a,
.dropdown-menu > .active > a:hover,
.dropdown-menu > .active > a:focus {
  color: #fff;
  text-decoration: none;
  outline: 0;
  background-color: #337ab7;
}
.dropdown-menu > .disabled > a,
.dropdown-menu > .disabled > a:hover,
.dropdown-menu > .disabled > a:focus {
  color: #777777;
}
.dropdown-menu > .disabled > a:hover,
.dropdown-menu > .disabled > a:focus {
  text-decoration: none;
  background-color: transparent;
  background-image: none;
  filter: progid:DXImageTransform.Microsoft.gradient(enabled = false);
  cursor: not-allowed;
}
.open > .dropdown-menu {
  display: block;
}
.open > a {
  outline: 0;
}
.dropdown-menu-right {
  left: auto;
  right: 0;
}
.dropdown-menu-left {
  left: 0;
  right: auto;
}
.dropdown-header {
  display: block;
  padding: 3px 20px;
  font-size: 12px;
  line-height: 1.42857143;
  color: #777777;
  white-space: nowrap;
}
.dropdown-backdrop {
  position: fixed;
  left: 0;
  right: 0;
  bottom: 0;
  top: 0;
  z-index: 990;
}
.pull-right > .dropdown-menu {
  right: 0;
  left: auto;
}
.dropup .caret,
.navbar-fixed-bottom .dropdown .caret {
  border-top: 0;
  border-bottom: 4px dashed;
  border-bottom: 4px solid \9;
  content: "";
}
.dropup .dropdown-menu,
.navbar-fixed-bottom .dropdown .dropdown-menu {
  top: auto;
  bottom: 100%;
  margin-bottom: 2px;
}
@media (min-width: 541px) {
  .navbar-right .dropdown-menu {
    left: auto;
    right: 0;
  }
  .navbar-right .dropdown-menu-left {
    left: 0;
    right: auto;
  }
}
.btn-group,
.btn-group-vertical {
  position: relative;
  display: inline-block;
  vertical-align: middle;
}
.btn-group > .btn,
.btn-group-vertical > .btn {
  position: relative;
  float: left;
}
.btn-group > .btn:hover,
.btn-group-vertical > .btn:hover,
.btn-group > .btn:focus,
.btn-group-vertical > .btn:focus,
.btn-group > .btn:active,
.btn-group-vertical > .btn:active,
.btn-group > .btn.active,
.btn-group-vertical > .btn.active {
  z-index: 2;
}
.btn-group .btn + .btn,
.btn-group .btn + .btn-group,
.btn-group .btn-group + .btn,
.btn-group .btn-group + .btn-group {
  margin-left: -1px;
}
.btn-toolbar {
  margin-left: -5px;
}
.btn-toolbar .btn,
.btn-toolbar .btn-group,
.btn-toolbar .input-group {
  float: left;
}
.btn-toolbar > .btn,
.btn-toolbar > .btn-group,
.btn-toolbar > .input-group {
  margin-left: 5px;
}
.btn-group > .btn:not(:first-child):not(:last-child):not(.dropdown-toggle) {
  border-radius: 0;
}
.btn-group > .btn:first-child {
  margin-left: 0;
}
.btn-group > .btn:first-child:not(:last-child):not(.dropdown-toggle) {
  border-bottom-right-radius: 0;
  border-top-right-radius: 0;
}
.btn-group > .btn:last-child:not(:first-child),
.btn-group > .dropdown-toggle:not(:first-child) {
  border-bottom-left-radius: 0;
  border-top-left-radius: 0;
}
.btn-group > .btn-group {
  float: left;
}
.btn-group > .btn-group:not(:first-child):not(:last-child) > .btn {
  border-radius: 0;
}
.btn-group > .btn-group:first-child:not(:last-child) > .btn:last-child,
.btn-group > .btn-group:first-child:not(:last-child) > .dropdown-toggle {
  border-bottom-right-radius: 0;
  border-top-right-radius: 0;
}
.btn-group > .btn-group:last-child:not(:first-child) > .btn:first-child {
  border-bottom-left-radius: 0;
  border-top-left-radius: 0;
}
.btn-group .dropdown-toggle:active,
.btn-group.open .dropdown-toggle {
  outline: 0;
}
.btn-group > .btn + .dropdown-toggle {
  padding-left: 8px;
  padding-right: 8px;
}
.btn-group > .btn-lg + .dropdown-toggle {
  padding-left: 12px;
  padding-right: 12px;
}
.btn-group.open .dropdown-toggle {
  -webkit-box-shadow: inset 0 3px 5px rgba(0, 0, 0, 0.125);
  box-shadow: inset 0 3px 5px rgba(0, 0, 0, 0.125);
}
.btn-group.open .dropdown-toggle.btn-link {
  -webkit-box-shadow: none;
  box-shadow: none;
}
.btn .caret {
  margin-left: 0;
}
.btn-lg .caret {
  border-width: 5px 5px 0;
  border-bottom-width: 0;
}
.dropup .btn-lg .caret {
  border-width: 0 5px 5px;
}
.btn-group-vertical > .btn,
.btn-group-vertical > .btn-group,
.btn-group-vertical > .btn-group > .btn {
  display: block;
  float: none;
  width: 100%;
  max-width: 100%;
}
.btn-group-vertical > .btn-group > .btn {
  float: none;
}
.btn-group-vertical > .btn + .btn,
.btn-group-vertical > .btn + .btn-group,
.btn-group-vertical > .btn-group + .btn,
.btn-group-vertical > .btn-group + .btn-group {
  margin-top: -1px;
  margin-left: 0;
}
.btn-group-vertical > .btn:not(:first-child):not(:last-child) {
  border-radius: 0;
}
.btn-group-vertical > .btn:first-child:not(:last-child) {
  border-top-right-radius: 2px;
  border-top-left-radius: 2px;
  border-bottom-right-radius: 0;
  border-bottom-left-radius: 0;
}
.btn-group-vertical > .btn:last-child:not(:first-child) {
  border-top-right-radius: 0;
  border-top-left-radius: 0;
  border-bottom-right-radius: 2px;
  border-bottom-left-radius: 2px;
}
.btn-group-vertical > .btn-group:not(:first-child):not(:last-child) > .btn {
  border-radius: 0;
}
.btn-group-vertical > .btn-group:first-child:not(:last-child) > .btn:last-child,
.btn-group-vertical > .btn-group:first-child:not(:last-child) > .dropdown-toggle {
  border-bottom-right-radius: 0;
  border-bottom-left-radius: 0;
}
.btn-group-vertical > .btn-group:last-child:not(:first-child) > .btn:first-child {
  border-top-right-radius: 0;
  border-top-left-radius: 0;
}
.btn-group-justified {
  display: table;
  width: 100%;
  table-layout: fixed;
  border-collapse: separate;
}
.btn-group-justified > .btn,
.btn-group-justified > .btn-group {
  float: none;
  display: table-cell;
  width: 1%;
}
.btn-group-justified > .btn-group .btn {
  width: 100%;
}
.btn-group-justified > .btn-group .dropdown-menu {
  left: auto;
}
[data-toggle="buttons"] > .btn input[type="radio"],
[data-toggle="buttons"] > .btn-group > .btn input[type="radio"],
[data-toggle="buttons"] > .btn input[type="checkbox"],
[data-toggle="buttons"] > .btn-group > .btn input[type="checkbox"] {
  position: absolute;
  clip: rect(0, 0, 0, 0);
  pointer-events: none;
}
.input-group {
  position: relative;
  display: table;
  border-collapse: separate;
}
.input-group[class*="col-"] {
  float: none;
  padding-left: 0;
  padding-right: 0;
}
.input-group .form-control {
  position: relative;
  z-index: 2;
  float: left;
  width: 100%;
  margin-bottom: 0;
}
.input-group .form-control:focus {
  z-index: 3;
}
.input-group-lg > .form-control,
.input-group-lg > .input-group-addon,
.input-group-lg > .input-group-btn > .btn {
  height: 45px;
  padding: 10px 16px;
  font-size: 17px;
  line-height: 1.3333333;
  border-radius: 3px;
}
select.input-group-lg > .form-control,
select.input-group-lg > .input-group-addon,
select.input-group-lg > .input-group-btn > .btn {
  height: 45px;
  line-height: 45px;
}
textarea.input-group-lg > .form-control,
textarea.input-group-lg > .input-group-addon,
textarea.input-group-lg > .input-group-btn > .btn,
select[multiple].input-group-lg > .form-control,
select[multiple].input-group-lg > .input-group-addon,
select[multiple].input-group-lg > .input-group-btn > .btn {
  height: auto;
}
.input-group-sm > .form-control,
.input-group-sm > .input-group-addon,
.input-group-sm > .input-group-btn > .btn {
  height: 30px;
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
}
select.input-group-sm > .form-control,
select.input-group-sm > .input-group-addon,
select.input-group-sm > .input-group-btn > .btn {
  height: 30px;
  line-height: 30px;
}
textarea.input-group-sm > .form-control,
textarea.input-group-sm > .input-group-addon,
textarea.input-group-sm > .input-group-btn > .btn,
select[multiple].input-group-sm > .form-control,
select[multiple].input-group-sm > .input-group-addon,
select[multiple].input-group-sm > .input-group-btn > .btn {
  height: auto;
}
.input-group-addon,
.input-group-btn,
.input-group .form-control {
  display: table-cell;
}
.input-group-addon:not(:first-child):not(:last-child),
.input-group-btn:not(:first-child):not(:last-child),
.input-group .form-control:not(:first-child):not(:last-child) {
  border-radius: 0;
}
.input-group-addon,
.input-group-btn {
  width: 1%;
  white-space: nowrap;
  vertical-align: middle;
}
.input-group-addon {
  padding: 6px 12px;
  font-size: 13px;
  font-weight: normal;
  line-height: 1;
  color: #555555;
  text-align: center;
  background-color: #eeeeee;
  border: 1px solid #ccc;
  border-radius: 2px;
}
.input-group-addon.input-sm {
  padding: 5px 10px;
  font-size: 12px;
  border-radius: 1px;
}
.input-group-addon.input-lg {
  padding: 10px 16px;
  font-size: 17px;
  border-radius: 3px;
}
.input-group-addon input[type="radio"],
.input-group-addon input[type="checkbox"] {
  margin-top: 0;
}
.input-group .form-control:first-child,
.input-group-addon:first-child,
.input-group-btn:first-child > .btn,
.input-group-btn:first-child > .btn-group > .btn,
.input-group-btn:first-child > .dropdown-toggle,
.input-group-btn:last-child > .btn:not(:last-child):not(.dropdown-toggle),
.input-group-btn:last-child > .btn-group:not(:last-child) > .btn {
  border-bottom-right-radius: 0;
  border-top-right-radius: 0;
}
.input-group-addon:first-child {
  border-right: 0;
}
.input-group .form-control:last-child,
.input-group-addon:last-child,
.input-group-btn:last-child > .btn,
.input-group-btn:last-child > .btn-group > .btn,
.input-group-btn:last-child > .dropdown-toggle,
.input-group-btn:first-child > .btn:not(:first-child),
.input-group-btn:first-child > .btn-group:not(:first-child) > .btn {
  border-bottom-left-radius: 0;
  border-top-left-radius: 0;
}
.input-group-addon:last-child {
  border-left: 0;
}
.input-group-btn {
  position: relative;
  font-size: 0;
  white-space: nowrap;
}
.input-group-btn > .btn {
  position: relative;
}
.input-group-btn > .btn + .btn {
  margin-left: -1px;
}
.input-group-btn > .btn:hover,
.input-group-btn > .btn:focus,
.input-group-btn > .btn:active {
  z-index: 2;
}
.input-group-btn:first-child > .btn,
.input-group-btn:first-child > .btn-group {
  margin-right: -1px;
}
.input-group-btn:last-child > .btn,
.input-group-btn:last-child > .btn-group {
  z-index: 2;
  margin-left: -1px;
}
.nav {
  margin-bottom: 0;
  padding-left: 0;
  list-style: none;
}
.nav > li {
  position: relative;
  display: block;
}
.nav > li > a {
  position: relative;
  display: block;
  padding: 10px 15px;
}
.nav > li > a:hover,
.nav > li > a:focus {
  text-decoration: none;
  background-color: #eeeeee;
}
.nav > li.disabled > a {
  color: #777777;
}
.nav > li.disabled > a:hover,
.nav > li.disabled > a:focus {
  color: #777777;
  text-decoration: none;
  background-color: transparent;
  cursor: not-allowed;
}
.nav .open > a,
.nav .open > a:hover,
.nav .open > a:focus {
  background-color: #eeeeee;
  border-color: #337ab7;
}
.nav .nav-divider {
  height: 1px;
  margin: 8px 0;
  overflow: hidden;
  background-color: #e5e5e5;
}
.nav > li > a > img {
  max-width: none;
}
.nav-tabs {
  border-bottom: 1px solid #ddd;
}
.nav-tabs > li {
  float: left;
  margin-bottom: -1px;
}
.nav-tabs > li > a {
  margin-right: 2px;
  line-height: 1.42857143;
  border: 1px solid transparent;
  border-radius: 2px 2px 0 0;
}
.nav-tabs > li > a:hover {
  border-color: #eeeeee #eeeeee #ddd;
}
.nav-tabs > li.active > a,
.nav-tabs > li.active > a:hover,
.nav-tabs > li.active > a:focus {
  color: #555555;
  background-color: #fff;
  border: 1px solid #ddd;
  border-bottom-color: transparent;
  cursor: default;
}
.nav-tabs.nav-justified {
  width: 100%;
  border-bottom: 0;
}
.nav-tabs.nav-justified > li {
  float: none;
}
.nav-tabs.nav-justified > li > a {
  text-align: center;
  margin-bottom: 5px;
}
.nav-tabs.nav-justified > .dropdown .dropdown-menu {
  top: auto;
  left: auto;
}
@media (min-width: 768px) {
  .nav-tabs.nav-justified > li {
    display: table-cell;
    width: 1%;
  }
  .nav-tabs.nav-justified > li > a {
    margin-bottom: 0;
  }
}
.nav-tabs.nav-justified > li > a {
  margin-right: 0;
  border-radius: 2px;
}
.nav-tabs.nav-justified > .active > a,
.nav-tabs.nav-justified > .active > a:hover,
.nav-tabs.nav-justified > .active > a:focus {
  border: 1px solid #ddd;
}
@media (min-width: 768px) {
  .nav-tabs.nav-justified > li > a {
    border-bottom: 1px solid #ddd;
    border-radius: 2px 2px 0 0;
  }
  .nav-tabs.nav-justified > .active > a,
  .nav-tabs.nav-justified > .active > a:hover,
  .nav-tabs.nav-justified > .active > a:focus {
    border-bottom-color: #fff;
  }
}
.nav-pills > li {
  float: left;
}
.nav-pills > li > a {
  border-radius: 2px;
}
.nav-pills > li + li {
  margin-left: 2px;
}
.nav-pills > li.active > a,
.nav-pills > li.active > a:hover,
.nav-pills > li.active > a:focus {
  color: #fff;
  background-color: #337ab7;
}
.nav-stacked > li {
  float: none;
}
.nav-stacked > li + li {
  margin-top: 2px;
  margin-left: 0;
}
.nav-justified {
  width: 100%;
}
.nav-justified > li {
  float: none;
}
.nav-justified > li > a {
  text-align: center;
  margin-bottom: 5px;
}
.nav-justified > .dropdown .dropdown-menu {
  top: auto;
  left: auto;
}
@media (min-width: 768px) {
  .nav-justified > li {
    display: table-cell;
    width: 1%;
  }
  .nav-justified > li > a {
    margin-bottom: 0;
  }
}
.nav-tabs-justified {
  border-bottom: 0;
}
.nav-tabs-justified > li > a {
  margin-right: 0;
  border-radius: 2px;
}
.nav-tabs-justified > .active > a,
.nav-tabs-justified > .active > a:hover,
.nav-tabs-justified > .active > a:focus {
  border: 1px solid #ddd;
}
@media (min-width: 768px) {
  .nav-tabs-justified > li > a {
    border-bottom: 1px solid #ddd;
    border-radius: 2px 2px 0 0;
  }
  .nav-tabs-justified > .active > a,
  .nav-tabs-justified > .active > a:hover,
  .nav-tabs-justified > .active > a:focus {
    border-bottom-color: #fff;
  }
}
.tab-content > .tab-pane {
  display: none;
}
.tab-content > .active {
  display: block;
}
.nav-tabs .dropdown-menu {
  margin-top: -1px;
  border-top-right-radius: 0;
  border-top-left-radius: 0;
}
.navbar {
  position: relative;
  min-height: 30px;
  margin-bottom: 18px;
  border: 1px solid transparent;
}
@media (min-width: 541px) {
  .navbar {
    border-radius: 2px;
  }
}
@media (min-width: 541px) {
  .navbar-header {
    float: left;
  }
}
.navbar-collapse {
  overflow-x: visible;
  padding-right: 0px;
  padding-left: 0px;
  border-top: 1px solid transparent;
  box-shadow: inset 0 1px 0 rgba(255, 255, 255, 0.1);
  -webkit-overflow-scrolling: touch;
}
.navbar-collapse.in {
  overflow-y: auto;
}
@media (min-width: 541px) {
  .navbar-collapse {
    width: auto;
    border-top: 0;
    box-shadow: none;
  }
  .navbar-collapse.collapse {
    display: block !important;
    height: auto !important;
    padding-bottom: 0;
    overflow: visible !important;
  }
  .navbar-collapse.in {
    overflow-y: visible;
  }
  .navbar-fixed-top .navbar-collapse,
  .navbar-static-top .navbar-collapse,
  .navbar-fixed-bottom .navbar-collapse {
    padding-left: 0;
    padding-right: 0;
  }
}
.navbar-fixed-top .navbar-collapse,
.navbar-fixed-bottom .navbar-collapse {
  max-height: 340px;
}
@media (max-device-width: 540px) and (orientation: landscape) {
  .navbar-fixed-top .navbar-collapse,
  .navbar-fixed-bottom .navbar-collapse {
    max-height: 200px;
  }
}
.container > .navbar-header,
.container-fluid > .navbar-header,
.container > .navbar-collapse,
.container-fluid > .navbar-collapse {
  margin-right: 0px;
  margin-left: 0px;
}
@media (min-width: 541px) {
  .container > .navbar-header,
  .container-fluid > .navbar-header,
  .container > .navbar-collapse,
  .container-fluid > .navbar-collapse {
    margin-right: 0;
    margin-left: 0;
  }
}
.navbar-static-top {
  z-index: 1000;
  border-width: 0 0 1px;
}
@media (min-width: 541px) {
  .navbar-static-top {
    border-radius: 0;
  }
}
.navbar-fixed-top,
.navbar-fixed-bottom {
  position: fixed;
  right: 0;
  left: 0;
  z-index: 1030;
}
@media (min-width: 541px) {
  .navbar-fixed-top,
  .navbar-fixed-bottom {
    border-radius: 0;
  }
}
.navbar-fixed-top {
  top: 0;
  border-width: 0 0 1px;
}
.navbar-fixed-bottom {
  bottom: 0;
  margin-bottom: 0;
  border-width: 1px 0 0;
}
.navbar-brand {
  float: left;
  padding: 6px 0px;
  font-size: 17px;
  line-height: 18px;
  height: 30px;
}
.navbar-brand:hover,
.navbar-brand:focus {
  text-decoration: none;
}
.navbar-brand > img {
  display: block;
}
@media (min-width: 541px) {
  .navbar > .container .navbar-brand,
  .navbar > .container-fluid .navbar-brand {
    margin-left: 0px;
  }
}
.navbar-toggle {
  position: relative;
  float: right;
  margin-right: 0px;
  padding: 9px 10px;
  margin-top: -2px;
  margin-bottom: -2px;
  background-color: transparent;
  background-image: none;
  border: 1px solid transparent;
  border-radius: 2px;
}
.navbar-toggle:focus {
  outline: 0;
}
.navbar-toggle .icon-bar {
  display: block;
  width: 22px;
  height: 2px;
  border-radius: 1px;
}
.navbar-toggle .icon-bar + .icon-bar {
  margin-top: 4px;
}
@media (min-width: 541px) {
  .navbar-toggle {
    display: none;
  }
}
.navbar-nav {
  margin: 3px 0px;
}
.navbar-nav > li > a {
  padding-top: 10px;
  padding-bottom: 10px;
  line-height: 18px;
}
@media (max-width: 540px) {
  .navbar-nav .open .dropdown-menu {
    position: static;
    float: none;
    width: auto;
    margin-top: 0;
    background-color: transparent;
    border: 0;
    box-shadow: none;
  }
  .navbar-nav .open .dropdown-menu > li > a,
  .navbar-nav .open .dropdown-menu .dropdown-header {
    padding: 5px 15px 5px 25px;
  }
  .navbar-nav .open .dropdown-menu > li > a {
    line-height: 18px;
  }
  .navbar-nav .open .dropdown-menu > li > a:hover,
  .navbar-nav .open .dropdown-menu > li > a:focus {
    background-image: none;
  }
}
@media (min-width: 541px) {
  .navbar-nav {
    float: left;
    margin: 0;
  }
  .navbar-nav > li {
    float: left;
  }
  .navbar-nav > li > a {
    padding-top: 6px;
    padding-bottom: 6px;
  }
}
.navbar-form {
  margin-left: 0px;
  margin-right: 0px;
  padding: 10px 0px;
  border-top: 1px solid transparent;
  border-bottom: 1px solid transparent;
  -webkit-box-shadow: inset 0 1px 0 rgba(255, 255, 255, 0.1), 0 1px 0 rgba(255, 255, 255, 0.1);
  box-shadow: inset 0 1px 0 rgba(255, 255, 255, 0.1), 0 1px 0 rgba(255, 255, 255, 0.1);
  margin-top: -1px;
  margin-bottom: -1px;
}
@media (min-width: 768px) {
  .navbar-form .form-group {
    display: inline-block;
    margin-bottom: 0;
    vertical-align: middle;
  }
  .navbar-form .form-control {
    display: inline-block;
    width: auto;
    vertical-align: middle;
  }
  .navbar-form .form-control-static {
    display: inline-block;
  }
  .navbar-form .input-group {
    display: inline-table;
    vertical-align: middle;
  }
  .navbar-form .input-group .input-group-addon,
  .navbar-form .input-group .input-group-btn,
  .navbar-form .input-group .form-control {
    width: auto;
  }
  .navbar-form .input-group > .form-control {
    width: 100%;
  }
  .navbar-form .control-label {
    margin-bottom: 0;
    vertical-align: middle;
  }
  .navbar-form .radio,
  .navbar-form .checkbox {
    display: inline-block;
    margin-top: 0;
    margin-bottom: 0;
    vertical-align: middle;
  }
  .navbar-form .radio label,
  .navbar-form .checkbox label {
    padding-left: 0;
  }
  .navbar-form .radio input[type="radio"],
  .navbar-form .checkbox input[type="checkbox"] {
    position: relative;
    margin-left: 0;
  }
  .navbar-form .has-feedback .form-control-feedback {
    top: 0;
  }
}
@media (max-width: 540px) {
  .navbar-form .form-group {
    margin-bottom: 5px;
  }
  .navbar-form .form-group:last-child {
    margin-bottom: 0;
  }
}
@media (min-width: 541px) {
  .navbar-form {
    width: auto;
    border: 0;
    margin-left: 0;
    margin-right: 0;
    padding-top: 0;
    padding-bottom: 0;
    -webkit-box-shadow: none;
    box-shadow: none;
  }
}
.navbar-nav > li > .dropdown-menu {
  margin-top: 0;
  border-top-right-radius: 0;
  border-top-left-radius: 0;
}
.navbar-fixed-bottom .navbar-nav > li > .dropdown-menu {
  margin-bottom: 0;
  border-top-right-radius: 2px;
  border-top-left-radius: 2px;
  border-bottom-right-radius: 0;
  border-bottom-left-radius: 0;
}
.navbar-btn {
  margin-top: -1px;
  margin-bottom: -1px;
}
.navbar-btn.btn-sm {
  margin-top: 0px;
  margin-bottom: 0px;
}
.navbar-btn.btn-xs {
  margin-top: 4px;
  margin-bottom: 4px;
}
.navbar-text {
  margin-top: 6px;
  margin-bottom: 6px;
}
@media (min-width: 541px) {
  .navbar-text {
    float: left;
    margin-left: 0px;
    margin-right: 0px;
  }
}
@media (min-width: 541px) {
  .navbar-left {
    float: left !important;
    float: left;
  }
  .navbar-right {
    float: right !important;
    float: right;
    margin-right: 0px;
  }
  .navbar-right ~ .navbar-right {
    margin-right: 0;
  }
}
.navbar-default {
  background-color: #f8f8f8;
  border-color: #e7e7e7;
}
.navbar-default .navbar-brand {
  color: #777;
}
.navbar-default .navbar-brand:hover,
.navbar-default .navbar-brand:focus {
  color: #5e5e5e;
  background-color: transparent;
}
.navbar-default .navbar-text {
  color: #777;
}
.navbar-default .navbar-nav > li > a {
  color: #777;
}
.navbar-default .navbar-nav > li > a:hover,
.navbar-default .navbar-nav > li > a:focus {
  color: #333;
  background-color: transparent;
}
.navbar-default .navbar-nav > .active > a,
.navbar-default .navbar-nav > .active > a:hover,
.navbar-default .navbar-nav > .active > a:focus {
  color: #555;
  background-color: #e7e7e7;
}
.navbar-default .navbar-nav > .disabled > a,
.navbar-default .navbar-nav > .disabled > a:hover,
.navbar-default .navbar-nav > .disabled > a:focus {
  color: #ccc;
  background-color: transparent;
}
.navbar-default .navbar-toggle {
  border-color: #ddd;
}
.navbar-default .navbar-toggle:hover,
.navbar-default .navbar-toggle:focus {
  background-color: #ddd;
}
.navbar-default .navbar-toggle .icon-bar {
  background-color: #888;
}
.navbar-default .navbar-collapse,
.navbar-default .navbar-form {
  border-color: #e7e7e7;
}
.navbar-default .navbar-nav > .open > a,
.navbar-default .navbar-nav > .open > a:hover,
.navbar-default .navbar-nav > .open > a:focus {
  background-color: #e7e7e7;
  color: #555;
}
@media (max-width: 540px) {
  .navbar-default .navbar-nav .open .dropdown-menu > li > a {
    color: #777;
  }
  .navbar-default .navbar-nav .open .dropdown-menu > li > a:hover,
  .navbar-default .navbar-nav .open .dropdown-menu > li > a:focus {
    color: #333;
    background-color: transparent;
  }
  .navbar-default .navbar-nav .open .dropdown-menu > .active > a,
  .navbar-default .navbar-nav .open .dropdown-menu > .active > a:hover,
  .navbar-default .navbar-nav .open .dropdown-menu > .active > a:focus {
    color: #555;
    background-color: #e7e7e7;
  }
  .navbar-default .navbar-nav .open .dropdown-menu > .disabled > a,
  .navbar-default .navbar-nav .open .dropdown-menu > .disabled > a:hover,
  .navbar-default .navbar-nav .open .dropdown-menu > .disabled > a:focus {
    color: #ccc;
    background-color: transparent;
  }
}
.navbar-default .navbar-link {
  color: #777;
}
.navbar-default .navbar-link:hover {
  color: #333;
}
.navbar-default .btn-link {
  color: #777;
}
.navbar-default .btn-link:hover,
.navbar-default .btn-link:focus {
  color: #333;
}
.navbar-default .btn-link[disabled]:hover,
fieldset[disabled] .navbar-default .btn-link:hover,
.navbar-default .btn-link[disabled]:focus,
fieldset[disabled] .navbar-default .btn-link:focus {
  color: #ccc;
}
.navbar-inverse {
  background-color: #222;
  border-color: #080808;
}
.navbar-inverse .navbar-brand {
  color: #9d9d9d;
}
.navbar-inverse .navbar-brand:hover,
.navbar-inverse .navbar-brand:focus {
  color: #fff;
  background-color: transparent;
}
.navbar-inverse .navbar-text {
  color: #9d9d9d;
}
.navbar-inverse .navbar-nav > li > a {
  color: #9d9d9d;
}
.navbar-inverse .navbar-nav > li > a:hover,
.navbar-inverse .navbar-nav > li > a:focus {
  color: #fff;
  background-color: transparent;
}
.navbar-inverse .navbar-nav > .active > a,
.navbar-inverse .navbar-nav > .active > a:hover,
.navbar-inverse .navbar-nav > .active > a:focus {
  color: #fff;
  background-color: #080808;
}
.navbar-inverse .navbar-nav > .disabled > a,
.navbar-inverse .navbar-nav > .disabled > a:hover,
.navbar-inverse .navbar-nav > .disabled > a:focus {
  color: #444;
  background-color: transparent;
}
.navbar-inverse .navbar-toggle {
  border-color: #333;
}
.navbar-inverse .navbar-toggle:hover,
.navbar-inverse .navbar-toggle:focus {
  background-color: #333;
}
.navbar-inverse .navbar-toggle .icon-bar {
  background-color: #fff;
}
.navbar-inverse .navbar-collapse,
.navbar-inverse .navbar-form {
  border-color: #101010;
}
.navbar-inverse .navbar-nav > .open > a,
.navbar-inverse .navbar-nav > .open > a:hover,
.navbar-inverse .navbar-nav > .open > a:focus {
  background-color: #080808;
  color: #fff;
}
@media (max-width: 540px) {
  .navbar-inverse .navbar-nav .open .dropdown-menu > .dropdown-header {
    border-color: #080808;
  }
  .navbar-inverse .navbar-nav .open .dropdown-menu .divider {
    background-color: #080808;
  }
  .navbar-inverse .navbar-nav .open .dropdown-menu > li > a {
    color: #9d9d9d;
  }
  .navbar-inverse .navbar-nav .open .dropdown-menu > li > a:hover,
  .navbar-inverse .navbar-nav .open .dropdown-menu > li > a:focus {
    color: #fff;
    background-color: transparent;
  }
  .navbar-inverse .navbar-nav .open .dropdown-menu > .active > a,
  .navbar-inverse .navbar-nav .open .dropdown-menu > .active > a:hover,
  .navbar-inverse .navbar-nav .open .dropdown-menu > .active > a:focus {
    color: #fff;
    background-color: #080808;
  }
  .navbar-inverse .navbar-nav .open .dropdown-menu > .disabled > a,
  .navbar-inverse .navbar-nav .open .dropdown-menu > .disabled > a:hover,
  .navbar-inverse .navbar-nav .open .dropdown-menu > .disabled > a:focus {
    color: #444;
    background-color: transparent;
  }
}
.navbar-inverse .navbar-link {
  color: #9d9d9d;
}
.navbar-inverse .navbar-link:hover {
  color: #fff;
}
.navbar-inverse .btn-link {
  color: #9d9d9d;
}
.navbar-inverse .btn-link:hover,
.navbar-inverse .btn-link:focus {
  color: #fff;
}
.navbar-inverse .btn-link[disabled]:hover,
fieldset[disabled] .navbar-inverse .btn-link:hover,
.navbar-inverse .btn-link[disabled]:focus,
fieldset[disabled] .navbar-inverse .btn-link:focus {
  color: #444;
}
.breadcrumb {
  padding: 8px 15px;
  margin-bottom: 18px;
  list-style: none;
  background-color: #f5f5f5;
  border-radius: 2px;
}
.breadcrumb > li {
  display: inline-block;
}
.breadcrumb > li + li:before {
  content: "/\00a0";
  padding: 0 5px;
  color: #5e5e5e;
}
.breadcrumb > .active {
  color: #777777;
}
.pagination {
  display: inline-block;
  padding-left: 0;
  margin: 18px 0;
  border-radius: 2px;
}
.pagination > li {
  display: inline;
}
.pagination > li > a,
.pagination > li > span {
  position: relative;
  float: left;
  padding: 6px 12px;
  line-height: 1.42857143;
  text-decoration: none;
  color: #337ab7;
  background-color: #fff;
  border: 1px solid #ddd;
  margin-left: -1px;
}
.pagination > li:first-child > a,
.pagination > li:first-child > span {
  margin-left: 0;
  border-bottom-left-radius: 2px;
  border-top-left-radius: 2px;
}
.pagination > li:last-child > a,
.pagination > li:last-child > span {
  border-bottom-right-radius: 2px;
  border-top-right-radius: 2px;
}
.pagination > li > a:hover,
.pagination > li > span:hover,
.pagination > li > a:focus,
.pagination > li > span:focus {
  z-index: 2;
  color: #23527c;
  background-color: #eeeeee;
  border-color: #ddd;
}
.pagination > .active > a,
.pagination > .active > span,
.pagination > .active > a:hover,
.pagination > .active > span:hover,
.pagination > .active > a:focus,
.pagination > .active > span:focus {
  z-index: 3;
  color: #fff;
  background-color: #337ab7;
  border-color: #337ab7;
  cursor: default;
}
.pagination > .disabled > span,
.pagination > .disabled > span:hover,
.pagination > .disabled > span:focus,
.pagination > .disabled > a,
.pagination > .disabled > a:hover,
.pagination > .disabled > a:focus {
  color: #777777;
  background-color: #fff;
  border-color: #ddd;
  cursor: not-allowed;
}
.pagination-lg > li > a,
.pagination-lg > li > span {
  padding: 10px 16px;
  font-size: 17px;
  line-height: 1.3333333;
}
.pagination-lg > li:first-child > a,
.pagination-lg > li:first-child > span {
  border-bottom-left-radius: 3px;
  border-top-left-radius: 3px;
}
.pagination-lg > li:last-child > a,
.pagination-lg > li:last-child > span {
  border-bottom-right-radius: 3px;
  border-top-right-radius: 3px;
}
.pagination-sm > li > a,
.pagination-sm > li > span {
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
}
.pagination-sm > li:first-child > a,
.pagination-sm > li:first-child > span {
  border-bottom-left-radius: 1px;
  border-top-left-radius: 1px;
}
.pagination-sm > li:last-child > a,
.pagination-sm > li:last-child > span {
  border-bottom-right-radius: 1px;
  border-top-right-radius: 1px;
}
.pager {
  padding-left: 0;
  margin: 18px 0;
  list-style: none;
  text-align: center;
}
.pager li {
  display: inline;
}
.pager li > a,
.pager li > span {
  display: inline-block;
  padding: 5px 14px;
  background-color: #fff;
  border: 1px solid #ddd;
  border-radius: 15px;
}
.pager li > a:hover,
.pager li > a:focus {
  text-decoration: none;
  background-color: #eeeeee;
}
.pager .next > a,
.pager .next > span {
  float: right;
}
.pager .previous > a,
.pager .previous > span {
  float: left;
}
.pager .disabled > a,
.pager .disabled > a:hover,
.pager .disabled > a:focus,
.pager .disabled > span {
  color: #777777;
  background-color: #fff;
  cursor: not-allowed;
}
.label {
  display: inline;
  padding: .2em .6em .3em;
  font-size: 75%;
  font-weight: bold;
  line-height: 1;
  color: #fff;
  text-align: center;
  white-space: nowrap;
  vertical-align: baseline;
  border-radius: .25em;
}
a.label:hover,
a.label:focus {
  color: #fff;
  text-decoration: none;
  cursor: pointer;
}
.label:empty {
  display: none;
}
.btn .label {
  position: relative;
  top: -1px;
}
.label-default {
  background-color: #777777;
}
.label-default[href]:hover,
.label-default[href]:focus {
  background-color: #5e5e5e;
}
.label-primary {
  background-color: #337ab7;
}
.label-primary[href]:hover,
.label-primary[href]:focus {
  background-color: #286090;
}
.label-success {
  background-color: #5cb85c;
}
.label-success[href]:hover,
.label-success[href]:focus {
  background-color: #449d44;
}
.label-info {
  background-color: #5bc0de;
}
.label-info[href]:hover,
.label-info[href]:focus {
  background-color: #31b0d5;
}
.label-warning {
  background-color: #f0ad4e;
}
.label-warning[href]:hover,
.label-warning[href]:focus {
  background-color: #ec971f;
}
.label-danger {
  background-color: #d9534f;
}
.label-danger[href]:hover,
.label-danger[href]:focus {
  background-color: #c9302c;
}
.badge {
  display: inline-block;
  min-width: 10px;
  padding: 3px 7px;
  font-size: 12px;
  font-weight: bold;
  color: #fff;
  line-height: 1;
  vertical-align: middle;
  white-space: nowrap;
  text-align: center;
  background-color: #777777;
  border-radius: 10px;
}
.badge:empty {
  display: none;
}
.btn .badge {
  position: relative;
  top: -1px;
}
.btn-xs .badge,
.btn-group-xs > .btn .badge {
  top: 0;
  padding: 1px 5px;
}
a.badge:hover,
a.badge:focus {
  color: #fff;
  text-decoration: none;
  cursor: pointer;
}
.list-group-item.active > .badge,
.nav-pills > .active > a > .badge {
  color: #337ab7;
  background-color: #fff;
}
.list-group-item > .badge {
  float: right;
}
.list-group-item > .badge + .badge {
  margin-right: 5px;
}
.nav-pills > li > a > .badge {
  margin-left: 3px;
}
.jumbotron {
  padding-top: 30px;
  padding-bottom: 30px;
  margin-bottom: 30px;
  color: inherit;
  background-color: #eeeeee;
}
.jumbotron h1,
.jumbotron .h1 {
  color: inherit;
}
.jumbotron p {
  margin-bottom: 15px;
  font-size: 20px;
  font-weight: 200;
}
.jumbotron > hr {
  border-top-color: #d5d5d5;
}
.container .jumbotron,
.container-fluid .jumbotron {
  border-radius: 3px;
  padding-left: 0px;
  padding-right: 0px;
}
.jumbotron .container {
  max-width: 100%;
}
@media screen and (min-width: 768px) {
  .jumbotron {
    padding-top: 48px;
    padding-bottom: 48px;
  }
  .container .jumbotron,
  .container-fluid .jumbotron {
    padding-left: 60px;
    padding-right: 60px;
  }
  .jumbotron h1,
  .jumbotron .h1 {
    font-size: 59px;
  }
}
.thumbnail {
  display: block;
  padding: 4px;
  margin-bottom: 18px;
  line-height: 1.42857143;
  background-color: #fff;
  border: 1px solid #ddd;
  border-radius: 2px;
  -webkit-transition: border 0.2s ease-in-out;
  -o-transition: border 0.2s ease-in-out;
  transition: border 0.2s ease-in-out;
}
.thumbnail > img,
.thumbnail a > img {
  margin-left: auto;
  margin-right: auto;
}
a.thumbnail:hover,
a.thumbnail:focus,
a.thumbnail.active {
  border-color: #337ab7;
}
.thumbnail .caption {
  padding: 9px;
  color: #000;
}
.alert {
  padding: 15px;
  margin-bottom: 18px;
  border: 1px solid transparent;
  border-radius: 2px;
}
.alert h4 {
  margin-top: 0;
  color: inherit;
}
.alert .alert-link {
  font-weight: bold;
}
.alert > p,
.alert > ul {
  margin-bottom: 0;
}
.alert > p + p {
  margin-top: 5px;
}
.alert-dismissable,
.alert-dismissible {
  padding-right: 35px;
}
.alert-dismissable .close,
.alert-dismissible .close {
  position: relative;
  top: -2px;
  right: -21px;
  color: inherit;
}
.alert-success {
  background-color: #dff0d8;
  border-color: #d6e9c6;
  color: #3c763d;
}
.alert-success hr {
  border-top-color: #c9e2b3;
}
.alert-success .alert-link {
  color: #2b542c;
}
.alert-info {
  background-color: #d9edf7;
  border-color: #bce8f1;
  color: #31708f;
}
.alert-info hr {
  border-top-color: #a6e1ec;
}
.alert-info .alert-link {
  color: #245269;
}
.alert-warning {
  background-color: #fcf8e3;
  border-color: #faebcc;
  color: #8a6d3b;
}
.alert-warning hr {
  border-top-color: #f7e1b5;
}
.alert-warning .alert-link {
  color: #66512c;
}
.alert-danger {
  background-color: #f2dede;
  border-color: #ebccd1;
  color: #a94442;
}
.alert-danger hr {
  border-top-color: #e4b9c0;
}
.alert-danger .alert-link {
  color: #843534;
}
@-webkit-keyframes progress-bar-stripes {
  from {
    background-position: 40px 0;
  }
  to {
    background-position: 0 0;
  }
}
@keyframes progress-bar-stripes {
  from {
    background-position: 40px 0;
  }
  to {
    background-position: 0 0;
  }
}
.progress {
  overflow: hidden;
  height: 18px;
  margin-bottom: 18px;
  background-color: #f5f5f5;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 1px 2px rgba(0, 0, 0, 0.1);
  box-shadow: inset 0 1px 2px rgba(0, 0, 0, 0.1);
}
.progress-bar {
  float: left;
  width: 0%;
  height: 100%;
  font-size: 12px;
  line-height: 18px;
  color: #fff;
  text-align: center;
  background-color: #337ab7;
  -webkit-box-shadow: inset 0 -1px 0 rgba(0, 0, 0, 0.15);
  box-shadow: inset 0 -1px 0 rgba(0, 0, 0, 0.15);
  -webkit-transition: width 0.6s ease;
  -o-transition: width 0.6s ease;
  transition: width 0.6s ease;
}
.progress-striped .progress-bar,
.progress-bar-striped {
  background-image: -webkit-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: -o-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-size: 40px 40px;
}
.progress.active .progress-bar,
.progress-bar.active {
  -webkit-animation: progress-bar-stripes 2s linear infinite;
  -o-animation: progress-bar-stripes 2s linear infinite;
  animation: progress-bar-stripes 2s linear infinite;
}
.progress-bar-success {
  background-color: #5cb85c;
}
.progress-striped .progress-bar-success {
  background-image: -webkit-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: -o-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
}
.progress-bar-info {
  background-color: #5bc0de;
}
.progress-striped .progress-bar-info {
  background-image: -webkit-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: -o-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
}
.progress-bar-warning {
  background-color: #f0ad4e;
}
.progress-striped .progress-bar-warning {
  background-image: -webkit-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: -o-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
}
.progress-bar-danger {
  background-color: #d9534f;
}
.progress-striped .progress-bar-danger {
  background-image: -webkit-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: -o-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
}
.media {
  margin-top: 15px;
}
.media:first-child {
  margin-top: 0;
}
.media,
.media-body {
  zoom: 1;
  overflow: hidden;
}
.media-body {
  width: 10000px;
}
.media-object {
  display: block;
}
.media-object.img-thumbnail {
  max-width: none;
}
.media-right,
.media > .pull-right {
  padding-left: 10px;
}
.media-left,
.media > .pull-left {
  padding-right: 10px;
}
.media-left,
.media-right,
.media-body {
  display: table-cell;
  vertical-align: top;
}
.media-middle {
  vertical-align: middle;
}
.media-bottom {
  vertical-align: bottom;
}
.media-heading {
  margin-top: 0;
  margin-bottom: 5px;
}
.media-list {
  padding-left: 0;
  list-style: none;
}
.list-group {
  margin-bottom: 20px;
  padding-left: 0;
}
.list-group-item {
  position: relative;
  display: block;
  padding: 10px 15px;
  margin-bottom: -1px;
  background-color: #fff;
  border: 1px solid #ddd;
}
.list-group-item:first-child {
  border-top-right-radius: 2px;
  border-top-left-radius: 2px;
}
.list-group-item:last-child {
  margin-bottom: 0;
  border-bottom-right-radius: 2px;
  border-bottom-left-radius: 2px;
}
a.list-group-item,
button.list-group-item {
  color: #555;
}
a.list-group-item .list-group-item-heading,
button.list-group-item .list-group-item-heading {
  color: #333;
}
a.list-group-item:hover,
button.list-group-item:hover,
a.list-group-item:focus,
button.list-group-item:focus {
  text-decoration: none;
  color: #555;
  background-color: #f5f5f5;
}
button.list-group-item {
  width: 100%;
  text-align: left;
}
.list-group-item.disabled,
.list-group-item.disabled:hover,
.list-group-item.disabled:focus {
  background-color: #eeeeee;
  color: #777777;
  cursor: not-allowed;
}
.list-group-item.disabled .list-group-item-heading,
.list-group-item.disabled:hover .list-group-item-heading,
.list-group-item.disabled:focus .list-group-item-heading {
  color: inherit;
}
.list-group-item.disabled .list-group-item-text,
.list-group-item.disabled:hover .list-group-item-text,
.list-group-item.disabled:focus .list-group-item-text {
  color: #777777;
}
.list-group-item.active,
.list-group-item.active:hover,
.list-group-item.active:focus {
  z-index: 2;
  color: #fff;
  background-color: #337ab7;
  border-color: #337ab7;
}
.list-group-item.active .list-group-item-heading,
.list-group-item.active:hover .list-group-item-heading,
.list-group-item.active:focus .list-group-item-heading,
.list-group-item.active .list-group-item-heading > small,
.list-group-item.active:hover .list-group-item-heading > small,
.list-group-item.active:focus .list-group-item-heading > small,
.list-group-item.active .list-group-item-heading > .small,
.list-group-item.active:hover .list-group-item-heading > .small,
.list-group-item.active:focus .list-group-item-heading > .small {
  color: inherit;
}
.list-group-item.active .list-group-item-text,
.list-group-item.active:hover .list-group-item-text,
.list-group-item.active:focus .list-group-item-text {
  color: #c7ddef;
}
.list-group-item-success {
  color: #3c763d;
  background-color: #dff0d8;
}
a.list-group-item-success,
button.list-group-item-success {
  color: #3c763d;
}
a.list-group-item-success .list-group-item-heading,
button.list-group-item-success .list-group-item-heading {
  color: inherit;
}
a.list-group-item-success:hover,
button.list-group-item-success:hover,
a.list-group-item-success:focus,
button.list-group-item-success:focus {
  color: #3c763d;
  background-color: #d0e9c6;
}
a.list-group-item-success.active,
button.list-group-item-success.active,
a.list-group-item-success.active:hover,
button.list-group-item-success.active:hover,
a.list-group-item-success.active:focus,
button.list-group-item-success.active:focus {
  color: #fff;
  background-color: #3c763d;
  border-color: #3c763d;
}
.list-group-item-info {
  color: #31708f;
  background-color: #d9edf7;
}
a.list-group-item-info,
button.list-group-item-info {
  color: #31708f;
}
a.list-group-item-info .list-group-item-heading,
button.list-group-item-info .list-group-item-heading {
  color: inherit;
}
a.list-group-item-info:hover,
button.list-group-item-info:hover,
a.list-group-item-info:focus,
button.list-group-item-info:focus {
  color: #31708f;
  background-color: #c4e3f3;
}
a.list-group-item-info.active,
button.list-group-item-info.active,
a.list-group-item-info.active:hover,
button.list-group-item-info.active:hover,
a.list-group-item-info.active:focus,
button.list-group-item-info.active:focus {
  color: #fff;
  background-color: #31708f;
  border-color: #31708f;
}
.list-group-item-warning {
  color: #8a6d3b;
  background-color: #fcf8e3;
}
a.list-group-item-warning,
button.list-group-item-warning {
  color: #8a6d3b;
}
a.list-group-item-warning .list-group-item-heading,
button.list-group-item-warning .list-group-item-heading {
  color: inherit;
}
a.list-group-item-warning:hover,
button.list-group-item-warning:hover,
a.list-group-item-warning:focus,
button.list-group-item-warning:focus {
  color: #8a6d3b;
  background-color: #faf2cc;
}
a.list-group-item-warning.active,
button.list-group-item-warning.active,
a.list-group-item-warning.active:hover,
button.list-group-item-warning.active:hover,
a.list-group-item-warning.active:focus,
button.list-group-item-warning.active:focus {
  color: #fff;
  background-color: #8a6d3b;
  border-color: #8a6d3b;
}
.list-group-item-danger {
  color: #a94442;
  background-color: #f2dede;
}
a.list-group-item-danger,
button.list-group-item-danger {
  color: #a94442;
}
a.list-group-item-danger .list-group-item-heading,
button.list-group-item-danger .list-group-item-heading {
  color: inherit;
}
a.list-group-item-danger:hover,
button.list-group-item-danger:hover,
a.list-group-item-danger:focus,
button.list-group-item-danger:focus {
  color: #a94442;
  background-color: #ebcccc;
}
a.list-group-item-danger.active,
button.list-group-item-danger.active,
a.list-group-item-danger.active:hover,
button.list-group-item-danger.active:hover,
a.list-group-item-danger.active:focus,
button.list-group-item-danger.active:focus {
  color: #fff;
  background-color: #a94442;
  border-color: #a94442;
}
.list-group-item-heading {
  margin-top: 0;
  margin-bottom: 5px;
}
.list-group-item-text {
  margin-bottom: 0;
  line-height: 1.3;
}
.panel {
  margin-bottom: 18px;
  background-color: #fff;
  border: 1px solid transparent;
  border-radius: 2px;
  -webkit-box-shadow: 0 1px 1px rgba(0, 0, 0, 0.05);
  box-shadow: 0 1px 1px rgba(0, 0, 0, 0.05);
}
.panel-body {
  padding: 15px;
}
.panel-heading {
  padding: 10px 15px;
  border-bottom: 1px solid transparent;
  border-top-right-radius: 1px;
  border-top-left-radius: 1px;
}
.panel-heading > .dropdown .dropdown-toggle {
  color: inherit;
}
.panel-title {
  margin-top: 0;
  margin-bottom: 0;
  font-size: 15px;
  color: inherit;
}
.panel-title > a,
.panel-title > small,
.panel-title > .small,
.panel-title > small > a,
.panel-title > .small > a {
  color: inherit;
}
.panel-footer {
  padding: 10px 15px;
  background-color: #f5f5f5;
  border-top: 1px solid #ddd;
  border-bottom-right-radius: 1px;
  border-bottom-left-radius: 1px;
}
.panel > .list-group,
.panel > .panel-collapse > .list-group {
  margin-bottom: 0;
}
.panel > .list-group .list-group-item,
.panel > .panel-collapse > .list-group .list-group-item {
  border-width: 1px 0;
  border-radius: 0;
}
.panel > .list-group:first-child .list-group-item:first-child,
.panel > .panel-collapse > .list-group:first-child .list-group-item:first-child {
  border-top: 0;
  border-top-right-radius: 1px;
  border-top-left-radius: 1px;
}
.panel > .list-group:last-child .list-group-item:last-child,
.panel > .panel-collapse > .list-group:last-child .list-group-item:last-child {
  border-bottom: 0;
  border-bottom-right-radius: 1px;
  border-bottom-left-radius: 1px;
}
.panel > .panel-heading + .panel-collapse > .list-group .list-group-item:first-child {
  border-top-right-radius: 0;
  border-top-left-radius: 0;
}
.panel-heading + .list-group .list-group-item:first-child {
  border-top-width: 0;
}
.list-group + .panel-footer {
  border-top-width: 0;
}
.panel > .table,
.panel > .table-responsive > .table,
.panel > .panel-collapse > .table {
  margin-bottom: 0;
}
.panel > .table caption,
.panel > .table-responsive > .table caption,
.panel > .panel-collapse > .table caption {
  padding-left: 15px;
  padding-right: 15px;
}
.panel > .table:first-child,
.panel > .table-responsive:first-child > .table:first-child {
  border-top-right-radius: 1px;
  border-top-left-radius: 1px;
}
.panel > .table:first-child > thead:first-child > tr:first-child,
.panel > .table-responsive:first-child > .table:first-child > thead:first-child > tr:first-child,
.panel > .table:first-child > tbody:first-child > tr:first-child,
.panel > .table-responsive:first-child > .table:first-child > tbody:first-child > tr:first-child {
  border-top-left-radius: 1px;
  border-top-right-radius: 1px;
}
.panel > .table:first-child > thead:first-child > tr:first-child td:first-child,
.panel > .table-responsive:first-child > .table:first-child > thead:first-child > tr:first-child td:first-child,
.panel > .table:first-child > tbody:first-child > tr:first-child td:first-child,
.panel > .table-responsive:first-child > .table:first-child > tbody:first-child > tr:first-child td:first-child,
.panel > .table:first-child > thead:first-child > tr:first-child th:first-child,
.panel > .table-responsive:first-child > .table:first-child > thead:first-child > tr:first-child th:first-child,
.panel > .table:first-child > tbody:first-child > tr:first-child th:first-child,
.panel > .table-responsive:first-child > .table:first-child > tbody:first-child > tr:first-child th:first-child {
  border-top-left-radius: 1px;
}
.panel > .table:first-child > thead:first-child > tr:first-child td:last-child,
.panel > .table-responsive:first-child > .table:first-child > thead:first-child > tr:first-child td:last-child,
.panel > .table:first-child > tbody:first-child > tr:first-child td:last-child,
.panel > .table-responsive:first-child > .table:first-child > tbody:first-child > tr:first-child td:last-child,
.panel > .table:first-child > thead:first-child > tr:first-child th:last-child,
.panel > .table-responsive:first-child > .table:first-child > thead:first-child > tr:first-child th:last-child,
.panel > .table:first-child > tbody:first-child > tr:first-child th:last-child,
.panel > .table-responsive:first-child > .table:first-child > tbody:first-child > tr:first-child th:last-child {
  border-top-right-radius: 1px;
}
.panel > .table:last-child,
.panel > .table-responsive:last-child > .table:last-child {
  border-bottom-right-radius: 1px;
  border-bottom-left-radius: 1px;
}
.panel > .table:last-child > tbody:last-child > tr:last-child,
.panel > .table-responsive:last-child > .table:last-child > tbody:last-child > tr:last-child,
.panel > .table:last-child > tfoot:last-child > tr:last-child,
.panel > .table-responsive:last-child > .table:last-child > tfoot:last-child > tr:last-child {
  border-bottom-left-radius: 1px;
  border-bottom-right-radius: 1px;
}
.panel > .table:last-child > tbody:last-child > tr:last-child td:first-child,
.panel > .table-responsive:last-child > .table:last-child > tbody:last-child > tr:last-child td:first-child,
.panel > .table:last-child > tfoot:last-child > tr:last-child td:first-child,
.panel > .table-responsive:last-child > .table:last-child > tfoot:last-child > tr:last-child td:first-child,
.panel > .table:last-child > tbody:last-child > tr:last-child th:first-child,
.panel > .table-responsive:last-child > .table:last-child > tbody:last-child > tr:last-child th:first-child,
.panel > .table:last-child > tfoot:last-child > tr:last-child th:first-child,
.panel > .table-responsive:last-child > .table:last-child > tfoot:last-child > tr:last-child th:first-child {
  border-bottom-left-radius: 1px;
}
.panel > .table:last-child > tbody:last-child > tr:last-child td:last-child,
.panel > .table-responsive:last-child > .table:last-child > tbody:last-child > tr:last-child td:last-child,
.panel > .table:last-child > tfoot:last-child > tr:last-child td:last-child,
.panel > .table-responsive:last-child > .table:last-child > tfoot:last-child > tr:last-child td:last-child,
.panel > .table:last-child > tbody:last-child > tr:last-child th:last-child,
.panel > .table-responsive:last-child > .table:last-child > tbody:last-child > tr:last-child th:last-child,
.panel > .table:last-child > tfoot:last-child > tr:last-child th:last-child,
.panel > .table-responsive:last-child > .table:last-child > tfoot:last-child > tr:last-child th:last-child {
  border-bottom-right-radius: 1px;
}
.panel > .panel-body + .table,
.panel > .panel-body + .table-responsive,
.panel > .table + .panel-body,
.panel > .table-responsive + .panel-body {
  border-top: 1px solid #ddd;
}
.panel > .table > tbody:first-child > tr:first-child th,
.panel > .table > tbody:first-child > tr:first-child td {
  border-top: 0;
}
.panel > .table-bordered,
.panel > .table-responsive > .table-bordered {
  border: 0;
}
.panel > .table-bordered > thead > tr > th:first-child,
.panel > .table-responsive > .table-bordered > thead > tr > th:first-child,
.panel > .table-bordered > tbody > tr > th:first-child,
.panel > .table-responsive > .table-bordered > tbody > tr > th:first-child,
.panel > .table-bordered > tfoot > tr > th:first-child,
.panel > .table-responsive > .table-bordered > tfoot > tr > th:first-child,
.panel > .table-bordered > thead > tr > td:first-child,
.panel > .table-responsive > .table-bordered > thead > tr > td:first-child,
.panel > .table-bordered > tbody > tr > td:first-child,
.panel > .table-responsive > .table-bordered > tbody > tr > td:first-child,
.panel > .table-bordered > tfoot > tr > td:first-child,
.panel > .table-responsive > .table-bordered > tfoot > tr > td:first-child {
  border-left: 0;
}
.panel > .table-bordered > thead > tr > th:last-child,
.panel > .table-responsive > .table-bordered > thead > tr > th:last-child,
.panel > .table-bordered > tbody > tr > th:last-child,
.panel > .table-responsive > .table-bordered > tbody > tr > th:last-child,
.panel > .table-bordered > tfoot > tr > th:last-child,
.panel > .table-responsive > .table-bordered > tfoot > tr > th:last-child,
.panel > .table-bordered > thead > tr > td:last-child,
.panel > .table-responsive > .table-bordered > thead > tr > td:last-child,
.panel > .table-bordered > tbody > tr > td:last-child,
.panel > .table-responsive > .table-bordered > tbody > tr > td:last-child,
.panel > .table-bordered > tfoot > tr > td:last-child,
.panel > .table-responsive > .table-bordered > tfoot > tr > td:last-child {
  border-right: 0;
}
.panel > .table-bordered > thead > tr:first-child > td,
.panel > .table-responsive > .table-bordered > thead > tr:first-child > td,
.panel > .table-bordered > tbody > tr:first-child > td,
.panel > .table-responsive > .table-bordered > tbody > tr:first-child > td,
.panel > .table-bordered > thead > tr:first-child > th,
.panel > .table-responsive > .table-bordered > thead > tr:first-child > th,
.panel > .table-bordered > tbody > tr:first-child > th,
.panel > .table-responsive > .table-bordered > tbody > tr:first-child > th {
  border-bottom: 0;
}
.panel > .table-bordered > tbody > tr:last-child > td,
.panel > .table-responsive > .table-bordered > tbody > tr:last-child > td,
.panel > .table-bordered > tfoot > tr:last-child > td,
.panel > .table-responsive > .table-bordered > tfoot > tr:last-child > td,
.panel > .table-bordered > tbody > tr:last-child > th,
.panel > .table-responsive > .table-bordered > tbody > tr:last-child > th,
.panel > .table-bordered > tfoot > tr:last-child > th,
.panel > .table-responsive > .table-bordered > tfoot > tr:last-child > th {
  border-bottom: 0;
}
.panel > .table-responsive {
  border: 0;
  margin-bottom: 0;
}
.panel-group {
  margin-bottom: 18px;
}
.panel-group .panel {
  margin-bottom: 0;
  border-radius: 2px;
}
.panel-group .panel + .panel {
  margin-top: 5px;
}
.panel-group .panel-heading {
  border-bottom: 0;
}
.panel-group .panel-heading + .panel-collapse > .panel-body,
.panel-group .panel-heading + .panel-collapse > .list-group {
  border-top: 1px solid #ddd;
}
.panel-group .panel-footer {
  border-top: 0;
}
.panel-group .panel-footer + .panel-collapse .panel-body {
  border-bottom: 1px solid #ddd;
}
.panel-default {
  border-color: #ddd;
}
.panel-default > .panel-heading {
  color: #333333;
  background-color: #f5f5f5;
  border-color: #ddd;
}
.panel-default > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #ddd;
}
.panel-default > .panel-heading .badge {
  color: #f5f5f5;
  background-color: #333333;
}
.panel-default > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #ddd;
}
.panel-primary {
  border-color: #337ab7;
}
.panel-primary > .panel-heading {
  color: #fff;
  background-color: #337ab7;
  border-color: #337ab7;
}
.panel-primary > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #337ab7;
}
.panel-primary > .panel-heading .badge {
  color: #337ab7;
  background-color: #fff;
}
.panel-primary > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #337ab7;
}
.panel-success {
  border-color: #d6e9c6;
}
.panel-success > .panel-heading {
  color: #3c763d;
  background-color: #dff0d8;
  border-color: #d6e9c6;
}
.panel-success > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #d6e9c6;
}
.panel-success > .panel-heading .badge {
  color: #dff0d8;
  background-color: #3c763d;
}
.panel-success > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #d6e9c6;
}
.panel-info {
  border-color: #bce8f1;
}
.panel-info > .panel-heading {
  color: #31708f;
  background-color: #d9edf7;
  border-color: #bce8f1;
}
.panel-info > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #bce8f1;
}
.panel-info > .panel-heading .badge {
  color: #d9edf7;
  background-color: #31708f;
}
.panel-info > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #bce8f1;
}
.panel-warning {
  border-color: #faebcc;
}
.panel-warning > .panel-heading {
  color: #8a6d3b;
  background-color: #fcf8e3;
  border-color: #faebcc;
}
.panel-warning > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #faebcc;
}
.panel-warning > .panel-heading .badge {
  color: #fcf8e3;
  background-color: #8a6d3b;
}
.panel-warning > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #faebcc;
}
.panel-danger {
  border-color: #ebccd1;
}
.panel-danger > .panel-heading {
  color: #a94442;
  background-color: #f2dede;
  border-color: #ebccd1;
}
.panel-danger > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #ebccd1;
}
.panel-danger > .panel-heading .badge {
  color: #f2dede;
  background-color: #a94442;
}
.panel-danger > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #ebccd1;
}
.embed-responsive {
  position: relative;
  display: block;
  height: 0;
  padding: 0;
  overflow: hidden;
}
.embed-responsive .embed-responsive-item,
.embed-responsive iframe,
.embed-responsive embed,
.embed-responsive object,
.embed-responsive video {
  position: absolute;
  top: 0;
  left: 0;
  bottom: 0;
  height: 100%;
  width: 100%;
  border: 0;
}
.embed-responsive-16by9 {
  padding-bottom: 56.25%;
}
.embed-responsive-4by3 {
  padding-bottom: 75%;
}
.well {
  min-height: 20px;
  padding: 19px;
  margin-bottom: 20px;
  background-color: #f5f5f5;
  border: 1px solid #e3e3e3;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.05);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.05);
}
.well blockquote {
  border-color: #ddd;
  border-color: rgba(0, 0, 0, 0.15);
}
.well-lg {
  padding: 24px;
  border-radius: 3px;
}
.well-sm {
  padding: 9px;
  border-radius: 1px;
}
.close {
  float: right;
  font-size: 19.5px;
  font-weight: bold;
  line-height: 1;
  color: #000;
  text-shadow: 0 1px 0 #fff;
  opacity: 0.2;
  filter: alpha(opacity=20);
}
.close:hover,
.close:focus {
  color: #000;
  text-decoration: none;
  cursor: pointer;
  opacity: 0.5;
  filter: alpha(opacity=50);
}
button.close {
  padding: 0;
  cursor: pointer;
  background: transparent;
  border: 0;
  -webkit-appearance: none;
}
.modal-open {
  overflow: hidden;
}
.modal {
  display: none;
  overflow: hidden;
  position: fixed;
  top: 0;
  right: 0;
  bottom: 0;
  left: 0;
  z-index: 1050;
  -webkit-overflow-scrolling: touch;
  outline: 0;
}
.modal.fade .modal-dialog {
  -webkit-transform: translate(0, -25%);
  -ms-transform: translate(0, -25%);
  -o-transform: translate(0, -25%);
  transform: translate(0, -25%);
  -webkit-transition: -webkit-transform 0.3s ease-out;
  -moz-transition: -moz-transform 0.3s ease-out;
  -o-transition: -o-transform 0.3s ease-out;
  transition: transform 0.3s ease-out;
}
.modal.in .modal-dialog {
  -webkit-transform: translate(0, 0);
  -ms-transform: translate(0, 0);
  -o-transform: translate(0, 0);
  transform: translate(0, 0);
}
.modal-open .modal {
  overflow-x: hidden;
  overflow-y: auto;
}
.modal-dialog {
  position: relative;
  width: auto;
  margin: 10px;
}
.modal-content {
  position: relative;
  background-color: #fff;
  border: 1px solid #999;
  border: 1px solid rgba(0, 0, 0, 0.2);
  border-radius: 3px;
  -webkit-box-shadow: 0 3px 9px rgba(0, 0, 0, 0.5);
  box-shadow: 0 3px 9px rgba(0, 0, 0, 0.5);
  background-clip: padding-box;
  outline: 0;
}
.modal-backdrop {
  position: fixed;
  top: 0;
  right: 0;
  bottom: 0;
  left: 0;
  z-index: 1040;
  background-color: #000;
}
.modal-backdrop.fade {
  opacity: 0;
  filter: alpha(opacity=0);
}
.modal-backdrop.in {
  opacity: 0.5;
  filter: alpha(opacity=50);
}
.modal-header {
  padding: 15px;
  border-bottom: 1px solid #e5e5e5;
}
.modal-header .close {
  margin-top: -2px;
}
.modal-title {
  margin: 0;
  line-height: 1.42857143;
}
.modal-body {
  position: relative;
  padding: 15px;
}
.modal-footer {
  padding: 15px;
  text-align: right;
  border-top: 1px solid #e5e5e5;
}
.modal-footer .btn + .btn {
  margin-left: 5px;
  margin-bottom: 0;
}
.modal-footer .btn-group .btn + .btn {
  margin-left: -1px;
}
.modal-footer .btn-block + .btn-block {
  margin-left: 0;
}
.modal-scrollbar-measure {
  position: absolute;
  top: -9999px;
  width: 50px;
  height: 50px;
  overflow: scroll;
}
@media (min-width: 768px) {
  .modal-dialog {
    width: 600px;
    margin: 30px auto;
  }
  .modal-content {
    -webkit-box-shadow: 0 5px 15px rgba(0, 0, 0, 0.5);
    box-shadow: 0 5px 15px rgba(0, 0, 0, 0.5);
  }
  .modal-sm {
    width: 300px;
  }
}
@media (min-width: 992px) {
  .modal-lg {
    width: 900px;
  }
}
.tooltip {
  position: absolute;
  z-index: 1070;
  display: block;
  font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
  font-style: normal;
  font-weight: normal;
  letter-spacing: normal;
  line-break: auto;
  line-height: 1.42857143;
  text-align: left;
  text-align: start;
  text-decoration: none;
  text-shadow: none;
  text-transform: none;
  white-space: normal;
  word-break: normal;
  word-spacing: normal;
  word-wrap: normal;
  font-size: 12px;
  opacity: 0;
  filter: alpha(opacity=0);
}
.tooltip.in {
  opacity: 0.9;
  filter: alpha(opacity=90);
}
.tooltip.top {
  margin-top: -3px;
  padding: 5px 0;
}
.tooltip.right {
  margin-left: 3px;
  padding: 0 5px;
}
.tooltip.bottom {
  margin-top: 3px;
  padding: 5px 0;
}
.tooltip.left {
  margin-left: -3px;
  padding: 0 5px;
}
.tooltip-inner {
  max-width: 200px;
  padding: 3px 8px;
  color: #fff;
  text-align: center;
  background-color: #000;
  border-radius: 2px;
}
.tooltip-arrow {
  position: absolute;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
}
.tooltip.top .tooltip-arrow {
  bottom: 0;
  left: 50%;
  margin-left: -5px;
  border-width: 5px 5px 0;
  border-top-color: #000;
}
.tooltip.top-left .tooltip-arrow {
  bottom: 0;
  right: 5px;
  margin-bottom: -5px;
  border-width: 5px 5px 0;
  border-top-color: #000;
}
.tooltip.top-right .tooltip-arrow {
  bottom: 0;
  left: 5px;
  margin-bottom: -5px;
  border-width: 5px 5px 0;
  border-top-color: #000;
}
.tooltip.right .tooltip-arrow {
  top: 50%;
  left: 0;
  margin-top: -5px;
  border-width: 5px 5px 5px 0;
  border-right-color: #000;
}
.tooltip.left .tooltip-arrow {
  top: 50%;
  right: 0;
  margin-top: -5px;
  border-width: 5px 0 5px 5px;
  border-left-color: #000;
}
.tooltip.bottom .tooltip-arrow {
  top: 0;
  left: 50%;
  margin-left: -5px;
  border-width: 0 5px 5px;
  border-bottom-color: #000;
}
.tooltip.bottom-left .tooltip-arrow {
  top: 0;
  right: 5px;
  margin-top: -5px;
  border-width: 0 5px 5px;
  border-bottom-color: #000;
}
.tooltip.bottom-right .tooltip-arrow {
  top: 0;
  left: 5px;
  margin-top: -5px;
  border-width: 0 5px 5px;
  border-bottom-color: #000;
}
.popover {
  position: absolute;
  top: 0;
  left: 0;
  z-index: 1060;
  display: none;
  max-width: 276px;
  padding: 1px;
  font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
  font-style: normal;
  font-weight: normal;
  letter-spacing: normal;
  line-break: auto;
  line-height: 1.42857143;
  text-align: left;
  text-align: start;
  text-decoration: none;
  text-shadow: none;
  text-transform: none;
  white-space: normal;
  word-break: normal;
  word-spacing: normal;
  word-wrap: normal;
  font-size: 13px;
  background-color: #fff;
  background-clip: padding-box;
  border: 1px solid #ccc;
  border: 1px solid rgba(0, 0, 0, 0.2);
  border-radius: 3px;
  -webkit-box-shadow: 0 5px 10px rgba(0, 0, 0, 0.2);
  box-shadow: 0 5px 10px rgba(0, 0, 0, 0.2);
}
.popover.top {
  margin-top: -10px;
}
.popover.right {
  margin-left: 10px;
}
.popover.bottom {
  margin-top: 10px;
}
.popover.left {
  margin-left: -10px;
}
.popover-title {
  margin: 0;
  padding: 8px 14px;
  font-size: 13px;
  background-color: #f7f7f7;
  border-bottom: 1px solid #ebebeb;
  border-radius: 2px 2px 0 0;
}
.popover-content {
  padding: 9px 14px;
}
.popover > .arrow,
.popover > .arrow:after {
  position: absolute;
  display: block;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
}
.popover > .arrow {
  border-width: 11px;
}
.popover > .arrow:after {
  border-width: 10px;
  content: "";
}
.popover.top > .arrow {
  left: 50%;
  margin-left: -11px;
  border-bottom-width: 0;
  border-top-color: #999999;
  border-top-color: rgba(0, 0, 0, 0.25);
  bottom: -11px;
}
.popover.top > .arrow:after {
  content: " ";
  bottom: 1px;
  margin-left: -10px;
  border-bottom-width: 0;
  border-top-color: #fff;
}
.popover.right > .arrow {
  top: 50%;
  left: -11px;
  margin-top: -11px;
  border-left-width: 0;
  border-right-color: #999999;
  border-right-color: rgba(0, 0, 0, 0.25);
}
.popover.right > .arrow:after {
  content: " ";
  left: 1px;
  bottom: -10px;
  border-left-width: 0;
  border-right-color: #fff;
}
.popover.bottom > .arrow {
  left: 50%;
  margin-left: -11px;
  border-top-width: 0;
  border-bottom-color: #999999;
  border-bottom-color: rgba(0, 0, 0, 0.25);
  top: -11px;
}
.popover.bottom > .arrow:after {
  content: " ";
  top: 1px;
  margin-left: -10px;
  border-top-width: 0;
  border-bottom-color: #fff;
}
.popover.left > .arrow {
  top: 50%;
  right: -11px;
  margin-top: -11px;
  border-right-width: 0;
  border-left-color: #999999;
  border-left-color: rgba(0, 0, 0, 0.25);
}
.popover.left > .arrow:after {
  content: " ";
  right: 1px;
  border-right-width: 0;
  border-left-color: #fff;
  bottom: -10px;
}
.carousel {
  position: relative;
}
.carousel-inner {
  position: relative;
  overflow: hidden;
  width: 100%;
}
.carousel-inner > .item {
  display: none;
  position: relative;
  -webkit-transition: 0.6s ease-in-out left;
  -o-transition: 0.6s ease-in-out left;
  transition: 0.6s ease-in-out left;
}
.carousel-inner > .item > img,
.carousel-inner > .item > a > img {
  line-height: 1;
}
@media all and (transform-3d), (-webkit-transform-3d) {
  .carousel-inner > .item {
    -webkit-transition: -webkit-transform 0.6s ease-in-out;
    -moz-transition: -moz-transform 0.6s ease-in-out;
    -o-transition: -o-transform 0.6s ease-in-out;
    transition: transform 0.6s ease-in-out;
    -webkit-backface-visibility: hidden;
    -moz-backface-visibility: hidden;
    backface-visibility: hidden;
    -webkit-perspective: 1000px;
    -moz-perspective: 1000px;
    perspective: 1000px;
  }
  .carousel-inner > .item.next,
  .carousel-inner > .item.active.right {
    -webkit-transform: translate3d(100%, 0, 0);
    transform: translate3d(100%, 0, 0);
    left: 0;
  }
  .carousel-inner > .item.prev,
  .carousel-inner > .item.active.left {
    -webkit-transform: translate3d(-100%, 0, 0);
    transform: translate3d(-100%, 0, 0);
    left: 0;
  }
  .carousel-inner > .item.next.left,
  .carousel-inner > .item.prev.right,
  .carousel-inner > .item.active {
    -webkit-transform: translate3d(0, 0, 0);
    transform: translate3d(0, 0, 0);
    left: 0;
  }
}
.carousel-inner > .active,
.carousel-inner > .next,
.carousel-inner > .prev {
  display: block;
}
.carousel-inner > .active {
  left: 0;
}
.carousel-inner > .next,
.carousel-inner > .prev {
  position: absolute;
  top: 0;
  width: 100%;
}
.carousel-inner > .next {
  left: 100%;
}
.carousel-inner > .prev {
  left: -100%;
}
.carousel-inner > .next.left,
.carousel-inner > .prev.right {
  left: 0;
}
.carousel-inner > .active.left {
  left: -100%;
}
.carousel-inner > .active.right {
  left: 100%;
}
.carousel-control {
  position: absolute;
  top: 0;
  left: 0;
  bottom: 0;
  width: 15%;
  opacity: 0.5;
  filter: alpha(opacity=50);
  font-size: 20px;
  color: #fff;
  text-align: center;
  text-shadow: 0 1px 2px rgba(0, 0, 0, 0.6);
  background-color: rgba(0, 0, 0, 0);
}
.carousel-control.left {
  background-image: -webkit-linear-gradient(left, rgba(0, 0, 0, 0.5) 0%, rgba(0, 0, 0, 0.0001) 100%);
  background-image: -o-linear-gradient(left, rgba(0, 0, 0, 0.5) 0%, rgba(0, 0, 0, 0.0001) 100%);
  background-image: linear-gradient(to right, rgba(0, 0, 0, 0.5) 0%, rgba(0, 0, 0, 0.0001) 100%);
  background-repeat: repeat-x;
  filter: progid:DXImageTransform.Microsoft.gradient(startColorstr='#80000000', endColorstr='#00000000', GradientType=1);
}
.carousel-control.right {
  left: auto;
  right: 0;
  background-image: -webkit-linear-gradient(left, rgba(0, 0, 0, 0.0001) 0%, rgba(0, 0, 0, 0.5) 100%);
  background-image: -o-linear-gradient(left, rgba(0, 0, 0, 0.0001) 0%, rgba(0, 0, 0, 0.5) 100%);
  background-image: linear-gradient(to right, rgba(0, 0, 0, 0.0001) 0%, rgba(0, 0, 0, 0.5) 100%);
  background-repeat: repeat-x;
  filter: progid:DXImageTransform.Microsoft.gradient(startColorstr='#00000000', endColorstr='#80000000', GradientType=1);
}
.carousel-control:hover,
.carousel-control:focus {
  outline: 0;
  color: #fff;
  text-decoration: none;
  opacity: 0.9;
  filter: alpha(opacity=90);
}
.carousel-control .icon-prev,
.carousel-control .icon-next,
.carousel-control .glyphicon-chevron-left,
.carousel-control .glyphicon-chevron-right {
  position: absolute;
  top: 50%;
  margin-top: -10px;
  z-index: 5;
  display: inline-block;
}
.carousel-control .icon-prev,
.carousel-control .glyphicon-chevron-left {
  left: 50%;
  margin-left: -10px;
}
.carousel-control .icon-next,
.carousel-control .glyphicon-chevron-right {
  right: 50%;
  margin-right: -10px;
}
.carousel-control .icon-prev,
.carousel-control .icon-next {
  width: 20px;
  height: 20px;
  line-height: 1;
  font-family: serif;
}
.carousel-control .icon-prev:before {
  content: '\2039';
}
.carousel-control .icon-next:before {
  content: '\203a';
}
.carousel-indicators {
  position: absolute;
  bottom: 10px;
  left: 50%;
  z-index: 15;
  width: 60%;
  margin-left: -30%;
  padding-left: 0;
  list-style: none;
  text-align: center;
}
.carousel-indicators li {
  display: inline-block;
  width: 10px;
  height: 10px;
  margin: 1px;
  text-indent: -999px;
  border: 1px solid #fff;
  border-radius: 10px;
  cursor: pointer;
  background-color: #000 \9;
  background-color: rgba(0, 0, 0, 0);
}
.carousel-indicators .active {
  margin: 0;
  width: 12px;
  height: 12px;
  background-color: #fff;
}
.carousel-caption {
  position: absolute;
  left: 15%;
  right: 15%;
  bottom: 20px;
  z-index: 10;
  padding-top: 20px;
  padding-bottom: 20px;
  color: #fff;
  text-align: center;
  text-shadow: 0 1px 2px rgba(0, 0, 0, 0.6);
}
.carousel-caption .btn {
  text-shadow: none;
}
@media screen and (min-width: 768px) {
  .carousel-control .glyphicon-chevron-left,
  .carousel-control .glyphicon-chevron-right,
  .carousel-control .icon-prev,
  .carousel-control .icon-next {
    width: 30px;
    height: 30px;
    margin-top: -10px;
    font-size: 30px;
  }
  .carousel-control .glyphicon-chevron-left,
  .carousel-control .icon-prev {
    margin-left: -10px;
  }
  .carousel-control .glyphicon-chevron-right,
  .carousel-control .icon-next {
    margin-right: -10px;
  }
  .carousel-caption {
    left: 20%;
    right: 20%;
    padding-bottom: 30px;
  }
  .carousel-indicators {
    bottom: 20px;
  }
}
.clearfix:before,
.clearfix:after,
.dl-horizontal dd:before,
.dl-horizontal dd:after,
.container:before,
.container:after,
.container-fluid:before,
.container-fluid:after,
.row:before,
.row:after,
.form-horizontal .form-group:before,
.form-horizontal .form-group:after,
.btn-toolbar:before,
.btn-toolbar:after,
.btn-group-vertical > .btn-group:before,
.btn-group-vertical > .btn-group:after,
.nav:before,
.nav:after,
.navbar:before,
.navbar:after,
.navbar-header:before,
.navbar-header:after,
.navbar-collapse:before,
.navbar-collapse:after,
.pager:before,
.pager:after,
.panel-body:before,
.panel-body:after,
.modal-header:before,
.modal-header:after,
.modal-footer:before,
.modal-footer:after,
.item_buttons:before,
.item_buttons:after {
  content: " ";
  display: table;
}
.clearfix:after,
.dl-horizontal dd:after,
.container:after,
.container-fluid:after,
.row:after,
.form-horizontal .form-group:after,
.btn-toolbar:after,
.btn-group-vertical > .btn-group:after,
.nav:after,
.navbar:after,
.navbar-header:after,
.navbar-collapse:after,
.pager:after,
.panel-body:after,
.modal-header:after,
.modal-footer:after,
.item_buttons:after {
  clear: both;
}
.center-block {
  display: block;
  margin-left: auto;
  margin-right: auto;
}
.pull-right {
  float: right !important;
}
.pull-left {
  float: left !important;
}
.hide {
  display: none !important;
}
.show {
  display: block !important;
}
.invisible {
  visibility: hidden;
}
.text-hide {
  font: 0/0 a;
  color: transparent;
  text-shadow: none;
  background-color: transparent;
  border: 0;
}
.hidden {
  display: none !important;
}
.affix {
  position: fixed;
}
@-ms-viewport {
  width: device-width;
}
.visible-xs,
.visible-sm,
.visible-md,
.visible-lg {
  display: none !important;
}
.visible-xs-block,
.visible-xs-inline,
.visible-xs-inline-block,
.visible-sm-block,
.visible-sm-inline,
.visible-sm-inline-block,
.visible-md-block,
.visible-md-inline,
.visible-md-inline-block,
.visible-lg-block,
.visible-lg-inline,
.visible-lg-inline-block {
  display: none !important;
}
@media (max-width: 767px) {
  .visible-xs {
    display: block !important;
  }
  table.visible-xs {
    display: table !important;
  }
  tr.visible-xs {
    display: table-row !important;
  }
  th.visible-xs,
  td.visible-xs {
    display: table-cell !important;
  }
}
@media (max-width: 767px) {
  .visible-xs-block {
    display: block !important;
  }
}
@media (max-width: 767px) {
  .visible-xs-inline {
    display: inline !important;
  }
}
@media (max-width: 767px) {
  .visible-xs-inline-block {
    display: inline-block !important;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  .visible-sm {
    display: block !important;
  }
  table.visible-sm {
    display: table !important;
  }
  tr.visible-sm {
    display: table-row !important;
  }
  th.visible-sm,
  td.visible-sm {
    display: table-cell !important;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  .visible-sm-block {
    display: block !important;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  .visible-sm-inline {
    display: inline !important;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  .visible-sm-inline-block {
    display: inline-block !important;
  }
}
@media (min-width: 992px) and (max-width: 1199px) {
  .visible-md {
    display: block !important;
  }
  table.visible-md {
    display: table !important;
  }
  tr.visible-md {
    display: table-row !important;
  }
  th.visible-md,
  td.visible-md {
    display: table-cell !important;
  }
}
@media (min-width: 992px) and (max-width: 1199px) {
  .visible-md-block {
    display: block !important;
  }
}
@media (min-width: 992px) and (max-width: 1199px) {
  .visible-md-inline {
    display: inline !important;
  }
}
@media (min-width: 992px) and (max-width: 1199px) {
  .visible-md-inline-block {
    display: inline-block !important;
  }
}
@media (min-width: 1200px) {
  .visible-lg {
    display: block !important;
  }
  table.visible-lg {
    display: table !important;
  }
  tr.visible-lg {
    display: table-row !important;
  }
  th.visible-lg,
  td.visible-lg {
    display: table-cell !important;
  }
}
@media (min-width: 1200px) {
  .visible-lg-block {
    display: block !important;
  }
}
@media (min-width: 1200px) {
  .visible-lg-inline {
    display: inline !important;
  }
}
@media (min-width: 1200px) {
  .visible-lg-inline-block {
    display: inline-block !important;
  }
}
@media (max-width: 767px) {
  .hidden-xs {
    display: none !important;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  .hidden-sm {
    display: none !important;
  }
}
@media (min-width: 992px) and (max-width: 1199px) {
  .hidden-md {
    display: none !important;
  }
}
@media (min-width: 1200px) {
  .hidden-lg {
    display: none !important;
  }
}
.visible-print {
  display: none !important;
}
@media print {
  .visible-print {
    display: block !important;
  }
  table.visible-print {
    display: table !important;
  }
  tr.visible-print {
    display: table-row !important;
  }
  th.visible-print,
  td.visible-print {
    display: table-cell !important;
  }
}
.visible-print-block {
  display: none !important;
}
@media print {
  .visible-print-block {
    display: block !important;
  }
}
.visible-print-inline {
  display: none !important;
}
@media print {
  .visible-print-inline {
    display: inline !important;
  }
}
.visible-print-inline-block {
  display: none !important;
}
@media print {
  .visible-print-inline-block {
    display: inline-block !important;
  }
}
@media print {
  .hidden-print {
    display: none !important;
  }
}
/*!
*
* Font Awesome
*
*/
/*!
 *  Font Awesome 4.7.0 by @davegandy - http://fontawesome.io - @fontawesome
 *  License - http://fontawesome.io/license (Font: SIL OFL 1.1, CSS: MIT License)
 */
/* FONT PATH
 * -------------------------- */
@font-face {
  font-family: 'FontAwesome';
  src: url('../components/font-awesome/fonts/fontawesome-webfont.eot?v=4.7.0');
  src: url('../components/font-awesome/fonts/fontawesome-webfont.eot?#iefix&v=4.7.0') format('embedded-opentype'), url('../components/font-awesome/fonts/fontawesome-webfont.woff2?v=4.7.0') format('woff2'), url('../components/font-awesome/fonts/fontawesome-webfont.woff?v=4.7.0') format('woff'), url('../components/font-awesome/fonts/fontawesome-webfont.ttf?v=4.7.0') format('truetype'), url('../components/font-awesome/fonts/fontawesome-webfont.svg?v=4.7.0#fontawesomeregular') format('svg');
  font-weight: normal;
  font-style: normal;
}
.fa {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
}
/* makes the font 33% larger relative to the icon container */
.fa-lg {
  font-size: 1.33333333em;
  line-height: 0.75em;
  vertical-align: -15%;
}
.fa-2x {
  font-size: 2em;
}
.fa-3x {
  font-size: 3em;
}
.fa-4x {
  font-size: 4em;
}
.fa-5x {
  font-size: 5em;
}
.fa-fw {
  width: 1.28571429em;
  text-align: center;
}
.fa-ul {
  padding-left: 0;
  margin-left: 2.14285714em;
  list-style-type: none;
}
.fa-ul > li {
  position: relative;
}
.fa-li {
  position: absolute;
  left: -2.14285714em;
  width: 2.14285714em;
  top: 0.14285714em;
  text-align: center;
}
.fa-li.fa-lg {
  left: -1.85714286em;
}
.fa-border {
  padding: .2em .25em .15em;
  border: solid 0.08em #eee;
  border-radius: .1em;
}
.fa-pull-left {
  float: left;
}
.fa-pull-right {
  float: right;
}
.fa.fa-pull-left {
  margin-right: .3em;
}
.fa.fa-pull-right {
  margin-left: .3em;
}
/* Deprecated as of 4.4.0 */
.pull-right {
  float: right;
}
.pull-left {
  float: left;
}
.fa.pull-left {
  margin-right: .3em;
}
.fa.pull-right {
  margin-left: .3em;
}
.fa-spin {
  -webkit-animation: fa-spin 2s infinite linear;
  animation: fa-spin 2s infinite linear;
}
.fa-pulse {
  -webkit-animation: fa-spin 1s infinite steps(8);
  animation: fa-spin 1s infinite steps(8);
}
@-webkit-keyframes fa-spin {
  0% {
    -webkit-transform: rotate(0deg);
    transform: rotate(0deg);
  }
  100% {
    -webkit-transform: rotate(359deg);
    transform: rotate(359deg);
  }
}
@keyframes fa-spin {
  0% {
    -webkit-transform: rotate(0deg);
    transform: rotate(0deg);
  }
  100% {
    -webkit-transform: rotate(359deg);
    transform: rotate(359deg);
  }
}
.fa-rotate-90 {
  -ms-filter: "progid:DXImageTransform.Microsoft.BasicImage(rotation=1)";
  -webkit-transform: rotate(90deg);
  -ms-transform: rotate(90deg);
  transform: rotate(90deg);
}
.fa-rotate-180 {
  -ms-filter: "progid:DXImageTransform.Microsoft.BasicImage(rotation=2)";
  -webkit-transform: rotate(180deg);
  -ms-transform: rotate(180deg);
  transform: rotate(180deg);
}
.fa-rotate-270 {
  -ms-filter: "progid:DXImageTransform.Microsoft.BasicImage(rotation=3)";
  -webkit-transform: rotate(270deg);
  -ms-transform: rotate(270deg);
  transform: rotate(270deg);
}
.fa-flip-horizontal {
  -ms-filter: "progid:DXImageTransform.Microsoft.BasicImage(rotation=0, mirror=1)";
  -webkit-transform: scale(-1, 1);
  -ms-transform: scale(-1, 1);
  transform: scale(-1, 1);
}
.fa-flip-vertical {
  -ms-filter: "progid:DXImageTransform.Microsoft.BasicImage(rotation=2, mirror=1)";
  -webkit-transform: scale(1, -1);
  -ms-transform: scale(1, -1);
  transform: scale(1, -1);
}
:root .fa-rotate-90,
:root .fa-rotate-180,
:root .fa-rotate-270,
:root .fa-flip-horizontal,
:root .fa-flip-vertical {
  filter: none;
}
.fa-stack {
  position: relative;
  display: inline-block;
  width: 2em;
  height: 2em;
  line-height: 2em;
  vertical-align: middle;
}
.fa-stack-1x,
.fa-stack-2x {
  position: absolute;
  left: 0;
  width: 100%;
  text-align: center;
}
.fa-stack-1x {
  line-height: inherit;
}
.fa-stack-2x {
  font-size: 2em;
}
.fa-inverse {
  color: #fff;
}
/* Font Awesome uses the Unicode Private Use Area (PUA) to ensure screen
   readers do not read off random characters that represent icons */
.fa-glass:before {
  content: "\f000";
}
.fa-music:before {
  content: "\f001";
}
.fa-search:before {
  content: "\f002";
}
.fa-envelope-o:before {
  content: "\f003";
}
.fa-heart:before {
  content: "\f004";
}
.fa-star:before {
  content: "\f005";
}
.fa-star-o:before {
  content: "\f006";
}
.fa-user:before {
  content: "\f007";
}
.fa-film:before {
  content: "\f008";
}
.fa-th-large:before {
  content: "\f009";
}
.fa-th:before {
  content: "\f00a";
}
.fa-th-list:before {
  content: "\f00b";
}
.fa-check:before {
  content: "\f00c";
}
.fa-remove:before,
.fa-close:before,
.fa-times:before {
  content: "\f00d";
}
.fa-search-plus:before {
  content: "\f00e";
}
.fa-search-minus:before {
  content: "\f010";
}
.fa-power-off:before {
  content: "\f011";
}
.fa-signal:before {
  content: "\f012";
}
.fa-gear:before,
.fa-cog:before {
  content: "\f013";
}
.fa-trash-o:before {
  content: "\f014";
}
.fa-home:before {
  content: "\f015";
}
.fa-file-o:before {
  content: "\f016";
}
.fa-clock-o:before {
  content: "\f017";
}
.fa-road:before {
  content: "\f018";
}
.fa-download:before {
  content: "\f019";
}
.fa-arrow-circle-o-down:before {
  content: "\f01a";
}
.fa-arrow-circle-o-up:before {
  content: "\f01b";
}
.fa-inbox:before {
  content: "\f01c";
}
.fa-play-circle-o:before {
  content: "\f01d";
}
.fa-rotate-right:before,
.fa-repeat:before {
  content: "\f01e";
}
.fa-refresh:before {
  content: "\f021";
}
.fa-list-alt:before {
  content: "\f022";
}
.fa-lock:before {
  content: "\f023";
}
.fa-flag:before {
  content: "\f024";
}
.fa-headphones:before {
  content: "\f025";
}
.fa-volume-off:before {
  content: "\f026";
}
.fa-volume-down:before {
  content: "\f027";
}
.fa-volume-up:before {
  content: "\f028";
}
.fa-qrcode:before {
  content: "\f029";
}
.fa-barcode:before {
  content: "\f02a";
}
.fa-tag:before {
  content: "\f02b";
}
.fa-tags:before {
  content: "\f02c";
}
.fa-book:before {
  content: "\f02d";
}
.fa-bookmark:before {
  content: "\f02e";
}
.fa-print:before {
  content: "\f02f";
}
.fa-camera:before {
  content: "\f030";
}
.fa-font:before {
  content: "\f031";
}
.fa-bold:before {
  content: "\f032";
}
.fa-italic:before {
  content: "\f033";
}
.fa-text-height:before {
  content: "\f034";
}
.fa-text-width:before {
  content: "\f035";
}
.fa-align-left:before {
  content: "\f036";
}
.fa-align-center:before {
  content: "\f037";
}
.fa-align-right:before {
  content: "\f038";
}
.fa-align-justify:before {
  content: "\f039";
}
.fa-list:before {
  content: "\f03a";
}
.fa-dedent:before,
.fa-outdent:before {
  content: "\f03b";
}
.fa-indent:before {
  content: "\f03c";
}
.fa-video-camera:before {
  content: "\f03d";
}
.fa-photo:before,
.fa-image:before,
.fa-picture-o:before {
  content: "\f03e";
}
.fa-pencil:before {
  content: "\f040";
}
.fa-map-marker:before {
  content: "\f041";
}
.fa-adjust:before {
  content: "\f042";
}
.fa-tint:before {
  content: "\f043";
}
.fa-edit:before,
.fa-pencil-square-o:before {
  content: "\f044";
}
.fa-share-square-o:before {
  content: "\f045";
}
.fa-check-square-o:before {
  content: "\f046";
}
.fa-arrows:before {
  content: "\f047";
}
.fa-step-backward:before {
  content: "\f048";
}
.fa-fast-backward:before {
  content: "\f049";
}
.fa-backward:before {
  content: "\f04a";
}
.fa-play:before {
  content: "\f04b";
}
.fa-pause:before {
  content: "\f04c";
}
.fa-stop:before {
  content: "\f04d";
}
.fa-forward:before {
  content: "\f04e";
}
.fa-fast-forward:before {
  content: "\f050";
}
.fa-step-forward:before {
  content: "\f051";
}
.fa-eject:before {
  content: "\f052";
}
.fa-chevron-left:before {
  content: "\f053";
}
.fa-chevron-right:before {
  content: "\f054";
}
.fa-plus-circle:before {
  content: "\f055";
}
.fa-minus-circle:before {
  content: "\f056";
}
.fa-times-circle:before {
  content: "\f057";
}
.fa-check-circle:before {
  content: "\f058";
}
.fa-question-circle:before {
  content: "\f059";
}
.fa-info-circle:before {
  content: "\f05a";
}
.fa-crosshairs:before {
  content: "\f05b";
}
.fa-times-circle-o:before {
  content: "\f05c";
}
.fa-check-circle-o:before {
  content: "\f05d";
}
.fa-ban:before {
  content: "\f05e";
}
.fa-arrow-left:before {
  content: "\f060";
}
.fa-arrow-right:before {
  content: "\f061";
}
.fa-arrow-up:before {
  content: "\f062";
}
.fa-arrow-down:before {
  content: "\f063";
}
.fa-mail-forward:before,
.fa-share:before {
  content: "\f064";
}
.fa-expand:before {
  content: "\f065";
}
.fa-compress:before {
  content: "\f066";
}
.fa-plus:before {
  content: "\f067";
}
.fa-minus:before {
  content: "\f068";
}
.fa-asterisk:before {
  content: "\f069";
}
.fa-exclamation-circle:before {
  content: "\f06a";
}
.fa-gift:before {
  content: "\f06b";
}
.fa-leaf:before {
  content: "\f06c";
}
.fa-fire:before {
  content: "\f06d";
}
.fa-eye:before {
  content: "\f06e";
}
.fa-eye-slash:before {
  content: "\f070";
}
.fa-warning:before,
.fa-exclamation-triangle:before {
  content: "\f071";
}
.fa-plane:before {
  content: "\f072";
}
.fa-calendar:before {
  content: "\f073";
}
.fa-random:before {
  content: "\f074";
}
.fa-comment:before {
  content: "\f075";
}
.fa-magnet:before {
  content: "\f076";
}
.fa-chevron-up:before {
  content: "\f077";
}
.fa-chevron-down:before {
  content: "\f078";
}
.fa-retweet:before {
  content: "\f079";
}
.fa-shopping-cart:before {
  content: "\f07a";
}
.fa-folder:before {
  content: "\f07b";
}
.fa-folder-open:before {
  content: "\f07c";
}
.fa-arrows-v:before {
  content: "\f07d";
}
.fa-arrows-h:before {
  content: "\f07e";
}
.fa-bar-chart-o:before,
.fa-bar-chart:before {
  content: "\f080";
}
.fa-twitter-square:before {
  content: "\f081";
}
.fa-facebook-square:before {
  content: "\f082";
}
.fa-camera-retro:before {
  content: "\f083";
}
.fa-key:before {
  content: "\f084";
}
.fa-gears:before,
.fa-cogs:before {
  content: "\f085";
}
.fa-comments:before {
  content: "\f086";
}
.fa-thumbs-o-up:before {
  content: "\f087";
}
.fa-thumbs-o-down:before {
  content: "\f088";
}
.fa-star-half:before {
  content: "\f089";
}
.fa-heart-o:before {
  content: "\f08a";
}
.fa-sign-out:before {
  content: "\f08b";
}
.fa-linkedin-square:before {
  content: "\f08c";
}
.fa-thumb-tack:before {
  content: "\f08d";
}
.fa-external-link:before {
  content: "\f08e";
}
.fa-sign-in:before {
  content: "\f090";
}
.fa-trophy:before {
  content: "\f091";
}
.fa-github-square:before {
  content: "\f092";
}
.fa-upload:before {
  content: "\f093";
}
.fa-lemon-o:before {
  content: "\f094";
}
.fa-phone:before {
  content: "\f095";
}
.fa-square-o:before {
  content: "\f096";
}
.fa-bookmark-o:before {
  content: "\f097";
}
.fa-phone-square:before {
  content: "\f098";
}
.fa-twitter:before {
  content: "\f099";
}
.fa-facebook-f:before,
.fa-facebook:before {
  content: "\f09a";
}
.fa-github:before {
  content: "\f09b";
}
.fa-unlock:before {
  content: "\f09c";
}
.fa-credit-card:before {
  content: "\f09d";
}
.fa-feed:before,
.fa-rss:before {
  content: "\f09e";
}
.fa-hdd-o:before {
  content: "\f0a0";
}
.fa-bullhorn:before {
  content: "\f0a1";
}
.fa-bell:before {
  content: "\f0f3";
}
.fa-certificate:before {
  content: "\f0a3";
}
.fa-hand-o-right:before {
  content: "\f0a4";
}
.fa-hand-o-left:before {
  content: "\f0a5";
}
.fa-hand-o-up:before {
  content: "\f0a6";
}
.fa-hand-o-down:before {
  content: "\f0a7";
}
.fa-arrow-circle-left:before {
  content: "\f0a8";
}
.fa-arrow-circle-right:before {
  content: "\f0a9";
}
.fa-arrow-circle-up:before {
  content: "\f0aa";
}
.fa-arrow-circle-down:before {
  content: "\f0ab";
}
.fa-globe:before {
  content: "\f0ac";
}
.fa-wrench:before {
  content: "\f0ad";
}
.fa-tasks:before {
  content: "\f0ae";
}
.fa-filter:before {
  content: "\f0b0";
}
.fa-briefcase:before {
  content: "\f0b1";
}
.fa-arrows-alt:before {
  content: "\f0b2";
}
.fa-group:before,
.fa-users:before {
  content: "\f0c0";
}
.fa-chain:before,
.fa-link:before {
  content: "\f0c1";
}
.fa-cloud:before {
  content: "\f0c2";
}
.fa-flask:before {
  content: "\f0c3";
}
.fa-cut:before,
.fa-scissors:before {
  content: "\f0c4";
}
.fa-copy:before,
.fa-files-o:before {
  content: "\f0c5";
}
.fa-paperclip:before {
  content: "\f0c6";
}
.fa-save:before,
.fa-floppy-o:before {
  content: "\f0c7";
}
.fa-square:before {
  content: "\f0c8";
}
.fa-navicon:before,
.fa-reorder:before,
.fa-bars:before {
  content: "\f0c9";
}
.fa-list-ul:before {
  content: "\f0ca";
}
.fa-list-ol:before {
  content: "\f0cb";
}
.fa-strikethrough:before {
  content: "\f0cc";
}
.fa-underline:before {
  content: "\f0cd";
}
.fa-table:before {
  content: "\f0ce";
}
.fa-magic:before {
  content: "\f0d0";
}
.fa-truck:before {
  content: "\f0d1";
}
.fa-pinterest:before {
  content: "\f0d2";
}
.fa-pinterest-square:before {
  content: "\f0d3";
}
.fa-google-plus-square:before {
  content: "\f0d4";
}
.fa-google-plus:before {
  content: "\f0d5";
}
.fa-money:before {
  content: "\f0d6";
}
.fa-caret-down:before {
  content: "\f0d7";
}
.fa-caret-up:before {
  content: "\f0d8";
}
.fa-caret-left:before {
  content: "\f0d9";
}
.fa-caret-right:before {
  content: "\f0da";
}
.fa-columns:before {
  content: "\f0db";
}
.fa-unsorted:before,
.fa-sort:before {
  content: "\f0dc";
}
.fa-sort-down:before,
.fa-sort-desc:before {
  content: "\f0dd";
}
.fa-sort-up:before,
.fa-sort-asc:before {
  content: "\f0de";
}
.fa-envelope:before {
  content: "\f0e0";
}
.fa-linkedin:before {
  content: "\f0e1";
}
.fa-rotate-left:before,
.fa-undo:before {
  content: "\f0e2";
}
.fa-legal:before,
.fa-gavel:before {
  content: "\f0e3";
}
.fa-dashboard:before,
.fa-tachometer:before {
  content: "\f0e4";
}
.fa-comment-o:before {
  content: "\f0e5";
}
.fa-comments-o:before {
  content: "\f0e6";
}
.fa-flash:before,
.fa-bolt:before {
  content: "\f0e7";
}
.fa-sitemap:before {
  content: "\f0e8";
}
.fa-umbrella:before {
  content: "\f0e9";
}
.fa-paste:before,
.fa-clipboard:before {
  content: "\f0ea";
}
.fa-lightbulb-o:before {
  content: "\f0eb";
}
.fa-exchange:before {
  content: "\f0ec";
}
.fa-cloud-download:before {
  content: "\f0ed";
}
.fa-cloud-upload:before {
  content: "\f0ee";
}
.fa-user-md:before {
  content: "\f0f0";
}
.fa-stethoscope:before {
  content: "\f0f1";
}
.fa-suitcase:before {
  content: "\f0f2";
}
.fa-bell-o:before {
  content: "\f0a2";
}
.fa-coffee:before {
  content: "\f0f4";
}
.fa-cutlery:before {
  content: "\f0f5";
}
.fa-file-text-o:before {
  content: "\f0f6";
}
.fa-building-o:before {
  content: "\f0f7";
}
.fa-hospital-o:before {
  content: "\f0f8";
}
.fa-ambulance:before {
  content: "\f0f9";
}
.fa-medkit:before {
  content: "\f0fa";
}
.fa-fighter-jet:before {
  content: "\f0fb";
}
.fa-beer:before {
  content: "\f0fc";
}
.fa-h-square:before {
  content: "\f0fd";
}
.fa-plus-square:before {
  content: "\f0fe";
}
.fa-angle-double-left:before {
  content: "\f100";
}
.fa-angle-double-right:before {
  content: "\f101";
}
.fa-angle-double-up:before {
  content: "\f102";
}
.fa-angle-double-down:before {
  content: "\f103";
}
.fa-angle-left:before {
  content: "\f104";
}
.fa-angle-right:before {
  content: "\f105";
}
.fa-angle-up:before {
  content: "\f106";
}
.fa-angle-down:before {
  content: "\f107";
}
.fa-desktop:before {
  content: "\f108";
}
.fa-laptop:before {
  content: "\f109";
}
.fa-tablet:before {
  content: "\f10a";
}
.fa-mobile-phone:before,
.fa-mobile:before {
  content: "\f10b";
}
.fa-circle-o:before {
  content: "\f10c";
}
.fa-quote-left:before {
  content: "\f10d";
}
.fa-quote-right:before {
  content: "\f10e";
}
.fa-spinner:before {
  content: "\f110";
}
.fa-circle:before {
  content: "\f111";
}
.fa-mail-reply:before,
.fa-reply:before {
  content: "\f112";
}
.fa-github-alt:before {
  content: "\f113";
}
.fa-folder-o:before {
  content: "\f114";
}
.fa-folder-open-o:before {
  content: "\f115";
}
.fa-smile-o:before {
  content: "\f118";
}
.fa-frown-o:before {
  content: "\f119";
}
.fa-meh-o:before {
  content: "\f11a";
}
.fa-gamepad:before {
  content: "\f11b";
}
.fa-keyboard-o:before {
  content: "\f11c";
}
.fa-flag-o:before {
  content: "\f11d";
}
.fa-flag-checkered:before {
  content: "\f11e";
}
.fa-terminal:before {
  content: "\f120";
}
.fa-code:before {
  content: "\f121";
}
.fa-mail-reply-all:before,
.fa-reply-all:before {
  content: "\f122";
}
.fa-star-half-empty:before,
.fa-star-half-full:before,
.fa-star-half-o:before {
  content: "\f123";
}
.fa-location-arrow:before {
  content: "\f124";
}
.fa-crop:before {
  content: "\f125";
}
.fa-code-fork:before {
  content: "\f126";
}
.fa-unlink:before,
.fa-chain-broken:before {
  content: "\f127";
}
.fa-question:before {
  content: "\f128";
}
.fa-info:before {
  content: "\f129";
}
.fa-exclamation:before {
  content: "\f12a";
}
.fa-superscript:before {
  content: "\f12b";
}
.fa-subscript:before {
  content: "\f12c";
}
.fa-eraser:before {
  content: "\f12d";
}
.fa-puzzle-piece:before {
  content: "\f12e";
}
.fa-microphone:before {
  content: "\f130";
}
.fa-microphone-slash:before {
  content: "\f131";
}
.fa-shield:before {
  content: "\f132";
}
.fa-calendar-o:before {
  content: "\f133";
}
.fa-fire-extinguisher:before {
  content: "\f134";
}
.fa-rocket:before {
  content: "\f135";
}
.fa-maxcdn:before {
  content: "\f136";
}
.fa-chevron-circle-left:before {
  content: "\f137";
}
.fa-chevron-circle-right:before {
  content: "\f138";
}
.fa-chevron-circle-up:before {
  content: "\f139";
}
.fa-chevron-circle-down:before {
  content: "\f13a";
}
.fa-html5:before {
  content: "\f13b";
}
.fa-css3:before {
  content: "\f13c";
}
.fa-anchor:before {
  content: "\f13d";
}
.fa-unlock-alt:before {
  content: "\f13e";
}
.fa-bullseye:before {
  content: "\f140";
}
.fa-ellipsis-h:before {
  content: "\f141";
}
.fa-ellipsis-v:before {
  content: "\f142";
}
.fa-rss-square:before {
  content: "\f143";
}
.fa-play-circle:before {
  content: "\f144";
}
.fa-ticket:before {
  content: "\f145";
}
.fa-minus-square:before {
  content: "\f146";
}
.fa-minus-square-o:before {
  content: "\f147";
}
.fa-level-up:before {
  content: "\f148";
}
.fa-level-down:before {
  content: "\f149";
}
.fa-check-square:before {
  content: "\f14a";
}
.fa-pencil-square:before {
  content: "\f14b";
}
.fa-external-link-square:before {
  content: "\f14c";
}
.fa-share-square:before {
  content: "\f14d";
}
.fa-compass:before {
  content: "\f14e";
}
.fa-toggle-down:before,
.fa-caret-square-o-down:before {
  content: "\f150";
}
.fa-toggle-up:before,
.fa-caret-square-o-up:before {
  content: "\f151";
}
.fa-toggle-right:before,
.fa-caret-square-o-right:before {
  content: "\f152";
}
.fa-euro:before,
.fa-eur:before {
  content: "\f153";
}
.fa-gbp:before {
  content: "\f154";
}
.fa-dollar:before,
.fa-usd:before {
  content: "\f155";
}
.fa-rupee:before,
.fa-inr:before {
  content: "\f156";
}
.fa-cny:before,
.fa-rmb:before,
.fa-yen:before,
.fa-jpy:before {
  content: "\f157";
}
.fa-ruble:before,
.fa-rouble:before,
.fa-rub:before {
  content: "\f158";
}
.fa-won:before,
.fa-krw:before {
  content: "\f159";
}
.fa-bitcoin:before,
.fa-btc:before {
  content: "\f15a";
}
.fa-file:before {
  content: "\f15b";
}
.fa-file-text:before {
  content: "\f15c";
}
.fa-sort-alpha-asc:before {
  content: "\f15d";
}
.fa-sort-alpha-desc:before {
  content: "\f15e";
}
.fa-sort-amount-asc:before {
  content: "\f160";
}
.fa-sort-amount-desc:before {
  content: "\f161";
}
.fa-sort-numeric-asc:before {
  content: "\f162";
}
.fa-sort-numeric-desc:before {
  content: "\f163";
}
.fa-thumbs-up:before {
  content: "\f164";
}
.fa-thumbs-down:before {
  content: "\f165";
}
.fa-youtube-square:before {
  content: "\f166";
}
.fa-youtube:before {
  content: "\f167";
}
.fa-xing:before {
  content: "\f168";
}
.fa-xing-square:before {
  content: "\f169";
}
.fa-youtube-play:before {
  content: "\f16a";
}
.fa-dropbox:before {
  content: "\f16b";
}
.fa-stack-overflow:before {
  content: "\f16c";
}
.fa-instagram:before {
  content: "\f16d";
}
.fa-flickr:before {
  content: "\f16e";
}
.fa-adn:before {
  content: "\f170";
}
.fa-bitbucket:before {
  content: "\f171";
}
.fa-bitbucket-square:before {
  content: "\f172";
}
.fa-tumblr:before {
  content: "\f173";
}
.fa-tumblr-square:before {
  content: "\f174";
}
.fa-long-arrow-down:before {
  content: "\f175";
}
.fa-long-arrow-up:before {
  content: "\f176";
}
.fa-long-arrow-left:before {
  content: "\f177";
}
.fa-long-arrow-right:before {
  content: "\f178";
}
.fa-apple:before {
  content: "\f179";
}
.fa-windows:before {
  content: "\f17a";
}
.fa-android:before {
  content: "\f17b";
}
.fa-linux:before {
  content: "\f17c";
}
.fa-dribbble:before {
  content: "\f17d";
}
.fa-skype:before {
  content: "\f17e";
}
.fa-foursquare:before {
  content: "\f180";
}
.fa-trello:before {
  content: "\f181";
}
.fa-female:before {
  content: "\f182";
}
.fa-male:before {
  content: "\f183";
}
.fa-gittip:before,
.fa-gratipay:before {
  content: "\f184";
}
.fa-sun-o:before {
  content: "\f185";
}
.fa-moon-o:before {
  content: "\f186";
}
.fa-archive:before {
  content: "\f187";
}
.fa-bug:before {
  content: "\f188";
}
.fa-vk:before {
  content: "\f189";
}
.fa-weibo:before {
  content: "\f18a";
}
.fa-renren:before {
  content: "\f18b";
}
.fa-pagelines:before {
  content: "\f18c";
}
.fa-stack-exchange:before {
  content: "\f18d";
}
.fa-arrow-circle-o-right:before {
  content: "\f18e";
}
.fa-arrow-circle-o-left:before {
  content: "\f190";
}
.fa-toggle-left:before,
.fa-caret-square-o-left:before {
  content: "\f191";
}
.fa-dot-circle-o:before {
  content: "\f192";
}
.fa-wheelchair:before {
  content: "\f193";
}
.fa-vimeo-square:before {
  content: "\f194";
}
.fa-turkish-lira:before,
.fa-try:before {
  content: "\f195";
}
.fa-plus-square-o:before {
  content: "\f196";
}
.fa-space-shuttle:before {
  content: "\f197";
}
.fa-slack:before {
  content: "\f198";
}
.fa-envelope-square:before {
  content: "\f199";
}
.fa-wordpress:before {
  content: "\f19a";
}
.fa-openid:before {
  content: "\f19b";
}
.fa-institution:before,
.fa-bank:before,
.fa-university:before {
  content: "\f19c";
}
.fa-mortar-board:before,
.fa-graduation-cap:before {
  content: "\f19d";
}
.fa-yahoo:before {
  content: "\f19e";
}
.fa-google:before {
  content: "\f1a0";
}
.fa-reddit:before {
  content: "\f1a1";
}
.fa-reddit-square:before {
  content: "\f1a2";
}
.fa-stumbleupon-circle:before {
  content: "\f1a3";
}
.fa-stumbleupon:before {
  content: "\f1a4";
}
.fa-delicious:before {
  content: "\f1a5";
}
.fa-digg:before {
  content: "\f1a6";
}
.fa-pied-piper-pp:before {
  content: "\f1a7";
}
.fa-pied-piper-alt:before {
  content: "\f1a8";
}
.fa-drupal:before {
  content: "\f1a9";
}
.fa-joomla:before {
  content: "\f1aa";
}
.fa-language:before {
  content: "\f1ab";
}
.fa-fax:before {
  content: "\f1ac";
}
.fa-building:before {
  content: "\f1ad";
}
.fa-child:before {
  content: "\f1ae";
}
.fa-paw:before {
  content: "\f1b0";
}
.fa-spoon:before {
  content: "\f1b1";
}
.fa-cube:before {
  content: "\f1b2";
}
.fa-cubes:before {
  content: "\f1b3";
}
.fa-behance:before {
  content: "\f1b4";
}
.fa-behance-square:before {
  content: "\f1b5";
}
.fa-steam:before {
  content: "\f1b6";
}
.fa-steam-square:before {
  content: "\f1b7";
}
.fa-recycle:before {
  content: "\f1b8";
}
.fa-automobile:before,
.fa-car:before {
  content: "\f1b9";
}
.fa-cab:before,
.fa-taxi:before {
  content: "\f1ba";
}
.fa-tree:before {
  content: "\f1bb";
}
.fa-spotify:before {
  content: "\f1bc";
}
.fa-deviantart:before {
  content: "\f1bd";
}
.fa-soundcloud:before {
  content: "\f1be";
}
.fa-database:before {
  content: "\f1c0";
}
.fa-file-pdf-o:before {
  content: "\f1c1";
}
.fa-file-word-o:before {
  content: "\f1c2";
}
.fa-file-excel-o:before {
  content: "\f1c3";
}
.fa-file-powerpoint-o:before {
  content: "\f1c4";
}
.fa-file-photo-o:before,
.fa-file-picture-o:before,
.fa-file-image-o:before {
  content: "\f1c5";
}
.fa-file-zip-o:before,
.fa-file-archive-o:before {
  content: "\f1c6";
}
.fa-file-sound-o:before,
.fa-file-audio-o:before {
  content: "\f1c7";
}
.fa-file-movie-o:before,
.fa-file-video-o:before {
  content: "\f1c8";
}
.fa-file-code-o:before {
  content: "\f1c9";
}
.fa-vine:before {
  content: "\f1ca";
}
.fa-codepen:before {
  content: "\f1cb";
}
.fa-jsfiddle:before {
  content: "\f1cc";
}
.fa-life-bouy:before,
.fa-life-buoy:before,
.fa-life-saver:before,
.fa-support:before,
.fa-life-ring:before {
  content: "\f1cd";
}
.fa-circle-o-notch:before {
  content: "\f1ce";
}
.fa-ra:before,
.fa-resistance:before,
.fa-rebel:before {
  content: "\f1d0";
}
.fa-ge:before,
.fa-empire:before {
  content: "\f1d1";
}
.fa-git-square:before {
  content: "\f1d2";
}
.fa-git:before {
  content: "\f1d3";
}
.fa-y-combinator-square:before,
.fa-yc-square:before,
.fa-hacker-news:before {
  content: "\f1d4";
}
.fa-tencent-weibo:before {
  content: "\f1d5";
}
.fa-qq:before {
  content: "\f1d6";
}
.fa-wechat:before,
.fa-weixin:before {
  content: "\f1d7";
}
.fa-send:before,
.fa-paper-plane:before {
  content: "\f1d8";
}
.fa-send-o:before,
.fa-paper-plane-o:before {
  content: "\f1d9";
}
.fa-history:before {
  content: "\f1da";
}
.fa-circle-thin:before {
  content: "\f1db";
}
.fa-header:before {
  content: "\f1dc";
}
.fa-paragraph:before {
  content: "\f1dd";
}
.fa-sliders:before {
  content: "\f1de";
}
.fa-share-alt:before {
  content: "\f1e0";
}
.fa-share-alt-square:before {
  content: "\f1e1";
}
.fa-bomb:before {
  content: "\f1e2";
}
.fa-soccer-ball-o:before,
.fa-futbol-o:before {
  content: "\f1e3";
}
.fa-tty:before {
  content: "\f1e4";
}
.fa-binoculars:before {
  content: "\f1e5";
}
.fa-plug:before {
  content: "\f1e6";
}
.fa-slideshare:before {
  content: "\f1e7";
}
.fa-twitch:before {
  content: "\f1e8";
}
.fa-yelp:before {
  content: "\f1e9";
}
.fa-newspaper-o:before {
  content: "\f1ea";
}
.fa-wifi:before {
  content: "\f1eb";
}
.fa-calculator:before {
  content: "\f1ec";
}
.fa-paypal:before {
  content: "\f1ed";
}
.fa-google-wallet:before {
  content: "\f1ee";
}
.fa-cc-visa:before {
  content: "\f1f0";
}
.fa-cc-mastercard:before {
  content: "\f1f1";
}
.fa-cc-discover:before {
  content: "\f1f2";
}
.fa-cc-amex:before {
  content: "\f1f3";
}
.fa-cc-paypal:before {
  content: "\f1f4";
}
.fa-cc-stripe:before {
  content: "\f1f5";
}
.fa-bell-slash:before {
  content: "\f1f6";
}
.fa-bell-slash-o:before {
  content: "\f1f7";
}
.fa-trash:before {
  content: "\f1f8";
}
.fa-copyright:before {
  content: "\f1f9";
}
.fa-at:before {
  content: "\f1fa";
}
.fa-eyedropper:before {
  content: "\f1fb";
}
.fa-paint-brush:before {
  content: "\f1fc";
}
.fa-birthday-cake:before {
  content: "\f1fd";
}
.fa-area-chart:before {
  content: "\f1fe";
}
.fa-pie-chart:before {
  content: "\f200";
}
.fa-line-chart:before {
  content: "\f201";
}
.fa-lastfm:before {
  content: "\f202";
}
.fa-lastfm-square:before {
  content: "\f203";
}
.fa-toggle-off:before {
  content: "\f204";
}
.fa-toggle-on:before {
  content: "\f205";
}
.fa-bicycle:before {
  content: "\f206";
}
.fa-bus:before {
  content: "\f207";
}
.fa-ioxhost:before {
  content: "\f208";
}
.fa-angellist:before {
  content: "\f209";
}
.fa-cc:before {
  content: "\f20a";
}
.fa-shekel:before,
.fa-sheqel:before,
.fa-ils:before {
  content: "\f20b";
}
.fa-meanpath:before {
  content: "\f20c";
}
.fa-buysellads:before {
  content: "\f20d";
}
.fa-connectdevelop:before {
  content: "\f20e";
}
.fa-dashcube:before {
  content: "\f210";
}
.fa-forumbee:before {
  content: "\f211";
}
.fa-leanpub:before {
  content: "\f212";
}
.fa-sellsy:before {
  content: "\f213";
}
.fa-shirtsinbulk:before {
  content: "\f214";
}
.fa-simplybuilt:before {
  content: "\f215";
}
.fa-skyatlas:before {
  content: "\f216";
}
.fa-cart-plus:before {
  content: "\f217";
}
.fa-cart-arrow-down:before {
  content: "\f218";
}
.fa-diamond:before {
  content: "\f219";
}
.fa-ship:before {
  content: "\f21a";
}
.fa-user-secret:before {
  content: "\f21b";
}
.fa-motorcycle:before {
  content: "\f21c";
}
.fa-street-view:before {
  content: "\f21d";
}
.fa-heartbeat:before {
  content: "\f21e";
}
.fa-venus:before {
  content: "\f221";
}
.fa-mars:before {
  content: "\f222";
}
.fa-mercury:before {
  content: "\f223";
}
.fa-intersex:before,
.fa-transgender:before {
  content: "\f224";
}
.fa-transgender-alt:before {
  content: "\f225";
}
.fa-venus-double:before {
  content: "\f226";
}
.fa-mars-double:before {
  content: "\f227";
}
.fa-venus-mars:before {
  content: "\f228";
}
.fa-mars-stroke:before {
  content: "\f229";
}
.fa-mars-stroke-v:before {
  content: "\f22a";
}
.fa-mars-stroke-h:before {
  content: "\f22b";
}
.fa-neuter:before {
  content: "\f22c";
}
.fa-genderless:before {
  content: "\f22d";
}
.fa-facebook-official:before {
  content: "\f230";
}
.fa-pinterest-p:before {
  content: "\f231";
}
.fa-whatsapp:before {
  content: "\f232";
}
.fa-server:before {
  content: "\f233";
}
.fa-user-plus:before {
  content: "\f234";
}
.fa-user-times:before {
  content: "\f235";
}
.fa-hotel:before,
.fa-bed:before {
  content: "\f236";
}
.fa-viacoin:before {
  content: "\f237";
}
.fa-train:before {
  content: "\f238";
}
.fa-subway:before {
  content: "\f239";
}
.fa-medium:before {
  content: "\f23a";
}
.fa-yc:before,
.fa-y-combinator:before {
  content: "\f23b";
}
.fa-optin-monster:before {
  content: "\f23c";
}
.fa-opencart:before {
  content: "\f23d";
}
.fa-expeditedssl:before {
  content: "\f23e";
}
.fa-battery-4:before,
.fa-battery:before,
.fa-battery-full:before {
  content: "\f240";
}
.fa-battery-3:before,
.fa-battery-three-quarters:before {
  content: "\f241";
}
.fa-battery-2:before,
.fa-battery-half:before {
  content: "\f242";
}
.fa-battery-1:before,
.fa-battery-quarter:before {
  content: "\f243";
}
.fa-battery-0:before,
.fa-battery-empty:before {
  content: "\f244";
}
.fa-mouse-pointer:before {
  content: "\f245";
}
.fa-i-cursor:before {
  content: "\f246";
}
.fa-object-group:before {
  content: "\f247";
}
.fa-object-ungroup:before {
  content: "\f248";
}
.fa-sticky-note:before {
  content: "\f249";
}
.fa-sticky-note-o:before {
  content: "\f24a";
}
.fa-cc-jcb:before {
  content: "\f24b";
}
.fa-cc-diners-club:before {
  content: "\f24c";
}
.fa-clone:before {
  content: "\f24d";
}
.fa-balance-scale:before {
  content: "\f24e";
}
.fa-hourglass-o:before {
  content: "\f250";
}
.fa-hourglass-1:before,
.fa-hourglass-start:before {
  content: "\f251";
}
.fa-hourglass-2:before,
.fa-hourglass-half:before {
  content: "\f252";
}
.fa-hourglass-3:before,
.fa-hourglass-end:before {
  content: "\f253";
}
.fa-hourglass:before {
  content: "\f254";
}
.fa-hand-grab-o:before,
.fa-hand-rock-o:before {
  content: "\f255";
}
.fa-hand-stop-o:before,
.fa-hand-paper-o:before {
  content: "\f256";
}
.fa-hand-scissors-o:before {
  content: "\f257";
}
.fa-hand-lizard-o:before {
  content: "\f258";
}
.fa-hand-spock-o:before {
  content: "\f259";
}
.fa-hand-pointer-o:before {
  content: "\f25a";
}
.fa-hand-peace-o:before {
  content: "\f25b";
}
.fa-trademark:before {
  content: "\f25c";
}
.fa-registered:before {
  content: "\f25d";
}
.fa-creative-commons:before {
  content: "\f25e";
}
.fa-gg:before {
  content: "\f260";
}
.fa-gg-circle:before {
  content: "\f261";
}
.fa-tripadvisor:before {
  content: "\f262";
}
.fa-odnoklassniki:before {
  content: "\f263";
}
.fa-odnoklassniki-square:before {
  content: "\f264";
}
.fa-get-pocket:before {
  content: "\f265";
}
.fa-wikipedia-w:before {
  content: "\f266";
}
.fa-safari:before {
  content: "\f267";
}
.fa-chrome:before {
  content: "\f268";
}
.fa-firefox:before {
  content: "\f269";
}
.fa-opera:before {
  content: "\f26a";
}
.fa-internet-explorer:before {
  content: "\f26b";
}
.fa-tv:before,
.fa-television:before {
  content: "\f26c";
}
.fa-contao:before {
  content: "\f26d";
}
.fa-500px:before {
  content: "\f26e";
}
.fa-amazon:before {
  content: "\f270";
}
.fa-calendar-plus-o:before {
  content: "\f271";
}
.fa-calendar-minus-o:before {
  content: "\f272";
}
.fa-calendar-times-o:before {
  content: "\f273";
}
.fa-calendar-check-o:before {
  content: "\f274";
}
.fa-industry:before {
  content: "\f275";
}
.fa-map-pin:before {
  content: "\f276";
}
.fa-map-signs:before {
  content: "\f277";
}
.fa-map-o:before {
  content: "\f278";
}
.fa-map:before {
  content: "\f279";
}
.fa-commenting:before {
  content: "\f27a";
}
.fa-commenting-o:before {
  content: "\f27b";
}
.fa-houzz:before {
  content: "\f27c";
}
.fa-vimeo:before {
  content: "\f27d";
}
.fa-black-tie:before {
  content: "\f27e";
}
.fa-fonticons:before {
  content: "\f280";
}
.fa-reddit-alien:before {
  content: "\f281";
}
.fa-edge:before {
  content: "\f282";
}
.fa-credit-card-alt:before {
  content: "\f283";
}
.fa-codiepie:before {
  content: "\f284";
}
.fa-modx:before {
  content: "\f285";
}
.fa-fort-awesome:before {
  content: "\f286";
}
.fa-usb:before {
  content: "\f287";
}
.fa-product-hunt:before {
  content: "\f288";
}
.fa-mixcloud:before {
  content: "\f289";
}
.fa-scribd:before {
  content: "\f28a";
}
.fa-pause-circle:before {
  content: "\f28b";
}
.fa-pause-circle-o:before {
  content: "\f28c";
}
.fa-stop-circle:before {
  content: "\f28d";
}
.fa-stop-circle-o:before {
  content: "\f28e";
}
.fa-shopping-bag:before {
  content: "\f290";
}
.fa-shopping-basket:before {
  content: "\f291";
}
.fa-hashtag:before {
  content: "\f292";
}
.fa-bluetooth:before {
  content: "\f293";
}
.fa-bluetooth-b:before {
  content: "\f294";
}
.fa-percent:before {
  content: "\f295";
}
.fa-gitlab:before {
  content: "\f296";
}
.fa-wpbeginner:before {
  content: "\f297";
}
.fa-wpforms:before {
  content: "\f298";
}
.fa-envira:before {
  content: "\f299";
}
.fa-universal-access:before {
  content: "\f29a";
}
.fa-wheelchair-alt:before {
  content: "\f29b";
}
.fa-question-circle-o:before {
  content: "\f29c";
}
.fa-blind:before {
  content: "\f29d";
}
.fa-audio-description:before {
  content: "\f29e";
}
.fa-volume-control-phone:before {
  content: "\f2a0";
}
.fa-braille:before {
  content: "\f2a1";
}
.fa-assistive-listening-systems:before {
  content: "\f2a2";
}
.fa-asl-interpreting:before,
.fa-american-sign-language-interpreting:before {
  content: "\f2a3";
}
.fa-deafness:before,
.fa-hard-of-hearing:before,
.fa-deaf:before {
  content: "\f2a4";
}
.fa-glide:before {
  content: "\f2a5";
}
.fa-glide-g:before {
  content: "\f2a6";
}
.fa-signing:before,
.fa-sign-language:before {
  content: "\f2a7";
}
.fa-low-vision:before {
  content: "\f2a8";
}
.fa-viadeo:before {
  content: "\f2a9";
}
.fa-viadeo-square:before {
  content: "\f2aa";
}
.fa-snapchat:before {
  content: "\f2ab";
}
.fa-snapchat-ghost:before {
  content: "\f2ac";
}
.fa-snapchat-square:before {
  content: "\f2ad";
}
.fa-pied-piper:before {
  content: "\f2ae";
}
.fa-first-order:before {
  content: "\f2b0";
}
.fa-yoast:before {
  content: "\f2b1";
}
.fa-themeisle:before {
  content: "\f2b2";
}
.fa-google-plus-circle:before,
.fa-google-plus-official:before {
  content: "\f2b3";
}
.fa-fa:before,
.fa-font-awesome:before {
  content: "\f2b4";
}
.fa-handshake-o:before {
  content: "\f2b5";
}
.fa-envelope-open:before {
  content: "\f2b6";
}
.fa-envelope-open-o:before {
  content: "\f2b7";
}
.fa-linode:before {
  content: "\f2b8";
}
.fa-address-book:before {
  content: "\f2b9";
}
.fa-address-book-o:before {
  content: "\f2ba";
}
.fa-vcard:before,
.fa-address-card:before {
  content: "\f2bb";
}
.fa-vcard-o:before,
.fa-address-card-o:before {
  content: "\f2bc";
}
.fa-user-circle:before {
  content: "\f2bd";
}
.fa-user-circle-o:before {
  content: "\f2be";
}
.fa-user-o:before {
  content: "\f2c0";
}
.fa-id-badge:before {
  content: "\f2c1";
}
.fa-drivers-license:before,
.fa-id-card:before {
  content: "\f2c2";
}
.fa-drivers-license-o:before,
.fa-id-card-o:before {
  content: "\f2c3";
}
.fa-quora:before {
  content: "\f2c4";
}
.fa-free-code-camp:before {
  content: "\f2c5";
}
.fa-telegram:before {
  content: "\f2c6";
}
.fa-thermometer-4:before,
.fa-thermometer:before,
.fa-thermometer-full:before {
  content: "\f2c7";
}
.fa-thermometer-3:before,
.fa-thermometer-three-quarters:before {
  content: "\f2c8";
}
.fa-thermometer-2:before,
.fa-thermometer-half:before {
  content: "\f2c9";
}
.fa-thermometer-1:before,
.fa-thermometer-quarter:before {
  content: "\f2ca";
}
.fa-thermometer-0:before,
.fa-thermometer-empty:before {
  content: "\f2cb";
}
.fa-shower:before {
  content: "\f2cc";
}
.fa-bathtub:before,
.fa-s15:before,
.fa-bath:before {
  content: "\f2cd";
}
.fa-podcast:before {
  content: "\f2ce";
}
.fa-window-maximize:before {
  content: "\f2d0";
}
.fa-window-minimize:before {
  content: "\f2d1";
}
.fa-window-restore:before {
  content: "\f2d2";
}
.fa-times-rectangle:before,
.fa-window-close:before {
  content: "\f2d3";
}
.fa-times-rectangle-o:before,
.fa-window-close-o:before {
  content: "\f2d4";
}
.fa-bandcamp:before {
  content: "\f2d5";
}
.fa-grav:before {
  content: "\f2d6";
}
.fa-etsy:before {
  content: "\f2d7";
}
.fa-imdb:before {
  content: "\f2d8";
}
.fa-ravelry:before {
  content: "\f2d9";
}
.fa-eercast:before {
  content: "\f2da";
}
.fa-microchip:before {
  content: "\f2db";
}
.fa-snowflake-o:before {
  content: "\f2dc";
}
.fa-superpowers:before {
  content: "\f2dd";
}
.fa-wpexplorer:before {
  content: "\f2de";
}
.fa-meetup:before {
  content: "\f2e0";
}
.sr-only {
  position: absolute;
  width: 1px;
  height: 1px;
  padding: 0;
  margin: -1px;
  overflow: hidden;
  clip: rect(0, 0, 0, 0);
  border: 0;
}
.sr-only-focusable:active,
.sr-only-focusable:focus {
  position: static;
  width: auto;
  height: auto;
  margin: 0;
  overflow: visible;
  clip: auto;
}
.sr-only-focusable:active,
.sr-only-focusable:focus {
  position: static;
  width: auto;
  height: auto;
  margin: 0;
  overflow: visible;
  clip: auto;
}
/*!
*
* IPython base
*
*/
.modal.fade .modal-dialog {
  -webkit-transform: translate(0, 0);
  -ms-transform: translate(0, 0);
  -o-transform: translate(0, 0);
  transform: translate(0, 0);
}
code {
  color: #000;
}
pre {
  font-size: inherit;
  line-height: inherit;
}
label {
  font-weight: normal;
}
/* Make the page background atleast 100% the height of the view port */
/* Make the page itself atleast 70% the height of the view port */
.border-box-sizing {
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
}
.corner-all {
  border-radius: 2px;
}
.no-padding {
  padding: 0px;
}
/* Flexible box model classes */
/* Taken from Alex Russell http://infrequently.org/2009/08/css-3-progress/ */
/* This file is a compatability layer.  It allows the usage of flexible box 
model layouts accross multiple browsers, including older browsers.  The newest,
universal implementation of the flexible box model is used when available (see
`Modern browsers` comments below).  Browsers that are known to implement this 
new spec completely include:

    Firefox 28.0+
    Chrome 29.0+
    Internet Explorer 11+ 
    Opera 17.0+

Browsers not listed, including Safari, are supported via the styling under the
`Old browsers` comments below.
*/
.hbox {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
}
.hbox > * {
  /* Old browsers */
  -webkit-box-flex: 0;
  -moz-box-flex: 0;
  box-flex: 0;
  /* Modern browsers */
  flex: none;
}
.vbox {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
}
.vbox > * {
  /* Old browsers */
  -webkit-box-flex: 0;
  -moz-box-flex: 0;
  box-flex: 0;
  /* Modern browsers */
  flex: none;
}
.hbox.reverse,
.vbox.reverse,
.reverse {
  /* Old browsers */
  -webkit-box-direction: reverse;
  -moz-box-direction: reverse;
  box-direction: reverse;
  /* Modern browsers */
  flex-direction: row-reverse;
}
.hbox.box-flex0,
.vbox.box-flex0,
.box-flex0 {
  /* Old browsers */
  -webkit-box-flex: 0;
  -moz-box-flex: 0;
  box-flex: 0;
  /* Modern browsers */
  flex: none;
  width: auto;
}
.hbox.box-flex1,
.vbox.box-flex1,
.box-flex1 {
  /* Old browsers */
  -webkit-box-flex: 1;
  -moz-box-flex: 1;
  box-flex: 1;
  /* Modern browsers */
  flex: 1;
}
.hbox.box-flex,
.vbox.box-flex,
.box-flex {
  /* Old browsers */
  /* Old browsers */
  -webkit-box-flex: 1;
  -moz-box-flex: 1;
  box-flex: 1;
  /* Modern browsers */
  flex: 1;
}
.hbox.box-flex2,
.vbox.box-flex2,
.box-flex2 {
  /* Old browsers */
  -webkit-box-flex: 2;
  -moz-box-flex: 2;
  box-flex: 2;
  /* Modern browsers */
  flex: 2;
}
.box-group1 {
  /*  Deprecated */
  -webkit-box-flex-group: 1;
  -moz-box-flex-group: 1;
  box-flex-group: 1;
}
.box-group2 {
  /* Deprecated */
  -webkit-box-flex-group: 2;
  -moz-box-flex-group: 2;
  box-flex-group: 2;
}
.hbox.start,
.vbox.start,
.start {
  /* Old browsers */
  -webkit-box-pack: start;
  -moz-box-pack: start;
  box-pack: start;
  /* Modern browsers */
  justify-content: flex-start;
}
.hbox.end,
.vbox.end,
.end {
  /* Old browsers */
  -webkit-box-pack: end;
  -moz-box-pack: end;
  box-pack: end;
  /* Modern browsers */
  justify-content: flex-end;
}
.hbox.center,
.vbox.center,
.center {
  /* Old browsers */
  -webkit-box-pack: center;
  -moz-box-pack: center;
  box-pack: center;
  /* Modern browsers */
  justify-content: center;
}
.hbox.baseline,
.vbox.baseline,
.baseline {
  /* Old browsers */
  -webkit-box-pack: baseline;
  -moz-box-pack: baseline;
  box-pack: baseline;
  /* Modern browsers */
  justify-content: baseline;
}
.hbox.stretch,
.vbox.stretch,
.stretch {
  /* Old browsers */
  -webkit-box-pack: stretch;
  -moz-box-pack: stretch;
  box-pack: stretch;
  /* Modern browsers */
  justify-content: stretch;
}
.hbox.align-start,
.vbox.align-start,
.align-start {
  /* Old browsers */
  -webkit-box-align: start;
  -moz-box-align: start;
  box-align: start;
  /* Modern browsers */
  align-items: flex-start;
}
.hbox.align-end,
.vbox.align-end,
.align-end {
  /* Old browsers */
  -webkit-box-align: end;
  -moz-box-align: end;
  box-align: end;
  /* Modern browsers */
  align-items: flex-end;
}
.hbox.align-center,
.vbox.align-center,
.align-center {
  /* Old browsers */
  -webkit-box-align: center;
  -moz-box-align: center;
  box-align: center;
  /* Modern browsers */
  align-items: center;
}
.hbox.align-baseline,
.vbox.align-baseline,
.align-baseline {
  /* Old browsers */
  -webkit-box-align: baseline;
  -moz-box-align: baseline;
  box-align: baseline;
  /* Modern browsers */
  align-items: baseline;
}
.hbox.align-stretch,
.vbox.align-stretch,
.align-stretch {
  /* Old browsers */
  -webkit-box-align: stretch;
  -moz-box-align: stretch;
  box-align: stretch;
  /* Modern browsers */
  align-items: stretch;
}
div.error {
  margin: 2em;
  text-align: center;
}
div.error > h1 {
  font-size: 500%;
  line-height: normal;
}
div.error > p {
  font-size: 200%;
  line-height: normal;
}
div.traceback-wrapper {
  text-align: left;
  max-width: 800px;
  margin: auto;
}
div.traceback-wrapper pre.traceback {
  max-height: 600px;
  overflow: auto;
}
/**
 * Primary styles
 *
 * Author: Jupyter Development Team
 */
body {
  background-color: #fff;
  /* This makes sure that the body covers the entire window and needs to
       be in a different element than the display: box in wrapper below */
  position: absolute;
  left: 0px;
  right: 0px;
  top: 0px;
  bottom: 0px;
  overflow: visible;
}
body > #header {
  /* Initially hidden to prevent FLOUC */
  display: none;
  background-color: #fff;
  /* Display over codemirror */
  position: relative;
  z-index: 100;
}
body > #header #header-container {
  display: flex;
  flex-direction: row;
  justify-content: space-between;
  padding: 5px;
  padding-bottom: 5px;
  padding-top: 5px;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
}
body > #header .header-bar {
  width: 100%;
  height: 1px;
  background: #e7e7e7;
  margin-bottom: -1px;
}
@media print {
  body > #header {
    display: none !important;
  }
}
#header-spacer {
  width: 100%;
  visibility: hidden;
}
@media print {
  #header-spacer {
    display: none;
  }
}
#ipython_notebook {
  padding-left: 0px;
  padding-top: 1px;
  padding-bottom: 1px;
}
[dir="rtl"] #ipython_notebook {
  margin-right: 10px;
  margin-left: 0;
}
[dir="rtl"] #ipython_notebook.pull-left {
  float: right !important;
  float: right;
}
.flex-spacer {
  flex: 1;
}
#noscript {
  width: auto;
  padding-top: 16px;
  padding-bottom: 16px;
  text-align: center;
  font-size: 22px;
  color: red;
  font-weight: bold;
}
#ipython_notebook img {
  height: 28px;
}
#site {
  width: 100%;
  display: none;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  overflow: auto;
}
@media print {
  #site {
    height: auto !important;
  }
}
/* Smaller buttons */
.ui-button .ui-button-text {
  padding: 0.2em 0.8em;
  font-size: 77%;
}
input.ui-button {
  padding: 0.3em 0.9em;
}
span#kernel_logo_widget {
  margin: 0 10px;
}
span#login_widget {
  float: right;
}
[dir="rtl"] span#login_widget {
  float: left;
}
span#login_widget > .button,
#logout {
  color: #333;
  background-color: #fff;
  border-color: #ccc;
}
span#login_widget > .button:focus,
#logout:focus,
span#login_widget > .button.focus,
#logout.focus {
  color: #333;
  background-color: #e6e6e6;
  border-color: #8c8c8c;
}
span#login_widget > .button:hover,
#logout:hover {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
span#login_widget > .button:active,
#logout:active,
span#login_widget > .button.active,
#logout.active,
.open > .dropdown-togglespan#login_widget > .button,
.open > .dropdown-toggle#logout {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
span#login_widget > .button:active:hover,
#logout:active:hover,
span#login_widget > .button.active:hover,
#logout.active:hover,
.open > .dropdown-togglespan#login_widget > .button:hover,
.open > .dropdown-toggle#logout:hover,
span#login_widget > .button:active:focus,
#logout:active:focus,
span#login_widget > .button.active:focus,
#logout.active:focus,
.open > .dropdown-togglespan#login_widget > .button:focus,
.open > .dropdown-toggle#logout:focus,
span#login_widget > .button:active.focus,
#logout:active.focus,
span#login_widget > .button.active.focus,
#logout.active.focus,
.open > .dropdown-togglespan#login_widget > .button.focus,
.open > .dropdown-toggle#logout.focus {
  color: #333;
  background-color: #d4d4d4;
  border-color: #8c8c8c;
}
span#login_widget > .button:active,
#logout:active,
span#login_widget > .button.active,
#logout.active,
.open > .dropdown-togglespan#login_widget > .button,
.open > .dropdown-toggle#logout {
  background-image: none;
}
span#login_widget > .button.disabled:hover,
#logout.disabled:hover,
span#login_widget > .button[disabled]:hover,
#logout[disabled]:hover,
fieldset[disabled] span#login_widget > .button:hover,
fieldset[disabled] #logout:hover,
span#login_widget > .button.disabled:focus,
#logout.disabled:focus,
span#login_widget > .button[disabled]:focus,
#logout[disabled]:focus,
fieldset[disabled] span#login_widget > .button:focus,
fieldset[disabled] #logout:focus,
span#login_widget > .button.disabled.focus,
#logout.disabled.focus,
span#login_widget > .button[disabled].focus,
#logout[disabled].focus,
fieldset[disabled] span#login_widget > .button.focus,
fieldset[disabled] #logout.focus {
  background-color: #fff;
  border-color: #ccc;
}
span#login_widget > .button .badge,
#logout .badge {
  color: #fff;
  background-color: #333;
}
.nav-header {
  text-transform: none;
}
#header > span {
  margin-top: 10px;
}
.modal_stretch .modal-dialog {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
  min-height: 80vh;
}
.modal_stretch .modal-dialog .modal-body {
  max-height: calc(100vh - 200px);
  overflow: auto;
  flex: 1;
}
.modal-header {
  cursor: move;
}
@media (min-width: 768px) {
  .modal .modal-dialog {
    width: 700px;
  }
}
@media (min-width: 768px) {
  select.form-control {
    margin-left: 12px;
    margin-right: 12px;
  }
}
/*!
*
* IPython auth
*
*/
.center-nav {
  display: inline-block;
  margin-bottom: -4px;
}
[dir="rtl"] .center-nav form.pull-left {
  float: right !important;
  float: right;
}
[dir="rtl"] .center-nav .navbar-text {
  float: right;
}
[dir="rtl"] .navbar-inner {
  text-align: right;
}
[dir="rtl"] div.text-left {
  text-align: right;
}
/*!
*
* IPython tree view
*
*/
/* We need an invisible input field on top of the sentense*/
/* "Drag file onto the list ..." */
.alternate_upload {
  background-color: none;
  display: inline;
}
.alternate_upload.form {
  padding: 0;
  margin: 0;
}
.alternate_upload input.fileinput {
  position: absolute;
  display: block;
  width: 100%;
  height: 100%;
  overflow: hidden;
  cursor: pointer;
  opacity: 0;
  z-index: 2;
}
.alternate_upload .btn-xs > input.fileinput {
  margin: -1px -5px;
}
.alternate_upload .btn-upload {
  position: relative;
  height: 22px;
}
::-webkit-file-upload-button {
  cursor: pointer;
}
/**
 * Primary styles
 *
 * Author: Jupyter Development Team
 */
ul#tabs {
  margin-bottom: 4px;
}
ul#tabs a {
  padding-top: 6px;
  padding-bottom: 4px;
}
[dir="rtl"] ul#tabs.nav-tabs > li {
  float: right;
}
[dir="rtl"] ul#tabs.nav.nav-tabs {
  padding-right: 0;
}
ul.breadcrumb a:focus,
ul.breadcrumb a:hover {
  text-decoration: none;
}
ul.breadcrumb i.icon-home {
  font-size: 16px;
  margin-right: 4px;
}
ul.breadcrumb span {
  color: #5e5e5e;
}
.list_toolbar {
  padding: 4px 0 4px 0;
  vertical-align: middle;
}
.list_toolbar .tree-buttons {
  padding-top: 1px;
}
[dir="rtl"] .list_toolbar .tree-buttons .pull-right {
  float: left !important;
  float: left;
}
[dir="rtl"] .list_toolbar .col-sm-4,
[dir="rtl"] .list_toolbar .col-sm-8 {
  float: right;
}
.dynamic-buttons {
  padding-top: 3px;
  display: inline-block;
}
.list_toolbar [class*="span"] {
  min-height: 24px;
}
.list_header {
  font-weight: bold;
  background-color: #EEE;
}
.list_placeholder {
  font-weight: bold;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 7px;
  padding-right: 7px;
}
.list_container {
  margin-top: 4px;
  margin-bottom: 20px;
  border: 1px solid #ddd;
  border-radius: 2px;
}
.list_container > div {
  border-bottom: 1px solid #ddd;
}
.list_container > div:hover .list-item {
  background-color: red;
}
.list_container > div:last-child {
  border: none;
}
.list_item:hover .list_item {
  background-color: #ddd;
}
.list_item a {
  text-decoration: none;
}
.list_item:hover {
  background-color: #fafafa;
}
.list_header > div,
.list_item > div {
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 7px;
  padding-right: 7px;
  line-height: 22px;
}
.list_header > div input,
.list_item > div input {
  margin-right: 7px;
  margin-left: 14px;
  vertical-align: text-bottom;
  line-height: 22px;
  position: relative;
  top: -1px;
}
.list_header > div .item_link,
.list_item > div .item_link {
  margin-left: -1px;
  vertical-align: baseline;
  line-height: 22px;
}
[dir="rtl"] .list_item > div input {
  margin-right: 0;
}
.new-file input[type=checkbox] {
  visibility: hidden;
}
.item_name {
  line-height: 22px;
  height: 24px;
}
.item_icon {
  font-size: 14px;
  color: #5e5e5e;
  margin-right: 7px;
  margin-left: 7px;
  line-height: 22px;
  vertical-align: baseline;
}
.item_modified {
  margin-right: 7px;
  margin-left: 7px;
}
[dir="rtl"] .item_modified.pull-right {
  float: left !important;
  float: left;
}
.item_buttons {
  line-height: 1em;
  margin-left: -5px;
}
.item_buttons .btn,
.item_buttons .btn-group,
.item_buttons .input-group {
  float: left;
}
.item_buttons > .btn,
.item_buttons > .btn-group,
.item_buttons > .input-group {
  margin-left: 5px;
}
.item_buttons .btn {
  min-width: 13ex;
}
.item_buttons .running-indicator {
  padding-top: 4px;
  color: #5cb85c;
}
.item_buttons .kernel-name {
  padding-top: 4px;
  color: #5bc0de;
  margin-right: 7px;
  float: left;
}
[dir="rtl"] .item_buttons.pull-right {
  float: left !important;
  float: left;
}
[dir="rtl"] .item_buttons .kernel-name {
  margin-left: 7px;
  float: right;
}
.toolbar_info {
  height: 24px;
  line-height: 24px;
}
.list_item input:not([type=checkbox]) {
  padding-top: 3px;
  padding-bottom: 3px;
  height: 22px;
  line-height: 14px;
  margin: 0px;
}
.highlight_text {
  color: blue;
}
#project_name {
  display: inline-block;
  padding-left: 7px;
  margin-left: -2px;
}
#project_name > .breadcrumb {
  padding: 0px;
  margin-bottom: 0px;
  background-color: transparent;
  font-weight: bold;
}
.sort_button {
  display: inline-block;
  padding-left: 7px;
}
[dir="rtl"] .sort_button.pull-right {
  float: left !important;
  float: left;
}
#tree-selector {
  padding-right: 0px;
}
#button-select-all {
  min-width: 50px;
}
[dir="rtl"] #button-select-all.btn {
  float: right ;
}
#select-all {
  margin-left: 7px;
  margin-right: 2px;
  margin-top: 2px;
  height: 16px;
}
[dir="rtl"] #select-all.pull-left {
  float: right !important;
  float: right;
}
.menu_icon {
  margin-right: 2px;
}
.tab-content .row {
  margin-left: 0px;
  margin-right: 0px;
}
.folder_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f114";
}
.folder_icon:before.fa-pull-left {
  margin-right: .3em;
}
.folder_icon:before.fa-pull-right {
  margin-left: .3em;
}
.folder_icon:before.pull-left {
  margin-right: .3em;
}
.folder_icon:before.pull-right {
  margin-left: .3em;
}
.notebook_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f02d";
  position: relative;
  top: -1px;
}
.notebook_icon:before.fa-pull-left {
  margin-right: .3em;
}
.notebook_icon:before.fa-pull-right {
  margin-left: .3em;
}
.notebook_icon:before.pull-left {
  margin-right: .3em;
}
.notebook_icon:before.pull-right {
  margin-left: .3em;
}
.running_notebook_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f02d";
  position: relative;
  top: -1px;
  color: #5cb85c;
}
.running_notebook_icon:before.fa-pull-left {
  margin-right: .3em;
}
.running_notebook_icon:before.fa-pull-right {
  margin-left: .3em;
}
.running_notebook_icon:before.pull-left {
  margin-right: .3em;
}
.running_notebook_icon:before.pull-right {
  margin-left: .3em;
}
.file_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f016";
  position: relative;
  top: -2px;
}
.file_icon:before.fa-pull-left {
  margin-right: .3em;
}
.file_icon:before.fa-pull-right {
  margin-left: .3em;
}
.file_icon:before.pull-left {
  margin-right: .3em;
}
.file_icon:before.pull-right {
  margin-left: .3em;
}
#notebook_toolbar .pull-right {
  padding-top: 0px;
  margin-right: -1px;
}
ul#new-menu {
  left: auto;
  right: 0;
}
#new-menu .dropdown-header {
  font-size: 10px;
  border-bottom: 1px solid #e5e5e5;
  padding: 0 0 3px;
  margin: -3px 20px 0;
}
.kernel-menu-icon {
  padding-right: 12px;
  width: 24px;
  content: "\f096";
}
.kernel-menu-icon:before {
  content: "\f096";
}
.kernel-menu-icon-current:before {
  content: "\f00c";
}
#tab_content {
  padding-top: 20px;
}
#running .panel-group .panel {
  margin-top: 3px;
  margin-bottom: 1em;
}
#running .panel-group .panel .panel-heading {
  background-color: #EEE;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 7px;
  padding-right: 7px;
  line-height: 22px;
}
#running .panel-group .panel .panel-heading a:focus,
#running .panel-group .panel .panel-heading a:hover {
  text-decoration: none;
}
#running .panel-group .panel .panel-body {
  padding: 0px;
}
#running .panel-group .panel .panel-body .list_container {
  margin-top: 0px;
  margin-bottom: 0px;
  border: 0px;
  border-radius: 0px;
}
#running .panel-group .panel .panel-body .list_container .list_item {
  border-bottom: 1px solid #ddd;
}
#running .panel-group .panel .panel-body .list_container .list_item:last-child {
  border-bottom: 0px;
}
.delete-button {
  display: none;
}
.duplicate-button {
  display: none;
}
.rename-button {
  display: none;
}
.move-button {
  display: none;
}
.download-button {
  display: none;
}
.shutdown-button {
  display: none;
}
.dynamic-instructions {
  display: inline-block;
  padding-top: 4px;
}
/*!
*
* IPython text editor webapp
*
*/
.selected-keymap i.fa {
  padding: 0px 5px;
}
.selected-keymap i.fa:before {
  content: "\f00c";
}
#mode-menu {
  overflow: auto;
  max-height: 20em;
}
.edit_app #header {
  -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
}
.edit_app #menubar .navbar {
  /* Use a negative 1 bottom margin, so the border overlaps the border of the
    header */
  margin-bottom: -1px;
}
.dirty-indicator {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  width: 20px;
}
.dirty-indicator.fa-pull-left {
  margin-right: .3em;
}
.dirty-indicator.fa-pull-right {
  margin-left: .3em;
}
.dirty-indicator.pull-left {
  margin-right: .3em;
}
.dirty-indicator.pull-right {
  margin-left: .3em;
}
.dirty-indicator-dirty {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  width: 20px;
}
.dirty-indicator-dirty.fa-pull-left {
  margin-right: .3em;
}
.dirty-indicator-dirty.fa-pull-right {
  margin-left: .3em;
}
.dirty-indicator-dirty.pull-left {
  margin-right: .3em;
}
.dirty-indicator-dirty.pull-right {
  margin-left: .3em;
}
.dirty-indicator-clean {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  width: 20px;
}
.dirty-indicator-clean.fa-pull-left {
  margin-right: .3em;
}
.dirty-indicator-clean.fa-pull-right {
  margin-left: .3em;
}
.dirty-indicator-clean.pull-left {
  margin-right: .3em;
}
.dirty-indicator-clean.pull-right {
  margin-left: .3em;
}
.dirty-indicator-clean:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f00c";
}
.dirty-indicator-clean:before.fa-pull-left {
  margin-right: .3em;
}
.dirty-indicator-clean:before.fa-pull-right {
  margin-left: .3em;
}
.dirty-indicator-clean:before.pull-left {
  margin-right: .3em;
}
.dirty-indicator-clean:before.pull-right {
  margin-left: .3em;
}
#filename {
  font-size: 16pt;
  display: table;
  padding: 0px 5px;
}
#current-mode {
  padding-left: 5px;
  padding-right: 5px;
}
#texteditor-backdrop {
  padding-top: 20px;
  padding-bottom: 20px;
}
@media not print {
  #texteditor-backdrop {
    background-color: #EEE;
  }
}
@media print {
  #texteditor-backdrop #texteditor-container .CodeMirror-gutter,
  #texteditor-backdrop #texteditor-container .CodeMirror-gutters {
    background-color: #fff;
  }
}
@media not print {
  #texteditor-backdrop #texteditor-container .CodeMirror-gutter,
  #texteditor-backdrop #texteditor-container .CodeMirror-gutters {
    background-color: #fff;
  }
}
@media not print {
  #texteditor-backdrop #texteditor-container {
    padding: 0px;
    background-color: #fff;
    -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
    box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  }
}
.CodeMirror-dialog {
  background-color: #fff;
}
/*!
*
* IPython notebook
*
*/
/* CSS font colors for translated ANSI escape sequences */
/* The color values are a mix of
   http://www.xcolors.net/dl/baskerville-ivorylight and
   http://www.xcolors.net/dl/euphrasia */
.ansi-black-fg {
  color: #3E424D;
}
.ansi-black-bg {
  background-color: #3E424D;
}
.ansi-black-intense-fg {
  color: #282C36;
}
.ansi-black-intense-bg {
  background-color: #282C36;
}
.ansi-red-fg {
  color: #E75C58;
}
.ansi-red-bg {
  background-color: #E75C58;
}
.ansi-red-intense-fg {
  color: #B22B31;
}
.ansi-red-intense-bg {
  background-color: #B22B31;
}
.ansi-green-fg {
  color: #00A250;
}
.ansi-green-bg {
  background-color: #00A250;
}
.ansi-green-intense-fg {
  color: #007427;
}
.ansi-green-intense-bg {
  background-color: #007427;
}
.ansi-yellow-fg {
  color: #DDB62B;
}
.ansi-yellow-bg {
  background-color: #DDB62B;
}
.ansi-yellow-intense-fg {
  color: #B27D12;
}
.ansi-yellow-intense-bg {
  background-color: #B27D12;
}
.ansi-blue-fg {
  color: #208FFB;
}
.ansi-blue-bg {
  background-color: #208FFB;
}
.ansi-blue-intense-fg {
  color: #0065CA;
}
.ansi-blue-intense-bg {
  background-color: #0065CA;
}
.ansi-magenta-fg {
  color: #D160C4;
}
.ansi-magenta-bg {
  background-color: #D160C4;
}
.ansi-magenta-intense-fg {
  color: #A03196;
}
.ansi-magenta-intense-bg {
  background-color: #A03196;
}
.ansi-cyan-fg {
  color: #60C6C8;
}
.ansi-cyan-bg {
  background-color: #60C6C8;
}
.ansi-cyan-intense-fg {
  color: #258F8F;
}
.ansi-cyan-intense-bg {
  background-color: #258F8F;
}
.ansi-white-fg {
  color: #C5C1B4;
}
.ansi-white-bg {
  background-color: #C5C1B4;
}
.ansi-white-intense-fg {
  color: #A1A6B2;
}
.ansi-white-intense-bg {
  background-color: #A1A6B2;
}
.ansi-default-inverse-fg {
  color: #FFFFFF;
}
.ansi-default-inverse-bg {
  background-color: #000000;
}
.ansi-bold {
  font-weight: bold;
}
.ansi-underline {
  text-decoration: underline;
}
/* The following styles are deprecated an will be removed in a future version */
.ansibold {
  font-weight: bold;
}
.ansi-inverse {
  outline: 0.5px dotted;
}
/* use dark versions for foreground, to improve visibility */
.ansiblack {
  color: black;
}
.ansired {
  color: darkred;
}
.ansigreen {
  color: darkgreen;
}
.ansiyellow {
  color: #c4a000;
}
.ansiblue {
  color: darkblue;
}
.ansipurple {
  color: darkviolet;
}
.ansicyan {
  color: steelblue;
}
.ansigray {
  color: gray;
}
/* and light for background, for the same reason */
.ansibgblack {
  background-color: black;
}
.ansibgred {
  background-color: red;
}
.ansibggreen {
  background-color: green;
}
.ansibgyellow {
  background-color: yellow;
}
.ansibgblue {
  background-color: blue;
}
.ansibgpurple {
  background-color: magenta;
}
.ansibgcyan {
  background-color: cyan;
}
.ansibggray {
  background-color: gray;
}
div.cell {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
  border-radius: 2px;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  border-width: 1px;
  border-style: solid;
  border-color: transparent;
  width: 100%;
  padding: 5px;
  /* This acts as a spacer between cells, that is outside the border */
  margin: 0px;
  outline: none;
  position: relative;
  overflow: visible;
}
div.cell:before {
  position: absolute;
  display: block;
  top: -1px;
  left: -1px;
  width: 5px;
  height: calc(100% +  2px);
  content: '';
  background: transparent;
}
div.cell.jupyter-soft-selected {
  border-left-color: #E3F2FD;
  border-left-width: 1px;
  padding-left: 5px;
  border-right-color: #E3F2FD;
  border-right-width: 1px;
  background: #E3F2FD;
}
@media print {
  div.cell.jupyter-soft-selected {
    border-color: transparent;
  }
}
div.cell.selected,
div.cell.selected.jupyter-soft-selected {
  border-color: #ababab;
}
div.cell.selected:before,
div.cell.selected.jupyter-soft-selected:before {
  position: absolute;
  display: block;
  top: -1px;
  left: -1px;
  width: 5px;
  height: calc(100% +  2px);
  content: '';
  background: #42A5F5;
}
@media print {
  div.cell.selected,
  div.cell.selected.jupyter-soft-selected {
    border-color: transparent;
  }
}
.edit_mode div.cell.selected {
  border-color: #66BB6A;
}
.edit_mode div.cell.selected:before {
  position: absolute;
  display: block;
  top: -1px;
  left: -1px;
  width: 5px;
  height: calc(100% +  2px);
  content: '';
  background: #66BB6A;
}
@media print {
  .edit_mode div.cell.selected {
    border-color: transparent;
  }
}
.prompt {
  /* This needs to be wide enough for 3 digit prompt numbers: In[100]: */
  min-width: 14ex;
  /* This padding is tuned to match the padding on the CodeMirror editor. */
  padding: 0.4em;
  margin: 0px;
  font-family: monospace;
  text-align: right;
  /* This has to match that of the the CodeMirror class line-height below */
  line-height: 1.21429em;
  /* Don't highlight prompt number selection */
  -webkit-touch-callout: none;
  -webkit-user-select: none;
  -khtml-user-select: none;
  -moz-user-select: none;
  -ms-user-select: none;
  user-select: none;
  /* Use default cursor */
  cursor: default;
}
@media (max-width: 540px) {
  .prompt {
    text-align: left;
  }
}
div.inner_cell {
  min-width: 0;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
  /* Old browsers */
  -webkit-box-flex: 1;
  -moz-box-flex: 1;
  box-flex: 1;
  /* Modern browsers */
  flex: 1;
}
/* input_area and input_prompt must match in top border and margin for alignment */
div.input_area {
  border: 1px solid #cfcfcf;
  border-radius: 2px;
  background: #f7f7f7;
  line-height: 1.21429em;
}
/* This is needed so that empty prompt areas can collapse to zero height when there
   is no content in the output_subarea and the prompt. The main purpose of this is
   to make sure that empty JavaScript output_subareas have no height. */
div.prompt:empty {
  padding-top: 0;
  padding-bottom: 0;
}
div.unrecognized_cell {
  padding: 5px 5px 5px 0px;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
}
div.unrecognized_cell .inner_cell {
  border-radius: 2px;
  padding: 5px;
  font-weight: bold;
  color: red;
  border: 1px solid #cfcfcf;
  background: #eaeaea;
}
div.unrecognized_cell .inner_cell a {
  color: inherit;
  text-decoration: none;
}
div.unrecognized_cell .inner_cell a:hover {
  color: inherit;
  text-decoration: none;
}
@media (max-width: 540px) {
  div.unrecognized_cell > div.prompt {
    display: none;
  }
}
div.code_cell {
  /* avoid page breaking on code cells when printing */
}
@media print {
  div.code_cell {
    page-break-inside: avoid;
  }
}
/* any special styling for code cells that are currently running goes here */
div.input {
  page-break-inside: avoid;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
}
@media (max-width: 540px) {
  div.input {
    /* Old browsers */
    display: -webkit-box;
    -webkit-box-orient: vertical;
    -webkit-box-align: stretch;
    display: -moz-box;
    -moz-box-orient: vertical;
    -moz-box-align: stretch;
    display: box;
    box-orient: vertical;
    box-align: stretch;
    /* Modern browsers */
    display: flex;
    flex-direction: column;
    align-items: stretch;
  }
}
/* input_area and input_prompt must match in top border and margin for alignment */
div.input_prompt {
  color: #303F9F;
  border-top: 1px solid transparent;
}
div.input_area > div.highlight {
  margin: 0.4em;
  border: none;
  padding: 0px;
  background-color: transparent;
}
div.input_area > div.highlight > pre {
  margin: 0px;
  border: none;
  padding: 0px;
  background-color: transparent;
}
/* The following gets added to the <head> if it is detected that the user has a
 * monospace font with inconsistent normal/bold/italic height.  See
 * notebookmain.js.  Such fonts will have keywords vertically offset with
 * respect to the rest of the text.  The user should select a better font.
 * See: https://github.com/ipython/ipython/issues/1503
 *
 * .CodeMirror span {
 *      vertical-align: bottom;
 * }
 */
.CodeMirror {
  line-height: 1.21429em;
  /* Changed from 1em to our global default */
  font-size: 14px;
  height: auto;
  /* Changed to auto to autogrow */
  background: none;
  /* Changed from white to allow our bg to show through */
}
.CodeMirror-scroll {
  /*  The CodeMirror docs are a bit fuzzy on if overflow-y should be hidden or visible.*/
  /*  We have found that if it is visible, vertical scrollbars appear with font size changes.*/
  overflow-y: hidden;
  overflow-x: auto;
}
.CodeMirror-lines {
  /* In CM2, this used to be 0.4em, but in CM3 it went to 4px. We need the em value because */
  /* we have set a different line-height and want this to scale with that. */
  /* Note that this should set vertical padding only, since CodeMirror assumes
       that horizontal padding will be set on CodeMirror pre */
  padding: 0.4em 0;
}
.CodeMirror-linenumber {
  padding: 0 8px 0 4px;
}
.CodeMirror-gutters {
  border-bottom-left-radius: 2px;
  border-top-left-radius: 2px;
}
.CodeMirror pre {
  /* In CM3 this went to 4px from 0 in CM2. This sets horizontal padding only,
    use .CodeMirror-lines for vertical */
  padding: 0 0.4em;
  border: 0;
  border-radius: 0;
}
.CodeMirror-cursor {
  border-left: 1.4px solid black;
}
@media screen and (min-width: 2138px) and (max-width: 4319px) {
  .CodeMirror-cursor {
    border-left: 2px solid black;
  }
}
@media screen and (min-width: 4320px) {
  .CodeMirror-cursor {
    border-left: 4px solid black;
  }
}
/*

Original style from softwaremaniacs.org (c) Ivan Sagalaev <Maniac@SoftwareManiacs.Org>
Adapted from GitHub theme

*/
.highlight-base {
  color: #000;
}
.highlight-variable {
  color: #000;
}
.highlight-variable-2 {
  color: #1a1a1a;
}
.highlight-variable-3 {
  color: #333333;
}
.highlight-string {
  color: #BA2121;
}
.highlight-comment {
  color: #408080;
  font-style: italic;
}
.highlight-number {
  color: #080;
}
.highlight-atom {
  color: #88F;
}
.highlight-keyword {
  color: #008000;
  font-weight: bold;
}
.highlight-builtin {
  color: #008000;
}
.highlight-error {
  color: #f00;
}
.highlight-operator {
  color: #AA22FF;
  font-weight: bold;
}
.highlight-meta {
  color: #AA22FF;
}
/* previously not defined, copying from default codemirror */
.highlight-def {
  color: #00f;
}
.highlight-string-2 {
  color: #f50;
}
.highlight-qualifier {
  color: #555;
}
.highlight-bracket {
  color: #997;
}
.highlight-tag {
  color: #170;
}
.highlight-attribute {
  color: #00c;
}
.highlight-header {
  color: blue;
}
.highlight-quote {
  color: #090;
}
.highlight-link {
  color: #00c;
}
/* apply the same style to codemirror */
.cm-s-ipython span.cm-keyword {
  color: #008000;
  font-weight: bold;
}
.cm-s-ipython span.cm-atom {
  color: #88F;
}
.cm-s-ipython span.cm-number {
  color: #080;
}
.cm-s-ipython span.cm-def {
  color: #00f;
}
.cm-s-ipython span.cm-variable {
  color: #000;
}
.cm-s-ipython span.cm-operator {
  color: #AA22FF;
  font-weight: bold;
}
.cm-s-ipython span.cm-variable-2 {
  color: #1a1a1a;
}
.cm-s-ipython span.cm-variable-3 {
  color: #333333;
}
.cm-s-ipython span.cm-comment {
  color: #408080;
  font-style: italic;
}
.cm-s-ipython span.cm-string {
  color: #BA2121;
}
.cm-s-ipython span.cm-string-2 {
  color: #f50;
}
.cm-s-ipython span.cm-meta {
  color: #AA22FF;
}
.cm-s-ipython span.cm-qualifier {
  color: #555;
}
.cm-s-ipython span.cm-builtin {
  color: #008000;
}
.cm-s-ipython span.cm-bracket {
  color: #997;
}
.cm-s-ipython span.cm-tag {
  color: #170;
}
.cm-s-ipython span.cm-attribute {
  color: #00c;
}
.cm-s-ipython span.cm-header {
  color: blue;
}
.cm-s-ipython span.cm-quote {
  color: #090;
}
.cm-s-ipython span.cm-link {
  color: #00c;
}
.cm-s-ipython span.cm-error {
  color: #f00;
}
.cm-s-ipython span.cm-tab {
  background: url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAADAAAAAMCAYAAAAkuj5RAAAAAXNSR0IArs4c6QAAAGFJREFUSMft1LsRQFAQheHPowAKoACx3IgEKtaEHujDjORSgWTH/ZOdnZOcM/sgk/kFFWY0qV8foQwS4MKBCS3qR6ixBJvElOobYAtivseIE120FaowJPN75GMu8j/LfMwNjh4HUpwg4LUAAAAASUVORK5CYII=);
  background-position: right;
  background-repeat: no-repeat;
}
div.output_wrapper {
  /* this position must be relative to enable descendents to be absolute within it */
  position: relative;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
  z-index: 1;
}
/* class for the output area when it should be height-limited */
div.output_scroll {
  /* ideally, this would be max-height, but FF barfs all over that */
  height: 24em;
  /* FF needs this *and the wrapper* to specify full width, or it will shrinkwrap */
  width: 100%;
  overflow: auto;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 2px 8px rgba(0, 0, 0, 0.8);
  box-shadow: inset 0 2px 8px rgba(0, 0, 0, 0.8);
  display: block;
}
/* output div while it is collapsed */
div.output_collapsed {
  margin: 0px;
  padding: 0px;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
}
div.out_prompt_overlay {
  height: 100%;
  padding: 0px 0.4em;
  position: absolute;
  border-radius: 2px;
}
div.out_prompt_overlay:hover {
  /* use inner shadow to get border that is computed the same on WebKit/FF */
  -webkit-box-shadow: inset 0 0 1px #000;
  box-shadow: inset 0 0 1px #000;
  background: rgba(240, 240, 240, 0.5);
}
div.output_prompt {
  color: #D84315;
}
/* This class is the outer container of all output sections. */
div.output_area {
  padding: 0px;
  page-break-inside: avoid;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
}
div.output_area .MathJax_Display {
  text-align: left !important;
}
div.output_area .rendered_html table {
  margin-left: 0;
  margin-right: 0;
}
div.output_area .rendered_html img {
  margin-left: 0;
  margin-right: 0;
}
div.output_area img,
div.output_area svg {
  max-width: 100%;
  height: auto;
}
div.output_area img.unconfined,
div.output_area svg.unconfined {
  max-width: none;
}
div.output_area .mglyph > img {
  max-width: none;
}
/* This is needed to protect the pre formating from global settings such
   as that of bootstrap */
.output {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
}
@media (max-width: 540px) {
  div.output_area {
    /* Old browsers */
    display: -webkit-box;
    -webkit-box-orient: vertical;
    -webkit-box-align: stretch;
    display: -moz-box;
    -moz-box-orient: vertical;
    -moz-box-align: stretch;
    display: box;
    box-orient: vertical;
    box-align: stretch;
    /* Modern browsers */
    display: flex;
    flex-direction: column;
    align-items: stretch;
  }
}
div.output_area pre {
  margin: 0;
  padding: 1px 0 1px 0;
  border: 0;
  vertical-align: baseline;
  color: black;
  background-color: transparent;
  border-radius: 0;
}
/* This class is for the output subarea inside the output_area and after
   the prompt div. */
div.output_subarea {
  overflow-x: auto;
  padding: 0.4em;
  /* Old browsers */
  -webkit-box-flex: 1;
  -moz-box-flex: 1;
  box-flex: 1;
  /* Modern browsers */
  flex: 1;
  max-width: calc(100% - 14ex);
}
div.output_scroll div.output_subarea {
  overflow-x: visible;
}
/* The rest of the output_* classes are for special styling of the different
   output types */
/* all text output has this class: */
div.output_text {
  text-align: left;
  color: #000;
  /* This has to match that of the the CodeMirror class line-height below */
  line-height: 1.21429em;
}
/* stdout/stderr are 'text' as well as 'stream', but execute_result/error are *not* streams */
div.output_stderr {
  background: #fdd;
  /* very light red background for stderr */
}
div.output_latex {
  text-align: left;
}
/* Empty output_javascript divs should have no height */
div.output_javascript:empty {
  padding: 0;
}
.js-error {
  color: darkred;
}
/* raw_input styles */
div.raw_input_container {
  line-height: 1.21429em;
  padding-top: 5px;
}
pre.raw_input_prompt {
  /* nothing needed here. */
}
input.raw_input {
  font-family: monospace;
  font-size: inherit;
  color: inherit;
  width: auto;
  /* make sure input baseline aligns with prompt */
  vertical-align: baseline;
  /* padding + margin = 0.5em between prompt and cursor */
  padding: 0em 0.25em;
  margin: 0em 0.25em;
}
input.raw_input:focus {
  box-shadow: none;
}
p.p-space {
  margin-bottom: 10px;
}
div.output_unrecognized {
  padding: 5px;
  font-weight: bold;
  color: red;
}
div.output_unrecognized a {
  color: inherit;
  text-decoration: none;
}
div.output_unrecognized a:hover {
  color: inherit;
  text-decoration: none;
}
.rendered_html {
  color: #000;
  /* any extras will just be numbers: */
}
.rendered_html em {
  font-style: italic;
}
.rendered_html strong {
  font-weight: bold;
}
.rendered_html u {
  text-decoration: underline;
}
.rendered_html :link {
  text-decoration: underline;
}
.rendered_html :visited {
  text-decoration: underline;
}
.rendered_html h1 {
  font-size: 185.7%;
  margin: 1.08em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
}
.rendered_html h2 {
  font-size: 157.1%;
  margin: 1.27em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
}
.rendered_html h3 {
  font-size: 128.6%;
  margin: 1.55em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
}
.rendered_html h4 {
  font-size: 100%;
  margin: 2em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
}
.rendered_html h5 {
  font-size: 100%;
  margin: 2em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
  font-style: italic;
}
.rendered_html h6 {
  font-size: 100%;
  margin: 2em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
  font-style: italic;
}
.rendered_html h1:first-child {
  margin-top: 0.538em;
}
.rendered_html h2:first-child {
  margin-top: 0.636em;
}
.rendered_html h3:first-child {
  margin-top: 0.777em;
}
.rendered_html h4:first-child {
  margin-top: 1em;
}
.rendered_html h5:first-child {
  margin-top: 1em;
}
.rendered_html h6:first-child {
  margin-top: 1em;
}
.rendered_html ul:not(.list-inline),
.rendered_html ol:not(.list-inline) {
  padding-left: 2em;
}
.rendered_html ul {
  list-style: disc;
}
.rendered_html ul ul {
  list-style: square;
  margin-top: 0;
}
.rendered_html ul ul ul {
  list-style: circle;
}
.rendered_html ol {
  list-style: decimal;
}
.rendered_html ol ol {
  list-style: upper-alpha;
  margin-top: 0;
}
.rendered_html ol ol ol {
  list-style: lower-alpha;
}
.rendered_html ol ol ol ol {
  list-style: lower-roman;
}
.rendered_html ol ol ol ol ol {
  list-style: decimal;
}
.rendered_html * + ul {
  margin-top: 1em;
}
.rendered_html * + ol {
  margin-top: 1em;
}
.rendered_html hr {
  color: black;
  background-color: black;
}
.rendered_html pre {
  margin: 1em 2em;
  padding: 0px;
  background-color: #fff;
}
.rendered_html code {
  background-color: #eff0f1;
}
.rendered_html p code {
  padding: 1px 5px;
}
.rendered_html pre code {
  background-color: #fff;
}
.rendered_html pre,
.rendered_html code {
  border: 0;
  color: #000;
  font-size: 100%;
}
.rendered_html blockquote {
  margin: 1em 2em;
}
.rendered_html table {
  margin-left: auto;
  margin-right: auto;
  border: none;
  border-collapse: collapse;
  border-spacing: 0;
  color: black;
  font-size: 12px;
  table-layout: fixed;
}
.rendered_html thead {
  border-bottom: 1px solid black;
  vertical-align: bottom;
}
.rendered_html tr,
.rendered_html th,
.rendered_html td {
  text-align: right;
  vertical-align: middle;
  padding: 0.5em 0.5em;
  line-height: normal;
  white-space: normal;
  max-width: none;
  border: none;
}
.rendered_html th {
  font-weight: bold;
}
.rendered_html tbody tr:nth-child(odd) {
  background: #f5f5f5;
}
.rendered_html tbody tr:hover {
  background: rgba(66, 165, 245, 0.2);
}
.rendered_html * + table {
  margin-top: 1em;
}
.rendered_html p {
  text-align: left;
}
.rendered_html * + p {
  margin-top: 1em;
}
.rendered_html img {
  display: block;
  margin-left: auto;
  margin-right: auto;
}
.rendered_html * + img {
  margin-top: 1em;
}
.rendered_html img,
.rendered_html svg {
  max-width: 100%;
  height: auto;
}
.rendered_html img.unconfined,
.rendered_html svg.unconfined {
  max-width: none;
}
.rendered_html .alert {
  margin-bottom: initial;
}
.rendered_html * + .alert {
  margin-top: 1em;
}
[dir="rtl"] .rendered_html p {
  text-align: right;
}
div.text_cell {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
}
@media (max-width: 540px) {
  div.text_cell > div.prompt {
    display: none;
  }
}
div.text_cell_render {
  /*font-family: "Helvetica Neue", Arial, Helvetica, Geneva, sans-serif;*/
  outline: none;
  resize: none;
  width: inherit;
  border-style: none;
  padding: 0.5em 0.5em 0.5em 0.4em;
  color: #000;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
}
a.anchor-link:link {
  text-decoration: none;
  padding: 0px 20px;
  visibility: hidden;
}
h1:hover .anchor-link,
h2:hover .anchor-link,
h3:hover .anchor-link,
h4:hover .anchor-link,
h5:hover .anchor-link,
h6:hover .anchor-link {
  visibility: visible;
}
.text_cell.rendered .input_area {
  display: none;
}
.text_cell.rendered .rendered_html {
  overflow-x: auto;
  overflow-y: hidden;
}
.text_cell.rendered .rendered_html tr,
.text_cell.rendered .rendered_html th,
.text_cell.rendered .rendered_html td {
  max-width: none;
}
.text_cell.unrendered .text_cell_render {
  display: none;
}
.text_cell .dropzone .input_area {
  border: 2px dashed #bababa;
  margin: -1px;
}
.cm-header-1,
.cm-header-2,
.cm-header-3,
.cm-header-4,
.cm-header-5,
.cm-header-6 {
  font-weight: bold;
  font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
}
.cm-header-1 {
  font-size: 185.7%;
}
.cm-header-2 {
  font-size: 157.1%;
}
.cm-header-3 {
  font-size: 128.6%;
}
.cm-header-4 {
  font-size: 110%;
}
.cm-header-5 {
  font-size: 100%;
  font-style: italic;
}
.cm-header-6 {
  font-size: 100%;
  font-style: italic;
}
/*!
*
* IPython notebook webapp
*
*/
@media (max-width: 767px) {
  .notebook_app {
    padding-left: 0px;
    padding-right: 0px;
  }
}
#ipython-main-app {
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  height: 100%;
}
div#notebook_panel {
  margin: 0px;
  padding: 0px;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  height: 100%;
}
div#notebook {
  font-size: 14px;
  line-height: 20px;
  overflow-y: hidden;
  overflow-x: auto;
  width: 100%;
  /* This spaces the page away from the edge of the notebook area */
  padding-top: 20px;
  margin: 0px;
  outline: none;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  min-height: 100%;
}
@media not print {
  #notebook-container {
    padding: 15px;
    background-color: #fff;
    min-height: 0;
    -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
    box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  }
}
@media print {
  #notebook-container {
    width: 100%;
  }
}
div.ui-widget-content {
  border: 1px solid #ababab;
  outline: none;
}
pre.dialog {
  background-color: #f7f7f7;
  border: 1px solid #ddd;
  border-radius: 2px;
  padding: 0.4em;
  padding-left: 2em;
}
p.dialog {
  padding: 0.2em;
}
/* Word-wrap output correctly.  This is the CSS3 spelling, though Firefox seems
   to not honor it correctly.  Webkit browsers (Chrome, rekonq, Safari) do.
 */
pre,
code,
kbd,
samp {
  white-space: pre-wrap;
}
#fonttest {
  font-family: monospace;
}
p {
  margin-bottom: 0;
}
.end_space {
  min-height: 100px;
  transition: height .2s ease;
}
.notebook_app > #header {
  -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
}
@media not print {
  .notebook_app {
    background-color: #EEE;
  }
}
kbd {
  border-style: solid;
  border-width: 1px;
  box-shadow: none;
  margin: 2px;
  padding-left: 2px;
  padding-right: 2px;
  padding-top: 1px;
  padding-bottom: 1px;
}
.jupyter-keybindings {
  padding: 1px;
  line-height: 24px;
  border-bottom: 1px solid gray;
}
.jupyter-keybindings input {
  margin: 0;
  padding: 0;
  border: none;
}
.jupyter-keybindings i {
  padding: 6px;
}
.well code {
  background-color: #ffffff;
  border-color: #ababab;
  border-width: 1px;
  border-style: solid;
  padding: 2px;
  padding-top: 1px;
  padding-bottom: 1px;
}
/* CSS for the cell toolbar */
.celltoolbar {
  border: thin solid #CFCFCF;
  border-bottom: none;
  background: #EEE;
  border-radius: 2px 2px 0px 0px;
  width: 100%;
  height: 29px;
  padding-right: 4px;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
  /* Old browsers */
  -webkit-box-pack: end;
  -moz-box-pack: end;
  box-pack: end;
  /* Modern browsers */
  justify-content: flex-end;
  display: -webkit-flex;
}
@media print {
  .celltoolbar {
    display: none;
  }
}
.ctb_hideshow {
  display: none;
  vertical-align: bottom;
}
/* ctb_show is added to the ctb_hideshow div to show the cell toolbar.
   Cell toolbars are only shown when the ctb_global_show class is also set.
*/
.ctb_global_show .ctb_show.ctb_hideshow {
  display: block;
}
.ctb_global_show .ctb_show + .input_area,
.ctb_global_show .ctb_show + div.text_cell_input,
.ctb_global_show .ctb_show ~ div.text_cell_render {
  border-top-right-radius: 0px;
  border-top-left-radius: 0px;
}
.ctb_global_show .ctb_show ~ div.text_cell_render {
  border: 1px solid #cfcfcf;
}
.celltoolbar {
  font-size: 87%;
  padding-top: 3px;
}
.celltoolbar select {
  display: block;
  width: 100%;
  height: 32px;
  padding: 6px 12px;
  font-size: 13px;
  line-height: 1.42857143;
  color: #555555;
  background-color: #fff;
  background-image: none;
  border: 1px solid #ccc;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  -webkit-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  -o-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  height: 30px;
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
  width: inherit;
  font-size: inherit;
  height: 22px;
  padding: 0px;
  display: inline-block;
}
.celltoolbar select:focus {
  border-color: #66afe9;
  outline: 0;
  -webkit-box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
  box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
}
.celltoolbar select::-moz-placeholder {
  color: #999;
  opacity: 1;
}
.celltoolbar select:-ms-input-placeholder {
  color: #999;
}
.celltoolbar select::-webkit-input-placeholder {
  color: #999;
}
.celltoolbar select::-ms-expand {
  border: 0;
  background-color: transparent;
}
.celltoolbar select[disabled],
.celltoolbar select[readonly],
fieldset[disabled] .celltoolbar select {
  background-color: #eeeeee;
  opacity: 1;
}
.celltoolbar select[disabled],
fieldset[disabled] .celltoolbar select {
  cursor: not-allowed;
}
textarea.celltoolbar select {
  height: auto;
}
select.celltoolbar select {
  height: 30px;
  line-height: 30px;
}
textarea.celltoolbar select,
select[multiple].celltoolbar select {
  height: auto;
}
.celltoolbar label {
  margin-left: 5px;
  margin-right: 5px;
}
.tags_button_container {
  width: 100%;
  display: flex;
}
.tag-container {
  display: flex;
  flex-direction: row;
  flex-grow: 1;
  overflow: hidden;
  position: relative;
}
.tag-container > * {
  margin: 0 4px;
}
.remove-tag-btn {
  margin-left: 4px;
}
.tags-input {
  display: flex;
}
.cell-tag:last-child:after {
  content: "";
  position: absolute;
  right: 0;
  width: 40px;
  height: 100%;
  /* Fade to background color of cell toolbar */
  background: linear-gradient(to right, rgba(0, 0, 0, 0), #EEE);
}
.tags-input > * {
  margin-left: 4px;
}
.cell-tag,
.tags-input input,
.tags-input button {
  display: block;
  width: 100%;
  height: 32px;
  padding: 6px 12px;
  font-size: 13px;
  line-height: 1.42857143;
  color: #555555;
  background-color: #fff;
  background-image: none;
  border: 1px solid #ccc;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  -webkit-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  -o-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  height: 30px;
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
  box-shadow: none;
  width: inherit;
  font-size: inherit;
  height: 22px;
  line-height: 22px;
  padding: 0px 4px;
  display: inline-block;
}
.cell-tag:focus,
.tags-input input:focus,
.tags-input button:focus {
  border-color: #66afe9;
  outline: 0;
  -webkit-box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
  box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
}
.cell-tag::-moz-placeholder,
.tags-input input::-moz-placeholder,
.tags-input button::-moz-placeholder {
  color: #999;
  opacity: 1;
}
.cell-tag:-ms-input-placeholder,
.tags-input input:-ms-input-placeholder,
.tags-input button:-ms-input-placeholder {
  color: #999;
}
.cell-tag::-webkit-input-placeholder,
.tags-input input::-webkit-input-placeholder,
.tags-input button::-webkit-input-placeholder {
  color: #999;
}
.cell-tag::-ms-expand,
.tags-input input::-ms-expand,
.tags-input button::-ms-expand {
  border: 0;
  background-color: transparent;
}
.cell-tag[disabled],
.tags-input input[disabled],
.tags-input button[disabled],
.cell-tag[readonly],
.tags-input input[readonly],
.tags-input button[readonly],
fieldset[disabled] .cell-tag,
fieldset[disabled] .tags-input input,
fieldset[disabled] .tags-input button {
  background-color: #eeeeee;
  opacity: 1;
}
.cell-tag[disabled],
.tags-input input[disabled],
.tags-input button[disabled],
fieldset[disabled] .cell-tag,
fieldset[disabled] .tags-input input,
fieldset[disabled] .tags-input button {
  cursor: not-allowed;
}
textarea.cell-tag,
textarea.tags-input input,
textarea.tags-input button {
  height: auto;
}
select.cell-tag,
select.tags-input input,
select.tags-input button {
  height: 30px;
  line-height: 30px;
}
textarea.cell-tag,
textarea.tags-input input,
textarea.tags-input button,
select[multiple].cell-tag,
select[multiple].tags-input input,
select[multiple].tags-input button {
  height: auto;
}
.cell-tag,
.tags-input button {
  padding: 0px 4px;
}
.cell-tag {
  background-color: #fff;
  white-space: nowrap;
}
.tags-input input[type=text]:focus {
  outline: none;
  box-shadow: none;
  border-color: #ccc;
}
.completions {
  position: absolute;
  z-index: 110;
  overflow: hidden;
  border: 1px solid #ababab;
  border-radius: 2px;
  -webkit-box-shadow: 0px 6px 10px -1px #adadad;
  box-shadow: 0px 6px 10px -1px #adadad;
  line-height: 1;
}
.completions select {
  background: white;
  outline: none;
  border: none;
  padding: 0px;
  margin: 0px;
  overflow: auto;
  font-family: monospace;
  font-size: 110%;
  color: #000;
  width: auto;
}
.completions select option.context {
  color: #286090;
}
#kernel_logo_widget .current_kernel_logo {
  display: none;
  margin-top: -1px;
  margin-bottom: -1px;
  width: 32px;
  height: 32px;
}
[dir="rtl"] #kernel_logo_widget {
  float: left !important;
  float: left;
}
.modal .modal-body .move-path {
  display: flex;
  flex-direction: row;
  justify-content: space;
  align-items: center;
}
.modal .modal-body .move-path .server-root {
  padding-right: 20px;
}
.modal .modal-body .move-path .path-input {
  flex: 1;
}
#menubar {
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  margin-top: 1px;
}
#menubar .navbar {
  border-top: 1px;
  border-radius: 0px 0px 2px 2px;
  margin-bottom: 0px;
}
#menubar .navbar-toggle {
  float: left;
  padding-top: 7px;
  padding-bottom: 7px;
  border: none;
}
#menubar .navbar-collapse {
  clear: left;
}
[dir="rtl"] #menubar .navbar-toggle {
  float: right;
}
[dir="rtl"] #menubar .navbar-collapse {
  clear: right;
}
[dir="rtl"] #menubar .navbar-nav {
  float: right;
}
[dir="rtl"] #menubar .nav {
  padding-right: 0px;
}
[dir="rtl"] #menubar .navbar-nav > li {
  float: right;
}
[dir="rtl"] #menubar .navbar-right {
  float: left !important;
}
[dir="rtl"] ul.dropdown-menu {
  text-align: right;
  left: auto;
}
[dir="rtl"] ul#new-menu.dropdown-menu {
  right: auto;
  left: 0;
}
.nav-wrapper {
  border-bottom: 1px solid #e7e7e7;
}
i.menu-icon {
  padding-top: 4px;
}
[dir="rtl"] i.menu-icon.pull-right {
  float: left !important;
  float: left;
}
ul#help_menu li a {
  overflow: hidden;
  padding-right: 2.2em;
}
ul#help_menu li a i {
  margin-right: -1.2em;
}
[dir="rtl"] ul#help_menu li a {
  padding-left: 2.2em;
}
[dir="rtl"] ul#help_menu li a i {
  margin-right: 0;
  margin-left: -1.2em;
}
[dir="rtl"] ul#help_menu li a i.pull-right {
  float: left !important;
  float: left;
}
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu > .dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
}
[dir="rtl"] .dropdown-submenu > .dropdown-menu {
  right: 100%;
  margin-right: -1px;
}
.dropdown-submenu:hover > .dropdown-menu {
  display: block;
}
.dropdown-submenu > a:after {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  display: block;
  content: "\f0da";
  float: right;
  color: #333333;
  margin-top: 2px;
  margin-right: -10px;
}
.dropdown-submenu > a:after.fa-pull-left {
  margin-right: .3em;
}
.dropdown-submenu > a:after.fa-pull-right {
  margin-left: .3em;
}
.dropdown-submenu > a:after.pull-left {
  margin-right: .3em;
}
.dropdown-submenu > a:after.pull-right {
  margin-left: .3em;
}
[dir="rtl"] .dropdown-submenu > a:after {
  float: left;
  content: "\f0d9";
  margin-right: 0;
  margin-left: -10px;
}
.dropdown-submenu:hover > a:after {
  color: #262626;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left > .dropdown-menu {
  left: -100%;
  margin-left: 10px;
}
#notification_area {
  float: right !important;
  float: right;
  z-index: 10;
}
[dir="rtl"] #notification_area {
  float: left !important;
  float: left;
}
.indicator_area {
  float: right !important;
  float: right;
  color: #777;
  margin-left: 5px;
  margin-right: 5px;
  width: 11px;
  z-index: 10;
  text-align: center;
  width: auto;
}
[dir="rtl"] .indicator_area {
  float: left !important;
  float: left;
}
#kernel_indicator {
  float: right !important;
  float: right;
  color: #777;
  margin-left: 5px;
  margin-right: 5px;
  width: 11px;
  z-index: 10;
  text-align: center;
  width: auto;
  border-left: 1px solid;
}
#kernel_indicator .kernel_indicator_name {
  padding-left: 5px;
  padding-right: 5px;
}
[dir="rtl"] #kernel_indicator {
  float: left !important;
  float: left;
  border-left: 0;
  border-right: 1px solid;
}
#modal_indicator {
  float: right !important;
  float: right;
  color: #777;
  margin-left: 5px;
  margin-right: 5px;
  width: 11px;
  z-index: 10;
  text-align: center;
  width: auto;
}
[dir="rtl"] #modal_indicator {
  float: left !important;
  float: left;
}
#readonly-indicator {
  float: right !important;
  float: right;
  color: #777;
  margin-left: 5px;
  margin-right: 5px;
  width: 11px;
  z-index: 10;
  text-align: center;
  width: auto;
  margin-top: 2px;
  margin-bottom: 0px;
  margin-left: 0px;
  margin-right: 0px;
  display: none;
}
.modal_indicator:before {
  width: 1.28571429em;
  text-align: center;
}
.edit_mode .modal_indicator:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f040";
}
.edit_mode .modal_indicator:before.fa-pull-left {
  margin-right: .3em;
}
.edit_mode .modal_indicator:before.fa-pull-right {
  margin-left: .3em;
}
.edit_mode .modal_indicator:before.pull-left {
  margin-right: .3em;
}
.edit_mode .modal_indicator:before.pull-right {
  margin-left: .3em;
}
.command_mode .modal_indicator:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: ' ';
}
.command_mode .modal_indicator:before.fa-pull-left {
  margin-right: .3em;
}
.command_mode .modal_indicator:before.fa-pull-right {
  margin-left: .3em;
}
.command_mode .modal_indicator:before.pull-left {
  margin-right: .3em;
}
.command_mode .modal_indicator:before.pull-right {
  margin-left: .3em;
}
.kernel_idle_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f10c";
}
.kernel_idle_icon:before.fa-pull-left {
  margin-right: .3em;
}
.kernel_idle_icon:before.fa-pull-right {
  margin-left: .3em;
}
.kernel_idle_icon:before.pull-left {
  margin-right: .3em;
}
.kernel_idle_icon:before.pull-right {
  margin-left: .3em;
}
.kernel_busy_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f111";
}
.kernel_busy_icon:before.fa-pull-left {
  margin-right: .3em;
}
.kernel_busy_icon:before.fa-pull-right {
  margin-left: .3em;
}
.kernel_busy_icon:before.pull-left {
  margin-right: .3em;
}
.kernel_busy_icon:before.pull-right {
  margin-left: .3em;
}
.kernel_dead_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f1e2";
}
.kernel_dead_icon:before.fa-pull-left {
  margin-right: .3em;
}
.kernel_dead_icon:before.fa-pull-right {
  margin-left: .3em;
}
.kernel_dead_icon:before.pull-left {
  margin-right: .3em;
}
.kernel_dead_icon:before.pull-right {
  margin-left: .3em;
}
.kernel_disconnected_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f127";
}
.kernel_disconnected_icon:before.fa-pull-left {
  margin-right: .3em;
}
.kernel_disconnected_icon:before.fa-pull-right {
  margin-left: .3em;
}
.kernel_disconnected_icon:before.pull-left {
  margin-right: .3em;
}
.kernel_disconnected_icon:before.pull-right {
  margin-left: .3em;
}
.notification_widget {
  color: #777;
  z-index: 10;
  background: rgba(240, 240, 240, 0.5);
  margin-right: 4px;
  color: #333;
  background-color: #fff;
  border-color: #ccc;
}
.notification_widget:focus,
.notification_widget.focus {
  color: #333;
  background-color: #e6e6e6;
  border-color: #8c8c8c;
}
.notification_widget:hover {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
.notification_widget:active,
.notification_widget.active,
.open > .dropdown-toggle.notification_widget {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
.notification_widget:active:hover,
.notification_widget.active:hover,
.open > .dropdown-toggle.notification_widget:hover,
.notification_widget:active:focus,
.notification_widget.active:focus,
.open > .dropdown-toggle.notification_widget:focus,
.notification_widget:active.focus,
.notification_widget.active.focus,
.open > .dropdown-toggle.notification_widget.focus {
  color: #333;
  background-color: #d4d4d4;
  border-color: #8c8c8c;
}
.notification_widget:active,
.notification_widget.active,
.open > .dropdown-toggle.notification_widget {
  background-image: none;
}
.notification_widget.disabled:hover,
.notification_widget[disabled]:hover,
fieldset[disabled] .notification_widget:hover,
.notification_widget.disabled:focus,
.notification_widget[disabled]:focus,
fieldset[disabled] .notification_widget:focus,
.notification_widget.disabled.focus,
.notification_widget[disabled].focus,
fieldset[disabled] .notification_widget.focus {
  background-color: #fff;
  border-color: #ccc;
}
.notification_widget .badge {
  color: #fff;
  background-color: #333;
}
.notification_widget.warning {
  color: #fff;
  background-color: #f0ad4e;
  border-color: #eea236;
}
.notification_widget.warning:focus,
.notification_widget.warning.focus {
  color: #fff;
  background-color: #ec971f;
  border-color: #985f0d;
}
.notification_widget.warning:hover {
  color: #fff;
  background-color: #ec971f;
  border-color: #d58512;
}
.notification_widget.warning:active,
.notification_widget.warning.active,
.open > .dropdown-toggle.notification_widget.warning {
  color: #fff;
  background-color: #ec971f;
  border-color: #d58512;
}
.notification_widget.warning:active:hover,
.notification_widget.warning.active:hover,
.open > .dropdown-toggle.notification_widget.warning:hover,
.notification_widget.warning:active:focus,
.notification_widget.warning.active:focus,
.open > .dropdown-toggle.notification_widget.warning:focus,
.notification_widget.warning:active.focus,
.notification_widget.warning.active.focus,
.open > .dropdown-toggle.notification_widget.warning.focus {
  color: #fff;
  background-color: #d58512;
  border-color: #985f0d;
}
.notification_widget.warning:active,
.notification_widget.warning.active,
.open > .dropdown-toggle.notification_widget.warning {
  background-image: none;
}
.notification_widget.warning.disabled:hover,
.notification_widget.warning[disabled]:hover,
fieldset[disabled] .notification_widget.warning:hover,
.notification_widget.warning.disabled:focus,
.notification_widget.warning[disabled]:focus,
fieldset[disabled] .notification_widget.warning:focus,
.notification_widget.warning.disabled.focus,
.notification_widget.warning[disabled].focus,
fieldset[disabled] .notification_widget.warning.focus {
  background-color: #f0ad4e;
  border-color: #eea236;
}
.notification_widget.warning .badge {
  color: #f0ad4e;
  background-color: #fff;
}
.notification_widget.success {
  color: #fff;
  background-color: #5cb85c;
  border-color: #4cae4c;
}
.notification_widget.success:focus,
.notification_widget.success.focus {
  color: #fff;
  background-color: #449d44;
  border-color: #255625;
}
.notification_widget.success:hover {
  color: #fff;
  background-color: #449d44;
  border-color: #398439;
}
.notification_widget.success:active,
.notification_widget.success.active,
.open > .dropdown-toggle.notification_widget.success {
  color: #fff;
  background-color: #449d44;
  border-color: #398439;
}
.notification_widget.success:active:hover,
.notification_widget.success.active:hover,
.open > .dropdown-toggle.notification_widget.success:hover,
.notification_widget.success:active:focus,
.notification_widget.success.active:focus,
.open > .dropdown-toggle.notification_widget.success:focus,
.notification_widget.success:active.focus,
.notification_widget.success.active.focus,
.open > .dropdown-toggle.notification_widget.success.focus {
  color: #fff;
  background-color: #398439;
  border-color: #255625;
}
.notification_widget.success:active,
.notification_widget.success.active,
.open > .dropdown-toggle.notification_widget.success {
  background-image: none;
}
.notification_widget.success.disabled:hover,
.notification_widget.success[disabled]:hover,
fieldset[disabled] .notification_widget.success:hover,
.notification_widget.success.disabled:focus,
.notification_widget.success[disabled]:focus,
fieldset[disabled] .notification_widget.success:focus,
.notification_widget.success.disabled.focus,
.notification_widget.success[disabled].focus,
fieldset[disabled] .notification_widget.success.focus {
  background-color: #5cb85c;
  border-color: #4cae4c;
}
.notification_widget.success .badge {
  color: #5cb85c;
  background-color: #fff;
}
.notification_widget.info {
  color: #fff;
  background-color: #5bc0de;
  border-color: #46b8da;
}
.notification_widget.info:focus,
.notification_widget.info.focus {
  color: #fff;
  background-color: #31b0d5;
  border-color: #1b6d85;
}
.notification_widget.info:hover {
  color: #fff;
  background-color: #31b0d5;
  border-color: #269abc;
}
.notification_widget.info:active,
.notification_widget.info.active,
.open > .dropdown-toggle.notification_widget.info {
  color: #fff;
  background-color: #31b0d5;
  border-color: #269abc;
}
.notification_widget.info:active:hover,
.notification_widget.info.active:hover,
.open > .dropdown-toggle.notification_widget.info:hover,
.notification_widget.info:active:focus,
.notification_widget.info.active:focus,
.open > .dropdown-toggle.notification_widget.info:focus,
.notification_widget.info:active.focus,
.notification_widget.info.active.focus,
.open > .dropdown-toggle.notification_widget.info.focus {
  color: #fff;
  background-color: #269abc;
  border-color: #1b6d85;
}
.notification_widget.info:active,
.notification_widget.info.active,
.open > .dropdown-toggle.notification_widget.info {
  background-image: none;
}
.notification_widget.info.disabled:hover,
.notification_widget.info[disabled]:hover,
fieldset[disabled] .notification_widget.info:hover,
.notification_widget.info.disabled:focus,
.notification_widget.info[disabled]:focus,
fieldset[disabled] .notification_widget.info:focus,
.notification_widget.info.disabled.focus,
.notification_widget.info[disabled].focus,
fieldset[disabled] .notification_widget.info.focus {
  background-color: #5bc0de;
  border-color: #46b8da;
}
.notification_widget.info .badge {
  color: #5bc0de;
  background-color: #fff;
}
.notification_widget.danger {
  color: #fff;
  background-color: #d9534f;
  border-color: #d43f3a;
}
.notification_widget.danger:focus,
.notification_widget.danger.focus {
  color: #fff;
  background-color: #c9302c;
  border-color: #761c19;
}
.notification_widget.danger:hover {
  color: #fff;
  background-color: #c9302c;
  border-color: #ac2925;
}
.notification_widget.danger:active,
.notification_widget.danger.active,
.open > .dropdown-toggle.notification_widget.danger {
  color: #fff;
  background-color: #c9302c;
  border-color: #ac2925;
}
.notification_widget.danger:active:hover,
.notification_widget.danger.active:hover,
.open > .dropdown-toggle.notification_widget.danger:hover,
.notification_widget.danger:active:focus,
.notification_widget.danger.active:focus,
.open > .dropdown-toggle.notification_widget.danger:focus,
.notification_widget.danger:active.focus,
.notification_widget.danger.active.focus,
.open > .dropdown-toggle.notification_widget.danger.focus {
  color: #fff;
  background-color: #ac2925;
  border-color: #761c19;
}
.notification_widget.danger:active,
.notification_widget.danger.active,
.open > .dropdown-toggle.notification_widget.danger {
  background-image: none;
}
.notification_widget.danger.disabled:hover,
.notification_widget.danger[disabled]:hover,
fieldset[disabled] .notification_widget.danger:hover,
.notification_widget.danger.disabled:focus,
.notification_widget.danger[disabled]:focus,
fieldset[disabled] .notification_widget.danger:focus,
.notification_widget.danger.disabled.focus,
.notification_widget.danger[disabled].focus,
fieldset[disabled] .notification_widget.danger.focus {
  background-color: #d9534f;
  border-color: #d43f3a;
}
.notification_widget.danger .badge {
  color: #d9534f;
  background-color: #fff;
}
div#pager {
  background-color: #fff;
  font-size: 14px;
  line-height: 20px;
  overflow: hidden;
  display: none;
  position: fixed;
  bottom: 0px;
  width: 100%;
  max-height: 50%;
  padding-top: 8px;
  -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  /* Display over codemirror */
  z-index: 100;
  /* Hack which prevents jquery ui resizable from changing top. */
  top: auto !important;
}
div#pager pre {
  line-height: 1.21429em;
  color: #000;
  background-color: #f7f7f7;
  padding: 0.4em;
}
div#pager #pager-button-area {
  position: absolute;
  top: 8px;
  right: 20px;
}
div#pager #pager-contents {
  position: relative;
  overflow: auto;
  width: 100%;
  height: 100%;
}
div#pager #pager-contents #pager-container {
  position: relative;
  padding: 15px 0px;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
}
div#pager .ui-resizable-handle {
  top: 0px;
  height: 8px;
  background: #f7f7f7;
  border-top: 1px solid #cfcfcf;
  border-bottom: 1px solid #cfcfcf;
  /* This injects handle bars (a short, wide = symbol) for 
        the resize handle. */
}
div#pager .ui-resizable-handle::after {
  content: '';
  top: 2px;
  left: 50%;
  height: 3px;
  width: 30px;
  margin-left: -15px;
  position: absolute;
  border-top: 1px solid #cfcfcf;
}
.quickhelp {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
  line-height: 1.8em;
}
.shortcut_key {
  display: inline-block;
  width: 21ex;
  text-align: right;
  font-family: monospace;
}
.shortcut_descr {
  display: inline-block;
  /* Old browsers */
  -webkit-box-flex: 1;
  -moz-box-flex: 1;
  box-flex: 1;
  /* Modern browsers */
  flex: 1;
}
span.save_widget {
  height: 30px;
  margin-top: 4px;
  display: flex;
  justify-content: flex-start;
  align-items: baseline;
  width: 50%;
  flex: 1;
}
span.save_widget span.filename {
  height: 100%;
  line-height: 1em;
  margin-left: 16px;
  border: none;
  font-size: 146.5%;
  text-overflow: ellipsis;
  overflow: hidden;
  white-space: nowrap;
  border-radius: 2px;
}
span.save_widget span.filename:hover {
  background-color: #e6e6e6;
}
[dir="rtl"] span.save_widget.pull-left {
  float: right !important;
  float: right;
}
[dir="rtl"] span.save_widget span.filename {
  margin-left: 0;
  margin-right: 16px;
}
span.checkpoint_status,
span.autosave_status {
  font-size: small;
  white-space: nowrap;
  padding: 0 5px;
}
@media (max-width: 767px) {
  span.save_widget {
    font-size: small;
    padding: 0 0 0 5px;
  }
  span.checkpoint_status,
  span.autosave_status {
    display: none;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  span.checkpoint_status {
    display: none;
  }
  span.autosave_status {
    font-size: x-small;
  }
}
.toolbar {
  padding: 0px;
  margin-left: -5px;
  margin-top: 2px;
  margin-bottom: 5px;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
}
.toolbar select,
.toolbar label {
  width: auto;
  vertical-align: middle;
  margin-right: 2px;
  margin-bottom: 0px;
  display: inline;
  font-size: 92%;
  margin-left: 0.3em;
  margin-right: 0.3em;
  padding: 0px;
  padding-top: 3px;
}
.toolbar .btn {
  padding: 2px 8px;
}
.toolbar .btn-group {
  margin-top: 0px;
  margin-left: 5px;
}
.toolbar-btn-label {
  margin-left: 6px;
}
#maintoolbar {
  margin-bottom: -3px;
  margin-top: -8px;
  border: 0px;
  min-height: 27px;
  margin-left: 0px;
  padding-top: 11px;
  padding-bottom: 3px;
}
#maintoolbar .navbar-text {
  float: none;
  vertical-align: middle;
  text-align: right;
  margin-left: 5px;
  margin-right: 0px;
  margin-top: 0px;
}
.select-xs {
  height: 24px;
}
[dir="rtl"] .btn-group > .btn,
.btn-group-vertical > .btn {
  float: right;
}
.pulse,
.dropdown-menu > li > a.pulse,
li.pulse > a.dropdown-toggle,
li.pulse.open > a.dropdown-toggle {
  background-color: #F37626;
  color: white;
}
/**
 * Primary styles
 *
 * Author: Jupyter Development Team
 */
/** WARNING IF YOU ARE EDITTING THIS FILE, if this is a .css file, It has a lot
 * of chance of beeing generated from the ../less/[samename].less file, you can
 * try to get back the less file by reverting somme commit in history
 **/
/*
 * We'll try to get something pretty, so we
 * have some strange css to have the scroll bar on
 * the left with fix button on the top right of the tooltip
 */
@-moz-keyframes fadeOut {
  from {
    opacity: 1;
  }
  to {
    opacity: 0;
  }
}
@-webkit-keyframes fadeOut {
  from {
    opacity: 1;
  }
  to {
    opacity: 0;
  }
}
@-moz-keyframes fadeIn {
  from {
    opacity: 0;
  }
  to {
    opacity: 1;
  }
}
@-webkit-keyframes fadeIn {
  from {
    opacity: 0;
  }
  to {
    opacity: 1;
  }
}
/*properties of tooltip after "expand"*/
.bigtooltip {
  overflow: auto;
  height: 200px;
  -webkit-transition-property: height;
  -webkit-transition-duration: 500ms;
  -moz-transition-property: height;
  -moz-transition-duration: 500ms;
  transition-property: height;
  transition-duration: 500ms;
}
/*properties of tooltip before "expand"*/
.smalltooltip {
  -webkit-transition-property: height;
  -webkit-transition-duration: 500ms;
  -moz-transition-property: height;
  -moz-transition-duration: 500ms;
  transition-property: height;
  transition-duration: 500ms;
  text-overflow: ellipsis;
  overflow: hidden;
  height: 80px;
}
.tooltipbuttons {
  position: absolute;
  padding-right: 15px;
  top: 0px;
  right: 0px;
}
.tooltiptext {
  /*avoid the button to overlap on some docstring*/
  padding-right: 30px;
}
.ipython_tooltip {
  max-width: 700px;
  /*fade-in animation when inserted*/
  -webkit-animation: fadeOut 400ms;
  -moz-animation: fadeOut 400ms;
  animation: fadeOut 400ms;
  -webkit-animation: fadeIn 400ms;
  -moz-animation: fadeIn 400ms;
  animation: fadeIn 400ms;
  vertical-align: middle;
  background-color: #f7f7f7;
  overflow: visible;
  border: #ababab 1px solid;
  outline: none;
  padding: 3px;
  margin: 0px;
  padding-left: 7px;
  font-family: monospace;
  min-height: 50px;
  -moz-box-shadow: 0px 6px 10px -1px #adadad;
  -webkit-box-shadow: 0px 6px 10px -1px #adadad;
  box-shadow: 0px 6px 10px -1px #adadad;
  border-radius: 2px;
  position: absolute;
  z-index: 1000;
}
.ipython_tooltip a {
  float: right;
}
.ipython_tooltip .tooltiptext pre {
  border: 0;
  border-radius: 0;
  font-size: 100%;
  background-color: #f7f7f7;
}
.pretooltiparrow {
  left: 0px;
  margin: 0px;
  top: -16px;
  width: 40px;
  height: 16px;
  overflow: hidden;
  position: absolute;
}
.pretooltiparrow:before {
  background-color: #f7f7f7;
  border: 1px #ababab solid;
  z-index: 11;
  content: "";
  position: absolute;
  left: 15px;
  top: 10px;
  width: 25px;
  height: 25px;
  -webkit-transform: rotate(45deg);
  -moz-transform: rotate(45deg);
  -ms-transform: rotate(45deg);
  -o-transform: rotate(45deg);
}
ul.typeahead-list i {
  margin-left: -10px;
  width: 18px;
}
[dir="rtl"] ul.typeahead-list i {
  margin-left: 0;
  margin-right: -10px;
}
ul.typeahead-list {
  max-height: 80vh;
  overflow: auto;
}
ul.typeahead-list > li > a {
  /** Firefox bug **/
  /* see https://github.com/jupyter/notebook/issues/559 */
  white-space: normal;
}
ul.typeahead-list  > li > a.pull-right {
  float: left !important;
  float: left;
}
[dir="rtl"] .typeahead-list {
  text-align: right;
}
.cmd-palette .modal-body {
  padding: 7px;
}
.cmd-palette form {
  background: white;
}
.cmd-palette input {
  outline: none;
}
.no-shortcut {
  min-width: 20px;
  color: transparent;
}
[dir="rtl"] .no-shortcut.pull-right {
  float: left !important;
  float: left;
}
[dir="rtl"] .command-shortcut.pull-right {
  float: left !important;
  float: left;
}
.command-shortcut:before {
  content: "(command mode)";
  padding-right: 3px;
  color: #777777;
}
.edit-shortcut:before {
  content: "(edit)";
  padding-right: 3px;
  color: #777777;
}
[dir="rtl"] .edit-shortcut.pull-right {
  float: left !important;
  float: left;
}
#find-and-replace #replace-preview .match,
#find-and-replace #replace-preview .insert {
  background-color: #BBDEFB;
  border-color: #90CAF9;
  border-style: solid;
  border-width: 1px;
  border-radius: 0px;
}
[dir="ltr"] #find-and-replace .input-group-btn + .form-control {
  border-left: none;
}
[dir="rtl"] #find-and-replace .input-group-btn + .form-control {
  border-right: none;
}
#find-and-replace #replace-preview .replace .match {
  background-color: #FFCDD2;
  border-color: #EF9A9A;
  border-radius: 0px;
}
#find-and-replace #replace-preview .replace .insert {
  background-color: #C8E6C9;
  border-color: #A5D6A7;
  border-radius: 0px;
}
#find-and-replace #replace-preview {
  max-height: 60vh;
  overflow: auto;
}
#find-and-replace #replace-preview pre {
  padding: 5px 10px;
}
.terminal-app {
  background: #EEE;
}
.terminal-app #header {
  background: #fff;
  -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
}
.terminal-app .terminal {
  width: 100%;
  float: left;
  font-family: monospace;
  color: white;
  background: black;
  padding: 0.4em;
  border-radius: 2px;
  -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.4);
  box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.4);
}
.terminal-app .terminal,
.terminal-app .terminal dummy-screen {
  line-height: 1em;
  font-size: 14px;
}
.terminal-app .terminal .xterm-rows {
  padding: 10px;
}
.terminal-app .terminal-cursor {
  color: black;
  background: white;
}
.terminal-app #terminado-container {
  margin-top: 20px;
}
/*# sourceMappingURL=style.min.css.map */
    </style>
<style type="text/css">
    .highlight .hll { background-color: #ffffcc }
.highlight  { background: #f8f8f8; }
.highlight .c { color: #408080; font-style: italic } /* Comment */
.highlight .err { border: 1px solid #FF0000 } /* Error */
.highlight .k { color: #008000; font-weight: bold } /* Keyword */
.highlight .o { color: #666666 } /* Operator */
.highlight .ch { color: #408080; font-style: italic } /* Comment.Hashbang */
.highlight .cm { color: #408080; font-style: italic } /* Comment.Multiline */
.highlight .cp { color: #BC7A00 } /* Comment.Preproc */
.highlight .cpf { color: #408080; font-style: italic } /* Comment.PreprocFile */
.highlight .c1 { color: #408080; font-style: italic } /* Comment.Single */
.highlight .cs { color: #408080; font-style: italic } /* Comment.Special */
.highlight .gd { color: #A00000 } /* Generic.Deleted */
.highlight .ge { font-style: italic } /* Generic.Emph */
.highlight .gr { color: #FF0000 } /* Generic.Error */
.highlight .gh { color: #000080; font-weight: bold } /* Generic.Heading */
.highlight .gi { color: #00A000 } /* Generic.Inserted */
.highlight .go { color: #888888 } /* Generic.Output */
.highlight .gp { color: #000080; font-weight: bold } /* Generic.Prompt */
.highlight .gs { font-weight: bold } /* Generic.Strong */
.highlight .gu { color: #800080; font-weight: bold } /* Generic.Subheading */
.highlight .gt { color: #0044DD } /* Generic.Traceback */
.highlight .kc { color: #008000; font-weight: bold } /* Keyword.Constant */
.highlight .kd { color: #008000; font-weight: bold } /* Keyword.Declaration */
.highlight .kn { color: #008000; font-weight: bold } /* Keyword.Namespace */
.highlight .kp { color: #008000 } /* Keyword.Pseudo */
.highlight .kr { color: #008000; font-weight: bold } /* Keyword.Reserved */
.highlight .kt { color: #B00040 } /* Keyword.Type */
.highlight .m { color: #666666 } /* Literal.Number */
.highlight .s { color: #BA2121 } /* Literal.String */
.highlight .na { color: #7D9029 } /* Name.Attribute */
.highlight .nb { color: #008000 } /* Name.Builtin */
.highlight .nc { color: #0000FF; font-weight: bold } /* Name.Class */
.highlight .no { color: #880000 } /* Name.Constant */
.highlight .nd { color: #AA22FF } /* Name.Decorator */
.highlight .ni { color: #999999; font-weight: bold } /* Name.Entity */
.highlight .ne { color: #D2413A; font-weight: bold } /* Name.Exception */
.highlight .nf { color: #0000FF } /* Name.Function */
.highlight .nl { color: #A0A000 } /* Name.Label */
.highlight .nn { color: #0000FF; font-weight: bold } /* Name.Namespace */
.highlight .nt { color: #008000; font-weight: bold } /* Name.Tag */
.highlight .nv { color: #19177C } /* Name.Variable */
.highlight .ow { color: #AA22FF; font-weight: bold } /* Operator.Word */
.highlight .w { color: #bbbbbb } /* Text.Whitespace */
.highlight .mb { color: #666666 } /* Literal.Number.Bin */
.highlight .mf { color: #666666 } /* Literal.Number.Float */
.highlight .mh { color: #666666 } /* Literal.Number.Hex */
.highlight .mi { color: #666666 } /* Literal.Number.Integer */
.highlight .mo { color: #666666 } /* Literal.Number.Oct */
.highlight .sa { color: #BA2121 } /* Literal.String.Affix */
.highlight .sb { color: #BA2121 } /* Literal.String.Backtick */
.highlight .sc { color: #BA2121 } /* Literal.String.Char */
.highlight .dl { color: #BA2121 } /* Literal.String.Delimiter */
.highlight .sd { color: #BA2121; font-style: italic } /* Literal.String.Doc */
.highlight .s2 { color: #BA2121 } /* Literal.String.Double */
.highlight .se { color: #BB6622; font-weight: bold } /* Literal.String.Escape */
.highlight .sh { color: #BA2121 } /* Literal.String.Heredoc */
.highlight .si { color: #BB6688; font-weight: bold } /* Literal.String.Interpol */
.highlight .sx { color: #008000 } /* Literal.String.Other */
.highlight .sr { color: #BB6688 } /* Literal.String.Regex */
.highlight .s1 { color: #BA2121 } /* Literal.String.Single */
.highlight .ss { color: #19177C } /* Literal.String.Symbol */
.highlight .bp { color: #008000 } /* Name.Builtin.Pseudo */
.highlight .fm { color: #0000FF } /* Name.Function.Magic */
.highlight .vc { color: #19177C } /* Name.Variable.Class */
.highlight .vg { color: #19177C } /* Name.Variable.Global */
.highlight .vi { color: #19177C } /* Name.Variable.Instance */
.highlight .vm { color: #19177C } /* Name.Variable.Magic */
.highlight .il { color: #666666 } /* Literal.Number.Integer.Long */
    </style>


<style type="text/css">
/* Overrides of notebook CSS for static HTML export */
body {
  overflow: visible;
  padding: 8px;
}

div#notebook {
  overflow: visible;
  border-top: none;
}@media print {
  div.cell {
    display: block;
    page-break-inside: avoid;
  } 
  div.output_wrapper { 
    display: block;
    page-break-inside: avoid; 
  }
  div.output { 
    display: block;
    page-break-inside: avoid; 
  }
}
</style>

<!-- Custom stylesheet, it must be in the same directory as the html file -->
<link rel="stylesheet" href="custom.css">

<!-- Loading mathjax macro -->
<!-- Load mathjax -->
    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/latest.js?config=TeX-AMS_HTML"></script>
    <!-- MathJax configuration -->
    <script type="text/x-mathjax-config">
    MathJax.Hub.Config({
        tex2jax: {
            inlineMath: [ ['$','$'], ["\\(","\\)"] ],
            displayMath: [ ['$$','$$'], ["\\[","\\]"] ],
            processEscapes: true,
            processEnvironments: true
        },
        // Center justify equations in code and markdown cells. Elsewhere
        // we use CSS to left justify single line equations in code cells.
        displayAlign: 'center',
        "HTML-CSS": {
            styles: {'.MathJax_Display': {"margin": 0}},
            linebreaks: { automatic: true }
        }
    });
    </script>
    <!-- End of mathjax configuration --></head>
<body>
  <div tabindex="-1" id="notebook" class="border-box-sizing">
    <div class="container" id="notebook-container">

<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<h1 id="Load-the-data">Load the data<a class="anchor-link" href="#Load-the-data">&#182;</a></h1>
</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[44]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">from</span> <span class="nn">IPython.display</span> <span class="kn">import</span> <span class="n">display</span>
<span class="kn">from</span> <span class="nn">IPython.display</span> <span class="kn">import</span> <span class="n">HTML</span>
<span class="kn">import</span> <span class="nn">IPython.core.display</span> <span class="k">as</span> <span class="nn">di</span> <span class="c1"># Example: di.display_html(&#39;&lt;h3&gt;%s:&lt;/h3&gt;&#39; % str, raw=True)</span>

<span class="c1"># This line will hide code by default when the notebook is exported as HTML</span>
<span class="n">di</span><span class="o">.</span><span class="n">display_html</span><span class="p">(</span><span class="s1">&#39;&lt;script&gt;jQuery(function() {if (jQuery(&quot;body.notebook_app&quot;).length == 0) { jQuery(&quot;.input_area&quot;).toggle(); jQuery(&quot;.prompt&quot;).toggle();}});&lt;/script&gt;&#39;</span><span class="p">,</span> <span class="n">raw</span><span class="o">=</span><span class="kc">True</span><span class="p">)</span>

<span class="c1"># This line will add a button to toggle visibility of code blocks, for use with the HTML export version</span>
<span class="n">di</span><span class="o">.</span><span class="n">display_html</span><span class="p">(</span><span class="s1">&#39;&#39;&#39;&lt;button onclick=&quot;jQuery(&#39;.input_area&#39;).toggle(); jQuery(&#39;.prompt&#39;).toggle();&quot;&gt;Toggle code&lt;/button&gt;&#39;&#39;&#39;</span><span class="p">,</span> <span class="n">raw</span><span class="o">=</span><span class="kc">True</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<script>jQuery(function() {if (jQuery("body.notebook_app").length == 0) { jQuery(".input_area").toggle(); jQuery(".prompt").toggle();}});</script>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<button onclick="jQuery('.input_area').toggle(); jQuery('.prompt').toggle();">Toggle code</button>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[25]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">import</span> <span class="nn">pandas</span> <span class="k">as</span> <span class="nn">pd</span>
<span class="kn">import</span> <span class="nn">re</span>
<span class="kn">import</span> <span class="nn">string</span>
<span class="kn">import</span> <span class="nn">seaborn</span> <span class="k">as</span> <span class="nn">sns</span>
<span class="kn">from</span> <span class="nn">nltk.corpus</span> <span class="kn">import</span> <span class="n">stopwords</span>
<span class="kn">from</span> <span class="nn">collections</span> <span class="kn">import</span>  <span class="n">Counter</span>
<span class="kn">import</span> <span class="nn">numpy</span> <span class="k">as</span> <span class="nn">np</span>
<span class="kn">from</span> <span class="nn">sklearn.feature_extraction.text</span> <span class="kn">import</span> <span class="n">CountVectorizer</span>
<span class="kn">from</span> <span class="nn">collections</span> <span class="kn">import</span>  <span class="n">Counter</span>
<span class="kn">import</span> <span class="nn">nltk</span>
<span class="kn">import</span> <span class="nn">gensim</span>
<span class="kn">from</span> <span class="nn">nltk.stem</span> <span class="kn">import</span> <span class="n">WordNetLemmatizer</span><span class="p">,</span><span class="n">PorterStemmer</span>
<span class="kn">from</span> <span class="nn">nltk.tokenize</span> <span class="kn">import</span> <span class="n">word_tokenize</span>
<span class="kn">import</span> <span class="nn">pyLDAvis.gensim</span>
<span class="n">nltk</span><span class="o">.</span><span class="n">download</span><span class="p">(</span><span class="s1">&#39;wordnet&#39;</span><span class="p">)</span>
<span class="kn">from</span> <span class="nn">nltk.tokenize</span> <span class="kn">import</span> <span class="n">word_tokenize</span>
<span class="kn">from</span> <span class="nn">wordcloud</span> <span class="kn">import</span> <span class="n">WordCloud</span><span class="p">,</span> <span class="n">STOPWORDS</span>
<span class="kn">from</span> <span class="nn">textblob</span> <span class="kn">import</span> <span class="n">TextBlob</span>
<span class="kn">from</span> <span class="nn">nltk.sentiment.vader</span> <span class="kn">import</span> <span class="n">SentimentIntensityAnalyzer</span>
<span class="kn">import</span> <span class="nn">spacy</span>
<span class="kn">import</span> <span class="nn">matplotlib.pyplot</span> <span class="k">as</span> <span class="nn">plt</span>
<span class="kn">from</span> <span class="nn">spacy</span> <span class="kn">import</span> <span class="n">displacy</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stderr output_text">
<pre>[nltk_data] Downloading package wordnet to
[nltk_data]     /home/teamscool/nltk_data...
[nltk_data]   Package wordnet is already up-to-date!
</pre>
</div>
</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[2]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">data</span><span class="o">=</span> <span class="n">pd</span><span class="o">.</span><span class="n">read_csv</span><span class="p">(</span><span class="s1">&#39;scraped.csv&#39;</span><span class="p">,</span><span class="n">nrows</span><span class="o">=</span><span class="mi">1000</span><span class="p">)</span>
<span class="n">data</span><span class="o">.</span><span class="n">head</span><span class="p">()</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[2]:</div>



<div class="output_html rendered_html output_subarea output_execute_result">
<div>
<style scoped>
    .dataframe tbody tr th:only-of-type {
        vertical-align: middle;
    }

    .dataframe tbody tr th {
        vertical-align: top;
    }

    .dataframe thead th {
        text-align: right;
    }
</style>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>url</th>
      <th>title</th>
      <th>body</th>
      <th>summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>0</th>
      <td>https://www.newindianexpress.com/nation/2020/m...</td>
      <td>Travel guidelines eased in Rajasthan with intr...</td>
      <td>By PTI\n\nJAIPUR: The Rajasthan government has...</td>
      <td>By PTIJAIPUR: The Rajasthan government has rel...</td>
    </tr>
    <tr>
      <th>1</th>
      <td>https://www.newindianexpress.com/sport/other/2...</td>
      <td>Renowned para-athlete Deepa Malik to announce ...</td>
      <td>By ANI\n\nNEW DELHI: Renowned para-athlete Dee...</td>
      <td>By ANINEW DELHI: Renowned para-athlete Deepa M...</td>
    </tr>
    <tr>
      <th>2</th>
      <td>https://www.newindianexpress.com/world/2020/ma...</td>
      <td>Official sacked after new COVID-19 cases in Ch...</td>
      <td>By IANS\n\nWUHAN: An official has been sacked ...</td>
      <td>By IANSWUHAN: An official has been sacked in W...</td>
    </tr>
    <tr>
      <th>3</th>
      <td>https://www.newindianexpress.com/world/2020/ma...</td>
      <td>COVID-19 lockdown: Domestic flights in Pakista...</td>
      <td>By PTI\n\nISLAMABAD: Pakistan has extended the...</td>
      <td>Pakistan Civil Aviation Authority (PCAA) exten...</td>
    </tr>
    <tr>
      <th>4</th>
      <td>https://www.newindianexpress.com/nation/2020/m...</td>
      <td>SC orders setting up of panel to consider plea...</td>
      <td>By PTI\n\nNEW DELHI: The Supreme Court Monday ...</td>
      <td>By PTINEW DELHI: The Supreme Court Monday orde...</td>
    </tr>
  </tbody>
</table>
</div>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[3]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="k">def</span> <span class="nf">clean_text</span><span class="p">(</span><span class="n">data</span><span class="p">):</span>
    <span class="n">clean1</span> <span class="o">=</span> <span class="n">re</span><span class="o">.</span><span class="n">sub</span><span class="p">(</span><span class="sa">r</span><span class="s1">&#39;[&#39;</span><span class="o">+</span><span class="n">string</span><span class="o">.</span><span class="n">punctuation</span> <span class="o">+</span> <span class="s1">&#39;&#39;</span><span class="o">+</span><span class="s1">&#39;]&#39;</span><span class="p">,</span> <span class="s2">&quot;&quot;</span><span class="p">,</span> <span class="n">data</span><span class="o">.</span><span class="n">lower</span><span class="p">())</span>
    <span class="k">return</span> <span class="n">re</span><span class="o">.</span><span class="n">sub</span><span class="p">(</span><span class="sa">r</span><span class="s1">&#39;\W+&#39;</span><span class="p">,</span> <span class="s1">&#39; &#39;</span><span class="p">,</span> <span class="n">clean1</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[4]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">data</span><span class="p">[</span><span class="s1">&#39;paragraphs&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">data</span><span class="p">[</span><span class="s1">&#39;body&#39;</span><span class="p">]</span><span class="o">.</span><span class="n">map</span><span class="p">(</span><span class="k">lambda</span> <span class="n">x</span><span class="p">:</span> <span class="n">clean_text</span><span class="p">(</span><span class="nb">str</span><span class="p">(</span><span class="n">x</span><span class="p">)))</span>
</pre></div>

    </div>
</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[5]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">TEXT_COLUMN</span> <span class="o">=</span> <span class="s1">&#39;paragraphs&#39;</span>
<span class="n">text</span> <span class="o">=</span> <span class="n">data</span><span class="p">[</span><span class="n">TEXT_COLUMN</span><span class="p">]</span>
</pre></div>

    </div>
</div>
</div>

</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<h1 id="Text-Statistics">Text Statistics<a class="anchor-link" href="#Text-Statistics">&#182;</a></h1><h3 id="Character-Length-Histogram">Character Length Histogram<a class="anchor-link" href="#Character-Length-Histogram">&#182;</a></h3>
</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[29]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="k">def</span> <span class="nf">plot_character_length_histogram</span><span class="p">(</span><span class="n">text</span><span class="p">):</span>
    <span class="n">text</span><span class="o">.</span><span class="n">str</span><span class="o">.</span><span class="n">len</span><span class="p">()</span><span class="o">.</span>\
        <span class="n">hist</span><span class="p">()</span>
</pre></div>

    </div>
</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[30]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">plot_character_length_histogram</span><span class="p">(</span><span class="n">text</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,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
"
>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<h3 id="Word-Number-Histogram">Word Number Histogram<a class="anchor-link" href="#Word-Number-Histogram">&#182;</a></h3>
</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[31]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="k">def</span> <span class="nf">plot_word_number_histogram</span><span class="p">(</span><span class="n">text</span><span class="p">):</span>
    <span class="n">text</span><span class="o">.</span><span class="n">str</span><span class="o">.</span><span class="n">split</span><span class="p">()</span><span class="o">.</span>\
        <span class="nb">map</span><span class="p">(</span><span class="k">lambda</span> <span class="n">x</span><span class="p">:</span> <span class="nb">len</span><span class="p">(</span><span class="n">x</span><span class="p">))</span><span class="o">.</span>\
        <span class="n">hist</span><span class="p">()</span>
</pre></div>

    </div>
</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[32]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">plot_word_number_histogram</span><span class="p">(</span><span class="n">text</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,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
"
>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<h3 id="Top-Stopwords-Barchart">Top Stopwords Barchart<a class="anchor-link" href="#Top-Stopwords-Barchart">&#182;</a></h3>
</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[41]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">import</span> <span class="nn">matplotlib.pyplot</span> <span class="k">as</span> <span class="nn">plt</span>
<span class="kn">import</span> <span class="nn">numpy</span> <span class="k">as</span> <span class="nn">np</span>
<span class="kn">from</span> <span class="nn">nltk.corpus</span> <span class="kn">import</span> <span class="n">stopwords</span>

<span class="k">def</span> <span class="nf">plot_top_stopwords_barchart</span><span class="p">(</span><span class="n">text</span><span class="p">):</span>
    <span class="n">stop</span><span class="o">=</span><span class="nb">set</span><span class="p">(</span><span class="n">stopwords</span><span class="o">.</span><span class="n">words</span><span class="p">(</span><span class="s1">&#39;english&#39;</span><span class="p">))</span>
    
    <span class="n">new</span><span class="o">=</span> <span class="n">text</span><span class="o">.</span><span class="n">str</span><span class="o">.</span><span class="n">split</span><span class="p">()</span>
    <span class="n">new</span><span class="o">=</span><span class="n">new</span><span class="o">.</span><span class="n">values</span><span class="o">.</span><span class="n">tolist</span><span class="p">()</span>
    <span class="n">corpus</span><span class="o">=</span><span class="p">[</span><span class="n">word</span> <span class="k">for</span> <span class="n">i</span> <span class="ow">in</span> <span class="n">new</span> <span class="k">for</span> <span class="n">word</span> <span class="ow">in</span> <span class="n">i</span><span class="p">]</span>
    <span class="kn">from</span> <span class="nn">collections</span> <span class="kn">import</span> <span class="n">defaultdict</span>
    <span class="n">dic</span><span class="o">=</span><span class="n">defaultdict</span><span class="p">(</span><span class="nb">int</span><span class="p">)</span>
    <span class="k">for</span> <span class="n">word</span> <span class="ow">in</span> <span class="n">corpus</span><span class="p">:</span>
        <span class="k">if</span> <span class="n">word</span> <span class="ow">in</span> <span class="n">stop</span><span class="p">:</span>
            <span class="n">dic</span><span class="p">[</span><span class="n">word</span><span class="p">]</span><span class="o">+=</span><span class="mi">1</span>
            
    <span class="n">top</span><span class="o">=</span><span class="nb">sorted</span><span class="p">(</span><span class="n">dic</span><span class="o">.</span><span class="n">items</span><span class="p">(),</span> <span class="n">key</span><span class="o">=</span><span class="k">lambda</span> <span class="n">x</span><span class="p">:</span><span class="n">x</span><span class="p">[</span><span class="mi">1</span><span class="p">],</span><span class="n">reverse</span><span class="o">=</span><span class="kc">True</span><span class="p">)[:</span><span class="mi">10</span><span class="p">]</span> 
    <span class="n">x</span><span class="p">,</span><span class="n">y</span><span class="o">=</span><span class="nb">zip</span><span class="p">(</span><span class="o">*</span><span class="n">top</span><span class="p">)</span>
    <span class="n">plt</span><span class="o">.</span><span class="n">bar</span><span class="p">(</span><span class="n">x</span><span class="p">,</span><span class="n">y</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[42]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">plot_top_stopwords_barchart</span><span class="p">(</span><span class="n">text</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,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
"
>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<h3 id="Top-Non-Stopwords-Barchart">Top Non-Stopwords Barchart<a class="anchor-link" href="#Top-Non-Stopwords-Barchart">&#182;</a></h3>
</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[43]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="k">def</span> <span class="nf">plot_top_non_stopwords_barchart</span><span class="p">(</span><span class="n">text</span><span class="p">):</span>
    <span class="n">stop</span><span class="o">=</span><span class="nb">set</span><span class="p">(</span><span class="n">stopwords</span><span class="o">.</span><span class="n">words</span><span class="p">(</span><span class="s1">&#39;english&#39;</span><span class="p">))</span>
    
    <span class="n">new</span><span class="o">=</span> <span class="n">text</span><span class="o">.</span><span class="n">str</span><span class="o">.</span><span class="n">split</span><span class="p">()</span>
    <span class="n">new</span><span class="o">=</span><span class="n">new</span><span class="o">.</span><span class="n">values</span><span class="o">.</span><span class="n">tolist</span><span class="p">()</span>
    <span class="n">corpus</span><span class="o">=</span><span class="p">[</span><span class="n">word</span> <span class="k">for</span> <span class="n">i</span> <span class="ow">in</span> <span class="n">new</span> <span class="k">for</span> <span class="n">word</span> <span class="ow">in</span> <span class="n">i</span><span class="p">]</span>

    <span class="n">counter</span><span class="o">=</span><span class="n">Counter</span><span class="p">(</span><span class="n">corpus</span><span class="p">)</span>
    <span class="n">most</span><span class="o">=</span><span class="n">counter</span><span class="o">.</span><span class="n">most_common</span><span class="p">()</span>
    <span class="n">x</span><span class="p">,</span> <span class="n">y</span><span class="o">=</span><span class="p">[],</span> <span class="p">[]</span>
    <span class="k">for</span> <span class="n">word</span><span class="p">,</span><span class="n">count</span> <span class="ow">in</span> <span class="n">most</span><span class="p">[:</span><span class="mi">40</span><span class="p">]:</span>
        <span class="k">if</span> <span class="p">(</span><span class="n">word</span> <span class="ow">not</span> <span class="ow">in</span> <span class="n">stop</span><span class="p">):</span>
            <span class="n">x</span><span class="o">.</span><span class="n">append</span><span class="p">(</span><span class="n">word</span><span class="p">)</span>
            <span class="n">y</span><span class="o">.</span><span class="n">append</span><span class="p">(</span><span class="n">count</span><span class="p">)</span>
            
    <span class="n">sns</span><span class="o">.</span><span class="n">barplot</span><span class="p">(</span><span class="n">x</span><span class="o">=</span><span class="n">y</span><span class="p">,</span><span class="n">y</span><span class="o">=</span><span class="n">x</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[44]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">plot_top_non_stopwords_barchart</span><span class="p">(</span><span class="n">text</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,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
"
>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<h1 id="Top-N-grams-Barchart">Top N-grams Barchart<a class="anchor-link" href="#Top-N-grams-Barchart">&#182;</a></h1>
</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[47]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="k">def</span> <span class="nf">plot_top_ngrams_barchart</span><span class="p">(</span><span class="n">text</span><span class="p">,</span> <span class="n">n</span><span class="o">=</span><span class="mi">2</span><span class="p">):</span>
    <span class="n">stop</span><span class="o">=</span><span class="nb">set</span><span class="p">(</span><span class="n">stopwords</span><span class="o">.</span><span class="n">words</span><span class="p">(</span><span class="s1">&#39;english&#39;</span><span class="p">))</span>

    <span class="n">new</span><span class="o">=</span> <span class="n">text</span><span class="o">.</span><span class="n">str</span><span class="o">.</span><span class="n">split</span><span class="p">()</span>
    <span class="n">new</span><span class="o">=</span><span class="n">new</span><span class="o">.</span><span class="n">values</span><span class="o">.</span><span class="n">tolist</span><span class="p">()</span>
    <span class="n">corpus</span><span class="o">=</span><span class="p">[</span><span class="n">word</span> <span class="k">for</span> <span class="n">i</span> <span class="ow">in</span> <span class="n">new</span> <span class="k">for</span> <span class="n">word</span> <span class="ow">in</span> <span class="n">i</span><span class="p">]</span>

    <span class="k">def</span> <span class="nf">_get_top_ngram</span><span class="p">(</span><span class="n">corpus</span><span class="p">,</span> <span class="n">n</span><span class="o">=</span><span class="kc">None</span><span class="p">):</span>
        <span class="n">vec</span> <span class="o">=</span> <span class="n">CountVectorizer</span><span class="p">(</span><span class="n">ngram_range</span><span class="o">=</span><span class="p">(</span><span class="n">n</span><span class="p">,</span> <span class="n">n</span><span class="p">))</span><span class="o">.</span><span class="n">fit</span><span class="p">(</span><span class="n">corpus</span><span class="p">)</span>
        <span class="n">bag_of_words</span> <span class="o">=</span> <span class="n">vec</span><span class="o">.</span><span class="n">transform</span><span class="p">(</span><span class="n">corpus</span><span class="p">)</span>
        <span class="n">sum_words</span> <span class="o">=</span> <span class="n">bag_of_words</span><span class="o">.</span><span class="n">sum</span><span class="p">(</span><span class="n">axis</span><span class="o">=</span><span class="mi">0</span><span class="p">)</span> 
        <span class="n">words_freq</span> <span class="o">=</span> <span class="p">[(</span><span class="n">word</span><span class="p">,</span> <span class="n">sum_words</span><span class="p">[</span><span class="mi">0</span><span class="p">,</span> <span class="n">idx</span><span class="p">])</span> 
                      <span class="k">for</span> <span class="n">word</span><span class="p">,</span> <span class="n">idx</span> <span class="ow">in</span> <span class="n">vec</span><span class="o">.</span><span class="n">vocabulary_</span><span class="o">.</span><span class="n">items</span><span class="p">()]</span>
        <span class="n">words_freq</span> <span class="o">=</span><span class="nb">sorted</span><span class="p">(</span><span class="n">words_freq</span><span class="p">,</span> <span class="n">key</span> <span class="o">=</span> <span class="k">lambda</span> <span class="n">x</span><span class="p">:</span> <span class="n">x</span><span class="p">[</span><span class="mi">1</span><span class="p">],</span> <span class="n">reverse</span><span class="o">=</span><span class="kc">True</span><span class="p">)</span>
        <span class="k">return</span> <span class="n">words_freq</span><span class="p">[:</span><span class="mi">10</span><span class="p">]</span>

    <span class="n">top_n_bigrams</span><span class="o">=</span><span class="n">_get_top_ngram</span><span class="p">(</span><span class="n">text</span><span class="p">,</span><span class="n">n</span><span class="p">)[:</span><span class="mi">10</span><span class="p">]</span>
    <span class="n">x</span><span class="p">,</span><span class="n">y</span><span class="o">=</span><span class="nb">map</span><span class="p">(</span><span class="nb">list</span><span class="p">,</span><span class="nb">zip</span><span class="p">(</span><span class="o">*</span><span class="n">top_n_bigrams</span><span class="p">))</span>
    <span class="n">sns</span><span class="o">.</span><span class="n">barplot</span><span class="p">(</span><span class="n">x</span><span class="o">=</span><span class="n">y</span><span class="p">,</span><span class="n">y</span><span class="o">=</span><span class="n">x</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<h3 id="Bigrams">Bigrams<a class="anchor-link" href="#Bigrams">&#182;</a></h3>
</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[48]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">plot_top_ngrams_barchart</span><span class="p">(</span><span class="n">text</span><span class="p">,</span><span class="mi">2</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZcAAAD4CAYAAAAgs6s2AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjEsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy8QZhcZAAAaRUlEQVR4nO3dfZRV1X3/8fcnAioPioqmoDGj1Cc0CjJYEbQYjamuNCaV/owxK2paqeUXKTHiD6srtc1yLQ39xTSmSzP1Z0wjtUai+VmblFgRMUTFGRxGFEk00oT6/IxPqOTbP84euV5nmIe778NcP6+1Zs0+++x97vduuPc7+5xz71ZEYGZmltOH6h2AmZk1HycXMzPLzsnFzMyyc3IxM7PsnFzMzCy7YfUOoJrGjRsXLS0t9Q7DzGxI6ejoeC4idq/kGE2dXFpaWmhvb693GGZmQ4qk/6r0GD4tZmZm2TX1zGXdxueZuuCf6x2GmVlNdSz6Yr1D8MzFzMzyc3IxM7PsnFzMzCw7JxczM8sue3KR9IsBtj9T0oSS7Q2SxuWOy8zMaid7comIowbY5UxgQl+NzMxs6KjGzOXV9HuWpOWSlkh6RNJiSSprOxtoBRZL6pS0Y9p1rqTVkh6UdGBqO0rStZLul/SApJNzx25mZnlU+5rLFGA+MAnYF5hRujMilgDtwOkRMTki3ki7nouIw4GrgPNT3UXAsoiYBhwLLJI0qvwBJc2R1C6p/Z3XN1XlSZmZ2bZVO7msioiNEfE7oBNo6We/m9PvjpI+JwALJXUCy4EdgL3LO0ZEW0S0RkTrsJFjKgjdzMwGq9qf0N9cUt4ygMfr7lfaR8ApEbE+U2xmZlYljXAr8iagP1OMpRTXYgQgaUpVozIzs0FrhORyHXB12QX9nnwdGA50SVqbts3MrAFlPy0WEaPT7+UU10a667/cS/sfAT8qqWop2dcOzErlN4C/yByumZlVQSPMXMzMrMk4uZiZWXZOLmZmll1TLxZ20F670d4Ai+aYmX3QeOZiZmbZObmYmVl2Ti5mZpZdU19zeevJh/jN332s3mGYmdXE3l97sN4hvMszFzMzy87JxczMsnNyMTOz7JxczMwsOycXMzPLrmbJRdI8SeskLS6rnyzppJLtSySd//4jmJnZUFHLW5HnAidGxONl9ZOBVuAnNYzFzMyqKPvMRdJ5ktamn/mp7mpgX+BWSV8paTsC+Dvg1LRY2Klp1yRJyyX9WtK8kvZfkLQqtf2upO1yx29mZpXLmlwkTQXOAv4AOBI4W9KUiDgHeAI4NiKu6G4fEW8BXwNujIjJEXFj2nUg8EngCOBvJA2XdBBwKjAjIiYDW4DTe4hhjqR2Se0vvLYl59MzM7N+yn1abCZwS0S8BiDpZuBo4IEBHuffI2IzsFnSM8CHgeOAqcD9kgB2BJ4p7xgRbUAbwKF77hiDfB5mZlaB3MlFmY6zuaS8hSJOAd+PiAszPYaZmVVJ7msuK4DPSBopaRTwWeDuPvpsAsb049h3ALMl7QEgaVdJH60oWjMzq4qsySUiVgPXAauA+4BrIqKvU2J3UlzAL72g39OxHwYuBn4mqQu4HRifJXAzM8sq+63IEfFN4Js91Lf00v4FYNo2jndISflG4Mbe2pqZWWPwJ/TNzCw7JxczM8vOycXMzLJr6pUoR4w/mL2/1l7vMMzMPnA8czEzs+ycXMzMLDsnFzMzy66pr7k88swjzLhyRr3DsA+IleeurHcIZg3DMxczM8vOycXMzLJzcjEzs+ycXMzMLDsnFzMzyy73MsdjJc2tpI+kWZJuyxmXmZnVVu6Zy1hgQMllkH3MzKyB5U4ulwET08Jfi1RYJGmtpAd7WQzsPX1S3WhJSyQ9ImmxJAFImirpLkkdkpZK8mJhZmYNKPeHKBcCh0TEZABJpwCTgcOAccD9klZExJPb6DMLmAIcDDwBrARmSLoPuBI4OSKeTYnqUuBLpQFImgPMARixy4jMT8/MzPqj2p/QnwncEBFbgKcl3UWx6uStffRbFREbASR1Ai3AS8AhwO1pIrMd8GR5x4hoA9oARu89OvI8DTMzG4hqJxcNst/mkvIWijgFPBQR0yuOyszMqir3NZdNwJiS7RXAqZK2k7Q7cAywqo8+vVkP7C5pOoCk4ZIOzhCzmZlllnXmEhHPS1opaS3wU+ACYDqwBgjggoh4qo8+/97Lsd+SNBv4tqSdU+zfAh7K+RzMzKxyimjeyxKj9x4dhy04rN5h2AeEvxXZmoWkjohoreQY/oS+mZll5+RiZmbZNfViYQfucaBPVZiZ1YFnLmZmlp2Ti5mZZefkYmZm2Tm5mJlZdk19QX/T+vXcdcwf1jsM68Mfrrir3iGYWWaeuZiZWXZOLmZmlp2Ti5mZZefkYmZm2VU1uUgaK2nuAPu0pG9INjOzIaraM5exwICSi5mZDX3VTi6XARMldUpapMIiSWslPSjp1F76DZP0fUldkpZIGgkgaaqkuyR1SFoqaXyV4zczs0GodnJZCDwWEZMjYgHwJ8Bk4DDgeGBRLwniAKAtIg4FXgHmShoOXAnMjoipwLXApeUdJc2R1C6p/eW3367OszIzs22q9QX9mcANEbElIp4G7gKm9dDutxHR/XXG16d+BwCHALdL6gQuBvYq7xgRbRHRGhGtOw8fXpUnYWZm21brT+irn+3Kl8eM1PehiJieNyQzM8ut2jOXTcCYku0VwKmStpO0O3AMsKqHfntL6k4ipwE/B9YDu3fXSxou6eDqhW5mZoNV1eQSEc8DK9MF/EXALUAXsAZYBlwQEU/10HUdcIakLmBX4KqIeAuYDVwuaQ3QCRxVzfjNzGxwqn5aLCI+X1a1IP301n4DMKmXfZ0Usx0zM2tg/oS+mZll5+RiZmbZObmYmVl2Tb1Y2JgDDvBCVGZmdeCZi5mZZefkYmZm2Tm5mJlZdk4uZmaWXVNf0H9m48t856v/Vu8wrAdf/r9/XO8QzKyKPHMxM7PsnFzMzCw7JxczM8vOycXMzLKrOLlImidpnaTFg+zfIunzJdtnSvpOpXGZmVn95Ji5zAVOiojT+9NYUvkdai1A+dfym5nZEFZRcpF0NbAvcKukr0jaVdKPJXVJulfSoandJZLaJP0M+Oeyw1wGHC2pU9JXUt0ESf8h6VeSvlHyeCdIukfSakk3SRpdSfxmZlYdFSWXiDgHeAI4NiKuAP4WeCAiDgX+mvcmkqnAyT0sHrYQuDsiJqdjAEwGTgU+RrEs8kckjQMuBo6PiMOBduC88pgkzZHULqn91ddfruTpmZnZIOX+EOVM4BSAiFgmaTdJO6d9t0bEG/08zh0R8TKApIeBjwJjKVaoXCkJYARwT3nHiGgD2gD2/r39ooLnYmZmg5Q7uaiHuu43+NcGcJzNJeUtFHEKuD0iThtkbGZmViO5b0VeAZwOIGkW8FxEvNJHn03AmH4c+15ghqTfT8cfKWn/CmI1M7MqyT1zuQT4nqQu4HXgjH706QLekbQGuA54sadGEfGspDOBGyRtn6ovBn5ZYcxmZpZZxcklIlpKyi8AJ/fQ5pJt9H8bOK6s+rqS/Z8qKS8Dpg06WDMzqwl/Qt/MzLJzcjEzs+ycXMzMLLumXixsj7129qJUZmZ14JmLmZll5+RiZmbZObmYmVl2TX3N5cnHH+PSL8yudxgfaBddv6TeIZhZHXjmYmZm2Tm5mJlZdk4uZmaWnZOLmZll5+RiZmbZ1T25SPqMpEkl28sltdYzJjMzq0zdkwvwGYrli83MrElkSS6SzpO0Nv3MT3UtktZJ+idJD0n6maQdy/odBXwaWCSpU9LEtOtPJa2S9EtJR6e220laJOl+SV2S/iJH7GZmll/FyUXSVOAs4A+AI4GzJU1Ju/cD/jEiDgZeAk4p7RsRvwBuBRZExOSIeCztGhYRRwDzgb9JdX8GvBwR0ygWDDtb0j49xDNHUruk9tfe3Fzp0zMzs0HIMXOZCdwSEa9FxKvAzcDRad/jEdGZyh1ASz+PeXMPfU4AviipE7gP2I0ieb1HRLRFRGtEtI7aYfvy3WZmVgM5vv5F29hXOnXYAuzYW8Ne+m1ha4wCzo2IpQMLz8zMai3HzGUF8BlJIyWNAj4L3D2A/puAMf1otxT4S0nDASTtnx7PzMwaTMXJJSJWA9cBqyhOV10TEQ8M4BD/CiyQ9EDJBf2eXAM8DKyWtBb4Lk3+xZtmZkOVIqLeMVTNnrvtEnNPPK7eYXyg+VuRzYYeSR0RUdHnDRvhcy5mZtZknFzMzCw7JxczM8uuqS+Ij99nos/5m5nVgWcuZmaWnZOLmZll5+RiZmbZNfU1lzef3MS6S5fVO4ymdtBFH693CGbWgDxzMTOz7JxczMwsOycXMzPLzsnFzMyyc3IxM7Pscixz/BNJY9PP3JL6WZJu60f/MyVNKNneIGlcpXGZmVn95FjP5aSIeAkYC8ztq30PzgQm9NXIzMyGjm0mF0kXSJqXyldIWpbKx0m6PpW7ZxqXARMldUpalA4xWtISSY9IWixJZcefDbQCi1O/7mWQz5W0WtKDkg5MbUdJulbS/WlhsZNzDYKZmeXV18xlBXB0KrdSJIvhwEzev5TxQuCxiJgcEQtS3RRgPjAJ2BeYUdohIpYA7cDpqd8baddzEXE4cBVwfqq7CFgWEdOAY4FFPS1zLGmOpHZJ7S+89lIfT8/MzKqhr+TSAUyVNAbYDNxDkWSO5v3JpSerImJjRPwO6ARa+hnXzSWP393nBGChpE5gObADsHd5x4hoi4jWiGjdddTYfj6cmZnltM2vf4mItyVtAM4CfgF0UcwaJgLr+nH8zSXlLX09Xg/9SvsIOCUi1vfzGGZmVif9uaC/guLU1AqK2co5QGdERFm7TcCYQcTQ335LKa7FCEDSlEE8lpmZ1UB/ksvdwHjgnoh4GniTHk6JRcTzwEpJa0su6PfHdcDVZRf0e/J1YDjQJWlt2jYzswak909Amschex4QN829qt5hNDV/K7JZ85HUERGtlRzDn9A3M7PsnFzMzCy7pl4sbIfxY3zaxsysDjxzMTOz7JxczMwsOycXMzPLzsnFzMyya+oL+k888QSXXHJJvcMY8jyGZjZQnrmYmVl2Ti5mZpadk4uZmWXn5GJmZtnVNLlIerWHurGS5pZsz5J0Wy3jMjOzvBph5jIWmNtnKzMzGzIGlFwk/VhSh6SHJM0pqX9V0qWS1ki6V9KHU/0+ku6RdL+k3tZfuQyYmNZz6V4HZrSkJZIekbS4ZIGwqZLuSjEslTR+EM/ZzMyqbKAzly9FxFSgFZgnabdUPwq4NyIOo1ix8uxU/w/AVRExDXiql2MuBB6LiMkRsSDVTQHmA5OAfYEZkoYDVwKzUwzXApeWH0zSHEntktpff/31AT49MzPLYaAfopwn6bOp/BFgP+B54C2g+zpJB/CJVJ4BnJLKPwAu7+fjrIqIjQCSOoEW4CXgEOD2NJHZDniyvGNEtAFtABMmTGjeldDMzBpYv5OLpFnA8cD0iHhd0nJgh7T77di6pOWWsuMO5g1+c0m5+3gCHoqI6YM4npmZ1dBATovtDLyYEsuBwJH96LMS+Fwqn95Lm03AmH4caz2wu6TpAJKGSzq4H/3MzKzGBpJc/gMYJqkL+Dpwbz/6/BXwvyXdT5Gc3icingdWSlpbckG/p3ZvAbOByyWtATqBowYQv5mZ1Ui/T4tFxGbgxF72jS4pLwGWpPLjQOlprMt66f/5sqrlJfu+XFLuBI7pb8xmZlYfjfA5FzMzazJOLmZmlp2Ti5mZZaetdxA3n9bW1mhvb693GGZmQ4qkjohoreQYnrmYmVl2Ti5mZpadk4uZmWU30O8WG1JefHEdP7zpiHqHMWT8rz9dVe8QzKxJeOZiZmbZObmYmVl2Ti5mZpadk4uZmWXn5GJmZtnVJLlI+omksan8avrdImltD21nSbqtvN7MzIaOmtyKHBEn1eJxzMysMVQ8c5F0gaR5qXyFpGWpfJyk61N5g6RxAzjsTpJukfSwpKslfSgd5wRJ90haLekmSaP7OpCZmdVejtNiK4CjU7kVGC1pODATuHuQxzwC+CrwMWAi8CcpOV0MHB8RhwPtwHnlHSXNkdQuqf2VV94Z5MObmVklcpwW6wCmShoDbAZWUySZo4F5gzzmqoj4NYCkGygS1ZvAJIolkQFGAPeUd4yINqANYOLEUc37lc9mZg2s4uQSEW9L2gCcBfwC6AKOpZhxrBvsYXvYFnB7RJw2yGOamVmN5LpbbAVwfvp9N3AO0BmDXyzmCEn7pGstpwI/B+4FZkj6fQBJIyXtX3noZmaWW67kcjcwHrgnIp6mOIU12OstUJzuugxYCzwO3BIRzwJnAjdI6qJINgdWErSZmVVHlluRI+IOYHjJ9v5l+1tKyqPT7w3AIT0cazmwvJfHWQZMqzxiMzOrJn9C38zMsnNyMTOz7JxczMwsu6ZeiXKXXQ7y6opmZnXgmYuZmWXn5GJmZtk5uZiZWXZNfc3l4Rdf4bAlS+sdRsNZM/uT9Q7BzJqcZy5mZpadk4uZmWXn5GJmZtk5uZiZWXZOLmZmll3FyUVSi6S1FfSfL2lkyfarlcZkZmb11Qgzl/nAyD5bmZnZkJEruQyT9H1JXZKWpFUij5N0S3cDSZ+QdHNpJ0nzgAnAnZLuLKm/VNIaSfdK+nCq213SjyTdn35mZIrdzMwyy5VcDgDaIuJQ4BVgLrAMOEjS7qnNWcD3SjtFxLeBJ4BjI+LYVD0KuDciDqNYNvnsVP8PwBURMQ04Bbimp0AkzZHULqn9nVdezvT0zMxsIHIll99GxMpUvh6YGREB/AD4gqSxwHTgp/041lvAbancAbSk8vHAdyR1ArcCO0kaU945ItoiojUiWofttPOgn5CZmQ1erq9/iV62vwf8G/AmcFNEvNOPY72dEhPAFrbG+CFgekS8UWmwZmZWXblmLntLmp7KpwE/B4iIJyhOe10MXNdL303A+2YgPfgZ8OXuDUmTBxusmZlVV67ksg44Q1IXsCtwVcm+xRSnzR7upW8b8NPSC/q9mAe0ppsGHgbOqTRoMzOrjopPi0XEBmDSNprMBP5pG/2vBK4s2R5dUl4CLEnl54BTKwzXzMxqoKpfuS+pA3gN+Go1H8fMzBpLVZNLREyt5vHNzKwxNcIn9M3MrMk09UqUk3bZiXavumhmVnOeuZiZWXba+nnF5iNpE7C+3nH0wzjguXoH0YehECMMjTiHQozgOHMaCjHC1jg/GhG799V4W5r6tBiwPiJa6x1EXyS1N3qcQyFGGBpxDoUYwXHmNBRihLxx+rSYmZll5+RiZmbZNXtyaat3AP00FOIcCjHC0IhzKMQIjjOnoRAjZIyzqS/om5lZfTT7zMXMzOrAycXMzLJryuQi6Y8krZf0qKSFdY7lI5LulLRO0kOS/irV7yrpdkm/Sr93SfWS9O0Ue5ekw2sY63aSHpB0W9reR9J9KcYbJY1I9dun7UfT/pYaxjhW0hJJj6Qxnd6gY/mV9O+9VtINknZohPGUdK2kZyStLakb8PhJOiO1/5WkM2oQ46L0b94l6Za0um33vgtTjOslfbKkvqrvAz3FWbLvfEkhaVzabpixTPXnprF5SNI3SurzjWVENNUPsB3wGLAvMAJYA0yqYzzjgcNTeQzwS4olCr4BLEz1C4HLU/kkiuWgBRwJ3FfDWM8D/gW4LW3/EPhcKl8N/GUqzwWuTuXPATfWMMbvA3+eyiOAsY02lsCewOPAjiXjeGYjjCdwDHA4sLakbkDjR7Fm06/T711SeZcqx3gCMCyVLy+JcVJ6jW8P7JNe+9vV4n2gpzhT/UeApcB/AeMacCyPBf4T2D5t71GNsaz6C63WP8B0YGnJ9oXAhfWOqySe/w98guKbA8anuvEUH/gE+C5wWkn7d9tVOa69gDuAjwO3pRfBcyUv6HfHNb1wpqfysNRONYhxJ4o3bZXVN9pY7gn8Nr1hDEvj+clGGU+gpezNZkDjR7Ha7HdL6t/Trhoxlu37LLA4ld/z+u4ey1q9D/QUJ8UaVIcBG9iaXBpmLCn+yDm+h3ZZx7IZT4t1v7C7bUx1dZdOd0wB7gM+HBFPAqTfe6Rm9Yr/W8AFwO/S9m7ASxHxTg9xvBtj2v9yal9t+wLPAt9Lp++ukTSKBhvLiPhv4O+B3wBPUoxPB403nt0GOn71fo19iWIWwDZiqUuMkj4N/HdErCnb1Uhx7g8cnU7B3iVpWjVibMbkoh7q6n6/taTRwI+A+RHxyraa9lBX1fglfQp4JiI6+hlHvcZ4GMUU/6qImEKxEN22zv/WJc50zeJkilMLE4BRwInbiKUh/8/Se1x1i1fSRcA7FMuns41Y6vE6GglcBHytp929xFOPsRxGcQruSGAB8ENJ2kYsg4qxGZPLRopznt32Ap6oUywASBpOkVgWR8TNqfppSePT/vHAM6m+HvHPAD4taQPwrxSnxr4FjJXU/f1zpXG8G2PavzPwQpVj7H7cjRFxX9peQpFsGmksAY4HHo+IZyPibeBm4Cgabzy7DXT86jKu6WL3p4DTI52fabAYJ1L8QbEmvZb2AlZL+r0Gi3MjcHMUVlGcrRiXO8ZmTC73A/ulO3NGUFwgvbVewaS/CP4fsC4ivlmy61ag+86QMyiuxXTXfzHdXXIk8HL3KYtqiYgLI2KviGihGK9lEXE6cCcwu5cYu2OfndpX/S/XiHgK+K2kA1LVccDDNNBYJr8BjpQ0Mv37d8fZUONZYqDjtxQ4QdIuaZZ2QqqrGkl/BPwf4NMR8XpZ7J9TccfdPsB+wCrq8D4QEQ9GxB4R0ZJeSxspbuZ5igYaS+DHFH9AIml/iov0z5F7LHNf4GqEH4o7M35JcYfDRXWOZSbFFLIL6Ew/J1GcU78D+FX6vWtqL+AfU+wPAq01jncWW+8W2zf953oUuImtd5fskLYfTfv3rWF8k4H2NJ4/ppjeN9xYAn8LPAKsBX5AcQdO3ccTuIHiOtDbFG9+fzaY8aO47vFo+jmrBjE+SnHev/s1dHVJ+4tSjOuBE0vqq/o+0FOcZfs3sPWCfiON5Qjg+vR/czXw8WqMpb/+xczMsmvG02JmZlZnTi5mZpadk4uZmWXn5GJmZtk5uZiZWXZOLmZmlp2Ti5mZZfc/pfOy4JBUfL8AAAAASUVORK5CYII=
"
>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<h3 id="Trigrams">Trigrams<a class="anchor-link" href="#Trigrams">&#182;</a></h3>
</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[49]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">plot_top_ngrams_barchart</span><span class="p">(</span><span class="n">text</span><span class="p">,</span><span class="mi">3</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,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
"
>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<h1 id="Topic-Modelling-LDA-visualization">Topic Modelling LDA visualization<a class="anchor-link" href="#Topic-Modelling-LDA-visualization">&#182;</a></h1>
</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[52]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="k">def</span> <span class="nf">get_lda_objects</span><span class="p">(</span><span class="n">text</span><span class="p">):</span>
    <span class="n">nltk</span><span class="o">.</span><span class="n">download</span><span class="p">(</span><span class="s1">&#39;stopwords&#39;</span><span class="p">)</span>    
    <span class="n">stop</span><span class="o">=</span><span class="nb">set</span><span class="p">(</span><span class="n">stopwords</span><span class="o">.</span><span class="n">words</span><span class="p">(</span><span class="s1">&#39;english&#39;</span><span class="p">))</span>

    
    <span class="k">def</span> <span class="nf">_preprocess_text</span><span class="p">(</span><span class="n">text</span><span class="p">):</span>
        <span class="n">corpus</span><span class="o">=</span><span class="p">[]</span>
        <span class="n">stem</span><span class="o">=</span><span class="n">PorterStemmer</span><span class="p">()</span>
        <span class="n">lem</span><span class="o">=</span><span class="n">WordNetLemmatizer</span><span class="p">()</span>
        <span class="k">for</span> <span class="n">news</span> <span class="ow">in</span> <span class="n">text</span><span class="p">:</span>
            <span class="n">words</span><span class="o">=</span><span class="p">[</span><span class="n">w</span> <span class="k">for</span> <span class="n">w</span> <span class="ow">in</span> <span class="n">word_tokenize</span><span class="p">(</span><span class="n">news</span><span class="p">)</span> <span class="k">if</span> <span class="p">(</span><span class="n">w</span> <span class="ow">not</span> <span class="ow">in</span> <span class="n">stop</span><span class="p">)]</span>

            <span class="n">words</span><span class="o">=</span><span class="p">[</span><span class="n">lem</span><span class="o">.</span><span class="n">lemmatize</span><span class="p">(</span><span class="n">w</span><span class="p">)</span> <span class="k">for</span> <span class="n">w</span> <span class="ow">in</span> <span class="n">words</span> <span class="k">if</span> <span class="nb">len</span><span class="p">(</span><span class="n">w</span><span class="p">)</span><span class="o">&gt;</span><span class="mi">2</span><span class="p">]</span>

            <span class="n">corpus</span><span class="o">.</span><span class="n">append</span><span class="p">(</span><span class="n">words</span><span class="p">)</span>
        <span class="k">return</span> <span class="n">corpus</span>
    
    <span class="n">corpus</span><span class="o">=</span><span class="n">_preprocess_text</span><span class="p">(</span><span class="n">text</span><span class="p">)</span>
    
    <span class="n">dic</span><span class="o">=</span><span class="n">gensim</span><span class="o">.</span><span class="n">corpora</span><span class="o">.</span><span class="n">Dictionary</span><span class="p">(</span><span class="n">corpus</span><span class="p">)</span>
    <span class="n">bow_corpus</span> <span class="o">=</span> <span class="p">[</span><span class="n">dic</span><span class="o">.</span><span class="n">doc2bow</span><span class="p">(</span><span class="n">doc</span><span class="p">)</span> <span class="k">for</span> <span class="n">doc</span> <span class="ow">in</span> <span class="n">corpus</span><span class="p">]</span>
    
    <span class="n">lda_model</span> <span class="o">=</span>  <span class="n">gensim</span><span class="o">.</span><span class="n">models</span><span class="o">.</span><span class="n">LdaMulticore</span><span class="p">(</span><span class="n">bow_corpus</span><span class="p">,</span> 
                                   <span class="n">num_topics</span> <span class="o">=</span> <span class="mi">4</span><span class="p">,</span> 
                                   <span class="n">id2word</span> <span class="o">=</span> <span class="n">dic</span><span class="p">,</span>                                    
                                   <span class="n">passes</span> <span class="o">=</span> <span class="mi">10</span><span class="p">,</span>
                                   <span class="n">workers</span> <span class="o">=</span> <span class="mi">2</span><span class="p">)</span>
    
    <span class="k">return</span> <span class="n">lda_model</span><span class="p">,</span> <span class="n">bow_corpus</span><span class="p">,</span> <span class="n">dic</span>

<span class="k">def</span> <span class="nf">plot_lda_vis</span><span class="p">(</span><span class="n">lda_model</span><span class="p">,</span> <span class="n">bow_corpus</span><span class="p">,</span> <span class="n">dic</span><span class="p">):</span>
    <span class="n">pyLDAvis</span><span class="o">.</span><span class="n">enable_notebook</span><span class="p">()</span>
    <span class="n">vis</span> <span class="o">=</span> <span class="n">pyLDAvis</span><span class="o">.</span><span class="n">gensim</span><span class="o">.</span><span class="n">prepare</span><span class="p">(</span><span class="n">lda_model</span><span class="p">,</span> <span class="n">bow_corpus</span><span class="p">,</span> <span class="n">dic</span><span class="p">)</span>
    <span class="k">return</span> <span class="n">vis</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stderr output_text">
<pre>[nltk_data] Downloading package wordnet to
[nltk_data]     /home/teamscool/nltk_data...
[nltk_data]   Unzipping corpora/wordnet.zip.
</pre>
</div>
</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[53]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">lda_model</span><span class="p">,</span> <span class="n">bow_corpus</span><span class="p">,</span> <span class="n">dic</span> <span class="o">=</span> <span class="n">get_lda_objects</span><span class="p">(</span><span class="n">text</span><span class="p">)</span>
<span class="n">lda_model</span><span class="o">.</span><span class="n">show_topics</span><span class="p">()</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stderr output_text">
<pre>[nltk_data] Downloading package stopwords to
[nltk_data]     /home/teamscool/nltk_data...
[nltk_data]   Package stopwords is already up-to-date!
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt output_prompt">Out[53]:</div>




<div class="output_text output_subarea output_execute_result">
<pre>[(0,
  &#39;0.011*&#34;company&#34; + 0.005*&#34;said&#34; + 0.004*&#34;one&#34; + 0.004*&#34;people&#34; + 0.004*&#34;year&#34; + 0.004*&#34;new&#34; + 0.004*&#34;per&#34; + 0.003*&#34;also&#34; + 0.003*&#34;culture&#34; + 0.003*&#34;work&#34;&#39;),
 (1,
  &#39;0.005*&#34;company&#34; + 0.005*&#34;covid19&#34; + 0.005*&#34;share&#34; + 0.005*&#34;time&#34; + 0.005*&#34;process&#34; + 0.004*&#34;patient&#34; + 0.004*&#34;product&#34; + 0.004*&#34;said&#34; + 0.004*&#34;also&#34; + 0.004*&#34;drug&#34;&#39;),
 (2,
  &#39;0.005*&#34;data&#34; + 0.005*&#34;covid19&#34; + 0.005*&#34;said&#34; + 0.005*&#34;company&#34; + 0.004*&#34;policy&#34; + 0.004*&#34;new&#34; + 0.004*&#34;year&#34; + 0.004*&#34;health&#34; + 0.004*&#34;government&#34; + 0.004*&#34;india&#34;&#39;),
 (3,
  &#39;0.008*&#34;said&#34; + 0.006*&#34;company&#34; + 0.006*&#34;new&#34; + 0.004*&#34;also&#34; + 0.004*&#34;india&#34; + 0.004*&#34;lockdown&#34; + 0.003*&#34;state&#34; + 0.003*&#34;covid19&#34; + 0.003*&#34;service&#34; + 0.003*&#34;people&#34;&#39;)]</pre>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[55]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">plot_lda_vis</span><span class="p">(</span><span class="n">lda_model</span><span class="p">,</span> <span class="n">bow_corpus</span><span class="p">,</span> <span class="n">dic</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[55]:</div>



<div class="output_html rendered_html output_subarea output_execute_result">

<link rel="stylesheet" type="text/css" href="https://cdn.rawgit.com/bmabey/pyLDAvis/files/ldavis.v1.0.0.css">


<div id="ldavis_el21461398123938686241926430848"></div>
<script type="text/javascript">

var ldavis_el21461398123938686241926430848_data = {"mdsDat": {"x": [-0.012847907885142736, 0.080633749329017, 0.019118163060226977, -0.08690400450410125], "y": [-0.09129935203520705, 0.011625678696091803, 0.04540119911355574, 0.03427247422555952], "topics": [1, 2, 3, 4], "cluster": [1, 1, 1, 1], "Freq": [29.100688934326172, 26.30845069885254, 25.371610641479492, 19.219249725341797]}, "tinfo": {"Term": ["policy", "culture", "company", "privacy", "contag", "cookie", "cooky", "process", "data", "arrowhead", "share", "cent", "accept", "anzalone", "per", "website", "billion", "updated", "covid19", "nan", "trial", "service", "oil", "respondent", "money", "patent", "clinical", "price", "health", "manufacturing", "scm", "cytokine", "econsent", "lsl", "calcimedica", "zoom", "athira", "glympse", "kawas", "visibility", "loew", "flexion", "caroline", "634", "leheny", "734", "711", "matthew", "417", "582", "traversa", "clayman", "wotton", "zahid", "lockdown4", "hpapis", "plague", "deviation", "rachel", "antidepressant", "sport", "packaging", "sterile", "batch", "singleuse", "supplier", "authorisation", "process", "share", "participant", "app", "clinical", "trial", "manufacturing", "video", "site", "religion", "dealer", "system", "product", "time", "quality", "patient", "chain", "technology", "covid19", "supply", "drug", "regulatory", "data", "industry", "material", "pharmaceutical", "also", "use", "company", "people", "work", "one", "may", "new", "said", "pandemic", "need", "development", "day", "year", "cookie", "arrowhead", "anzalone", "cooky", "mcmanus", "realestate", "hydroxychloroquine", "antisemitic", "saudi", "assume", "abortion", "ransomware", "iqvia", "prolife", "stressful", "arabia", "cobra", "qrm", "steal", "sophos", "trillion", "intuition", "bhasin", "cyber", "ciso", "dear", "pixel", "iran", "indiatimescom", "ignore", "privacy", "malware", "updated", "accept", "hacker", "policy", "criminal", "align", "roche", "website", "european", "biosimilars", "choose", "receive", "payment", "billion", "decision", "military", "data", "china", "union", "health", "message", "crisis", "percent", "covid19", "price", "government", "world", "use", "million", "india", "year", "patient", "hospital", "business", "said", "drug", "new", "company", "also", "country", "market", "may", "time", "would", "people", "treatment", "dod", "borrower", "lhon", "advertising", "acc20", "manpower", "softbank", "fadnavis", "attra", "sarkar", "beauty", "moratorium", "provisioning", "ashish", "liquidity", "zee5", "uber", "titling", "sezs", "marriott", "airfinity", "kols", "agriculture", "exhibition", "kol", "barda", "bhal", "supplyside", "nonformulary", "inequality", "telco", "airtel", "milk", "miner", "labour", "blatt", "accounting", "aligos", "tower", "sponsored", "minister", "edition", "neuroscience", "service", "revenue", "ad", "lockdown", "district", "large", "said", "bank", "state", "federal", "india", "new", "home", "crore", "vehicle", "city", "sector", "must", "conference", "disease", "live", "market", "also", "country", "case", "would", "company", "activity", "government", "social", "chief", "like", "need", "people", "covid19", "work", "could", "may", "per", "pandemic", "time", "one", "business", "health", "coronavirus", "drug", "year", "nan", "jhaveri", "contag", "prescient", "cozadd", "itikaf", "lewis", "conn", "respondent", "stehmanbreen", "artist", "snake", "elaborates", "concentrx", "behavior", "russo", "xenogen", "schatzman", "jlabs", "rebrand", "electron", "caption", "oncolytic", "wound", "ongc", "mentor", "biontech", "sxsw", "dongfeng", "simon", "culture", "bioeclipse", "patent", "gas", "craft", "satisfaction", "submission", "money", "corporate", "mall", "company", "cent", "survey", "atm", "office", "oil", "per", "employee", "one", "going", "say", "pharma", "year", "board", "people", "cost", "said", "space", "work", "get", "new", "first", "around", "product", "also", "technology", "development", "help", "time", "make", "thing", "would", "business", "industry"], "Freq": [232.0, 114.0, 1105.0, 134.0, 85.0, 101.0, 92.0, 339.0, 500.0, 73.0, 392.0, 180.0, 93.0, 64.0, 333.0, 131.0, 213.0, 82.0, 651.0, 43.0, 217.0, 256.0, 91.0, 44.0, 110.0, 52.0, 220.0, 126.0, 332.0, 259.0, 40.80057144165039, 27.015932083129883, 22.418027877807617, 24.161468505859375, 24.0700626373291, 33.81122589111328, 20.4581241607666, 22.16002082824707, 18.583202362060547, 14.992560386657715, 20.290218353271484, 16.74571418762207, 18.469635009765625, 15.811107635498047, 16.676273345947266, 14.91246509552002, 14.906801223754883, 13.153314590454102, 14.90321159362793, 14.896968841552734, 14.022897720336914, 14.898653030395508, 14.839741706848145, 11.310847282409668, 11.305774688720703, 11.304703712463379, 12.169892311096191, 11.301177978515625, 12.997246742248535, 11.250988006591797, 22.229755401611328, 60.581146240234375, 24.08795166015625, 37.63579559326172, 14.520054817199707, 68.39543151855469, 19.22197151184082, 238.5282440185547, 251.30209350585938, 31.307668685913086, 89.85350799560547, 146.42381286621094, 143.93017578125, 166.52671813964844, 82.39213562011719, 45.56464767456055, 20.46174430847168, 35.143795013427734, 123.96683502197266, 198.34349060058594, 250.18997192382812, 77.77766418457031, 224.4556884765625, 95.3748779296875, 150.59942626953125, 254.6308135986328, 128.12464904785156, 189.35792541503906, 60.352569580078125, 188.1205291748047, 147.48165893554688, 47.155670166015625, 100.90251922607422, 190.3848876953125, 118.79798126220703, 257.2335205078125, 168.6364288330078, 132.35751342773438, 153.58348083496094, 140.65179443359375, 182.57798767089844, 197.96328735351562, 107.5789566040039, 117.13031768798828, 107.18163299560547, 106.1807861328125, 109.56620025634766, 100.2326431274414, 72.34202575683594, 63.321998596191406, 90.67471313476562, 21.797285079956055, 16.471534729003906, 21.660295486450195, 16.367416381835938, 14.64206600189209, 31.821012496948242, 16.35308074951172, 13.749470710754395, 14.581568717956543, 14.57686710357666, 14.562390327453613, 11.941606521606445, 12.777368545532227, 12.750960350036621, 11.03193473815918, 10.136178016662598, 10.134086608886719, 10.96364974975586, 10.11130428314209, 22.744855880737305, 9.25037956237793, 31.138145446777344, 9.228546142578125, 9.225072860717773, 9.211087226867676, 31.832361221313477, 123.86795806884766, 19.186222076416016, 74.23646545410156, 83.9183578491211, 25.46003532409668, 191.43307495117188, 13.294414520263672, 39.964412689208984, 25.34185218811035, 102.2254867553711, 78.65963745117188, 41.5147590637207, 32.77520751953125, 38.57197570800781, 67.47073364257812, 129.98495483398438, 123.47111511230469, 29.472511291503906, 240.07073974609375, 105.78441619873047, 49.57777786254883, 167.05120849609375, 38.82725524902344, 85.85443878173828, 86.80712890625, 224.88966369628906, 72.2016372680664, 166.2733612060547, 125.23936462402344, 130.7108612060547, 128.03851318359375, 163.72048950195312, 170.05496215820312, 161.8168182373047, 74.45398712158203, 126.06546020507812, 220.66622924804688, 143.46990966796875, 180.38604736328125, 216.67796325683594, 163.09133911132812, 115.63250732421875, 118.44498443603516, 124.69183349609375, 129.41836547851562, 109.26471710205078, 113.69425201416016, 95.65084838867188, 33.21830368041992, 17.62656021118164, 16.705644607543945, 20.04224395751953, 13.926064491271973, 13.036615371704102, 12.120123863220215, 12.109920501708984, 11.222606658935547, 11.21936321258545, 15.496917724609375, 10.30480670928955, 10.304606437683105, 10.297178268432617, 24.82570457458496, 9.389385223388672, 9.387619018554688, 8.477160453796387, 8.474321365356445, 8.467353820800781, 8.453492164611816, 8.449775695800781, 10.973461151123047, 8.438620567321777, 8.438252449035645, 8.393086433410645, 7.554713249206543, 7.553736686706543, 7.553861618041992, 7.552004337310791, 14.266080856323242, 19.206287384033203, 13.379112243652344, 8.368555068969727, 41.07639694213867, 20.331995010375977, 10.739033699035645, 16.676969528198242, 23.98694610595703, 19.2077579498291, 84.36060333251953, 18.3792724609375, 20.289997100830078, 150.2445526123047, 63.04261779785156, 24.420562744140625, 168.99986267089844, 45.33829879760742, 68.68524932861328, 371.34661865234375, 58.786468505859375, 152.6237335205078, 29.360258102416992, 185.8870849609375, 263.73773193359375, 114.48216247558594, 65.8604736328125, 42.463661193847656, 59.22470474243164, 66.2029037475586, 75.4356918334961, 55.15312957763672, 106.36662292480469, 39.76978302001953, 132.80160522460938, 198.2696533203125, 126.44400024414062, 102.8465347290039, 132.74838256835938, 265.92236328125, 63.64622497558594, 140.21148681640625, 73.78446197509766, 69.40592193603516, 105.54408264160156, 113.44876098632812, 141.24838256835938, 151.36207580566406, 112.00202941894531, 100.16842651367188, 118.13614654541016, 102.15161895751953, 91.02535247802734, 117.87905883789062, 110.5709228515625, 94.51960754394531, 92.23130798339844, 87.31453704833984, 95.01251983642578, 94.90579223632812, 42.37088394165039, 31.126367568969727, 82.94581604003906, 19.134803771972656, 28.98122215270996, 14.817768096923828, 20.547285079956055, 22.162561416625977, 41.83453369140625, 18.85555648803711, 31.148475646972656, 15.56828498840332, 17.206974029541016, 17.19327163696289, 18.002525329589844, 13.041096687316895, 12.221842765808105, 17.103723526000977, 12.206186294555664, 12.203289985656738, 11.384504318237305, 12.179952621459961, 10.501042366027832, 10.471670150756836, 9.663970947265625, 12.051412582397461, 9.597363471984863, 8.799528121948242, 8.789402961730957, 8.78268051147461, 101.69951629638672, 24.269880294799805, 43.561912536621094, 27.584182739257812, 13.0928316116333, 13.089229583740234, 19.678564071655273, 64.40988159179688, 50.40753936767578, 25.862428665161133, 365.37115478515625, 86.43480682373047, 35.955909729003906, 20.599245071411133, 71.95948791503906, 51.66061782836914, 123.69503021240234, 91.22313690185547, 145.88565063476562, 79.51014709472656, 76.36326599121094, 82.32010650634766, 131.09857177734375, 53.51045227050781, 132.1441192626953, 63.25711441040039, 162.73141479492188, 50.5643310546875, 93.93124389648438, 80.55866241455078, 129.3953094482422, 86.51191711425781, 70.63152313232422, 92.70751190185547, 108.6840591430664, 78.82891082763672, 75.28455352783203, 70.59883880615234, 85.6084213256836, 70.9765853881836, 61.2921028137207, 70.33023834228516, 67.1733169555664, 66.74456787109375], "Total": [232.0, 114.0, 1105.0, 134.0, 85.0, 101.0, 92.0, 339.0, 500.0, 73.0, 392.0, 180.0, 93.0, 64.0, 333.0, 131.0, 213.0, 82.0, 651.0, 43.0, 217.0, 256.0, 91.0, 44.0, 110.0, 52.0, 220.0, 126.0, 332.0, 259.0, 41.65239715576172, 27.76241111755371, 23.12950325012207, 24.980527877807617, 24.978723526000977, 35.142486572265625, 21.27525520324707, 23.126916885375977, 19.42183494567871, 15.717801094055176, 21.273704528808594, 17.569019317626953, 19.421009063720703, 16.63732147216797, 17.567445755004883, 15.712533950805664, 15.711687088012695, 13.865215301513672, 15.711668968200684, 15.711424827575684, 14.790596008300781, 15.71656608581543, 15.716268539428711, 12.01242446899414, 12.01309585571289, 12.012407302856445, 12.934246063232422, 12.012551307678223, 13.86187744140625, 12.011149406433105, 24.01387596130371, 67.20098876953125, 26.801244735717773, 43.37804412841797, 15.683501243591309, 83.08436584472656, 21.227903366088867, 339.4134521484375, 392.7652282714844, 36.88618087768555, 123.30895233154297, 220.87405395507812, 217.99440002441406, 259.1842041015625, 119.34918212890625, 59.74559783935547, 22.993865966796875, 45.216678619384766, 226.16085815429688, 419.80108642578125, 583.0958251953125, 128.69729614257812, 515.5783081054688, 169.0251007080078, 315.16546630859375, 651.0543212890625, 258.29986572265625, 484.1398010253906, 96.89603424072266, 500.7740173339844, 377.6826171875, 69.54229736328125, 234.9469757080078, 660.429931640625, 308.81439208984375, 1105.205078125, 555.7232055664062, 374.6154479980469, 500.8690185546875, 443.39892578125, 756.0971069335938, 952.70751953125, 280.1474914550781, 361.2539367675781, 290.7117004394531, 315.47918701171875, 505.6255187988281, 101.1360855102539, 73.14794158935547, 64.11637878417969, 92.94632720947266, 22.572935104370117, 17.15352439880371, 22.571428298950195, 17.155513763427734, 15.347204208374023, 33.36384963989258, 17.154878616333008, 14.44388198852539, 15.346516609191895, 15.348037719726562, 15.347967147827148, 12.6378755569458, 13.541558265686035, 13.542851448059082, 11.734676361083984, 10.8312406539917, 10.831212043762207, 11.736263275146484, 10.831221580505371, 24.394458770751953, 9.928318977355957, 33.42479705810547, 9.927374839782715, 9.928160667419434, 9.928422927856445, 34.351871490478516, 134.7886505126953, 20.775304794311523, 82.1598129272461, 93.85834503173828, 28.031620025634766, 232.32456970214844, 14.450592041015625, 46.95171356201172, 28.934755325317383, 131.83544921875, 99.45831298828125, 50.19406509399414, 39.66304397583008, 47.95429992675781, 93.1137466430664, 213.03334045410156, 202.04864501953125, 36.21920394897461, 500.7740173339844, 181.7959442138672, 69.75386810302734, 332.8847961425781, 51.45170593261719, 151.4517059326172, 161.9774169921875, 651.0543212890625, 126.490966796875, 425.8833923339844, 289.2707214355469, 308.81439208984375, 301.5748596191406, 471.1926574707031, 505.6255187988281, 515.5783081054688, 139.01605224609375, 345.7331237792969, 952.70751953125, 484.1398010253906, 756.0971069335938, 1105.205078125, 660.429931640625, 340.8783264160156, 365.7335510253906, 443.39892578125, 583.0958251953125, 382.67376708984375, 555.7232055664062, 230.82342529296875, 33.975982666015625, 18.355186462402344, 17.436481475830078, 21.09492301940918, 14.67667007446289, 13.760369300842285, 12.840719223022461, 12.841609001159668, 11.92336654663086, 11.922985076904297, 16.51751136779785, 11.004476547241211, 11.004600524902344, 11.003928184509277, 26.563264846801758, 10.085546493530273, 10.085830688476562, 9.167034149169922, 9.166709899902344, 9.166458129882812, 9.1653470993042, 9.165056228637695, 11.916157722473145, 9.164314270019531, 9.164291381835938, 9.16137981414795, 8.247749328613281, 8.247774124145508, 8.248098373413086, 8.247706413269043, 15.58164119720459, 21.059932708740234, 14.639876365661621, 9.163836479187012, 47.681678771972656, 22.955120086669922, 11.88997745513916, 19.280000686645508, 29.284523010253906, 22.89687156677246, 121.40824127197266, 21.986507415771484, 24.68703842163086, 256.8389587402344, 94.91466522216797, 31.168481826782227, 342.00347900390625, 67.48782348632812, 114.26455688476562, 952.70751953125, 96.80160522460938, 339.1009216308594, 41.10872268676758, 471.1926574707031, 756.0971069335938, 255.89767456054688, 122.7838134765625, 68.10274505615234, 107.57624053955078, 125.90286254882812, 151.00515747070312, 99.62631225585938, 255.93264770507812, 63.228614807128906, 365.7335510253906, 660.429931640625, 340.8783264160156, 259.473388671875, 382.67376708984375, 1105.205078125, 127.81379699707031, 425.8833923339844, 160.6871337890625, 150.4364776611328, 309.1711120605469, 361.2539367675781, 555.7232055664062, 651.0543212890625, 374.6154479980469, 308.9902038574219, 443.39892578125, 333.693115234375, 280.1474914550781, 583.0958251953125, 500.8690185546875, 345.7331237792969, 332.8847961425781, 288.4622497558594, 484.1398010253906, 505.6255187988281, 43.12029266357422, 31.925771713256836, 85.45497131347656, 19.85750961303711, 30.2330379486084, 15.549379348754883, 21.60284423828125, 23.33409881591797, 44.07237243652344, 19.877151489257812, 32.844635009765625, 16.416379928588867, 18.147031784057617, 18.147754669189453, 19.013866424560547, 13.829554557800293, 12.96519660949707, 18.155929565429688, 12.966187477111816, 12.9662504196167, 12.10202407836914, 12.967734336853027, 11.24155330657959, 11.242837905883789, 10.378331184387207, 12.975500106811523, 10.378653526306152, 9.516966819763184, 9.516714096069336, 9.517815589904785, 114.56377410888672, 26.865459442138672, 52.99861145019531, 33.045982360839844, 14.732270240783691, 14.735610008239746, 24.364479064941406, 110.25614929199219, 82.07807922363281, 35.0150146484375, 1105.205078125, 180.12716674804688, 55.48297119140625, 26.1823673248291, 143.2022705078125, 91.54812622070312, 333.693115234375, 220.58999633789062, 500.8690185546875, 207.03138732910156, 194.82736206054688, 221.47833251953125, 505.6255187988281, 119.25273895263672, 555.7232055664062, 169.81736755371094, 952.70751953125, 115.18827819824219, 374.6154479980469, 285.8466796875, 756.0971069335938, 347.29986572265625, 231.96249389648438, 419.80108642578125, 660.429931640625, 315.16546630859375, 290.7117004394531, 262.4888916015625, 583.0958251953125, 301.5989074707031, 189.1836395263672, 382.67376708984375, 345.7331237792969, 377.6826171875], "Category": ["Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Default", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic1", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic2", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic3", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4", "Topic4"], "logprob": [30.0, 29.0, 28.0, 27.0, 26.0, 25.0, 24.0, 23.0, 22.0, 21.0, 20.0, 19.0, 18.0, 17.0, 16.0, 15.0, 14.0, 13.0, 12.0, 11.0, 10.0, 9.0, 8.0, 7.0, 6.0, 5.0, 4.0, 3.0, 2.0, 1.0, -7.1234002113342285, -7.535699844360352, -7.722300052642822, -7.64739990234375, -7.651199817657471, -7.311299800872803, -7.813700199127197, -7.733799934387207, -7.909900188446045, -8.124600410461426, -7.822000026702881, -8.013999938964844, -7.915999889373779, -8.071399688720703, -8.018099784851074, -8.129899978637695, -8.13029956817627, -8.255499839782715, -8.130599975585938, -8.130999565124512, -8.191399574279785, -8.130900382995605, -8.13479995727539, -8.406399726867676, -8.406800270080566, -8.406900405883789, -8.333200454711914, -8.40719985961914, -8.267399787902832, -8.411700248718262, -7.7307000160217285, -6.728099822998047, -7.650400161743164, -7.20419979095459, -8.156599998474121, -6.606800079345703, -7.876100063323975, -5.357600212097168, -5.305500030517578, -7.388299942016602, -6.333899974822998, -5.845600128173828, -5.862800121307373, -5.7170000076293945, -6.420599937438965, -7.013000011444092, -7.813600063323975, -7.27269983291626, -6.0121002197265625, -5.542099952697754, -5.309899806976318, -6.478300094604492, -5.418399810791016, -6.2743000984191895, -5.817500114440918, -5.292300224304199, -5.979100227355957, -5.588500022888184, -6.731900215148926, -5.59499979019165, -5.838399887084961, -6.978700160980225, -6.2179999351501465, -5.583099842071533, -6.054699897766113, -5.282100200653076, -5.704400062561035, -5.946599960327148, -5.797900199890137, -5.885799884796143, -5.624899864196777, -5.544000148773193, -6.153900146484375, -6.06879997253418, -6.157599925994873, -6.166999816894531, -6.1356000900268555, -6.123799800872803, -6.44980001449585, -6.583000183105469, -6.223999977111816, -7.649499893188477, -7.929599761962891, -7.655799865722656, -7.935999870300293, -8.04740047454834, -7.271100044250488, -7.936800003051758, -8.110300064086914, -8.05150032043457, -8.051799774169922, -8.052800178527832, -8.251199722290039, -8.183600425720215, -8.185600280761719, -8.330499649047852, -8.41510009765625, -8.415399551391602, -8.336700439453125, -8.41759967803955, -7.606900215148926, -8.506600379943848, -7.292799949645996, -8.508999824523926, -8.509300231933594, -8.5108003616333, -7.2708001136779785, -5.9120001792907715, -7.777100086212158, -6.423999786376953, -6.301400184631348, -7.494100093841553, -5.4766998291015625, -8.143899917602539, -7.043300151824951, -7.498799800872803, -6.104100227355957, -6.366099834442139, -7.005199909210205, -7.241600036621094, -7.078700065612793, -6.519599914550781, -5.863800048828125, -5.915200233459473, -7.347799777984619, -5.25029993057251, -6.069900035858154, -6.827700138092041, -5.61299991607666, -7.0721001625061035, -6.278600215911865, -6.267600059509277, -5.3155999183654785, -6.4517998695373535, -5.617599964141846, -5.901000022888184, -5.85830020904541, -5.878900051116943, -5.6331000328063965, -5.595099925994873, -5.644800186157227, -6.42110013961792, -5.894499778747559, -5.33459997177124, -5.765100002288818, -5.536200046539307, -5.352799892425537, -5.636899948120117, -5.980800151824951, -5.9567999839782715, -5.905399799346924, -5.868199825286865, -6.037499904632568, -5.997700214385986, -6.170599937438965, -7.19189977645874, -7.8256001472473145, -7.879199981689453, -7.697199821472168, -8.061200141906738, -8.12720012664795, -8.20009994506836, -8.201000213623047, -8.277099609375, -8.277400016784668, -7.954400062561035, -8.36240005493164, -8.36240005493164, -8.363100051879883, -7.483099937438965, -8.455400466918945, -8.455599784851074, -8.557600021362305, -8.557999610900879, -8.558799743652344, -8.560400009155273, -8.56089973449707, -8.299500465393066, -8.562199592590332, -8.562199592590332, -8.56760025024414, -8.672800064086914, -8.67300033569336, -8.672900199890137, -8.673199653625488, -8.037099838256836, -7.739799976348877, -8.101300239562988, -8.570500373840332, -6.979599952697754, -7.682799816131592, -8.321100234985352, -7.88100004196167, -7.517499923706055, -7.739699840545654, -6.259900093078613, -7.78380012512207, -7.684899806976318, -5.682700157165527, -6.551199913024902, -7.499599933624268, -5.565100193023682, -6.880799770355225, -6.4654998779296875, -4.777900218963623, -6.621099948883057, -5.666999816894531, -7.315400123596191, -5.469900131225586, -5.119999885559082, -5.954599857330322, -6.507500171661377, -6.946300029754639, -6.613699913024902, -6.502299785614014, -6.371699810028076, -6.684899806976318, -6.02810001373291, -7.011899948120117, -5.806099891662598, -5.405399799346924, -5.855199813842773, -6.061800003051758, -5.80649995803833, -5.111800193786621, -6.5416998863220215, -5.751800060272217, -6.393799781799316, -6.454999923706055, -6.035900115966797, -5.963600158691406, -5.744500160217285, -5.675300121307373, -5.976500034332275, -6.088099956512451, -5.9232001304626465, -6.06850004196167, -6.183899879455566, -5.925300121307373, -5.989299774169922, -6.146200180053711, -6.1707000732421875, -6.225500106811523, -6.140999794006348, -6.142099857330322, -6.67080020904541, -6.9791998863220215, -5.999100208282471, -7.465799808502197, -7.050600051879883, -7.721399784088135, -7.394499778747559, -7.318900108337402, -6.683599948883057, -7.480500221252441, -6.978499889373779, -7.671999931335449, -7.572000026702881, -7.572800159454346, -7.526800155639648, -7.8491997718811035, -7.914100170135498, -7.578000068664551, -7.915299892425537, -7.915599822998047, -7.985000133514404, -7.917500019073486, -8.065799713134766, -8.068599700927734, -8.148900032043457, -7.928100109100342, -8.155799865722656, -8.242600440979004, -8.24370002746582, -8.244500160217285, -5.795300006866455, -7.228000164031982, -6.643099784851074, -7.099999904632568, -7.845200061798096, -7.8454999923706055, -7.437699794769287, -6.251999855041504, -6.497099876403809, -7.1645002365112305, -4.51639986038208, -5.957900047302246, -6.835000038146973, -7.392000198364258, -6.141200065612793, -6.472599983215332, -5.5995001792907715, -5.9039998054504395, -5.434500217437744, -6.041399955749512, -6.0817999839782715, -6.006700038909912, -5.541299819946289, -6.437399864196777, -5.533400058746338, -6.270100116729736, -5.325200080871582, -6.49399995803833, -5.87470006942749, -6.028299808502197, -5.5543999671936035, -5.956999778747559, -6.159800052642822, -5.887800216674805, -5.728799819946289, -6.050000190734863, -6.0960001945495605, -6.160299777984619, -5.96750020980835, -6.154900074005127, -6.301599979400635, -6.164100170135498, -6.210000038146973, -6.216400146484375], "loglift": [30.0, 29.0, 28.0, 27.0, 26.0, 25.0, 24.0, 23.0, 22.0, 21.0, 20.0, 19.0, 18.0, 17.0, 16.0, 15.0, 14.0, 13.0, 12.0, 11.0, 10.0, 9.0, 8.0, 7.0, 6.0, 5.0, 4.0, 3.0, 2.0, 1.0, 1.2137000560760498, 1.207200050354004, 1.2031999826431274, 1.2010999917984009, 1.1973999738693237, 1.1957999467849731, 1.195199966430664, 1.1916999816894531, 1.1902999877929688, 1.1871999502182007, 1.1871000528335571, 1.186400055885315, 1.1842000484466553, 1.183500051498413, 1.1822999715805054, 1.1821000576019287, 1.1818000078201294, 1.1816999912261963, 1.1815999746322632, 1.1812000274658203, 1.1811000108718872, 1.180999994277954, 1.1770000457763672, 1.1742000579833984, 1.173699975013733, 1.173699975013733, 1.1734999418258667, 1.1734000444412231, 1.1699999570846558, 1.1690000295639038, 1.1571999788284302, 1.1306999921798706, 1.1276999711990356, 1.0923999547958374, 1.1572999954223633, 1.0398999452590942, 1.13510000705719, 0.8816999793052673, 0.7878999710083008, 1.0703999996185303, 0.917900025844574, 0.8233000040054321, 0.8192999958992004, 0.7919999957084656, 0.8637999892234802, 0.9634000062942505, 1.1176999807357788, 0.9824000000953674, 0.6331999897956848, 0.4846000075340271, 0.38830000162124634, 0.7307999730110168, 0.4027999937534332, 0.6621999740600586, 0.4959000051021576, 0.2955999970436096, 0.53329998254776, 0.2957000136375427, 0.7609999775886536, 0.25529998540878296, 0.29409998655319214, 0.8458999991416931, 0.38920000195503235, -0.009399999864399433, 0.2791000008583069, -0.22339999675750732, 0.04190000146627426, 0.1940000057220459, 0.052299998700618744, 0.08619999885559082, -0.186599999666214, -0.3368000090122223, 0.27730000019073486, 0.10809999704360962, 0.23659999668598175, 0.14550000429153442, -0.29490000009536743, 1.326300024986267, 1.3242000341415405, 1.3228000402450562, 1.3105000257492065, 1.3003000020980835, 1.294700026512146, 1.294100046157837, 1.2883000373840332, 1.2882000207901, 1.2878999710083008, 1.2874000072479248, 1.2860000133514404, 1.28410005569458, 1.2836999893188477, 1.2826999425888062, 1.2785999774932861, 1.2771999835968018, 1.274999976158142, 1.2734999656677246, 1.2690000534057617, 1.2688000202178955, 1.267199993133545, 1.2664999961853027, 1.2653000354766846, 1.2646000385284424, 1.2644000053405762, 1.2623000144958496, 1.2618000507354736, 1.2603000402450562, 1.2590999603271484, 1.2508000135421753, 1.2556999921798706, 1.2338999509811401, 1.2232999801635742, 1.2390999794006348, 1.141700029373169, 1.2518999576568604, 1.1741000413894653, 1.2027000188827515, 1.080899953842163, 1.1007000207901, 1.145400047302246, 1.1445000171661377, 1.1175999641418457, 1.013200044631958, 0.8413000106811523, 0.8428000211715698, 1.12909996509552, 0.6000999808311462, 0.7937999963760376, 0.9937999844551086, 0.645799994468689, 1.0537999868392944, 0.7677000164985657, 0.7114999890327454, 0.27230000495910645, 0.7746000289916992, 0.39469999074935913, 0.49810001254081726, 0.4754999876022339, 0.47859999537467957, 0.2782000005245209, 0.24560000002384186, 0.17649999260902405, 0.7109000086784363, 0.3264000117778778, -0.1273999959230423, 0.11900000274181366, -0.09780000150203705, -0.29409998655319214, -0.0632999986410141, 0.2542000114917755, 0.2078000009059906, 0.06669999659061432, -0.17000000178813934, 0.08190000057220459, -0.2515000104904175, 0.4542999863624573, 1.3489999771118164, 1.3309999704360962, 1.3286999464035034, 1.3202999830245972, 1.319000005722046, 1.3174999952316284, 1.3137999773025513, 1.3128999471664429, 1.3109999895095825, 1.3107000589370728, 1.307800054550171, 1.305799961090088, 1.305799961090088, 1.3051999807357788, 1.3039000034332275, 1.2999999523162842, 1.2998000383377075, 1.2933000326156616, 1.2929999828338623, 1.292199969291687, 1.2906999588012695, 1.2903000116348267, 1.2891000509262085, 1.2890000343322754, 1.2890000343322754, 1.284000039100647, 1.2838000059127808, 1.2835999727249146, 1.2835999727249146, 1.283400058746338, 1.2833000421524048, 1.2793999910354614, 1.281499981880188, 1.2807999849319458, 1.2223999500274658, 1.2502000331878662, 1.269700050354004, 1.2265000343322754, 1.1720000505447388, 1.1958999633789062, 1.0075000524520874, 1.1922999620437622, 1.1754000186920166, 0.8353999853134155, 0.9624000191688538, 1.1275999546051025, 0.6665999889373779, 0.9736999869346619, 0.8626000285148621, 0.4293999969959259, 0.8727999925613403, 0.573199987411499, 1.034999966621399, 0.4413999915122986, 0.3183000087738037, 0.5672000050544739, 0.7487000226974487, 0.8992000222206116, 0.7746999859809875, 0.7287999987602234, 0.6775000095367432, 0.7802000045776367, 0.4934999942779541, 0.9078999757766724, 0.35850000381469727, 0.16830000281333923, 0.3797999918460846, 0.44609999656677246, 0.31279999017715454, -0.05299999937415123, 0.6743000149726868, 0.2605000138282776, 0.5932000279426575, 0.5979999899864197, 0.29679998755455017, 0.21330000460147858, 0.0017999999690800905, -0.08739999681711197, 0.16419999301433563, 0.2451000064611435, 0.048900000751018524, 0.18780000507831573, 0.24740000069141388, -0.2272000014781952, -0.13910000026226044, 0.0746999979019165, 0.08799999952316284, 0.17649999260902405, -0.25679999589920044, -0.30140000581741333, 1.631700038909912, 1.623900055885315, 1.6195000410079956, 1.6122000217437744, 1.6069999933242798, 1.601099967956543, 1.5992000102996826, 1.5976999998092651, 1.597100019454956, 1.596500039100647, 1.5961999893188477, 1.5961999893188477, 1.5960999727249146, 1.5951999425888062, 1.594599962234497, 1.5906000137329102, 1.5901999473571777, 1.5895999670028687, 1.5888999700546265, 1.5886000394821167, 1.5880999565124512, 1.5865999460220337, 1.5810999870300293, 1.5781999826431274, 1.5779000520706177, 1.5753999948501587, 1.5709999799728394, 1.5708999633789062, 1.5698000192642212, 1.5688999891281128, 1.5300999879837036, 1.547700047492981, 1.4531999826431274, 1.4686000347137451, 1.5312999486923218, 1.5307999849319458, 1.4357000589370728, 1.1117000579833984, 1.1617000102996826, 1.3463000059127808, 0.5424000024795532, 0.9150000214576721, 1.215499997138977, 1.4093999862670898, 0.9610999822616577, 1.0771000385284424, 0.6568999886512756, 0.7663000226020813, 0.4156999886035919, 0.692300021648407, 0.7125999927520752, 0.659500002861023, 0.2994000017642975, 0.8478999733924866, 0.21289999783039093, 0.6617000102996826, -0.11789999902248383, 0.8259000182151794, 0.26589998602867126, 0.38280001282691956, -0.11599999666213989, 0.25940001010894775, 0.4602000117301941, 0.1388999968767166, -0.15520000457763672, 0.26339998841285706, 0.29820001125335693, 0.3361000120639801, -0.26930001378059387, 0.20250000059604645, 0.5221999883651733, -0.04470000043511391, 0.010900000110268593, -0.08389999717473984]}, "token.table": {"Topic": [1, 1, 1, 1, 1, 2, 3, 1, 2, 3, 4, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 3, 3, 3, 2, 3, 4, 1, 2, 3, 4, 1, 3, 1, 2, 3, 4, 1, 2, 2, 1, 2, 3, 4, 2, 1, 2, 3, 4, 2, 1, 4, 3, 2, 4, 1, 3, 4, 3, 1, 2, 1, 2, 3, 4, 3, 1, 2, 3, 4, 1, 3, 4, 3, 2, 1, 2, 3, 4, 3, 4, 4, 2, 4, 1, 3, 1, 2, 3, 4, 3, 1, 2, 3, 4, 1, 4, 1, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 2, 3, 4, 2, 1, 2, 3, 4, 1, 1, 2, 3, 4, 2, 1, 2, 3, 4, 4, 1, 2, 3, 4, 1, 4, 3, 4, 2, 2, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 4, 1, 3, 4, 1, 2, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 1, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 1, 2, 1, 2, 3, 4, 1, 2, 3, 4, 1, 1, 2, 3, 4, 1, 2, 3, 4, 3, 4, 1, 2, 3, 4, 1, 1, 2, 3, 4, 4, 1, 2, 3, 4, 1, 2, 3, 4, 3, 3, 1, 2, 3, 4, 1, 2, 3, 4, 1, 1, 2, 3, 4, 1, 2, 3, 4, 1, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 1, 2, 1, 2, 3, 4, 2, 1, 2, 3, 4, 3, 2, 2, 2, 4, 4, 4, 1, 3, 3, 1, 2, 3, 1, 2, 3, 4, 1, 1, 4, 3, 1, 2, 3, 4, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 1, 1, 1, 2, 3, 4, 1, 2, 3, 4, 2, 3, 3, 1, 2, 3, 4, 1, 2, 3, 4, 3, 1, 2, 3, 4, 1, 1, 2, 3, 4, 2, 4, 1, 2, 4, 1, 2, 3, 3, 4, 1, 2, 3, 4, 3, 1, 2, 3, 4, 1, 2, 3, 4, 3, 1, 2, 3, 4, 4, 1, 2, 3, 4, 1, 3, 4, 1, 2, 3, 4, 3, 1, 2, 3, 4, 1, 2, 3, 4, 4, 1, 2, 3, 4, 4, 1, 2, 4, 1, 2, 3, 4, 1, 3, 4, 2, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 2, 1, 1, 2, 3, 4, 4, 1, 2, 3, 4, 1, 2, 3, 1, 2, 3, 4, 1, 2, 3, 4, 2, 3, 2, 1, 2, 3, 4, 1, 2, 2, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 4, 1, 4, 1, 2, 3, 4, 2, 3, 4, 1, 2, 3, 4, 3, 3, 4, 2, 1, 2, 3, 4, 1, 4, 1, 1, 2, 3, 4, 1, 2, 3, 4, 3, 1, 2, 3, 4, 4, 1, 4, 1, 2, 3, 4, 4, 1, 2, 3, 4, 3, 2, 1, 2, 3, 4, 1, 3, 4, 1, 2, 1, 2, 3, 4, 2, 4, 1, 3, 2, 1, 2, 3, 4, 1, 2, 3, 1, 2, 3, 4, 3, 1, 2, 3, 4, 4, 1, 2, 3, 4, 1, 2, 3, 4, 2, 3, 1, 2, 3, 4, 1, 2, 3, 4, 3, 2, 3, 1, 1, 2, 3, 4, 1, 2, 3, 4, 2, 3, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 1, 2, 3, 4, 1, 2, 3, 4, 1, 2, 3, 4, 1, 1, 2, 3, 4, 4, 4, 1, 2, 3, 4, 1, 3, 1, 4], "Freq": [0.9547044038772583, 0.9547192454338074, 0.961693286895752, 0.9547033309936523, 0.9546518921852112, 0.932679295539856, 0.953894853591919, 0.03196306154131889, 0.8949657082557678, 0.03196306154131889, 0.04261741414666176, 0.9251489639282227, 0.08410444855690002, 0.2503642141819, 0.17212539911270142, 0.5007284283638, 0.07823881506919861, 0.16041846573352814, 0.03208369389176369, 0.7700086236000061, 0.03208369389176369, 0.948095440864563, 0.9231163263320923, 0.8728529214859009, 0.04748353362083435, 0.9021871089935303, 0.04748353362083435, 0.042596954852342606, 0.8519390821456909, 0.06389543414115906, 0.042596954852342606, 0.10373443365097046, 0.8817427158355713, 0.2876913845539093, 0.24680891633033752, 0.2998047173023224, 0.16504400968551636, 0.9158157706260681, 0.932644784450531, 0.9825882315635681, 0.7298740148544312, 0.17030394077301025, 0.08109711110591888, 0.024329133331775665, 0.9495266675949097, 0.27590668201446533, 0.22848521173000336, 0.18968583643436432, 0.3060839772224426, 0.9843065738677979, 0.0304463729262352, 0.943837583065033, 0.9087663888931274, 0.9591219425201416, 0.029972560703754425, 0.940059244632721, 0.19096821546554565, 0.8020665049552917, 0.9225582480430603, 0.8950483798980713, 0.04710780829191208, 0.030991220846772194, 0.16528651118278503, 0.6094940304756165, 0.19627773761749268, 0.8732309341430664, 0.8760192394256592, 0.023053137585520744, 0.06915941089391708, 0.023053137585520744, 0.06054180860519409, 0.9081271290779114, 0.9466775059700012, 0.9699615836143494, 0.9232568740844727, 0.065717414021492, 0.6102331280708313, 0.27225786447525024, 0.05163510888814926, 0.07444503158330917, 0.8933404088020325, 0.963516116142273, 0.8367522954940796, 0.15938138961791992, 0.08712653070688248, 0.8712652921676636, 0.142554372549057, 0.218024343252182, 0.184482142329216, 0.4528197944164276, 0.9806492328643799, 0.16775944828987122, 0.36444294452667236, 0.27477842569351196, 0.19379109144210815, 0.9608176946640015, 0.9253736734390259, 0.9268313646316528, 0.3352944850921631, 0.18884402513504028, 0.3969578444957733, 0.07707919180393219, 0.016654901206493378, 0.2165137082338333, 0.2886849343776703, 0.4774404764175415, 0.5620467066764832, 0.1419907510280609, 0.17748843133449554, 0.1183256208896637, 0.18612506985664368, 0.15953578054904938, 0.4586653411388397, 0.18612506985664368, 0.2475302815437317, 0.5830712914466858, 0.1320161521434784, 0.038504708558321, 0.8320087790489197, 0.10084954649209976, 0.07563716173171997, 0.9064978957176208, 0.08366159349679947, 0.14873172342777252, 0.5484482645988464, 0.21380186080932617, 0.9544069766998291, 0.661010205745697, 0.21279095113277435, 0.05885707214474678, 0.0633845403790474, 0.9600076675415039, 0.23253603279590607, 0.19634364545345306, 0.2406793087720871, 0.3302554488182068, 0.9367550015449524, 0.11041259765625, 0.14052513241767883, 0.55206298828125, 0.19071267545223236, 0.04285573586821556, 0.9428262114524841, 0.023404138162732124, 0.9712717533111572, 0.9887667894363403, 0.979059636592865, 0.021517794579267502, 0.29119929671287537, 0.30506590008735657, 0.30159926414489746, 0.10053308308124542, 0.158385768532753, 0.08528465032577515, 0.14620225131511688, 0.6091760396957397, 0.22376981377601624, 0.28854528069496155, 0.11777358502149582, 0.37098678946495056, 0.2750896215438843, 0.21036265790462494, 0.3236348628997803, 0.19094456732273102, 0.19361747801303864, 0.3402973711490631, 0.36963334679603577, 0.09680873900651932, 0.39167237281799316, 0.34559327363967896, 0.23193149268627167, 0.03071940317749977, 0.03307639807462692, 0.959215521812439, 0.06787820160388947, 0.06787820160388947, 0.8824166059494019, 0.06920132040977478, 0.8996171355247498, 0.17827464640140533, 0.5678377747535706, 0.184877410531044, 0.07263041287660599, 0.08144395798444748, 0.3013426661491394, 0.5375301241874695, 0.08144395798444748, 0.06983010470867157, 0.017457526177167892, 0.02618628740310669, 0.8903337717056274, 0.040992915630340576, 0.9428370594978333, 0.9725379943847656, 0.37541884183883667, 0.47925809025764465, 0.08586707711219788, 0.05791035294532776, 0.3359968066215515, 0.2947896420955658, 0.19969621300697327, 0.16799840331077576, 0.7740506529808044, 0.06634719669818878, 0.1548101305961609, 0.05983581766486168, 0.9274551272392273, 0.2078707367181778, 0.6087642908096313, 0.1039353683590889, 0.07918885350227356, 0.36806222796440125, 0.20295020937919617, 0.16855186223983765, 0.2579875588417053, 0.9157088994979858, 0.39072778820991516, 0.09377466887235641, 0.4141714572906494, 0.10158922523260117, 0.11853989958763123, 0.11853989958763123, 0.6667869687080383, 0.08890492469072342, 0.9712743163108826, 0.9457045793533325, 0.3903830945491791, 0.2953692376613617, 0.19622431695461273, 0.11566907167434692, 0.9511661529541016, 0.045482438057661057, 0.09096487611532211, 0.818683922290802, 0.9367923140525818, 0.9089388847351074, 0.18586517870426178, 0.16773200035095215, 0.23119814693927765, 0.4125300347805023, 0.1105991005897522, 0.7943026423454285, 0.050272319465875626, 0.050272319465875626, 0.8729512691497803, 0.9344623684883118, 0.024325737729668617, 0.24325737357139587, 0.7054463624954224, 0.024325737729668617, 0.29081496596336365, 0.2533833384513855, 0.2073136419057846, 0.2505039870738983, 0.9676123261451721, 0.06052172929048538, 0.06052172929048538, 0.03026086464524269, 0.8473042249679565, 0.29036545753479004, 0.15043029189109802, 0.27987030148506165, 0.28336870670318604, 0.9512724876403809, 0.3091318607330322, 0.12558482587337494, 0.17871686816215515, 0.3864148259162903, 0.21132545173168182, 0.3897780478000641, 0.32872846722602844, 0.0704418197274208, 0.07134799659252167, 0.8918499946594238, 0.17723849415779114, 0.5016750693321228, 0.27637189626693726, 0.04506063461303711, 0.3123941719532013, 0.19048425555229187, 0.22858110070228577, 0.27048763632774353, 0.33607181906700134, 0.12504997849464417, 0.4454905688762665, 0.08987967669963837, 0.24457606673240662, 0.5323126316070557, 0.16544851660728455, 0.05754731222987175, 0.9157198667526245, 0.9746835827827454, 0.058220990002155304, 0.9315358400344849, 0.12309189885854721, 0.3480529487133026, 0.3947429955005646, 0.13582554459571838, 0.9064883589744568, 0.3892156779766083, 0.20122715830802917, 0.23035214841365814, 0.17739762365818024, 0.9699666500091553, 0.937265932559967, 0.9774205088615417, 0.9065123200416565, 0.9646687507629395, 0.9710023403167725, 0.9254840612411499, 0.9782803654670715, 0.872953474521637, 0.8728806376457214, 0.04194483160972595, 0.0838896632194519, 0.8598690629005432, 0.10501944273710251, 0.11377105861902237, 0.6038618087768555, 0.18378402292728424, 0.9676989912986755, 0.04629020020365715, 0.9720942378044128, 0.974967360496521, 0.3169765770435333, 0.13584710657596588, 0.3428522050380707, 0.207005113363266, 0.9411493539810181, 0.03764597326517105, 0.2688656151294708, 0.04744687303900719, 0.6326249837875366, 0.06326249241828918, 0.1578931361436844, 0.18420864641666412, 0.49414703249931335, 0.16374102234840393, 0.9156673550605774, 0.9401277303695679, 0.9607483148574829, 0.33156618475914, 0.265252947807312, 0.16578309237957, 0.23541198670864105, 0.11423670500516891, 0.05711835250258446, 0.08567753434181213, 0.7425386309623718, 0.914547324180603, 0.04813406988978386, 0.9447420835494995, 0.6443293690681458, 0.11960605531930923, 0.08873997628688812, 0.15047213435173035, 0.15311694145202637, 0.32263925671577454, 0.36365270614624023, 0.15858539938926697, 0.8727471232414246, 0.6758476495742798, 0.02875947579741478, 0.15817712247371674, 0.12941764295101166, 0.9375981092453003, 0.3179980516433716, 0.2819131910800934, 0.26612603664398193, 0.135318323969841, 0.9746184945106506, 0.924819827079773, 0.1554856151342392, 0.7579923868179321, 0.0777428075671196, 0.02760966308414936, 0.8006802201271057, 0.16565798223018646, 0.8879856467247009, 0.0683065876364708, 0.2586422562599182, 0.42443856596946716, 0.17574408650398254, 0.1392689049243927, 0.8729968070983887, 0.05765671283006668, 0.19768016040325165, 0.6918805241584778, 0.04942004010081291, 0.12697704136371613, 0.21767494082450867, 0.06348852068185806, 0.5804665088653564, 0.9087210893630981, 0.2052910029888153, 0.15893496572971344, 0.49667176604270935, 0.1324458122253418, 0.9740193486213684, 0.323871910572052, 0.18546511232852936, 0.3127993643283844, 0.17716069519519806, 0.08101417124271393, 0.8101417422294617, 0.08101417124271393, 0.24203240871429443, 0.23806466162204742, 0.3491615056991577, 0.17061300575733185, 0.9699205160140991, 0.20949389040470123, 0.0768144279718399, 0.20949389040470123, 0.502785325050354, 0.03276965022087097, 0.37138935923576355, 0.03276965022087097, 0.568007230758667, 0.9785124659538269, 0.3074656128883362, 0.1816842257976532, 0.22161482274532318, 0.29149338603019714, 0.9635460376739502, 0.9077247381210327, 0.01488073356449604, 0.07440366595983505, 0.38551121950149536, 0.2570074796676636, 0.3248288929462433, 0.035695482045412064, 0.8404231667518616, 0.10844169557094574, 0.05422084778547287, 0.1698157638311386, 0.8302104473114014, 0.43446359038352966, 0.31421026587486267, 0.1745612621307373, 0.07564321160316467, 0.010739552788436413, 0.7195500135421753, 0.21479105949401855, 0.05369776487350464, 0.30410823225975037, 0.20513810217380524, 0.2537234425544739, 0.23752832412719727, 0.12286738306283951, 0.19778652489185333, 0.3056700825691223, 0.3715989291667938, 0.15434250235557556, 0.5371119379997253, 0.030868500471115112, 0.277816504240036, 0.3612091541290283, 0.17157433927059174, 0.09933251887559891, 0.37023937702178955, 0.4298842251300812, 0.2894270122051239, 0.1106632649898529, 0.17025117576122284, 0.9065840840339661, 0.9277696013450623, 0.047347553074359894, 0.8221256732940674, 0.09469510614871979, 0.03443458303809166, 0.9568168520927429, 0.023717109113931656, 0.5692105889320374, 0.07905703037977219, 0.32413381338119507, 0.05935217812657356, 0.919958770275116, 0.022257067263126373, 0.7041559219360352, 0.06776396185159683, 0.09428029507398605, 0.13552792370319366, 0.47165194153785706, 0.15007106959819794, 0.15721730887889862, 0.22153349220752716, 0.9773236513137817, 0.9087108373641968, 0.9599159955978394, 0.6060733199119568, 0.14763325452804565, 0.10878239572048187, 0.1320929080247879, 0.9378238916397095, 0.9692685008049011, 0.9327529072761536, 0.9254795908927917, 0.10426593571901321, 0.8132743239402771, 0.06255955994129181, 0.020853187888860703, 0.6192203760147095, 0.08256271481513977, 0.16512542963027954, 0.13416442275047302, 0.8697971701622009, 0.08697971701622009, 0.022689951583743095, 0.9529779553413391, 0.031607337296009064, 0.2633945047855377, 0.6637541055679321, 0.031607337296009064, 0.8640128374099731, 0.1036815419793129, 0.9400157928466797, 0.20782873034477234, 0.23197045922279358, 0.3894164562225342, 0.17109133303165436, 0.9225877523422241, 0.06786281615495682, 0.8822166323661804, 0.9773766994476318, 0.23610647022724152, 0.2258409708738327, 0.1437169760465622, 0.3900889456272125, 0.055078424513339996, 0.9363332390785217, 0.9843370914459229, 0.06354104727506638, 0.2541641891002655, 0.5242136716842651, 0.15885262191295624, 0.13237866759300232, 0.17910055816173553, 0.5840235352516174, 0.10123074799776077, 0.8727231621742249, 0.6390585899353027, 0.07383545488119125, 0.17313142120838165, 0.11457225680351257, 0.9455951452255249, 0.9564191102981567, 0.06376127153635025, 0.7699311971664429, 0.11716344207525253, 0.06695053726434708, 0.05021290481090546, 0.9746363162994385, 0.2987171411514282, 0.1493585705757141, 0.46052223443984985, 0.09334910660982132, 0.9345270991325378, 0.9232552647590637, 0.13022159039974213, 0.05208863317966461, 0.38198330998420715, 0.4427533745765686, 0.08734817802906036, 0.829807698726654, 0.04367408901453018, 0.9161369800567627, 0.04164259135723114, 0.16219359636306763, 0.2801525890827179, 0.4511931240558624, 0.10616308450698853, 0.9373927116394043, 0.9558713436126709, 0.8954808115959167, 0.07462339848279953, 0.9773281216621399, 0.04104335606098175, 0.0820867121219635, 0.04104335606098175, 0.820867121219635, 0.8184452056884766, 0.09628766775131226, 0.08425170928239822, 0.4955480694770813, 0.2903601825237274, 0.12775848805904388, 0.08517232537269592, 0.9699586629867554, 0.09011773765087128, 0.03604709729552269, 0.21628257632255554, 0.648847758769989, 0.9456794261932373, 0.5482823252677917, 0.11496242135763168, 0.2476113736629486, 0.08843263238668442, 0.4791133999824524, 0.10787983983755112, 0.16499269008636475, 0.2506619691848755, 0.06417809426784515, 0.8984932899475098, 0.4228695333003998, 0.10571738332509995, 0.14800433814525604, 0.3224380314350128, 0.42874598503112793, 0.22123293578624725, 0.2023681104183197, 0.14748862385749817, 0.8726922869682312, 0.17073865234851837, 0.8195455074310303, 0.9465473890304565, 0.32492369413375854, 0.415902316570282, 0.16462799906730652, 0.0996432676911354, 0.6605674028396606, 0.23395095765590668, 0.04128546267747879, 0.06880910694599152, 0.9232577085494995, 0.8923409581184387, 0.028672244399785995, 0.7168061137199402, 0.2437140792608261, 0.028672244399785995, 0.036514200270175934, 0.9006836414337158, 0.024342801421880722, 0.036514200270175934, 0.3853447437286377, 0.4242030382156372, 0.08095477521419525, 0.11009849607944489, 0.05873478204011917, 0.1762043535709381, 0.6167152523994446, 0.13215325772762299, 0.6870595812797546, 0.025136325508356094, 0.19271183013916016, 0.09216652810573578, 0.9543319940567017, 0.03792606666684151, 0.7736917734146118, 0.12136340886354446, 0.06068170443177223, 0.3523613512516022, 0.09609854966402054, 0.2989732623100281, 0.2509239912033081, 0.2696436047554016, 0.4321211576461792, 0.17630542814731598, 0.12099392712116241, 0.954425036907196, 0.18292343616485596, 0.284837931394577, 0.3475545346736908, 0.18292343616485596, 0.8894551396369934, 0.9255548119544983, 0.2175523042678833, 0.3362171947956085, 0.1878860890865326, 0.2590850293636322, 0.9157185554504395, 0.8923661112785339, 0.9674898982048035, 0.02845558524131775], "Term": ["417", "582", "634", "711", "734", "abortion", "acc20", "accept", "accept", "accept", "accept", "accounting", "accounting", "activity", "activity", "activity", "activity", "ad", "ad", "ad", "ad", "advertising", "agriculture", "airfinity", "airtel", "airtel", "airtel", "align", "align", "align", "align", "aligos", "aligos", "also", "also", "also", "also", "antidepressant", "antisemitic", "anzalone", "app", "app", "app", "app", "arabia", "around", "around", "around", "around", "arrowhead", "artist", "artist", "ashish", "assume", "assume", "athira", "atm", "atm", "attra", "authorisation", "authorisation", "bank", "bank", "bank", "bank", "barda", "batch", "batch", "batch", "batch", "beauty", "beauty", "behavior", "bhal", "bhasin", "billion", "billion", "billion", "billion", "bioeclipse", "bioeclipse", "biontech", "biosimilars", "biosimilars", "blatt", "blatt", "board", "board", "board", "board", "borrower", "business", "business", "business", "business", "calcimedica", "caption", "caroline", "case", "case", "case", "case", "cent", "cent", "cent", "cent", "chain", "chain", "chain", "chain", "chief", "chief", "chief", "chief", "china", "china", "china", "china", "choose", "choose", "choose", "ciso", "city", "city", "city", "city", "clayman", "clinical", "clinical", "clinical", "clinical", "cobra", "company", "company", "company", "company", "concentrx", "conference", "conference", "conference", "conference", "conn", "conn", "contag", "contag", "cookie", "cooky", "cooky", "coronavirus", "coronavirus", "coronavirus", "coronavirus", "corporate", "corporate", "corporate", "corporate", "cost", "cost", "cost", "cost", "could", "could", "could", "could", "country", "country", "country", "country", "covid19", "covid19", "covid19", "covid19", "cozadd", "cozadd", "craft", "craft", "craft", "criminal", "criminal", "crisis", "crisis", "crisis", "crisis", "crore", "crore", "crore", "crore", "culture", "culture", "culture", "culture", "cyber", "cyber", "cytokine", "data", "data", "data", "data", "day", "day", "day", "day", "dealer", "dealer", "dealer", "dear", "dear", "decision", "decision", "decision", "decision", "development", "development", "development", "development", "deviation", "disease", "disease", "disease", "disease", "district", "district", "district", "district", "dod", "dongfeng", "drug", "drug", "drug", "drug", "econsent", "edition", "edition", "edition", "elaborates", "electron", "employee", "employee", "employee", "employee", "european", "european", "european", "european", "exhibition", "fadnavis", "federal", "federal", "federal", "federal", "first", "first", "first", "first", "flexion", "gas", "gas", "gas", "gas", "get", "get", "get", "get", "glympse", "going", "going", "going", "going", "government", "government", "government", "government", "hacker", "hacker", "health", "health", "health", "health", "help", "help", "help", "help", "home", "home", "home", "home", "hospital", "hospital", "hospital", "hospital", "hpapis", "hydroxychloroquine", "ignore", "ignore", "india", "india", "india", "india", "indiatimescom", "industry", "industry", "industry", "industry", "inequality", "intuition", "iqvia", "iran", "itikaf", "jhaveri", "jlabs", "kawas", "kol", "kols", "labour", "labour", "labour", "large", "large", "large", "large", "leheny", "lewis", "lewis", "lhon", "like", "like", "like", "like", "liquidity", "liquidity", "live", "live", "live", "live", "lockdown", "lockdown", "lockdown", "lockdown", "lockdown4", "loew", "lsl", "make", "make", "make", "make", "mall", "mall", "mall", "mall", "malware", "malware", "manpower", "manufacturing", "manufacturing", "manufacturing", "manufacturing", "market", "market", "market", "market", "marriott", "material", "material", "material", "material", "matthew", "may", "may", "may", "may", "mcmanus", "mentor", "message", "message", "message", "military", "military", "military", "milk", "milk", "million", "million", "million", "million", "miner", "minister", "minister", "minister", "minister", "money", "money", "money", "money", "moratorium", "must", "must", "must", "must", "nan", "need", "need", "need", "need", "neuroscience", "neuroscience", "neuroscience", "new", "new", "new", "new", "nonformulary", "office", "office", "office", "office", "oil", "oil", "oil", "oil", "oncolytic", "one", "one", "one", "one", "ongc", "packaging", "packaging", "packaging", "pandemic", "pandemic", "pandemic", "pandemic", "participant", "participant", "participant", "patent", "patent", "patient", "patient", "patient", "patient", "payment", "payment", "payment", "payment", "people", "people", "people", "people", "per", "per", "per", "per", "percent", "percent", "percent", "percent", "pharma", "pharma", "pharma", "pharma", "pharmaceutical", "pharmaceutical", "pharmaceutical", "pharmaceutical", "pixel", "plague", "policy", "policy", "policy", "policy", "prescient", "price", "price", "price", "price", "privacy", "privacy", "privacy", "process", "process", "process", "process", "product", "product", "product", "product", "prolife", "provisioning", "qrm", "quality", "quality", "quality", "quality", "rachel", "ransomware", "realestate", "rebrand", "receive", "receive", "receive", "receive", "regulatory", "regulatory", "regulatory", "regulatory", "religion", "religion", "respondent", "respondent", "revenue", "revenue", "revenue", "revenue", "roche", "roche", "russo", "said", "said", "said", "said", "sarkar", "satisfaction", "satisfaction", "saudi", "say", "say", "say", "say", "schatzman", "schatzman", "scm", "sector", "sector", "sector", "sector", "service", "service", "service", "service", "sezs", "share", "share", "share", "share", "simon", "singleuse", "singleuse", "site", "site", "site", "site", "snake", "social", "social", "social", "social", "softbank", "sophos", "space", "space", "space", "space", "sponsored", "sponsored", "sponsored", "sport", "sport", "state", "state", "state", "state", "steal", "stehmanbreen", "sterile", "sterile", "stressful", "submission", "submission", "submission", "submission", "supplier", "supplier", "supplier", "supply", "supply", "supply", "supply", "supplyside", "survey", "survey", "survey", "survey", "sxsw", "system", "system", "system", "system", "technology", "technology", "technology", "technology", "telco", "telco", "thing", "thing", "thing", "thing", "time", "time", "time", "time", "titling", "tower", "tower", "traversa", "treatment", "treatment", "treatment", "treatment", "trial", "trial", "trial", "trial", "trillion", "uber", "union", "union", "union", "union", "updated", "updated", "updated", "updated", "use", "use", "use", "use", "vehicle", "vehicle", "vehicle", "vehicle", "video", "video", "video", "video", "visibility", "website", "website", "website", "website", "work", "work", "work", "work", "world", "world", "world", "world", "wotton", "would", "would", "would", "would", "wound", "xenogen", "year", "year", "year", "year", "zahid", "zee5", "zoom", "zoom"]}, "R": 30, "lambda.step": 0.01, "plot.opts": {"xlab": "PC1", "ylab": "PC2"}, "topic.order": [2, 3, 4, 1]};

function LDAvis_load_lib(url, callback){
  var s = document.createElement('script');
  s.src = url;
  s.async = true;
  s.onreadystatechange = s.onload = callback;
  s.onerror = function(){console.warn("failed to load library " + url);};
  document.getElementsByTagName("head")[0].appendChild(s);
}

if(typeof(LDAvis) !== "undefined"){
   // already loaded: just create the visualization
   !function(LDAvis){
       new LDAvis("#" + "ldavis_el21461398123938686241926430848", ldavis_el21461398123938686241926430848_data);
   }(LDAvis);
}else if(typeof define === "function" && define.amd){
   // require.js is available: use it to load d3/LDAvis
   require.config({paths: {d3: "https://cdnjs.cloudflare.com/ajax/libs/d3/3.5.5/d3.min"}});
   require(["d3"], function(d3){
      window.d3 = d3;
      LDAvis_load_lib("https://cdn.rawgit.com/bmabey/pyLDAvis/files/ldavis.v1.0.0.js", function(){
        new LDAvis("#" + "ldavis_el21461398123938686241926430848", ldavis_el21461398123938686241926430848_data);
      });
    });
}else{
    // require.js not available: dynamically load d3 & LDAvis
    LDAvis_load_lib("https://cdnjs.cloudflare.com/ajax/libs/d3/3.5.5/d3.min.js", function(){
         LDAvis_load_lib("https://cdn.rawgit.com/bmabey/pyLDAvis/files/ldavis.v1.0.0.js", function(){
                 new LDAvis("#" + "ldavis_el21461398123938686241926430848", ldavis_el21461398123938686241926430848_data);
            })
         });
}
</script>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<h1 id="Wordcloud">Wordcloud<a class="anchor-link" href="#Wordcloud">&#182;</a></h1>
</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[57]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="k">def</span> <span class="nf">plot_wordcloud</span><span class="p">(</span><span class="n">text</span><span class="p">):</span>
    <span class="n">nltk</span><span class="o">.</span><span class="n">download</span><span class="p">(</span><span class="s1">&#39;stopwords&#39;</span><span class="p">)</span>
    <span class="n">stop</span><span class="o">=</span><span class="nb">set</span><span class="p">(</span><span class="n">stopwords</span><span class="o">.</span><span class="n">words</span><span class="p">(</span><span class="s1">&#39;english&#39;</span><span class="p">))</span>

    <span class="k">def</span> <span class="nf">_preprocess_text</span><span class="p">(</span><span class="n">text</span><span class="p">):</span>
        <span class="n">corpus</span><span class="o">=</span><span class="p">[]</span>
        <span class="n">stem</span><span class="o">=</span><span class="n">PorterStemmer</span><span class="p">()</span>
        <span class="n">lem</span><span class="o">=</span><span class="n">WordNetLemmatizer</span><span class="p">()</span>
        <span class="k">for</span> <span class="n">news</span> <span class="ow">in</span> <span class="n">text</span><span class="p">:</span>
            <span class="n">words</span><span class="o">=</span><span class="p">[</span><span class="n">w</span> <span class="k">for</span> <span class="n">w</span> <span class="ow">in</span> <span class="n">word_tokenize</span><span class="p">(</span><span class="n">news</span><span class="p">)</span> <span class="k">if</span> <span class="p">(</span><span class="n">w</span> <span class="ow">not</span> <span class="ow">in</span> <span class="n">stop</span><span class="p">)]</span>

            <span class="n">words</span><span class="o">=</span><span class="p">[</span><span class="n">lem</span><span class="o">.</span><span class="n">lemmatize</span><span class="p">(</span><span class="n">w</span><span class="p">)</span> <span class="k">for</span> <span class="n">w</span> <span class="ow">in</span> <span class="n">words</span> <span class="k">if</span> <span class="nb">len</span><span class="p">(</span><span class="n">w</span><span class="p">)</span><span class="o">&gt;</span><span class="mi">2</span><span class="p">]</span>

            <span class="n">corpus</span><span class="o">.</span><span class="n">append</span><span class="p">(</span><span class="n">words</span><span class="p">)</span>
        <span class="k">return</span> <span class="n">corpus</span>
    
    <span class="n">corpus</span><span class="o">=</span><span class="n">_preprocess_text</span><span class="p">(</span><span class="n">text</span><span class="p">)</span>
    
    <span class="n">wordcloud</span> <span class="o">=</span> <span class="n">WordCloud</span><span class="p">(</span>
        <span class="n">background_color</span><span class="o">=</span><span class="s1">&#39;white&#39;</span><span class="p">,</span>
        <span class="n">stopwords</span><span class="o">=</span><span class="nb">set</span><span class="p">(</span><span class="n">STOPWORDS</span><span class="p">),</span>
        <span class="n">max_words</span><span class="o">=</span><span class="mi">100</span><span class="p">,</span>
        <span class="n">max_font_size</span><span class="o">=</span><span class="mi">30</span><span class="p">,</span> 
        <span class="n">scale</span><span class="o">=</span><span class="mi">3</span><span class="p">,</span>
        <span class="n">random_state</span><span class="o">=</span><span class="mi">1</span><span class="p">)</span>
    
    <span class="n">wordcloud</span><span class="o">=</span><span class="n">wordcloud</span><span class="o">.</span><span class="n">generate</span><span class="p">(</span><span class="nb">str</span><span class="p">(</span><span class="n">corpus</span><span class="p">))</span>

    <span class="n">fig</span> <span class="o">=</span> <span class="n">plt</span><span class="o">.</span><span class="n">figure</span><span class="p">(</span><span class="mi">1</span><span class="p">,</span> <span class="n">figsize</span><span class="o">=</span><span class="p">(</span><span class="mi">12</span><span class="p">,</span> <span class="mi">12</span><span class="p">))</span>
    <span class="n">plt</span><span class="o">.</span><span class="n">axis</span><span class="p">(</span><span class="s1">&#39;off&#39;</span><span class="p">)</span>
 
    <span class="n">plt</span><span class="o">.</span><span class="n">imshow</span><span class="p">(</span><span class="n">wordcloud</span><span class="p">)</span>
    <span class="n">plt</span><span class="o">.</span><span class="n">show</span><span class="p">()</span>
</pre></div>

    </div>
</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[58]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">plot_wordcloud</span><span class="p">(</span><span class="n">text</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stderr output_text">
<pre>[nltk_data] Downloading package stopwords to
[nltk_data]     /home/teamscool/nltk_data...
[nltk_data]   Package stopwords is already up-to-date!
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,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
"
>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<h1 id="Text-Sentiment">Text Sentiment<a class="anchor-link" href="#Text-Sentiment">&#182;</a></h1><h3 id="Polarity-Histogram">Polarity Histogram<a class="anchor-link" href="#Polarity-Histogram">&#182;</a></h3>
</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[62]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="k">def</span> <span class="nf">plot_polarity_histogram</span><span class="p">(</span><span class="n">text</span><span class="p">):</span>
    
    <span class="k">def</span> <span class="nf">_polarity</span><span class="p">(</span><span class="n">text</span><span class="p">):</span>
        <span class="k">return</span> <span class="n">TextBlob</span><span class="p">(</span><span class="n">text</span><span class="p">)</span><span class="o">.</span><span class="n">sentiment</span><span class="o">.</span><span class="n">polarity</span>
        
    <span class="n">polarity_score</span> <span class="o">=</span><span class="n">text</span><span class="o">.</span><span class="n">apply</span><span class="p">(</span><span class="k">lambda</span> <span class="n">x</span> <span class="p">:</span> <span class="n">_polarity</span><span class="p">(</span><span class="n">x</span><span class="p">))</span>
    <span class="n">polarity_score</span><span class="o">.</span><span class="n">hist</span><span class="p">()</span>
</pre></div>

    </div>
</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[63]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">plot_polarity_histogram</span><span class="p">(</span><span class="n">text</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,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
"
>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<h3 id="Sentiment-Barchart">Sentiment Barchart<a class="anchor-link" href="#Sentiment-Barchart">&#182;</a></h3>
</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[65]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="k">def</span> <span class="nf">sentiment_vader</span><span class="p">(</span><span class="n">text</span><span class="p">,</span> <span class="n">sid</span><span class="p">):</span>
    <span class="n">ss</span> <span class="o">=</span> <span class="n">sid</span><span class="o">.</span><span class="n">polarity_scores</span><span class="p">(</span><span class="n">text</span><span class="p">)</span>
    <span class="n">ss</span><span class="o">.</span><span class="n">pop</span><span class="p">(</span><span class="s1">&#39;compound&#39;</span><span class="p">)</span>
    <span class="k">return</span> <span class="nb">max</span><span class="p">(</span><span class="n">ss</span><span class="p">,</span> <span class="n">key</span><span class="o">=</span><span class="n">ss</span><span class="o">.</span><span class="n">get</span><span class="p">)</span>

<span class="k">def</span> <span class="nf">sentiment_textblob</span><span class="p">(</span><span class="n">text</span><span class="p">):</span>
        <span class="n">x</span> <span class="o">=</span> <span class="n">TextBlob</span><span class="p">(</span><span class="n">text</span><span class="p">)</span><span class="o">.</span><span class="n">sentiment</span><span class="o">.</span><span class="n">polarity</span>
        
        <span class="k">if</span> <span class="n">x</span><span class="o">&lt;</span><span class="mi">0</span><span class="p">:</span>
            <span class="k">return</span> <span class="s1">&#39;neg&#39;</span>
        <span class="k">elif</span> <span class="n">x</span><span class="o">==</span><span class="mi">0</span><span class="p">:</span>
            <span class="k">return</span> <span class="s1">&#39;neu&#39;</span>
        <span class="k">else</span><span class="p">:</span>
            <span class="k">return</span> <span class="s1">&#39;pos&#39;</span>

<span class="k">def</span> <span class="nf">plot_sentiment_barchart</span><span class="p">(</span><span class="n">text</span><span class="p">,</span> <span class="n">method</span><span class="o">=</span><span class="s1">&#39;TextBlob&#39;</span><span class="p">):</span>
    <span class="k">if</span> <span class="n">method</span> <span class="o">==</span> <span class="s1">&#39;TextBlob&#39;</span><span class="p">:</span>
        <span class="n">sentiment</span> <span class="o">=</span> <span class="n">text</span><span class="o">.</span><span class="n">map</span><span class="p">(</span><span class="k">lambda</span> <span class="n">x</span><span class="p">:</span> <span class="n">sentiment_textblob</span><span class="p">(</span><span class="n">x</span><span class="p">))</span>
    <span class="k">elif</span> <span class="n">method</span> <span class="o">==</span> <span class="s1">&#39;Vader&#39;</span><span class="p">:</span>
        <span class="n">nltk</span><span class="o">.</span><span class="n">download</span><span class="p">(</span><span class="s1">&#39;vader_lexicon&#39;</span><span class="p">)</span>
        <span class="n">sid</span> <span class="o">=</span> <span class="n">SentimentIntensityAnalyzer</span><span class="p">()</span>
        <span class="n">sentiment</span> <span class="o">=</span> <span class="n">text</span><span class="o">.</span><span class="n">map</span><span class="p">(</span><span class="k">lambda</span> <span class="n">x</span><span class="p">:</span> <span class="n">sentiment_vader</span><span class="p">(</span><span class="n">x</span><span class="p">,</span> <span class="n">sid</span><span class="o">=</span><span class="n">sid</span><span class="p">))</span>
    <span class="k">else</span><span class="p">:</span>
        <span class="k">raise</span> <span class="ne">ValueError</span><span class="p">(</span><span class="s1">&#39;Textblob or Vader&#39;</span><span class="p">)</span>
    
    <span class="n">plt</span><span class="o">.</span><span class="n">bar</span><span class="p">(</span><span class="n">sentiment</span><span class="o">.</span><span class="n">value_counts</span><span class="p">()</span><span class="o">.</span><span class="n">index</span><span class="p">,</span>
            <span class="n">sentiment</span><span class="o">.</span><span class="n">value_counts</span><span class="p">())</span>
</pre></div>

    </div>
</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[66]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">plot_sentiment_barchart</span><span class="p">(</span><span class="n">text</span><span class="p">,</span> <span class="n">method</span><span class="o">=</span><span class="s1">&#39;TextBlob&#39;</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAXcAAAD4CAYAAAAXUaZHAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjEsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy8QZhcZAAANkElEQVR4nO3df6zd9V3H8edLCmxzk/LjQkhbvGQ0OqbCoGIniT+oWfhhLCpEyDIabNLEMDNEo9V/jGZ/QGLEESfaDUJR58bQhYaROSwwfyQwboWVsW5SGdKbEtoJFBGZYXv7x/3UXbjnck9v7+ltP30+kpvz/X6+n3vP5+ZLnvfLt+fcm6pCktSX71vsBUiSFp5xl6QOGXdJ6pBxl6QOGXdJ6tCSxV4AwCmnnFLj4+OLvQxJOqJs27btW1U1NujYYRH38fFxJiYmFnsZknRESfIfsx3ztowkdci4S1KHjLskdci4S1KHjLskdci4S1KHjLskdci4S1KHjLskdeiweIfqwRjf+PnFXkK3nrnxssVegqR58spdkjpk3CWpQ8Zdkjpk3CWpQ8Zdkjpk3CWpQ8Zdkjpk3CWpQ8Zdkjpk3CWpQ8Zdkjpk3CWpQ8Zdkjpk3CWpQ8Zdkjpk3CWpQ8Zdkjpk3CWpQ0PFPckzSZ5I8niSiTZ2UpL7kzzVHk9s40lyS5KdSbYnOW+U34AkaaYDuXL/2ao6t6pWtf2NwNaqWglsbfsAlwAr28cG4NaFWqwkaTgHc1tmLbC5bW8GLp82fmdNeRhYmuT0g3geSdIBGjbuBXwxybYkG9rYaVX1HEB7PLWNLwN2TfvcyTYmSTpElgw578Kq2p3kVOD+JF9/i7kZMFYzJk39kNgAcMYZZwy5DEnSMIa6cq+q3e1xD/A54ALg+f23W9rjnjZ9Elgx7dOXA7sHfM1NVbWqqlaNjY3N/zuQJM0wZ9yTfH+Sd+3fBj4AfBXYAqxr09YB97TtLcA17VUzq4F9+2/fSJIOjWFuy5wGfC7J/vmfqqovJHkUuCvJeuBZ4Mo2/z7gUmAn8Cpw7YKvWpL0luaMe1U9DZwzYPw/gTUDxgu4bkFWJ0maF9+hKkkdMu6S1CHjLkkdMu6S1CHjLkkdMu6S1CHjLkkdMu6S1CHjLkkdMu6S1CHjLkkdMu6S1CHjLkkdMu6S1CHjLkkdMu6S1CHjLkkdMu6S1CHjLkkdMu6S1CHjLkkdMu6S1CHjLkkdMu6S1CHjLkkdMu6S1CHjLkkdMu6S1KGh457kmCSPJbm37Z+Z5JEkTyX5TJLj2vjxbX9nOz4+mqVLkmZzIFfuHwF2TNu/Cbi5qlYCLwLr2/h64MWqOgu4uc2TJB1CQ8U9yXLgMuCTbT/ARcDdbcpm4PK2vbbt046vafMlSYfIsFfufwL8NvDdtn8y8FJVvd72J4FlbXsZsAugHd/X5r9Bkg1JJpJM7N27d57LlyQNMmfck/w8sKeqtk0fHjC1hjj2vYGqTVW1qqpWjY2NDbVYSdJwlgwx50LgF5JcCrwN+AGmruSXJlnSrs6XA7vb/ElgBTCZZAlwAvDCgq9ckjSrOa/cq+p3q2p5VY0DVwEPVNUHgQeBK9q0dcA9bXtL26cdf6CqZly5S5JG52Be5/47wA1JdjJ1T/22Nn4bcHIbvwHYeHBLlCQdqGFuy/y/qnoIeKhtPw1cMGDOa8CVC7A2SdI8+Q5VSeqQcZekDhl3SeqQcZekDhl3SeqQcZekDhl3SeqQcZekDhl3SeqQcZekDhl3SeqQcZekDhl3SeqQcZekDhl3SeqQcZekDhl3SeqQcZekDhl3SeqQcZekDhl3SeqQcZekDhl3SeqQcZekDhl3SeqQcZekDhl3SeqQcZekDs0Z9yRvS/LlJF9J8mSSP2jjZyZ5JMlTST6T5Lg2fnzb39mOj4/2W5AkvdkwV+7fBi6qqnOAc4GLk6wGbgJurqqVwIvA+jZ/PfBiVZ0F3NzmSZIOoTnjXlNeabvHto8CLgLubuObgcvb9tq2Tzu+JkkWbMWSpDkNdc89yTFJHgf2APcD/w68VFWvtymTwLK2vQzYBdCO7wNOHvA1NySZSDKxd+/eg/suJElvMFTcq+o7VXUusBy4AHjPoGntcdBVes0YqNpUVauqatXY2Niw65UkDeGAXi1TVS8BDwGrgaVJlrRDy4HdbXsSWAHQjp8AvLAQi5UkDWeYV8uMJVnatt8O/BywA3gQuKJNWwfc07a3tH3a8QeqasaVuyRpdJbMPYXTgc1JjmHqh8FdVXVvkq8Bn07yUeAx4LY2/zbgL5PsZOqK/aoRrFuS9BbmjHtVbQfeN2D8aabuv795/DXgygVZnSRpXnyHqiR1yLhLUoeMuyR1yLhLUoeMuyR1yLhLUoeMuyR1yLhLUoeMuyR1yLhLUoeMuyR1yLhLUoeMuyR1yLhLUoeMuyR1yLhLUoeMuyR1yLhLUoeMuyR1yLhLUoeMuyR1yLhLUoeMuyR1yLhLUoeMuyR1yLhLUoeMuyR1yLhLUofmjHuSFUkeTLIjyZNJPtLGT0pyf5Kn2uOJbTxJbkmyM8n2JOeN+puQJL3RMFfurwO/WVXvAVYD1yU5G9gIbK2qlcDWtg9wCbCyfWwAbl3wVUuS3tKcca+q56rqX9v2fwE7gGXAWmBzm7YZuLxtrwXurCkPA0uTnL7gK5ckzeqA7rknGQfeBzwCnFZVz8HUDwDg1DZtGbBr2qdNtrE3f60NSSaSTOzdu/fAVy5JmtXQcU/yTuBvgeur6uW3mjpgrGYMVG2qqlVVtWpsbGzYZUiShjBU3JMcy1TY/7qq/q4NP7//dkt73NPGJ4EV0z59ObB7YZYrSRrGMK+WCXAbsKOq/njaoS3Aura9Drhn2vg17VUzq4F9+2/fSJIOjSVDzLkQ+BDwRJLH29jvATcCdyVZDzwLXNmO3QdcCuwEXgWuXdAVS5LmNGfcq+qfGXwfHWDNgPkFXHeQ65IkHQTfoSpJHTLuktQh4y5JHTLuktQh4y5JHTLuktQh4y5JHTLuktQh4y5JHTLuktQh4y5JHTLuktQh4y5JHTLuktQh4y5JHTLuktQh4y5JHTLuktQh4y5JHTLuktQh4y5JHTLuktQh4y5JHTLuktQh4y5JHTLuktQh4y5JHTLuktShOeOe5PYke5J8ddrYSUnuT/JUezyxjSfJLUl2Jtme5LxRLl6SNNgwV+53ABe/aWwjsLWqVgJb2z7AJcDK9rEBuHVhlilJOhBzxr2q/hF44U3Da4HNbXszcPm08TtrysPA0iSnL9RiJUnDme8999Oq6jmA9nhqG18G7Jo2b7KNzZBkQ5KJJBN79+6d5zIkSYMs9D+oZsBYDZpYVZuqalVVrRobG1vgZUjS0W2+cX9+/+2W9rinjU8CK6bNWw7snv/yJEnzMd+4bwHWte11wD3Txq9pr5pZDezbf/tGknToLJlrQpK/AX4GOCXJJPD7wI3AXUnWA88CV7bp9wGXAjuBV4FrR7BmSdIc5ox7VV09y6E1A+YWcN3BLkqSdHB8h6okdci4S1KHjLskdci4S1KHjLskdci4S1KHjLskdci4S1KHjLskdWjOd6hKC2184+cXewndeubGyxZ7CTpMGHdJc/IH8uiM6geyt2UkqUPGXZI6ZNwlqUPGXZI6ZNwlqUPGXZI6ZNwlqUPGXZI6ZNwlqUPGXZI6ZNwlqUPGXZI6ZNwlqUPGXZI6ZNwlqUPGXZI6ZNwlqUMjiXuSi5N8I8nOJBtH8RySpNkteNyTHAN8HLgEOBu4OsnZC/08kqTZjeLK/QJgZ1U9XVX/C3waWDuC55EkzWIUfyB7GbBr2v4k8BNvnpRkA7Ch7b6S5BsjWMvh6BTgW4u9iGHkpsVewWHhiDlf4DlrjqZz9oOzHRhF3DNgrGYMVG0CNo3g+Q9rSSaqatVir0PD8XwdeTxnU0ZxW2YSWDFtfzmwewTPI0maxSji/iiwMsmZSY4DrgK2jOB5JEmzWPDbMlX1epIPA38PHAPcXlVPLvTzHMGOultRRzjP15HHcwakasbtcEnSEc53qEpSh4y7JHXIuEtSh4y7JHXIuC+wJONJvp5kc5LtSe5O8o4ka5I8luSJJLcnOb7NvzHJ19rcP1rs9R9t2vnakeQTSZ5M8sUkb0/y7iRfSLItyT8l+eE2/44kV0z7/FcWb/VHp3mcs3cneTjJo0n+8Gg5Z8Z9NH4I2FRVPwa8DNwA3AH8SlX9KFMvQf21JCcBvwi8t8396CKt92i3Evh4Vb0XeAn4ZaZeTvfrVXU+8FvAny3i+jTTgZyzjwEfq6of5yh6Q6VxH41dVfUvbfuvgDXAN6vq39rYZuCnmAr/a8Ank/wS8OohX6lg6tw83ra3AePATwKfTfI48BfA6Yu0Ng12IOfs/cBn2/anDuUiF9MofreMBvwunYGTpt7wdQFT8b8K+DBw0SgXpoG+PW37O8BpwEtVde6Aua/TLoqSBDhu9MvTAAdyzo5KXrmPxhlJ3t+2rwb+ARhPclYb+xDwpSTvBE6oqvuA6wH/wzw8vAx8M8mVMBXxJOe0Y88A57fttcCxh355GuCtztnDTN22gamLqKOCcR+NHcC6JNuBk4CbgWuZ+l/GJ4DvAn8OvAu4t837EvAbi7RezfRBYH2SrwBP8r2/SfAJ4KeTfJmpX2X934u0Ps002zm7HrihnbPTgX2LtL5Dyl8/sMCSjAP3VtWPLPJSJAFJ3gH8T1VVkquAq6uq+z8g5D13Sb07H/jT9m8kLwG/usjrOSS8cpekDnnPXZI6ZNwlqUPGXZI6ZNwlqUPGXZI69H9/sx49MlvRogAAAABJRU5ErkJggg==
"
>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<h1 id="Named-Entity-Recognition">Named Entity Recognition<a class="anchor-link" href="#Named-Entity-Recognition">&#182;</a></h1><h3 id="Named-Entity-Barchart">Named Entity Barchart<a class="anchor-link" href="#Named-Entity-Barchart">&#182;</a></h3>
</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[9]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="k">def</span> <span class="nf">plot_named_entity_barchart</span><span class="p">(</span><span class="n">text</span><span class="p">):</span>
    <span class="n">nlp</span> <span class="o">=</span> <span class="n">spacy</span><span class="o">.</span><span class="n">load</span><span class="p">(</span><span class="s2">&quot;en_core_web_sm&quot;</span><span class="p">)</span>
    
    <span class="k">def</span> <span class="nf">_get_ner</span><span class="p">(</span><span class="n">text</span><span class="p">):</span>
        <span class="n">doc</span><span class="o">=</span><span class="n">nlp</span><span class="p">(</span><span class="n">text</span><span class="p">)</span>
        <span class="k">return</span> <span class="p">[</span><span class="n">X</span><span class="o">.</span><span class="n">label_</span> <span class="k">for</span> <span class="n">X</span> <span class="ow">in</span> <span class="n">doc</span><span class="o">.</span><span class="n">ents</span><span class="p">]</span>
    
    <span class="n">ent</span><span class="o">=</span><span class="n">text</span><span class="o">.</span><span class="n">apply</span><span class="p">(</span><span class="k">lambda</span> <span class="n">x</span> <span class="p">:</span> <span class="n">_get_ner</span><span class="p">(</span><span class="n">x</span><span class="p">))</span>
    <span class="n">ent</span><span class="o">=</span><span class="p">[</span><span class="n">x</span> <span class="k">for</span> <span class="n">sub</span> <span class="ow">in</span> <span class="n">ent</span> <span class="k">for</span> <span class="n">x</span> <span class="ow">in</span> <span class="n">sub</span><span class="p">]</span>
    <span class="n">counter</span><span class="o">=</span><span class="n">Counter</span><span class="p">(</span><span class="n">ent</span><span class="p">)</span>
    <span class="n">count</span><span class="o">=</span><span class="n">counter</span><span class="o">.</span><span class="n">most_common</span><span class="p">()</span>
    
    <span class="n">x</span><span class="p">,</span><span class="n">y</span><span class="o">=</span><span class="nb">map</span><span class="p">(</span><span class="nb">list</span><span class="p">,</span><span class="nb">zip</span><span class="p">(</span><span class="o">*</span><span class="n">count</span><span class="p">))</span>
    <span class="n">sns</span><span class="o">.</span><span class="n">barplot</span><span class="p">(</span><span class="n">x</span><span class="o">=</span><span class="n">y</span><span class="p">,</span><span class="n">y</span><span class="o">=</span><span class="n">x</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[10]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">plot_named_entity_barchart</span><span class="p">(</span><span class="n">text</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAbEAAAD4CAYAAABi8NihAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjEsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy8QZhcZAAAgAElEQVR4nO3debxd873/8dfbEEnEEGIqKkIUUZJIW9dUWjU1LSm9pFS1et0a2nJrKnqrt02rpqKUm7aEXlONddHiIj9BioTIYMhAaioiSISY4vP7Y313ss7O3ufsnZx99t5nv5+Px35kr++aPmv3tJ9+v+u7PksRgZmZWTNaod4BmJmZLSsnMTMza1pOYmZm1rScxMzMrGk5iZmZWdNaqd4BdHf9+vWL/v371zsMM7OmMnHixNcjYp2OtnMSq7H+/fszYcKEeodhZtZUJP2jku2cxGrsozlvMOeS/6l3GGZmXWqdow7tkvPU/Z6YpPUlXStplqQnJd0haYu07nhJ70laI7f9bpLmSXpc0tOSzsmtO1zSnLRuhqQ7Je2YWz9G0oHp+1hJE3LrhkkaWxTbBZJekrRC0TkuqsmPYWZmValrEpMk4GZgbERsFhFbA6cC66VNRgKPAiOKdh0XEUOAIcBwSTvl1l0XEUMiYiBwJnCTpK3KhLCupH3KxLZCOu8LwK7LcHlmZlZj9e6J7Q58GBGXFhoiYlJEjJO0GdAHOJ0smS0lIhYCk4ANy6y/DxgNHFnm/Gen45eLbSpwSbnzm5lZfdU7iW0DTCyzbiRwDTAO+JSkdYs3kNQXGAjc3845HgO2LLNuPPC+pN3bOf/NZL29lds5R3FcR0qaIGnC3AXzK93NzMyqVO8k1p6DgWsj4mPgJuDruXW7SJoMvALcFhGvtHMcdXCeX1DUG5PUA9gXuCUi5gMPA3tWGnhEjI6IYRExbO0+q1e6m5mZVaneSWwasH1xo6RtyXpYd0uaTZbQ8kN64yJiW+DTwFGSBrdzjiHAU+VWRsS9QE9gh1zz3sAawJR0/p3xkKKZWcOpdxK7F1hF0r8VGiR9BrgAOCMi+qfPJ4ANJW2S3zkipgO/Ak4udXBJnye7H/b7DuIYBZyUWx4JfLdwfmBTYE9Jvau6OjMzq6m6JrHIXmY2AvhSmmI/DTgD2I3sXlTezWQ9smKXArtK2jQtHyRpkqTpZDMdD4iIsj2xFMcdwByAlKj2Am7PrX8HeAD4Smo6XNKLuc9GlV6zmZl1HvmlmLU1bNiwcMUOM7PqSJoYEcM62q7ew4lmZmbLzEnMzMyalmsn1tiHc17mld/9tN5hmFkLWv/on9U7hJrr9j0xSYvSRI9pkp6Q9B/5WohpmzY1EiV9O+0zSdIHkqak72fm6jNOyn22rs/VmZm1tlboiS2MiMEAqerH1WTPgP00tRXXSBwbEZcDl6f1s4HdI+L1tHw4WX3GY7v2MszMrFi374nlRcRrZM+NHZuKD4NrJJqZNa2WSmIAEfEs2XUXajEuS43Eg4qGE3vlV7atnfhup8ZvZmZLtFwSSwTLVSPxuogYnPsszK9sWzvRRT7MzGqlFe6JtSFpALAIeI2sAkehRiJAb+BdctU6zMyscbVUEpO0DlmZqosiIiQVaiRek9avCjwnqXdEeBzQzKzBtcJwYq/CFHvg/4C7gJ9VWCOxnOJ7YjvWKngzMyvPtRNrzLUTzcyq59qJZmbW7TmJmZlZ02qpiR31sHDOTCZf8tV6h2HWbW171K31DsHqqCV7YpI2kvQXSTPSyzgvkNRD0m6S5kl6XNLTks4p2m9vSY+kdZMkXSfpk/W6DjOzVtdySSyVm7qJ7AHngcAWQB9gVNpkXEQMAYaQVfDYKe23DfBb4FsRsWWqx3gV0L+LL8HMzJJWHE78AvBeKvJLRCySdDzwHHBfYaOIWChpErBhajoZ+GVEPJXbxuMYZmZ11HI9MWAQMDHfkEpOPQ9sXmiT1BcYCNyf2++xLorRzMwq0IpJTECph+MK7btImgy8AtwWEa8staG0dronNl3SCSXWLy4A/OaCDzo7fjMzS1oxiU0D2jxAJ2l1YGNgFtk9sW2BTwNHSRqc228oQETMTffERpPdT2sjXwC4b58etbsSM7MW14pJ7B6gt6TDACStCJwLjCEr/gtAREwHfkV2LwzgLOA0SVvljuUS9WZmddRySSyyOlsjgK9LmgFMB94DTi2x+aXArpI2jYgpwA+BK9MU+weBrcjeFG1mZnXg2ok15tqJZmbVc+1EMzPr9pzEzMysabXiw85dav7rM7jzj/vWOwyzhrPXEXfUOwTrBlq6JyZpPUlXS3pW0kRJ4yWNKKqh+JSkn6btC+35F2LuUe/rMDNrVS3bE0s1FG8BroiIb6S2TYCvAm+SPS82XNKqwCRJt6Vdx0XE8LoEbWZmbbRyT+wLwAcRcWmhISL+ERG/zW8UEe+QlanarIvjMzOzDrRyEquoFqKktYEdyCp2QFaWKj+c6ORmZlYnLTucWEzSxcDOwAfAiWTJ6nHgY+DMiJgmaTcqGE6UdCRwJMC6a/WsadxmZq2slZPYNOCAwkJEHCOpH1B4MnmZ731FxGiyuops0X8NP01uZlYjrTyceC/QU9JRuTbXQjQzayItm8RSDcX9gc9Lek7SI8AVLCn4W07xPbEDax6smZmV5NqJNebaiWZm1XPtRDMz6/acxMzMrGm18uzELjF37gz+NGaveodhVpFvHn5nvUMwq4p7YmZm1rSaJolJWpRmA06VdL2k3kXthc8pqX2spGckPSHpUUmDc8f6jqQpkian4+2X2iXpdEkzJE2XdJ+kQbn9Zku6Mbd8oKQxXfYjmJlZG800nLgwIgYDSLoK+B5wXr69hEMiYoKkbwNnA1+StBFwGjA0IuZJ6gOsk7Y/BtgR2C4i3pW0J3CrpEER8V7aZlhanlZ8MjMz61pN0xMrMg7YvIrtxwMbpu/rAm8DCwAiYkFEPJfWnQx8PyLeTevuAh4CDskd6xzg1GUP3czMOkvTJTFJKwH7AFNSU6+i4cSDSuy2N9lrVwCeAF4FnpN0uaSvpOOuDqwaEbOK9p1AViy44M/AUEllk6ikIyVNkDTh7bc/qPoazcysMs00nNhL0qT0fRzwx/S9veHEq9L7wFYEhgJExCJJewOfAb4I/EbS9mRDk6UIyD8RvohsaPLHwF9L7ZCvnbjppq6daGZWK83UE1sYEYPT5/sRUUkX5xBgU+Bq4OJCY2QeiYhfAQcDB0TEfOAdSQOKjjEUeLKo7U/ArsAnl/VizMxs+TVTElsmEfEhcDqwg6StJH1C0tDcJoOBf6TvZwMXSuoFIGkPstezXF3imL8Bjqt1/GZmVl4zDSeWkx9mBPhbRJyS3yAiFko6FzgB+C/gHEmfAN4D5pDNdAT4LdAXmCJpEfAKsF9ELCxx3j+SJUczM6sTFwCuMRcANjOrngsAm5lZt9cdhhMb2qtvzODca1qrduKPRrr+npl1DffEzMysaXXbJCYp0mSOwvIJks7ILR8p6en0eUTSzrl17dVdnJ3qLj4h6S5J63fZRZmZWRvdNokB7wNfk9SveIWk4cC/AztHxJZksxOvLkpIh0TEdsDvyKbe5+2e1k3AJajMzOqmOyexj8iqZhxfYt3JwIkR8TpARDwGXEFWALhYvu5isfuproajmZl1ou6cxCCr0nGIpDWK2gcBE4vaimskFuTrLhYbzpIajovlaye+49qJZmY1061nJ0bEfElXAj8ASj2wnFdcI3Gpuos596WHoSdT4oHnfO3EjQe4dqKZWa10954YwPnAEcCqubYnge2LtiuukViy7mKye6rheFhEvNXJ8ZqZWYW6fRKLiDfIXp9yRK75LODXktYGSLMPDyebxJHft03dxS4J2MzMKtathxNzzgWOLSxExK2SNgQekhRkL8k8NCL+WbxjUd3FI4rXm5lZ/bh2Yo25dqKZWfVcO9HMzLq9VhlOrJvZb83g2zfvXe8wqnb5iL/VOwQzsw65J2ZmZk2rYZOYpI0k/UXSDEmzJF0gqYek3STNk/R4qnt4Tm6fwyXNSetmSLpT0o659WMkHZi+j5U0IbdumKSxRTFcIOklSSsUneOiml68mZlVpCGTmCQBNwG3RMRAYAugDzAqbTIuIoYAQ4DhknbK7X5dRAxJ+50J3NTO9Ph1Je1TJoYVgBHAC8Cuy31RZmbW6RoyiQFfAN6LiMsBImIRWQ3E7wC9CxtFxEJgEmVqG0bEfWSVM44sc56zKVFxI9kdmApcAoys/hLMzKzWGjWJLVXbMCLmA8+TK7grqS8wkKwQbzmPAVuWWTceeF/S7iXWjQSuAW4m6+2tXGnw+dqJ78137UQzs1pp1CRWXMewuH0XSZOBV4DbIuKVDo7Vnl9Q1BuT1APYl2w4cz7wMLBnhbETEaMjYlhEDOu5eo9KdzMzsyo1ahKbBrR5yE3S6sDGwCyye2LbAp8Gjsq/tLKEIcBT5VZGxL1AT2CHXPPewBrAFEmzgZ3xkKKZWcNp1CR2D9Bb0mEAklYkKx01Bni3sFFETAd+RfZ+sKVI+jzZ/bDfd3C+UcBJueWRwHcjon9E9CcrBLynpN6ldjYzs/poyCQWWS2sEcDXJc0ApgPvUfotypcCu0raNC0fJGmSpOlp+wMiomxPLJ3vDmAOQEpUewG359a/AzwAfCU1HS7pxdxno2W9VjMzW3aunVhjrp1oZlY91040M7Nuz7UTa2zGWy+z7y0/6bLz3bH/z7vsXGZm9eaemJmZNa2mTWKSQtKfcssrpbqJt+Xa9pc0OdVYnCJp/9y6Maku4ippuV+aTo+k/pIWpgkihc9hkq6WdFTuGJ9Lx3eP1sysDpr5f3zfAbaR1CuVn/oS8FJhpaTtgHOAL0XEc2n24t2Sno2IyWmzRWSlrC4pcfxZEdHm+TNJdwLjJd0AzAUuAo6OiI86++LMzKxjTdsTS/4KfDl9L5SJKjgB+GVEPAeQ/v0VcGJum/OB4yvtSUXEq2SJ8Szge8DkiHhgua7AzMyWWbMnsWuBgyX1BLYlKw9VsFT9RWBCai94nuz5r2+WOPZmRcOJu6T2S4GtyZLhSSX2a1M78YP571R9UWZmVplmHk4kIiZL6k/WC7ujaHWp+oul2n4J3Eru4eZkqeHEdM6PJf03MCwi5paJazRZ9XzW2PwTfhDPzKxGmr0nBlkCOoe2Q4lQov4iMBR4Mt8QETPJXufyr1Wc8+P0MTOzOmrqnlhyGTAvIqZI2i3Xfg5wvaR7I2J26rGdChxY4hijWLonZmZmDa7pk1hEvAhcUKJ9kqSTgf9N7wL7EDgpIiaV2HaapMfIemoFm0nKb3tZRFzYyeGbmdlycO3EGnPtRDOz6rl2opmZdXtNP5zY6Ga8NYcv3/S75T7O7V87uhOiMTPrXtwTMzOzptWySUzSgjLtR6Zai09LekTSzrl1K0s6U9IMSVPT+n26LmozM8vzcGKOpOHAvwM7R8TrkoYCt0j6bES8Avwc2ADYJiLel7Qe8Pk6hmxm1tJatidWxsnAiRHxOkBEPAZcARwjqTfwb8D3I+L9tP7ViPhz3aI1M2txTmJttVdvcXPg+YiY39FB2tROnFdy1NLMzDqBk1jHStVbbFdEjI6IYRExrMcafWoUlpmZOYm19SSwfVFbod7iTOCTklbr8qjMzKwkJ7G2zgJ+LWltAEmDgcOB30XEu8AfgQsl9UjrN5B0aL2CNTNrda08O7G3pBdzy+dFxHmSNgQekhTA28ChEfHPtM3pwC+AJyW9R/Z26f/s0qjNzGwx106sMddONDOrnmsnmplZt9fKw4ldYuabbzD8hquW6xi3HXhIJ0VjZta9uCdmZmZNqyGTmKRFkial+oTXp2oZ+fbC55TUPlbSM5KekPRomlVYOFYfSf8taZakaZLul/S5Co43IXeMYaltr9y2C9I5J0m6smt/ITMzg8YdTlwYEYMBJF0FfA84L99ewiERMUHSt4GzgS+l9j8AzwEDI+JjSQOArYrPU8K6kvaJiL8WGiLiTuDOFNdY4ISI8KwNM7M6acieWJFxZCWfKjUe2BBA0mbA54DTI+JjgIh4NiJur+A4Z5NNqTczswbV0ElM0krAPsCU1NSraPjvoBK77Q3ckr4PAiZFxKIyp2jveOOB9yXtvgxxL6mdOL/DUotmZraMGnU4sZekSen7OLJKGdD+8N9VklYFViQrFVWJ9o4H2YPNp5NVt69YRIwGRgOsudkAP4hnZlYjjdoTWxgRg9Pn+xHxQQX7HAJsClwNXJzapgHbSVqm64yIe4GewA7Lsr+ZmdVWoyaxZRIRH5L1nHaQtFVEzCJ7lcrPJAlA0kBJ+1Vx2FHASZ0frZmZLa9mS2LF97DOLN4gIhYC5wInpKbvAusDMyVNAX4PvFzF8e4A5tTkaszMbLm4dmKNuXaimVn1XDvRzMy6vUadndhtzHxzHl+94bZl3v/WA4d3YjRmZt2Le2JmZta0WiaJSVo7N4HjFUkv5ZbfTdv0lxSSfp7br5+kDyVdlJbPKNp3kqQ163VdZmatrGWGEyNiLlCox3gGsCAizknLC3KbPgsMB36Slr9O9rxZ3m8K+5qZWf20TE+sCguBpyQVZsUcBPy5jvGYmVkZTmKlXQscLGkjYBFLnisrOD43lHhf8c5tayfO64p4zcxaUssMJ1bpb8DPgVeB60qsb3c4sW3txIF+EM/MrEbcEysh1WqcCPwIuLHO4ZiZWRnuiZV3LvD/ImJuKrtoZmYNxkmsjIiYxtKzEguOl3Robnn/iJhd+6jMzCzPtRNrzLUTzcyq59qJZmbW7Xk4scZmvfkOX7vx71Xtc9MBfgenmVkl3BMzM7Om1RA9sfRQ8cXA1sCKwB1k09tHAsMi4tjctmOBEyJiQloeAjwG7B0Rd+a2C+C8iPhRWj4B6AN8SFZKCuDTwJT0/TJgLWABsCmwE9AjfX8mbXM1sH1EHJSOuTrwOLBHRDzXST+HmZlVqO49MWXz128CbomIgcBAoBdwVoWHGAk8kP7Nex/4mqR++caIGBURgyNiMLCw8D0iLsxtc0xavy8wK7f92cBGkvZIm/4XcJkTmJlZfdQ9iQFfAN6LiMsBImIRcDxwGFnPqayUAA8EDgf2lNQzt/ojsqoZx3dWoJFN5TwKOD/VVvwiWWIzM7M6aIQkNoisOsZiETEfmE3Hw507Ac9FxCxgLFnPKe9i4BBJa3RKpFlsk4E7gXuAH6TqHm3kaye+P/+tzjq1mZkVaYQkJqDUw2oCyiWfwvYjyYr1kv5tM6SYkuGVwA+WP8w2LgZeioiliv+m846OiGERMWyV1f2qMTOzWmmEJDYNaPNAW5owsR7ZhI2+RduvBbwuaUXgAOA/Jc0GfgvsI2m1ou3PB44AVu3EmD9OHzMzq6NGSGL3AL0lHQaQktO5wEXAI8BOktZP64YBqwAvAHsAT0TExhHRPyI2ISvWu3/+4BHxBtn7wI7oousxM7MuUvckliZLjAAOlDQDmAt8nGYRvgr8ELhD0iSyXtXIiPiYbOjw5qLD3Qh8o8RpzgX6lWg3M7Mm1nC1EyXtCFwDfC0iJna0faNz7UQzs+pVWjuxIR52zouIh4BN6h2HmZk1vroPJ5qZmS2rhuuJdTcvvPUBP7j5haXaLxyxcR2iMTPrXlq6JyZpkaRJuU//3LoLJL0kaYWiffZJDzI/JelpSed0ddxmZpZp9Z7YwlQTsY2UuEaQTeXflawaCJK2IZv6/+WIeFrSSsCRXReumZnltXRPrB27A1OBS2hbBeQkYFREPA0QER9FxO/qEJ+ZmeEk1is3lJh/5mwk2TT/m4HhklZO7dtQVOexlHztxIXz3+j8qM3MDHASy7+KZQSApB5khYRvSbUXHwb2rOag+dqJvVZfq/OjNjMzwPfEStmbrPDwlOxNL/QG3gVuJ6vzuD3wRN2iMzOzxVq9J1bKSOC7qR5jf7I3O+8pqTfZu8NOlbQFZBNAJP1H/UI1M2ttTmI5KVHtRdbrAiAi3iF7c/RX0rvEjgOukfQU2eSPDeoRq5mZNWDtxO7GtRPNzKpXae1E98TMzKxpOYmZmVnT8uzEGnvjzY+45sY5S7WPPGCdOkRjZta9NExPLFfHcKqk69Mki+L2/5W0Zm6fQZLulTRd0gxJP1GaFy/pcElzJD2e1t2Z3lVW2HdselN0Ybm/pKm55c9Kul/SM6lG4h8kHZN7OPoDSVPS9zO75lcyM7O8hkliLHnweBvgA+B7JdrfAI4BkNQLuBU4MyK2ALYDdgSOzh3zuogYEhEDgTOBmyRt1VEgktYDrgdOjohPAVsBfwNuKDwcDbwM7J6WT1n+yzczs2o1UhLLGwdsXqJ9PLBh+v4N4MGIuAsgIt4FjgVKJpSIuA8YTWUFe48BroiI8WnfiIgbIuLVqq7CzMxqquGSWKoMvw8wpah9ReCLZL0vgEEU1TGMiFlAH0mrlzn8Y8CWFYRRUY3EcvK1E9+eP3dZD2NmZh1opCTWS9IkYALwPPDHova5wFrA3aldQLmH3Mq1q4NtOuWhuXztxNVWX7szDmlmZiU0UhLLF+P9fkR8kG8HNgF6kO6JkdUxbPMgnKQBwIKIeLvMOYYAT6Xvc4G+uXVrAa/njr39cl2NmZnVXCMlsXZFxDzgB8AJ6dUoVwE7S9oDFk/0uBA4q9T+kj5Pdj/s96lpLHBoYTYj8C3gvvT9IuBbkj6X2/9QSet36kWZmdlyaZokBhARj5NVkD84IhYC+wGnS3qG7B7ao2QJqOCgNAV+OnAqcEBEFHpio4G3gSckPQH0Ac5J53kVOBg4J02xfwrYBZhf84s0M7OKuXZijbl2oplZ9Vw70czMuj0nMTMza1pOYjW2YO5HPHjlHB68cun6iWZmtny6TQFgSYto+4D0tUBPYJWI+HFuu8HANRGxlaTZZJM7FqXV90fEDySNAb4EDIiI9yX1I3t+7SvAn9K2nwTmpc/rEbFHzS7OzMxK6jZJjCXPky0m6VPAX4Ef55oPBq7OLe8eEa+ztEXAd4BLCg0RMQUYnI49BrgtIm7olOjNzKxq3Xo4MSKeAd7KP+8F/CtZL60j5wPHpzJYZmbWgLpTEuuVe03KJEkHpfZryHpfSNoBmBsRM3L73Zfb5/hc+/PAA8A3uyR6MzOrWnfqZSw1nJhcCzwk6UdkyeyaovXlhhMBfklWcPj2agKRdCSpWv56a29Uza5mZlaF7tQTKykiXgBmA58HDgD+XMW+M4FJZEOQ1ZxzcQHgNVdzAWAzs1rpTj2x9lwD/AaYFREvVrnvKKrsiZmZWdfoTj2x4ntiZ+bWXU/2/rFSEzry98SuLF4ZEdPI3kNmZmYNxrUTa8y1E83MqufaiWZm1u05iZmZWdNyEquxD179kNnnv1LvMMzMuqWWS2KSFrSz7glJ1+SWt5M0Kbc8UtK76c3SSPq0pMm1jdjMzMppuSRWjqStyH6PXSWtmpqnAJtIWi0t7wg8DQzJLT/YpYGamdliTmJLfIOsQv1dwFcBIuJj4FGgUHtxe+BisuRF+vehrg3TzMwKnMSWOAi4juzB6JG59oeAHVPv7GNgLG2TmHtiZmZ14iQGSPoMMCci/gHcAwyV1DetfpAsWX0WeDQiZgGbS1oH6BMRz5Y43pGSJkiaMPeduV10FWZmrcdJLDMS2DK9JHMWsDpZnUWAvwOfAXYGxqe2F8mKCZccSszXTlx7VddONDOrlZZPYpJWAL4ObBsR/SOiP7AfaUgxIt4GXgAOZ0kSGw8ch++HmZnVVSsmsd6SXix8yJLRSxHxUm6b+4GtJW2Qlh8EVkkV8SFLYgNwEjMzqyvXTqwx1040M6ueayeamVm35yRmZmZNy0msxj58dWG9QzAz67acxMzMrGl1mMQk/UbScbnlOyX9Ibd8rqT/kDRI0r2SpkuaIeknkpS2OVzSnPT25KclHZ/b/wxJJ6TvPSXdLemn7cSzkaS/pHPMknSBpB5p3W6S5uXe1Px/FVxfm6K/qW2MpOfSMZ6Q9MXUfnNqm1l0nh1LH93MzGqpkp7YQ6QyS+mZqn7AoNz6HYGJwK3AmRGxBbBdaj86t911ETEY2Ak4TdLG+ZOkRHQjMDEiflYqkJQUbwJuiYiBwBZAH2BUbrNxETE4ffZo78LKFP0tODHFexxwKUBEjEht3y06j6fam5nVQSVJrFB2CbLkNRV4W1JfSasAWwFbAg9GxF0AEfEucCxwSvHBImIuMBPYINe8EnAtMCMilton5wvAexFxeTrWIuB44DuSeldwLcWWKvpbwnhgw2U4tpmZ1ViHSSwiXgY+kvRJsmQ2HngY+BdgGDAZ+BRZbyy/3yygj6TV8+3pOD3TfgUnAR9FxHG0b1CJ88wHngc2T0275Ib5TuvgeOWK/ubtDdzSwXHayNdOfOOdN6vZ1czMqrBShdsVemM7AueR9Ux2BOaRDTeuApR7arrQfpCk3ckS3r9FxHu5bR4A/kXSFhExvZ04VOY8+fZxETG8owvKF/1NlTsuk9Q3IgpZ52xJZwHrAjt0dLy8iBgNjAbYbuNBfprczKxGKp2dWLgv9mmy4cS/k/XECq8imUbWK1tM0gBgQao9CNk9sUHALsC5ktbPbX4/2b2nv0r6RDtxlDrP6sDGZIV7q9Fe0V+AE8l6d6cDV1R5bDMz6wKVJrEHgeHAGxGxKCLeANYkS2TjgauAnSXtASCpF3AhcFbxgSJiPNl9qB8Wtd8InA38TdKaZeK4h6z24WHpPCsC5wJj0n24inRU9DcX08fABcAKkvaq9PhmZtY1Kk1iU8hmJf69qG1eRLweEQvJksDpkp5J6x4FLipzvF8D35a0Wr4xIi4lm314q6SexTtFVuhxBPB1STOA6cB7wKkVXkfBrnRc9Dd/zl+Q3bczM7MG4gLANeYCwGZm1XMBYDMz6/YqnZ3YpSStTXb/q9gX03Nm1RzrNLL7X3nXR8SoUtt3to9em98VpzEza0kNmcRSohrcSccaRduKHmZm1k106XCipAXtrCtXw/ClVBkESf3SlPjC+oGSbks1FCdKuk/Srmnd4pqMue1nS+qXWx4hKSRtWbRde8fN14EsfLZejp/FzMyWUUPcE+ughuEi4Dsl9ukJ3A6MjojNItxxzJcAAAa7SURBVGJ74PvAgCpOPZLsQeuDqzzudbm6iYMj4skqzmlmZp2kIZIY7dcwPB84XlLx0OchwPiIuLXQEBFTI2JMJSeU1IesGPER5JLY8h7XzMy6TqMksfZqGD5P1lv6ZlH7IOCx5Tjn/sDfUpmrNyQNreK4BxUNJ/bKr8zXTpy7YN5yhGhmZu2pexLL1zAkm5E4VFLfos1+SVYGqmy86V1fUyXdlJo6quU4kqxyPunfkgWASxwXlh5ObPP65ogYHRHDImLY2n3WKBeymZktp7onMTquYUhEzAQmAf+aa54GDM1tMwI4HFgrNc0FipPhasBbaQr/F4A/pPOeSNa7UgXHNTOzBlHXJFZpDcNkFJCfbXg1sJOk/D20/DvF7ge+WihtJelrwBPpHWQHAldGxCbpvBsDzwE7V3BcMzNrEF39nFjv9NqTgvOovIbhNEmPkXpJEbFQ0nDgPEnnA68Cb5PVOSQiJku6CHhAUgCvkb2RGbIkeWZRbDcC34iIce0dNzlI0s655aP9dmczs67n2ok15tqJZmbVq7R2opNYjUl6G3im3nEso37A6/UOYhk0a9zg2OuhWeOG5o29krg3iYh1OjpQQ5ad6maeqeT/TTQiSROaMfZmjRscez00a9zQvLF3ZtyNMDvRzMxsmTiJmZlZ03ISq73R9Q5gOTRr7M0aNzj2emjWuKF5Y++0uD2xw8zMmpZ7YmZm1rScxMzMrGk5idWQpL0lPSNppqRT6h1PsfSS0CmpEv+E1LaWpLslzUj/9k3tknRhupbJuar/XRXrZZJekzQ111Z1rJK+lbafIelbdYz9jPTC18KbEPbNrftxiv0ZSXvl2rv070nSxumFsE9Jmibph6m9oX/3duJuht+8p6RHlL0keJqkn6X2TSU9nH6/6yT1SO2rpOWZaX3/jq6pi+MeI+m53G8+OLV33t9KRPhTgw+wIllB4wFAD+AJYOt6x1UU42ygX1HbWcAp6fspwK/T932BvwICdgAe7uJYdyUrOTZ1WWMlK+L8bPq3b/ret06xnwGcUGLbrdPfyirApulvaMV6/D0BGwBD0/fVgOkpvob+3duJuxl+cwF90veVgYfTb/ln4ODUfilwVPp+NHBp+n4w2Rs2yl5THeIeAxxYYvtO+1txT6x2PgvMjIhnI+IDste97FfnmCqxH3BF+n4F2XvXCu1XRubvwJoqqm9ZSxFxP/BGUXO1se4F3B0Rb0TEm8DdwN51ir2c/YBrI+L9iHgOmEn2t9Tlf08R8c+IeCx9fxt4CtiQBv/d24m7nEb6zSMiFqTFldMnyN66cUNqL/7NC/9Z3AB8UZLauaaujrucTvtbcRKrnQ2BF3LLL9L+f5HqIYC7JE2UdGRqWy8i/gnZ/xgA66b2RryeamNttGs4Ng2lXKYl79BryNjTMNUQsv+H3TS/e1Hc0AS/uaQVJU0iK1p+N1kv6q2I+KhEHItjTOvnAWvXI/biuCOi8JuPSr/5byStUhx3UXxVx+0kVjsq0dZozzPsFBFDgX2AYyTt2s62zXA9BeVibaRruATYDBgM/BM4N7U3XOyS+pC95eG4iJjf3qYl2uoWe4m4m+I3j4hFETEY2Iis97RVO3E0TOzFcUvaBvgxsCXwGbIhwpPT5p0Wt5NY7bwIbJxb3gh4uU6xlBQRL6d/XwNuJvsvzKuFYcL072tp80a8nmpjbZhriIhX03/pPwZ+z5KhnoaKXdLKZIngqogovN284X/3UnE3y29eEBFvAWPJ7hmtKalQ6zYfx+IY0/o1yIau6xZ7Lu6909BuRMT7wOXU4Dd3EqudR4GBaVZRD7KbrrfWOabFJK2qJS8MXRXYE5hKFmNhRtC3gL+k77cCh6VZRTsA8wpDSnVUbax3AntK6puGkvZMbV2u6H7iCLLfHrLYD06zzjYFBgKPUIe/p3Rv5Y/AUxFxXm5VQ//u5eJukt98HUlrpu+9gD3I7undR/YyX1j6Ny/8Z3EgcG9kMyTKXVNXxv107v/siOw+Xv4375y/lc6YmeJP2Rk7+5LNjJoFnFbveIpiG0A2e+kJYFohPrLx9HuAGenftVK7gIvTtUwBhnVxvNeQDQF9SPb/1o5YlliB75Dd5J4JfLuOsf8pxTY5/Rd6g9z2p6XYnwH2qdffE9mbziPFOCl99m30372duJvhN98WeDzFOBX4z9Q+gCwJzQSuB1ZJ7T3T8sy0fkBH19TFcd+bfvOpwP+wZAZjp/2tuOyUmZk1LQ8nmplZ03ISMzOzpuUkZmZmTctJzMzMmpaTmJmZNS0nMTMza1pOYmZm1rT+P+brJraJX5SjAAAAAElFTkSuQmCC
"
>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<h3 id="Most-Common-Entity-Barchart">Most Common Entity Barchart<a class="anchor-link" href="#Most-Common-Entity-Barchart">&#182;</a></h3>
</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[21]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="k">def</span> <span class="nf">plot_most_common_named_entity_barchart</span><span class="p">(</span><span class="n">text</span><span class="p">,</span> <span class="n">entity</span><span class="o">=</span><span class="s2">&quot;PERSON&quot;</span><span class="p">):</span>
    <span class="n">nlp</span> <span class="o">=</span> <span class="n">spacy</span><span class="o">.</span><span class="n">load</span><span class="p">(</span><span class="s2">&quot;en_core_web_sm&quot;</span><span class="p">)</span>
    
    <span class="k">def</span> <span class="nf">_get_ner</span><span class="p">(</span><span class="n">text</span><span class="p">,</span><span class="n">ent</span><span class="p">):</span>
        <span class="n">doc</span><span class="o">=</span><span class="n">nlp</span><span class="p">(</span><span class="n">text</span><span class="p">)</span>
        <span class="k">return</span> <span class="p">[</span><span class="n">X</span><span class="o">.</span><span class="n">text</span> <span class="k">for</span> <span class="n">X</span> <span class="ow">in</span> <span class="n">doc</span><span class="o">.</span><span class="n">ents</span> <span class="k">if</span> <span class="n">X</span><span class="o">.</span><span class="n">label_</span> <span class="o">==</span> <span class="n">ent</span><span class="p">]</span>

    <span class="n">entity_filtered</span><span class="o">=</span><span class="n">text</span><span class="o">.</span><span class="n">apply</span><span class="p">(</span><span class="k">lambda</span> <span class="n">x</span><span class="p">:</span> <span class="n">_get_ner</span><span class="p">(</span><span class="n">x</span><span class="p">,</span><span class="n">entity</span><span class="p">))</span>
    <span class="n">entity_filtered</span><span class="o">=</span><span class="p">[</span><span class="n">i</span> <span class="k">for</span> <span class="n">x</span> <span class="ow">in</span> <span class="n">entity_filtered</span> <span class="k">for</span> <span class="n">i</span> <span class="ow">in</span> <span class="n">x</span><span class="p">]</span>
    
    <span class="n">counter</span><span class="o">=</span><span class="n">Counter</span><span class="p">(</span><span class="n">entity_filtered</span><span class="p">)</span>
    <span class="n">x</span><span class="p">,</span><span class="n">y</span><span class="o">=</span><span class="nb">map</span><span class="p">(</span><span class="nb">list</span><span class="p">,</span><span class="nb">zip</span><span class="p">(</span><span class="o">*</span><span class="n">counter</span><span class="o">.</span><span class="n">most_common</span><span class="p">(</span><span class="mi">10</span><span class="p">)))</span>
    <span class="n">sns</span><span class="o">.</span><span class="n">barplot</span><span class="p">(</span><span class="n">y</span><span class="p">,</span><span class="n">x</span><span class="p">)</span><span class="o">.</span><span class="n">set_title</span><span class="p">(</span><span class="n">entity</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[22]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">ENTITIES</span> <span class="o">=</span> <span class="p">[</span>
    <span class="s2">&quot;PERSON&quot;</span><span class="p">,</span>
    <span class="s2">&quot;ORG&quot;</span><span class="p">,</span>
    <span class="s2">&quot;GPE&quot;</span><span class="p">,</span>
    <span class="s2">&quot;PRODUCT&quot;</span><span class="p">,</span>
    <span class="s2">&quot;MONEY&quot;</span><span class="p">,</span>
    <span class="s2">&quot;QUANTITY&quot;</span><span class="p">,</span>
<span class="p">]</span>

<span class="k">for</span> <span class="n">entity</span> <span class="ow">in</span> <span class="n">ENTITIES</span><span class="p">:</span>
    <span class="k">try</span><span class="p">:</span>
        <span class="n">fig</span> <span class="o">=</span> <span class="n">plt</span><span class="o">.</span><span class="n">figure</span><span class="p">()</span>
        <span class="n">plot_most_common_named_entity_barchart</span><span class="p">(</span><span class="n">text</span><span class="p">,</span> <span class="n">entity</span><span class="p">)</span>
        <span class="n">plt</span><span class="o">.</span><span class="n">show</span><span class="p">()</span>
    <span class="k">except</span> <span class="ne">Exception</span><span class="p">:</span>
        <span class="k">pass</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,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
"
>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,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
"
>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAbkAAAEICAYAAADCwor4AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjEsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy8QZhcZAAAcWUlEQVR4nO3de5hU1Znv8e9P5KI0Ae8SjTYyKiqjCK2jogSNyUkyZtQZTDQm6iQTYpwkx8wQx0SPQc+YeInmxBhN2lwwkSRG4hjHzHgJiiIq2I1cBdQR52jkEYmCIgfk8p4/9mopmuor1b2rd/8+z1NP7Vpr7VXvXnTz9lp7V21FBGZmZkW0U94BmJmZdRUnOTMzKywnOTMzKywnOTMzKywnOTMzKywnOTMzKywnOTMzKywnObNeTtLZkmZLekfSyrR9kTJTJL0raa2kNyQ9JGlE2m+ypI2prumxOu/jMSvlJGfWi0n6Z+D7wPXAvsA+wIXAWKBfanZdRNQA+wMrgSklXdwZETUljyHdFrxZOzjJmfVSkgYDVwEXRcS0iHg7Ms9ExLkRsaG0fUSsA34FjMwjXrPOcJIz672OB/oDv29PY0k1wLnAM10ZlFklOcmZ9V57AqsiYlNTgaQnJK2W9P8kjUvFk9K5theAGuCCkj4+mdo3PR7ptujN2mHnvAMws9z8GdhT0s5NiS4iTgCQ9Apb/wj+bkRc3kIfv42Iz3R9qGad45mcWe/1JLABOD3vQMy6imdyZr1URKyWdCVwiyQB9wPrgCOBgbkGZ1YhnsmZ9WIRcR3wT8AlZB8PeA34MfAvwBPt6OJTzT4nt1bS3l0XsVnHyDdNNTOzovJMzszMCstJzszMCstJzszMCstJzszMCssfIagie+65Z9TW1uYdhplZj9LY2LgqIvYqV+ckV0Vqa2tpaGjIOwwzsx5F0n+3VOflSjMzKyzP5KrIklf+zJiv/yLvMMzMulXj9ed1Wd+eyZmZWWE5yZmZWWE5yZmZWWE5yZmZWWE5yZUhqT3fvl7afryk+9L230i6tGsiMzOzjvDVlWU03R25k/veC9xbwXDMzKyTPJMrQ9La9Dxe0gxJ0yQtlTQ13VwSSR9NZY8Df1uy7wWSbk7bn5A0W9Izkv4oaZ9cDsjMrJdykmvb0cDFwOHAQcBYSQOA24BPACcB+7aw7+PAcRFxNPAbshtTbkPSREkNkho2rXu7K+I3M+u1vFzZtjkR8QqApHlALbAWWB4Rz6fyO4CJZfbdH7hT0lCgH7C8eYOIqAfqAQbuO8x3sDUzqyDP5Nq2oWR7M1v/MGhPQvoBcHNE/CXwRWBAhWMzM7NWOMl1zlJgmKTh6fU5LbQbDPwpbZ/f5VGZmdk2nOQ6ISLWky1P/iFdeNLSN2BPBu6SNBNY1U3hmZlZogifBqoWA/cdFiM+e2XeYZiZdasd/YJmSY0RUVeuzjM5MzMrLCc5MzMrLCc5MzMrLH9Orooctv8eNHThzQPNzHobz+TMzKywnOTMzKywnOTMzKywfE6uiry7YjH/96q/zDsMs0I54IqFeYdgOfJMzszMCstJzszMCstJzszMCstJzszMCstJzszMCstJzszMCstJzszMCsufk6sQSbXAfRExMr2eBNQAbwAXApuAZyPi7LxiNDPrbZzkut6lwLCI2CBpSPNKSRPJ7jLOfoP7dndsZmaF5uXKrrcAmCrpM2SzuW1ERH1E1EVE3e4D+3R/dGZmBeYkVzmb2HY8B6TnvwZ+CIwBGiV59mxm1k2c5CrnNWBvSXtI6g+cRja+H4iIR4BLgCFk5+nMzKwbeFZRIRGxUdJVwGxgObAU6APcIWkwIOB7EbE6xzDNzHoVJ7kKioibgJvyjsPMzDJerjQzs8JykjMzs8JykjMzs8LyObkq0m/oERxwRUPeYZiZFYZncmZmVlhOcmZmVlhOcmZmVlg+J1dFlq5cytgfjM07DOtBZn1lVt4hmFU1z+TMzKywnOTMzKywnOTMzKywnOTMzKywnOTMzKywnORaIWmKpAllyt8vaVoeMZmZWfv5IwSdEBGvAtslPzMzqy6eyZWQdJ6kBZLmS/plKh4n6QlJLzbN6iTVSlqUti+QdLek+yU9L+m6kv5uldQgabGkK3M4JDOzXs0zuUTSEcBlwNiIWCVpd+BGYChwIjACuBcot0w5Cjga2AAsk/SDiHgZuCwi3pDUB5gu6ciIWNDsfScCEwH67davi47OzKx38kxuq1OAaRGxCiAi3kjl90TEloh4FtinhX2nR8SaiFgPPAscmMo/KWku8AxwBHB48x0joj4i6iKirm9N30oej5lZr+eZ3FYCokz5hmZtyiltsxnYWdIwYBJwTES8KWkKMKASgZqZWft4JrfVdLKZ1x4AablyR7wPeAdYI2kf4GM72J+ZmXWQZ3JJRCyWdDXwqKTNZEuMO9LffEnPAIuBFwF/k66ZWTdTRLkVOstDzQE1cdTXj8o7DOtBfBcCM5DUGBF15eq8XGlmZoXlJGdmZoXlc3JVZMTeI7z8ZGZWQZ7JmZlZYTnJmZlZYTnJmZlZYTnJmZlZYfnCkyry9rJlPDrug3mH0S0++NijeYdgZr2AZ3JmZlZYTnJmZlZYTnJmZlZYTnJmZlZYVZ3kJNVKWlSm/CeStrsBaTv7nCGp7Bd5mplZsfTIqysj4h/yeF9JfSJicx7vbWZmHVfVM7lkZ0m3S1ogaZqkXUtnY5LOkbRQ0iJJ1zbtJGmtpBskzZU0XdJeJX2eJWmOpOcknZTa10qamdrPlXRCKh8v6RFJvwIWpnZL02xykaSpkk6VNEvS85KOTfsdK+kJSc+k50O7b8jMzAx6RpI7FKiPiCOBt4CLmiokvR+4FjgFGAUcI+mMVD0QmBsRo4FHgW+V9LlzRBwLXFxSvhL4cGr/KeCmkvbHApdFRNMS6V8A3weOBEYAnwZOBCYB30xtlgLjIuJo4Arg2+UOTtJESQ2SGtZs3Nj+UTEzszb1hOXKlyOi6av57wC+WlJ3DDAjIl4HkDQVGAfcA2wB7izZ7+6S/Zq2G4HatN0XuFnSKGAzcEhJ+zkRsbzk9fKIWJjeczEwPSJC0sKS/gYDt0s6GIjU/3Yioh6oBzh00CDfwdbMrIJ6wkyu+X/8pa/VyX42pOfNbE30XwNeA44C6oB+Je3fadbXhpLtLSWvt5T097+BRyJiJPAJYEAHYjUzswroCUnuAEnHp+1zgMdL6mYDH5S0p6Q+qb7p+6J2Aiak7U8326+cwcCKiNgCfBbos4NxDwb+lLYv2MG+zMysE3pCklsCnC9pAbA7cGtTRUSsAL4BPALMJzsH9/tU/Q5whKRGsnN2V7XxPrek93mKbKmy+eyto64DviNpFjueMM3MrBMUUczTQJLWRkRN3nF0xKGDBkX90aPzDqNb+AuazaxSJDVGRNnPP/eEmZyZmVmnFDbJ9bRZnJmZVV5hk5yZmVlP+JxcrzHo0EN9rsrMrII8kzMzs8JykjMzs8JykjMzs8JykjMzs8LyhSdVZOUra7j5n/897zC6zJdv+ETeIZhZL+OZnJmZFZaTnJmZFZaTnJmZFZaTnJmZFZaTXBskzZBU9tuty7WRtLaFNhdKOq8rYjQzs/J8dWU3iYgf5R2DmVlv0+NmcpJqJS2RdJukxZIelLRLqhsu6X5JjZJmShohqY+kF5UZImmLpHGp/UxJf9Gs/10k/UbSAkl3AruU1H1E0pOS5kq6S1LZOx1IulrSfElPSdonlU2WNKnLBsbMzLbT45JccjDww4g4AlgN/F0qrwe+EhFjgEnALRGxGXgOOBw4EWgETpLUH9g/Il5o1veXgHURcSRwNTAGQNKewOXAqRExGmgA/qlMbAOBpyLiKOAx4AutHYikiZIaJDWsXbemQ4NgZmat66nLlcsjYl7abgRq06zqBOAuSU3t+qfnmcA4YBjwHbLE8yjwdJm+xwE3AUTEAkkLUvlxZIlyVuq/H/Bkmf3fBe4rie3DrR1IRNSTJWcO2PfgYt6m3cwsJz01yW0o2d5MtqS4E7A6IkaVaT8TuBB4P3AF8HVgPNlMq5xyyUbAQxFxThuxbYyIpv0303PH2Mysx+upy5XbiYi3gOWSzgJI5+COStWzyWZ5WyJiPTAP+CJZ8mvuMeDc1MdI4MhU/hQwtukcnqRdJR3SVcdjZmY7rjBJLjkX+Lyk+cBi4HSAiNgAvEyWqCBLboOAhWX6uBWoScuUlwBzUh+vAxcAv051TwEjuuxIzMxsh2nryprl7YB9D45Lzr0x7zC6jL+g2cy6gqTGiCj7eeaizeTMzMze4yRnZmaF5SRnZmaF5cvbq8je+w/2eSszswryTM7MzArLSc7MzArLSc7MzArL5+SqyIrl/8XVn5mQdxgVcdkd0/IOwczMMzkzMysuJzkzMyssJzkzMyssJzkzMyssJzkzMyssJ7kuJGmGpLLfjG1mZl3PSc7MzArLn5OrAEm1wH0RMTK9ngTUlNTvBPwceDkiLs8jRjOz3sgzua63MzAVeK5cgpM0UVKDpIZ31m/o/ujMzArMSa7r/RhYFBFXl6uMiPqIqIuIuoED+ndzaGZmxeYkVxmb2HYsB5RsPwGcLGkAZmbWrZzkKuM1YG9Je0jqD5xWUvdT4D+AuyT5HKiZWTdykquAiNgIXAXMBu4DljarvxGYC/wyXYRiZmbdwDOLComIm4CbWqn/VjeGY2ZmeCZnZmYF5iRnZmaF5SRnZmaF5XNyVWTosOG+o7aZWQV5JmdmZoXlJGdmZoXlJGdmZoXlc3JVZP2Kt1ly9cN5h8Fhl52SdwhmZhXhmZyZmRWWk5yZmRWWk5yZmRWWk5yZmRWWk5yZmRVWq0lO0hBJF5W8Hi/pvq4Pa5sYfiLp8LT9zU7sf4Gkm9vZtlbSpyvVzszM8tXWTG4IcFEbbbpURPxDRDybXnY4yXVQLdCe5NXedmZmlqO2ktw1wHBJ8yRdn8pqJE2TtFTSVEkCkDRG0qOSGiU9IGlo884kTZE0oeT12vQ8XtKMFvqdIalO0jXALimWqanuM5LmpLIfS+qTyv9e0nOSHgXGljswSR9M+82T9IykQel4T0plX0sztpmS5qbHCSXjUtquj6TrJT0taYGkL6b3GCrpsdRukaST2vFvYmZmFdLWh8EvBUZGxCjIkhFwNHAE8CowCxgraTbwA+D0iHhd0qeAq4HPdSCW7foFHm+qjIhLJX25JJbDgE8BYyNio6RbgHMlPQRcCYwB1gCPAM+Ueb9JwD9GxCxJNcD6dLyTIuK09B67Ah+OiPWSDgZ+DdSVaTcRWBMRx0jqD8yS9CDwt8ADEXF1SsC7Ng8i7TsRYOjgvTswXGZm1pbOfOPJnIh4BUDSPLKlu9XASOChNAHrA6yoQL+Pt9L+Q2SJ7On0nrsAK4G/AmZExOuprzuBQ8rsPwu4Mc0K746IV1I/pfoCN0saBWxuoR+AjwBHlsxSBwMHA08DP5PUF7gnIuY13zEi6oF6gJH7HRqtHK+ZmXVQZ5LchpLtzakPAYsj4vg29t1EWiJNy5H92ui3NQJuj4hvbFMonQG0mSwi4hpJfwA+Djwl6dQyzb4GvAYcleJe30osX4mIB7arkMYBfw38UtL1EfGLtmIzM7PKaOuc3NvAoHb0swzYS9LxAJL6SjqiTLuXyGZfAKeTzZQ6YmOaFQFMByZI2ju95+6SDgRmA+Ml7ZHanlWuI0nDI2JhRFwLNAAj2P54BwMrImIL8FmyGSpl2j0AfKkpNkmHSBqY4lkZEbcBPwVGd/B4zcxsB7Q6W4qIP0uaJWkR8J/AH1po925aqrtJ0uDU7/8BFjdrehvwe0lzyJLUOx2Mtx5YIGluRJwr6XLgQUk7ARvJzrE9JWky8CTZkulctianUhdLOpls1vhsOr4twCZJ84EpwC3A7ySdRXZuryneBc3afZ9seXVumqG+DpwBjAe+LmkjsBY4r4PHa2ZmO0ARPg1ULUbud2jcddGteYfhuxCYWY8iqTEi6srV+RtPzMyssJzkzMyssHzT1CoyYOggLxWamVWQZ3JmZlZYTnJmZlZYTnJmZlZYTnJmZlZYvvCkirz66qtMnjy5on1Wuj8zs57EMzkzMyssJzkzMyssJzkzMyssJzkzMyssJ7l2kDSl5IaoZmbWQzjJmZlZYfWqJCfpEklfTdvfk/Rw2v6QpDskrS1pO0HSlJLdx0l6QtKLTbM6STWSpkuaK2mhpNNTea2kJZJuk7RY0oOSdum+IzUzM+hlSQ54DDgpbdcBNelu3icCM9vYd2hqdxpwTSpbD5wZEaOBk4Eb0k1TAQ4GfhgRRwCrgb8r16mkiZIaJDWsW7euk4dlZmbl9LYk1wiMkTQI2EB29/A6ssTXVpK7JyK2RMSzwD6pTMC3JS0A/gjsV1K3PCLmlbxvbblOI6I+Iuoiom7XXXft5GGZmVk5veobTyJio6SXgL8HngAWkM3AhgNLgNLbpA9otvuGku2m2dq5wF7AmJK+B5RpvxnwcqWZWTfrbTM5yJYsJ6XnmcCFwLyICOA1SYdJ2gk4sx19DQZWpgR3MnBgVwVtZmYd1xuT3Eyy82tPRsRrZOfVmpYqLwXuAx4GVrSjr6lAnaQGslnd0sqHa2ZmndWrlisBImI60Lfk9SEl29OAaWX2uaDZ65r0vAo4voW3GlnS/rs7FLSZmXVKb5zJmZlZL+EkZ2ZmheUkZ2ZmhaXsokKrBnV1ddHQ0JB3GGZmPYqkxoioK1fnmZyZmRWWk5yZmRWWk5yZmRVWr/ucXDV7880l/PauYyva5yfPmlPR/szMehLP5MzMrLCc5MzMrLCc5MzMrLCc5MzMrLCc5MzMrLCc5DpJ0hN5x2BmZq1zkusgSX0AIuKEvGMxM7PWFTLJSbpHUqOkxZImprK1kq5N5X+UdKykGZJelPQ3qU0fSddLelrSAklfTOXjJT0i6VfAwqb+St7vEkkLJc2XdE0q+0LqZ76k30natdsHwsyslytkkgM+FxFjgDrgq5L2AAYCM1L528C/Ah8GzgSuSvt9HlgTEccAxwBfkDQs1R0LXBYRh5e+kaSPAWcAfxURRwHXpaq7I+KYVLYk9b0dSRMlNUhqeOutTRU5eDMzyxT1G0++KunMtP0B4GDgXeD+VLYQ2BARGyUtBGpT+UeAIyVNSK8Hl+w7JyKWl3mvU4GfR8Q6gIh4I5WPlPSvwBCgBnigXKARUQ/UAwwfPtC3hDAzq6DCJTlJ48kSz/ERsU7SDGAAsDG23ldoC7ABICK2SGoaBwFfiYgHyvT5TktvCZRLTlOAMyJivqQLgPGdOyIzM+usIi5XDgbeTAluBHBcB/Z9APiSpL4Akg6RNLCNfR4EPtd0zk3S7ql8ELAi9XVuh47AzMwqonAzObIlyQslLQCWAU91YN+fkC1dzpUk4HWy820tioj7JY0CGiS9C/wH8E3gfwGzgf8mWx4d1MHjMDOzHeQ7g1eR4cMHxneuOaKiffouBGZWdL4zuJmZ9UpOcmZmVlhOcmZmVlhFvPCkx9ptt8N8Ds3MrII8kzMzs8JykjMzs8JykjMzs8LyObkq8uybb3HUtLJfcdkp8yf8j4r1ZWbWE3kmZ2ZmheUkZ2ZmheUkZ2ZmheUkZ2ZmheUkZ2ZmheUkl0h6Iu8YzMysspzkkog4Ie8YzMysspzkEklrJdVImi5prqSFkk5PdbWSlkq6XdICSdNK7gR+haSnJS2SVJ9utoqkGZKulTRH0nOSTsrz+MzMeiMnuW2tB86MiNHAycANTUkLOBSoj4gjgbeAi1L5zRFxTESMBHYBTivpb+eIOBa4GPhWuTeUNFFSg6SGTW+t6YJDMjPrvZzktiXg25IWAH8E9gP2SXUvR8SstH0HcGLaPlnSbEkLgVOA0lt7352eG4Hacm8YEfURURcRdTu/b3DljsTMzPy1Xs2cC+wFjImIjZJeAgakumjWNiQNAG4B6iLiZUmTS9oDbEjPm/FYm5l1O8/ktjUYWJkS3MnAgSV1B0g6Pm2fAzzO1oS2SlINMKH7QjUzs7Y4yW0VwFSgTlID2axuaUn9EuD8tJS5O3BrRKwGbgMWAvcAT3dvyGZm1hovoQGS9gDeiIhVwPFl6muBLRFxYfO6iLgcuLxM+fiS7VW0cE7OzMy6Tq+fyUl6P/Ak8N28YzEzs8rq9TO5iHgVOKSNNi8BI7slIDMzq5heP5MzM7Pi6vUzuWpy+G7vo8F38zYzqxjP5MzMrLAU0fwzzpYXSW8Dy/KOo532BFblHUQ7OdbK6ylxgmPtKtUU64ERsVe5Ci9XVpdlEVGXdxDtIanBsVZeT4m1p8QJjrWr9JRYvVxpZmaF5SRnZmaF5SRXXerzDqADHGvX6Cmx9pQ4wbF2lR4Rqy88MTOzwvJMzszMCstJzszMCstJrkpI+qikZZJekHRp3vE0J+klSQslzUu3IkLS7pIekvR8et4th7h+JmmlpEUlZWXjUuamNMYLJI2uglgnS/pTGtd5kj5eUveNFOsySd36VTiSPiDpEUlLJC2W9D9TeVWNbStxVt24ShogaY6k+SnWK1P5MEmz05jeKalfKu+fXr+Q6murINYpkpaXjOuoVJ7r71arIsKPnB9AH+C/gIOAfsB84PC842oW40vAns3KrgMuTduXAtfmENc4YDSwqK24gI8D/wkIOA6YXQWxTgYmlWl7ePo56A8MSz8ffbox1qHA6LQ9CHguxVRVY9tKnFU3rmlsatJ2X2B2GqvfAmen8h8BX0rbFwE/SttnA3d2479/S7FOASaUaZ/r71ZrD8/kqsOxwAsR8WJEvAv8Bjg955ja43Tg9rR9O3BGdwcQEY8BbzQrbimu04FfROYpYIikod0TaYuxtuR04DcRsSEilgMvkP2cdIuIWBERc9P222Q3Dd6PKhvbVuJsSW7jmsZmbXrZNz0COAWYlsqbj2nTWE8DPiRJOcfaklx/t1rjJFcd9gNeLnn9Cq3/ouYhgAclNUqamMr2iYgVkP1nA+ydW3Tbaimuah3nL6clnp+VLPlWTaxpmexosr/mq3Zsm8UJVTiukvpImgesBB4im0mujohNZeJ5L9ZUvwbYI69YI6JpXK9O4/o9Sf2bx5pUy++Wk1yVKPfXWbV9tmNsRIwGPgb8o6RxeQfUCdU4zrcCw4FRwArghlReFbFKqgF+B1wcEW+11rRMWbfFWybOqhzXiNgcEaOA/clmkIe1Ek9VxSppJPANYARwDLA78C+peVX8vJbjJFcdXgE+UPJ6f+DVnGIpK7KbyxIRK4F/I/sFfa1pSSI9r8wvwm20FFfVjXNEvJb+M9kC3MbWpbPcY5XUlyxxTI2Iu1Nx1Y1tuTireVxTfKuBGWTnr4ZIavoe4dJ43os11Q+m/cvdFVMS60fT8nBExAbg51TZuJbjJFcdngYOTldZ9SM7yXxvzjG9R9JASYOatoGPAIvIYjw/NTsf+H0+EW6npbjuBc5LV4IdB6xpWnrLS7PzFmeSjStksZ6drrAbBhwMzOnGuAT8FFgSETeWVFXV2LYUZzWOq6S9JA1J27sAp5KdQ3wEmJCaNR/TprGeADwc6SqPnGJdWvIHjsjOHZaOa1X9br0n7ytf/MgeZFcnPUe2Rn9Z3vE0i+0gsivS5gOLm+IjOz8wHXg+Pe+eQ2y/JluO2kj21+TnW4qLbEnlh2mMFwJ1VRDrL1MsC8j+oxha0v6yFOsy4GPdHOuJZMtNC4B56fHxahvbVuKsunEFjgSeSTEtAq5I5QeRJdoXgLuA/ql8QHr9Qqo/qApifTiN6yLgDrZegZnr71ZrD3+tl5mZFZaXK83MrLCc5MzMrLCc5MzMrLCc5MzMrLCc5MzMrLCc5MzMrLCc5MzMrLD+P4KHjajGHDCEAAAAAElFTkSuQmCC
"
>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,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
"
>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,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
"
>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,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
"
>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<p>MOST COMMON NOUNS</p>

</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[24]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="k">def</span> <span class="nf">get_adjs</span><span class="p">(</span><span class="n">text</span><span class="p">):</span>
    <span class="n">adj</span><span class="o">=</span><span class="p">[]</span>
    <span class="n">pos</span><span class="o">=</span><span class="n">nltk</span><span class="o">.</span><span class="n">pos_tag</span><span class="p">(</span><span class="n">word_tokenize</span><span class="p">(</span><span class="n">text</span><span class="p">))</span>
    <span class="k">for</span> <span class="n">word</span><span class="p">,</span><span class="n">tag</span> <span class="ow">in</span> <span class="n">pos</span><span class="p">:</span>
        <span class="k">if</span> <span class="n">tag</span><span class="o">==</span><span class="s1">&#39;NN&#39;</span><span class="p">:</span>
            <span class="n">adj</span><span class="o">.</span><span class="n">append</span><span class="p">(</span><span class="n">word</span><span class="p">)</span>
    <span class="k">return</span> <span class="n">adj</span>

<span class="n">nltk</span><span class="o">.</span><span class="n">download</span><span class="p">(</span><span class="s1">&#39;averaged_perceptron_tagger&#39;</span><span class="p">)</span>
<span class="n">words</span><span class="o">=</span><span class="n">data</span><span class="p">[</span><span class="s1">&#39;title&#39;</span><span class="p">]</span><span class="o">.</span><span class="n">apply</span><span class="p">(</span><span class="k">lambda</span> <span class="n">x</span> <span class="p">:</span> <span class="n">get_adjs</span><span class="p">(</span><span class="nb">str</span><span class="p">(</span><span class="n">x</span><span class="p">)))</span>
<span class="n">words</span><span class="o">=</span><span class="p">[</span><span class="n">x</span> <span class="k">for</span> <span class="n">l</span> <span class="ow">in</span> <span class="n">words</span> <span class="k">for</span> <span class="n">x</span> <span class="ow">in</span> <span class="n">l</span><span class="p">]</span>
<span class="n">counter</span><span class="o">=</span><span class="n">Counter</span><span class="p">(</span><span class="n">words</span><span class="p">)</span>

<span class="n">x</span><span class="p">,</span><span class="n">y</span><span class="o">=</span><span class="nb">list</span><span class="p">(</span><span class="nb">map</span><span class="p">(</span><span class="nb">list</span><span class="p">,</span><span class="nb">zip</span><span class="p">(</span><span class="o">*</span><span class="n">counter</span><span class="o">.</span><span class="n">most_common</span><span class="p">(</span><span class="mi">7</span><span class="p">))))</span>
<span class="n">sns</span><span class="o">.</span><span class="n">barplot</span><span class="p">(</span><span class="n">x</span><span class="o">=</span><span class="n">y</span><span class="p">,</span><span class="n">y</span><span class="o">=</span><span class="n">x</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stderr output_text">
<pre>[nltk_data] Downloading package averaged_perceptron_tagger to
[nltk_data]     /home/teamscool/nltk_data...
[nltk_data]   Unzipping taggers/averaged_perceptron_tagger.zip.
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt output_prompt">Out[24]:</div>




<div class="output_text output_subarea output_execute_result">
<pre>&lt;matplotlib.axes._subplots.AxesSubplot at 0x7f39b7d61590&gt;</pre>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>




<div class="output_png output_subarea ">
<img src="data:image/png;base64,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
"
>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[39]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="c1">#find our desired words in an articles</span>
<span class="k">def</span> <span class="nf">find_cc_wds</span><span class="p">(</span><span class="n">content</span><span class="p">,</span> <span class="n">cc_wds</span><span class="o">=</span><span class="p">[</span><span class="s1">&#39;pharma&#39;</span><span class="p">,</span><span class="s1">&#39;pharmaceutical&#39;</span><span class="p">]):</span>
    <span class="n">found</span> <span class="o">=</span> <span class="kc">False</span>
    <span class="k">for</span> <span class="n">w</span> <span class="ow">in</span> <span class="n">cc_wds</span><span class="p">:</span>
        <span class="k">if</span> <span class="n">w</span> <span class="ow">in</span> <span class="n">content</span><span class="p">:</span>
            <span class="n">found</span> <span class="o">=</span> <span class="kc">True</span>
            <span class="k">break</span>

    <span class="k">if</span> <span class="ow">not</span> <span class="n">found</span><span class="p">:</span>
        <span class="n">disj</span> <span class="o">=</span> <span class="n">re</span><span class="o">.</span><span class="n">compile</span><span class="p">(</span><span class="sa">r</span><span class="s1">&#39;(package\w+\W+(?:\w+\W+){1,5}?government) | (scheme\W+(?:\w+\W+){1,5}?government)&#39;</span><span class="p">)</span>
        <span class="k">if</span> <span class="n">disj</span><span class="o">.</span><span class="n">match</span><span class="p">(</span><span class="n">content</span><span class="p">):</span>
            <span class="n">found</span> <span class="o">=</span> <span class="kc">True</span>
    <span class="k">return</span> <span class="n">found</span>

<span class="n">data</span><span class="p">[</span><span class="s1">&#39;found_words&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">data</span><span class="p">[</span><span class="s1">&#39;paragraphs&#39;</span><span class="p">]</span><span class="o">.</span><span class="n">apply</span><span class="p">(</span><span class="n">find_cc_wds</span><span class="p">)</span>
<span class="n">data</span> <span class="o">=</span> <span class="n">data</span><span class="p">[</span><span class="n">data</span><span class="p">[</span><span class="s1">&#39;found_words&#39;</span><span class="p">]</span><span class="o">==</span><span class="kc">True</span><span class="p">]</span> 
</pre></div>

    </div>
</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[43]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">nlp</span> <span class="o">=</span> <span class="n">spacy</span><span class="o">.</span><span class="n">load</span><span class="p">(</span><span class="s2">&quot;en_core_web_sm&quot;</span><span class="p">)</span>
<span class="n">data</span><span class="p">[</span><span class="s1">&#39;summary&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">data</span><span class="p">[</span><span class="s1">&#39;summary&#39;</span><span class="p">]</span><span class="o">.</span><span class="n">map</span><span class="p">(</span><span class="k">lambda</span> <span class="n">x</span><span class="p">:</span> <span class="n">clean_text</span><span class="p">(</span><span class="nb">str</span><span class="p">(</span><span class="n">x</span><span class="p">)))</span>
<span class="k">for</span> <span class="n">i</span> <span class="ow">in</span> <span class="n">data</span><span class="o">.</span><span class="n">index</span><span class="p">:</span>
    <span class="k">try</span><span class="p">:</span>
        <span class="nb">print</span><span class="p">(</span><span class="s2">&quot;-----------------------------------------------&quot;</span><span class="p">)</span>
        <span class="n">displacy</span><span class="o">.</span><span class="n">render</span><span class="p">(</span><span class="n">nlp</span><span class="p">(</span><span class="nb">str</span><span class="p">(</span><span class="n">data</span><span class="o">.</span><span class="n">summary</span><span class="p">[</span><span class="n">i</span><span class="p">])),</span> <span class="n">style</span><span class="o">=</span><span class="s1">&#39;ent&#39;</span><span class="p">)</span>
    <span class="k">except</span><span class="p">:</span>
        <span class="k">continue</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">the opportunities for cdmos in the pharmaceutical 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    industry0
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 sharesposted 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    11
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 may 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    victoria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 rees 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 pharmaceutical review a pricewaterhousecoopers report has highlighted the directions that the growth of the contract development and manufacturing organisation cdmo outsourcing market will take in the near future a report from pricewaterhousecoopers 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pwc
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 has summarised the global contract development and manufacturing organisation cdmo market suggesting that there are a wide range of opportunities presented by the advances and changes in the pharmaceutical industry as quoted in the report the cdmo market is expected to be worth 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    158 billion
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 by 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2025
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 increasing from 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    99 billion
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2018
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 according to the authors of the report while the industry as a whole is thriving many cdmos are finding themselves confronted with unprecedented changes here we explore the opportunities and challenges faced by cdmos in the current climate however the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 is the main country for pharmaceutical development outsourcing mainly due to the number of research organisations available such as universityaffiliated pharmaceutical research clusters</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">sterile and antiviral packaging unlocking the potential of business continuity and resilience during covid19 pandemic9 sharesamid the disruptions due to covid19 companies providing sterile and antiviral packaging solutions look forward to opportunities arising from the concern over viral exposure itself the covid19 pandemic has presented a humanitarian crisis creating an extraordinary strain on society and affecting 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    millions
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of people around the world while pharma companies recognise and are responding to immediate needs pharmaceutical packaging companies are experiencing a new set of challenges in the covid19 era plastic is again emerging as the preferred material for sterile and antiviral packaging contradicting recent trends towards lowering reliance on plastic and protecting the environment nationwide lockdowns strict border controls and stock market turbulence triggered by covid19 are currently taking a toll on the pharmaceutical industry and the sterile and antiviral packaging in particular</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">how can we develop more effective antidepressants when speaking with 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 pharmaceutical reviews victoria rees traversa explained how a new kind of antidepressant could provide depressed patients with an alternative to current therapies current antidepressant therapiestraversa explained that at present there are 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    approximately 30
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 drugs approved for the treatment of depression many antidepressants inhibit the reuptake of serotonin or serotonin and norepinephrine another one in 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    three
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 patients responds only slightly to traditional ssri and snri antidepressants</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    four
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 mhra inspections and good practice guidances for the covid19 outbreak20 sharesposted 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    29
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 april 2020 md saddam nawaz 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    aci healthcare
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 limited md saddam nawaz discusses 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    four
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 guidances released by the mhra to help firms navigate the regulatory waters during the covid19 pandemic guidance 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    1
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 approval of 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    gxp
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 documents when working from home during covid19 outbreakdue to the covid19 pandemic remote or homebased working has increased further examples of issues regarding remote approval are included in examples of issues with remote approval guidance 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    3
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 guidance for good laboratory practice glp facilities in relation to covid19the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    uk
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 good laboratory practice monitoring authority 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    uk
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 glpma recognises there are potential challenges that covid19 will present to members of the 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    glp
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 monitoring programme guidance 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    4
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 exceptional good distribution practice gdp flexibilities for medicines during the covid19 outbreakthe mhras temporary regulatory flexibilities address the current exceptional circumstances</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">the quest for efficiency moving towards continuous processing21 sharesthere are many challenges faced by the biopharmaceutical industry in order to develop and provide sufficient drugs to treat a growing and ageing population this article discusses whether continuous processing provides the solution 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    today
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the pharmaceutical industry faces the challenge of an ageing population life expectancies across the developed world are increasing thanks to growing wealth and better medicines germanys average life expectancy has increased by 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    more than 10 years
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 since 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    19701
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 and in 
<mark class="entity" style="background: #ff9561; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    latin america
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">LOC</span>
</mark>
 the increase is dramatic with average life expectancy increasing by 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    almost 20 years
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 since 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    19602
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 consequence of people living longer combined with rising gdp is that more patients are now living with chronic complex conditions such as heart disease alzheimers and type ii diabetes</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">while parents have a role to play in the home by keeping medicine out of sight and reach the pharma industry has a responsibility to invest in packaging products that act as the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 line of defence here rich quelch explores the pressures on the pharma industry to meet ethical standards and assesses how the latest innovations in childresistance packaging are helping to shape a safer future an ethical requirementfor many businesses meeting baseline safety standards is key as it helps get their products on store shelves or in pharmacies as quickly as possible for companies bringing new drugs to market leniency towards safety standards for both primary and 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    secondary
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 packaging could have serious if not fatal repercussions for those currently meeting childresistant guidelines there is no reason why they cannot go above and beyond to lead the way in safety standards</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">how modern chromatography data systems are improving regulatory compliance in pharmaceutical manufacturing2 sharesdelivering confident 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    qa
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    qc
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 in pharmaceutical manufacturing is of critical importance this article discusses how the latest chromatography data systems are ensuring compliance with modern regulatory requirements robust quality assurance qa and quality control 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    qc
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 processes are essential for pharmaceutical companies to guarantee the release of safe and effective products with patient safety at stake ensuring reliability of the data in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    qa
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 and 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    qc
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 workflows has long been a key priority for the pharmaceutical industry however as regulatory bodies such as 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the us food and drug administration fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and the uks medicines and healthcare products regulatory agency 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    mhra place
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 additional focus on the accuracy completeness and consistency of pharmaceutical manufacturing data companies need efficient ways to securely maintain the integrity of their information and demonstrate the highest levels of compliance</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">application of liquid chromatography in characterisation of lipid nanoparticlebased 
<mark class="entity" style="background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    oligonucleotides1 sharesduplex
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FAC</span>
</mark>
 oligonucleotides ogn with lipid nanoparticles lnps as delivery vehicles for different therapeutic indications are of great interest in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 exemplified by the recent approval of 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    onpattro
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 from 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    alnylam pharmaceuticals
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 liquid chromatography is an essential analytical technique in the characterisation of lnps containing ogns this brief review is intended to highlight the major applications of liquid chromatography in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ogn
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 purity assessment lnp particle heterogeneity assessment and functional excipient analysis failure or deletion impurities are sequences that lack 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    at least one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 nucleotide of single strand full length products flps addition impurities are sequences that contain 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    at least one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 additional nucleotide over flp</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">biosimilars the future of 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    competition2
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 sharesposted 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    27
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    april 2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nikki
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 withers 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 pharmaceutical review 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    earlier this year
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    british
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 biosimilars association bba the trade body representing the interests of biosimilar manufacturers welcomed dr 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    andrew ellis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 as its new chair in this interview 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nikki
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 withers asks why biosimilars are so important for pharma and how he foresees the market evolving in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the coming years
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 a biosimilar is a biological product which through various regulated pathways and assessments is deemed to be equivalent to the original reference biologic in terms of quality efficacy and safety this is why the term biosimilar has been coined it is considered equivalent to the reference product but not identical due to their simplicity it is possible to manufacture an identical or generic version</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nanoparticle
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 delivery offers a possible alternative to opioid pain relief0 sharesposted 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    27
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    april 2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nikki
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 withers 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 pharmaceutical review an international team of researchers has used 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nanoparticles
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 to deliver a drug one that previously failed in clinical trials for pain into specific compartments of nerve cells dramatically increasing its ability to treat pain in mice and rats 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nikki
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 withers spoke to 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nigel bunnett
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 to hear more about the study and what it means for the treatment of chronic pain the problem with using opioids for treating chronic pain is that they do not work for everyone and with repeated use their effectiveness diminishes over time they also have the side effects of addiction as well as respiratory depression and constipation both of which do not diminish with increasing doses people therefore may take increasing doses to treat their pain but can end up struggling to breathe</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">expert view sterility testing of challenging samples3 sharesposted 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    27
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    april 2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 merck while 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    membrane
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 filtration is often straightforward some sample types can be challenging these include difficulttofilter viscous oils waterinoil emulsions and fatty base ointments as well as samples containing substances that inhibit microbial growth however 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    membrane
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 filtration can be made to work for most products perfectly well pharmacopeia standards such as usp 71 and ep 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    261
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 recommend 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    membrane
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 filtration as the preferred method for sterility testing whenever the nature of the product permits also for products with antimicrobial activity filtration allows rinsing and thus the removal of the inhibitory characteristics of the product</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">under the microscope highly potent apis and toxic payloads2 sharesposted 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    27
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    april 2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 dr 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    william
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 sanders 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    milliporesigmas madison
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 wi safc dr 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    william sanders
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 discusses trends in the development and manufacture of highly potent active pharmaceutical ingredients hpapis and toxic payloads for antibody drug conjugates adcs an industrywide understanding of the toxicology of highly potent materials has increased exponentially as the clinical pipeline has expanded how does process development philosophy change as a result 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cfm
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 is highly attractive for hpapi production and lends tremendous promise forexperienced chemical process development and engineering groups to design future processes that are safer and more efficient his current interests include implementation of an automated development platform pat and comprehensive data management solutions in process development</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">ema initiates rolling review of remdesivir potential covid19 treatment1 sharesposted 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    6
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 may 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    victoria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 rees 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 pharmaceutical review 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the emas human medicines committee
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has announced it has begun a rolling review of remdesivir for the treatment of covid19 to examine its safety and effectiveness the european medicines agencys ema human medicines committee chmp has announced it has started a rolling review of data on the use of the investigational antiviral medicine remdesivir for the treatment of 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    coronavirus disease
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 covid19 the start of the rolling review means that the evaluation of remdesivir has begun it does not imply that its benefits outweigh its risks in the case of a rolling review 
<mark class="entity" style="background: #bfeeb7; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    chmp
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PRODUCT</span>
</mark>
 rapporteurs are appointed whilst development is still ongoing and the ema reviews data as it becomes available the chmps decision to start the rolling review of remdesivir is based on preliminary results from the actt study which suggest a beneficial effect of remdesivir in the treatment of hospitalised patients with mildtomoderate or severe covid19</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">cdmo pledges increased production of hydroxychloroquine sulfate potential covid19 treatment2 sharesposted 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    5
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 may 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    victoria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 rees 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 pharmaceutical review the cdmo 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    amri
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has said it will boost its production of the malaria drug hydroxychloroquine sulfate identified as a potential covid19 treatment following an emergency use authorisation from the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 amri has announced it is increasing production of hydroxychloroquine sulfate considered as a potential therapeutic to treat covid19 amris active type ii dmf for hydroxychloroquine sulfate is available to support increased need the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 food and drug administration 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 authorised emergency use of hydroxychloroquine sulfate to treat some hospitalised patients with covid19 in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    march
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 however some researchers and scientists have suggested that a lack of supply of hydroxychloroquine sulfate may impact its ability to fight covid19</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">ema recommends 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    eight
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 drugs for approval from 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    april
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 meeting4 sharesposted 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    5
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 may 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    victoria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 rees 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 pharmaceutical review 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the emas human medicines committee
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has adopted a positive opinion for 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    eight
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 medicines recommending their marketing authorisation the 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 medicines agencys ema human medicines committee chmp has released the conclusions of its 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    april 2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 meeting recommending 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    eight
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 drugs for approval reblozyl luspatercept also received a positive opinion for the treatment of adults with transfusiondependent anaemia associated with myelodysplastic syndromes or betathalassaemia paliperidone janssencilag international paliperidone evaluated in an informed consent application received a positive opinion for the treatment of schizophrenia the chmp recommended extensions of indication for the drugs braftovi cablivi carmustine obvius ecalta 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    harvoni kalydeco
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    sovaldi taltz
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ultomiris
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 grants remdesivir emergency use authorisation to treat covid1919 sharesposted 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    4
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 may 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    victoria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 rees 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 pharmaceutical review 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the us fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has given emergency use authorisation to remdesivir for the treatment of patients in hospital with severe covid19 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    gilead sciences
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has announced that 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the us food and drug administration fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has granted emergency use authorisation eua for the investigational antiviral remdesivir to treat covid19 according to the company the eua will facilitate broader use of remdesivir to treat hospitalised patients with severe covid19 enabling access to the drug at additional hospitals across the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    optimal
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 duration of treatment with remdesivir is still being studied in ongoing clinical trials the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 government will coordinate the donation and distribution of remdesivir to hospitals in cities most heavily impacted by covid19</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 patient dosed with pfizers potential covid19 vaccine in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us6
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 sharesposted 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    6
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 may 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    victoria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 rees 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 pharmaceutical review 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pfizer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biontech
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 have initiated phase iii trials in the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 to determine the safety and 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    optimal dose
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    four
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    mrna
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 covid19 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    vaccine
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 candidates 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pfizer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biontech
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 have announced that the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 participants have been dosed in the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 in the phase iii clinical trial for the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bnt162
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 vaccine programme to prevent covid19 the phase iii study is designed to determine the safety immunogenicity and optimal dose level of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    four
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 mrna vaccine candidates evaluated in a single continuous study during the clinical development stage biontech will provide clinical supply of the vaccine from its good manufacturing practice gmpcertified mrna manufacturing facilities in 
<mark class="entity" style="background: #ff9561; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    europe
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">LOC</span>
</mark>
 pfizer plans to utilise its manufacturing network and invest at risk in an effort to produce the covid19 vaccine as quickly as possible</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">other features discuss the continual evolution of solid dosage forms and the opportunities that biosimilars present for pharma included in this issuethe rest of this content is restricted login or subscribe free to accessthank you for visiting our website to access this content in full youll need to login its completely free to subscribe and in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    less than a minute
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">TIME</span>
</mark>
 you can continue reading click here to subscribe 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    today
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 login here</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">a 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    360
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 overview of data integrity in life sciences11 sharesabout this webinartrustworthiness in data is critical for operations within the pharmaceutical and life sciences industries whether it is for compliance operational excellence reporting or development data integrity enables accessibility and trustworthiness in all types of data generated in several areas such as development by cmos or in production osisoft recently researched the maturity of data integrity within life sciences companies in 
<mark class="entity" style="background: #ff9561; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    europe
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">LOC</span>
</mark>
 northern america and 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    china
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 keynote speakerpetter moree life sciences industry principal osisoftpetter moree is global industry principal at osisoft specialising in the life sciences and pharmaceutical industries in technical chemistry with a specialisation towards chemometrics and data science from 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    umea university
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    sweden
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 and has over 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    20 years
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 experience helping leading global enterprises obtain optimal value using best practices in data science</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ftc
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 accepts proposal for to abbvie acquire 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    allergan
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 for 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    63
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 billion0 sharesposted 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    11
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 may 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    victoria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 rees 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 pharmaceutical review abbvie and 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    allergan
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 have announced 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the federal trade commission
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has accepted abbvies pending acquisition of 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    allergan
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 for 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    63 billion
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 abbvie and 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    allergan plc
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 have announced that 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the us federal trade commission ftc
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has accepted the proposed consent order in connection with abbvies pending acquisition of 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    allergan
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 for 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    63 billion
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 according to the companies the acceptance by the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ftc
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 satisfies all required antitrust clearances needed to be obtained for the acquisition of 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    allergan
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 by abbvie additionally abbvie and 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    allergan
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 have amended their transaction agreement to provide that only one 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    allergan
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 director will join the abbvie board following close as part of the proposed consent allergan has agreed to divest brazikumab an investigational 
<mark class="entity" style="background: #bfeeb7; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    il23
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PRODUCT</span>
</mark>
 inhibitor in development for autoimmune diseases to astrazeneca</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">triple antiviral drug combination shows early promise for treating covid19 in phase 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ii trial0
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 sharesposted 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    11
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 may 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    victoria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 rees 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 pharmaceutical review a phase ii clinical trial has shown that a twoweek course of 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    interferon beta1b plus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 lopinavirritonavir and 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ribavirin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 started within 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    seven days
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 of showing covid19 symptoms is safe and effective the study was conducted in patients with mild to moderate illness in the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 randomised trial of this triple combination therapy involving 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    127
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 adults aged 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    18
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 and older from 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    six
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 public hospitals in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    hong kong
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 these findings do not include severe cases of covid19 and the authors stress the need for larger phase iii trials to examine the effectiveness of this triple combination in critically ill patients furthermore the treatment combination appeared safe and welltolerated by patients said professor 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    kwokyung yuen
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 from 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the university of hong kong
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 who led the research secondary outcomes supported the findings indicating that clinical improvement was significantly better in the triple combination group with the triple therapy halving the time to complete alleviation of symptoms</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 approves 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    tabrecta
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 for treatment of metastatic 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nonsmall
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 cell lung cancer0 sharesposted 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    11
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 may 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    victoria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 rees 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 pharmaceutical review the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has approved 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    tabrecta capmatinib
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 for patients with metastatic 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nonsmall
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 cell lung cancer whose tumours have a mutation that leads to met exon 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    14
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 skipping novartis has announced that the us food and drug administration fda has approved 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    tabrecta capmatinib
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 formerly 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    inc280
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 an oral met inhibitor for adult patients with metastatic 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nonsmall
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 cell lung cancer nsclc whose tumours have a mutation that leads to met exon 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    14
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 skipping metex14 as detected by an fdaapproved test tabrecta is approved for firstline and previously treated patients regardless of prior treatment type and is expected to be available to patients in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the coming days
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 in the metex14 population the confirmed overall response rate was 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    68 percent
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERCENT</span>
</mark>
 and 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    41 percent
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERCENT</span>
</mark>
 among treatmentnaive and previously treated patients respectively 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    today
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 and especially during these difficult times we are incredibly proud that 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    tabrecta
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 is the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 treatment approved by the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 specifically to treat patients diagnosed with this aggressive 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nsclc
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 associated with metex14 said dr 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    susanne schaffert
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 president of novartis oncology</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">increased raw material verification capabilities with portable 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    raman
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    xrf
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 instruments12 sharesabout this webinarthis webinar explored the use of the thermo scientific 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    handheld raman
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 analyser truscan rm with 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    trutools onboard
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 chemometrics to verify the identity of challenging raw materials in pharmaceutical manufacturing handheld raman analysers are widely accepted for material verification of excipients and apis for 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    many years
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the pharmaceutical industry has used truscan rms embedded multivariate residual analysis decision engine to identify most pharmaceutical raw materials directly complementary to the use of 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    raman
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and nir portable instruments for raw material id is the new ionicx portable xrf analyser for identity testing of pharmaceutical ionic salts join dr 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    lin chen
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 thermo scientific application scientist and learn more on the enhanced capabilities of portable instruments for raw material verification</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">whitepaper what our remediation projects are saying about the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    industry4
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 sharesposted 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    31 january 2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 nsf international based on a study of the pharma industrys remediation projects this white paper from nsf looks at the key issues behind gmp nonconformance it also includes questions to ask yourself when making changes to your processes and systems a study on the pharma industrys gmpremediation projects reveals a lot about usand our inability to focus only on what is trulyvaluable says 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    john johnson
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 nsf internationals pharma team is in a unique position since we are regularly and intimately involved in a range of gmp remediation projects across the world and across all dosage forms when a system or process fails to provide sufficient levels of quality assurance or inadequately maintains compliance to cgmp the best case scenario is that your quality system identifies the issue and escalates it to the right people and those people study the problem and apply the right resources to fix it now and for the future</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    watsonmarlow fluid technology group
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 wmftg is the world leader in niche peristaltic pumps and associated fluid path technologies founded on 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nearly 60 years
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 of supplying engineering and process expertise and with 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    over one million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 pumps installed worldwide our pumps are tried tested and proven to deliver wmftg is a wholly owned subsidiary of 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    spiraxsarco engineering plc
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 lse spx a global organisation employing 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    approximately 4800
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 people worldwide watsonmarlow 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fluid technology group
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 comprises 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ten
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 established brands each with their own area of expertise but together offering our customers an unrivalled breadth of solutions for their pumping applicationswatsonmarlow pumps peristaltic tube pumps for biopharm and process industries peristaltic tube pumps for biopharm and process industries watsonmarlow tubing precision tubing for pumping and other purposes in a range of materials precision tubing for pumping and other purposes in a range of materials bredel high flow heavy duty hose pumps high flow heavy duty hose pumps alitea unique peristaltic solutions for oem customers unique peristaltic solutions for oem customers flexicon aseptic filling and capping systems aseptic filling and capping systems 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    masosine gentle
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 sinusoidal pumps for food chemical and cosmetics applications gentle sinusoidal pumps for food chemical and cosmetics applications biopure advanced singleuse tubing connector systemsadvanced singleuse tubing connector systems asepco aseptic valves for the biopharmaceutical industryaseptic valves for the biopharmaceutical industry flowsmart high purity sanitary gaskets silicone transfer tubing and reinforced silicone hoses for the biopharmaceutical industryhigh purity sanitary gaskets silicone transfer tubing and reinforced silicone hoses for the biopharmaceutical industry aflex hose specialises in the design and manufacture of ptfelined flexible hoseswatsonmarlow 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fluid technology group
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 is an international operation based in 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    falmouth cornwall
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    uk
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 watsonmarlow 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fluid technology group
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has offices in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    argentina
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    australia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    austria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    belgium
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    brazil
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 chile 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    china
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    canada
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 denmark 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    france germany ireland
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    india
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    indonesia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 italy 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    japan
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    south korea
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    malaysia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    mexico
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    netherlands
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    new zealand
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 poland 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    russia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 sharjah uae 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    singapore
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    south africa
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 sweden 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    switzerland
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    taiwan
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 thailand usa and 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    vietnam
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">while over 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    60000
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 covid positive patients are a big problem for 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    india
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 100200 covid positive patients for each of indias 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    730
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 districts is a smaller one to manage a tracking app should display realtime data of covid patients in each district like in the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    karnataka
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 model 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bitly2lsqcil
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 districts should be judged on 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    four
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 parameters number of tests performed number of negative tests deaths and satisfaction score of quarantined patients when a regular patient turns out to be covid positive instead of shutting the hospital authorities should just follow the international guidelines of quarantining and sanitisation in the end countries will not be judged by the number of positive cases but by the percentage of deaths of covid patients</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    new delhi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 researchers at 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    mit technology review
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 have given 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 out of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    5
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 points to aarogya setu app on its covid19 app tracker index saying it scores positively on the timely deletion of user data and collection of only useful datathe aarogya setu 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    app
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 which has 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nearly 100 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 users was compared with covid19 apps of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    25
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 other countriesthe findings of contacttracing apps were based on their enforcement handling of data privacy and transparency dynamics across the worldthe tracker documented 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    25
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 such tools after analysing what they are how they work and what policies and processes have been put in place around themaarogya setu scored positively on the timely deletion of user data and collection of only useful data but failed to score on voluntary use limitations of data usage and transparency said 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    mit technology
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 reviewmit technology reviews database shows that indias app is unique in a number of other ways too many countries are developing limited services that use bluetooth or gps to give exposure notifications to people who have interacted with someone found to have covid19 indias app though is a massive allinone undertaking that far exceeds what most other countries are building said the reportaarogya setu also offers access to telemedicine an epharmacy and diagnostic services its whitelisted by all 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    indian
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 telecom companies so using it does not count against mobile data 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    limitson
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    may 6
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 reacting to an ethical hackers claim that a security issue has been found in the app the aarogya setu team said the app is completely safethe aarogya setu team said the app fetches a users location by design and store the location data on the server in a secure encrypted and anonymised manner when users submit their contact tracing data voluntary through the app of when we fetch tracing data of a user after they have turned covid19 positive this special app also helps in finding out corona positive people present nearby</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">indias ecommerce market grew by around 35 to 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    32 billion
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2019
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 listings of workfromhome wfh jobs that pay around rs 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    5
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 lakh annually have doubled compared with 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    february
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 as per naukri the company which recorded 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    4050 yearonyear growth
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">QUANTITY</span>
</mark>
 in revenue till 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fiscal 2019
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 has significantly cut its revenue projection for 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    202021
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 currently 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    apple
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 sells phones worth 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    15 billion
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    india
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 of which 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    less than 05 billion
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 is locally manufactureda market share of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    23
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 according to market research firm idc apple in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    201819
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 held a 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    38
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 market share of global handset exports followed by samsung with a 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    22
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 share</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    new delhi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the commerce ministry
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 on 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    monday
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 said lease rent for units in the governmentowned special economic zones sezs will not be increased for 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    202021
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 due to the covid19 pandemic a move which will provide relief to these facilities it also said that payment of lease rent for 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the first quarter
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 is deferred up to 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    july 31
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 for all sez units and the deferment would not invite any interestthe ministry said that after consulting the proposal with department of expenditure these relief measures were decided for sez units on account of covid19 outbreakthere will be no increase in lease rent of the sez units for 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    202021
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 it saidfurther it asked development commissioners of other sezs to advise sez developers of state governments and privatelyowned zones to consider similar relief measures dcs are requested to advise developers of state governmentprivate sezs to consider similar relief measures in their zones it addedthere are 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    seven
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 governmentowned sezs which are located in 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    kandla
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 chennai falta cochin 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    noida santacruz
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and visakhapatnamall the zones are under the supervision of a development commissioner dca dc said this is a welcome step by the government and it will help units at a time when they are struggling to deal with the lockdown imposed due to the outbreak of 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    coronavirus
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 after the imposition of lockdown from 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    march 25
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 all units are closed barring food and pharma related facilities which have been allowed to operate during the periodan industry expert said that depending upon zone to zone generally the rent is increased by 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    710 per cent
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 annuallysezs are major export hubs in the country as the government provides several incentives and singlewindow clearance system for them exports from sezs rose 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    145 per cent
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 to rs 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    382
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 lakh crore in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    aprilseptember 201920
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 it was rs 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    702
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 lakh crore in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    entire 201819 financial year
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    new delhi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 researchers at 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    mit technology review
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 have given 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 out of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    5
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 points to aarogya setu app on its covid19 app tracker index saying it scores positively on the timely deletion of user data and collection of only useful datathe aarogya setu 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    app
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 which has 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nearly 100 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 users was compared with covid19 apps of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    25
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 other countriesthe findings of contacttracing apps were based on their enforcement handling of data privacy and transparency dynamics across the worldthe tracker documented 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    25
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 such tools after analysing what they are how they work and what policies and processes have been put in place around themaarogya setu scored positively on the timely deletion of user data and collection of only useful data but failed to score on voluntary use limitations of data usage and transparency said 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    mit technology
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 reviewmit technology reviews database shows that indias app is unique in a number of other ways too many countries are developing limited services that use bluetooth or gps to give exposure notifications to people who have interacted with someone found to have covid19 indias app though is a massive allinone undertaking that far exceeds what most other countries are building said the reportaarogya setu also offers access to telemedicine an epharmacy and diagnostic services its whitelisted by all 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    indian
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 telecom companies so using it does not count against mobile data 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    limitson
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    may 6
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 reacting to an ethical hackers claim that a security issue has been found in the app the aarogya setu team said the app is completely safethe aarogya setu team said the app fetches a users location by design and store the location data on the server in a secure encrypted and anonymised manner when users submit their contact tracing data voluntary through the app of when we fetch tracing data of a user after they have turned covid19 positive this special app also helps in finding out corona positive people present nearby</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">as many businesses in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    america
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 take steps toward carefully reopening top 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 officials guiding the pandemic response are dealing with a covid19 outbreak in the 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    countrys
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 most highprofile 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    workplacethe white house
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 after a 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    white house
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 staffer tested positive for covid19 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 commissioner 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    stephen hahn
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    md despite
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 millers test result pence is not quarantining and plans to be at 
<mark class="entity" style="background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the white house
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FAC</span>
</mark>
 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    today
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cnn
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 reports 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the white house
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 outbreak which comes as 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    dozens
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of states increasingly reopen their economies demonstrates how businesses nationwide face significant challenges in ensuring worker and customer safety no local business has the same resources as 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the white house
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and the cases there only raise more questions about how average businesses can cope</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    only days
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 after former 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    barda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 chief 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    rick bright
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 filed a whistleblower complaint alleging retaliation by the 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    trump
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 administration the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 office of the special counsel has recommended his temporary reinstatement 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the new york times
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 reports the agency found reasonable grounds to believe 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    hhs
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 officials were retaliating against bright when they reassigned him to a new publicprivate partnership focused on covid19 testing according to the newspaper which cites a statement from brights lawyers as director of 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    hhs barda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 unit bright had been handling critical covid19 drug vaccine and diagnostic partnerships with biopharmaceutical companies after he was transferred to the new outfit 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    last month
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 he claimed the move was in response to his early efforts to raise alarm about the impending pandemiceven as 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    hhs
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 officials sought to downplay the risk but the agencys recommendation isnt binding 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the new york times
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 points out and the administration isnt required to comply</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">with drugmakers and institutions racing after 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    coronavirus drugs
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and vaccines law enforcement agencies say hackers are trying to steal some of their discoveries now after news of a potential cyberattack from 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    iran
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 plans to implicate 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    china
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 in other hacking attempts on companies leading the covid19 pack gilead has been the focus of intense international interest since its remdesivir won emergency clearance from the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    last week
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the company is discussing licensing the med to generics makers in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    india
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 and 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pakistan
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 to supply patients in developing countries its also considering licensing the drug to the medicines patent pool and exploring using 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    unicefs
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 expertise for distribution in low and middleincome countries</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">when 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    gilead sciences
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 scored its groundbreaking 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 emergency use authorization for covid19 therapy remdesivir the company made the unusual move of handing distribution rights to the federal government but the rollout has gotten off to a rocky start according to reports instead some remdesivir doses went to the wrong places an unnamed senior trump administration told the publication that 32000dose distribution wave is only a small portion of the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    15 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 doses gilead will make available for distribution nationwide 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    4460
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 cost watchdog saysmeanwhile hospital administrators say the government has rebuffed their requests for the drug 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the wall street journal
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 reports</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">but in manufacturing facilities packed with workers covid19 presents a particularly difficult challengeand now 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    indian
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 plant has been forced to shutter due to a rash of infections cadila pharmaceuticals has shut down an active pharmaceutical ingredients api plant in dholka 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ahmedabad india
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 after 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    26
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 employees tested positive for covid19 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    reuters
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 reported register nowthe shutdown at the cadila plant comes 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    just weeks
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 after another 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    indian
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 manufacturing hub was temporarily locked down as a covid19 hotspot and underscores the dangers the novel coronavirus has posed for the global supply chain related 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    india
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 pharma manufacturing hub back up and running after covid19 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    lockdown reportin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    late april
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 a manufacturing hub in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    baddi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 indiaresponsible for 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    35 to 40
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of the nations pharmaceutical outputcame back online after 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    weeks
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 on lockdown as a covid19 containment zone business standard reported related 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    sanofi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 ceo amid covid19 supply push 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 fever means maybe 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    a half dozen
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 workers off the job</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    a week
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 after winning 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 emergency use authorization gilead sciences remdesivir has been cleared to treat the novel coronavirus in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    japan
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 in its 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 official global nod the biotech is also in talks with drugmakers around the globe for potential licensing deals around the drug gileads remdesvir wins fast nod for covid19 in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    japan
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 releasein its 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 full global nod gilead sciences remdesivir now called 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    veklury
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has been approved in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    japan
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 for 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    sarscov2 covid19 lilly
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 ramps up to beat the virus with neutralizing antibodies as scientists raise 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    worriesless than two months
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 after teaming up with 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    abcellera eli lilly
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has penned another coronavirus neutralizing antibody deal in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    january
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the pair said a combination of tyvyt alimta and platinum chemo also hit the goal in firstline nonsquamous nsclc</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">covid19 stocking of 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bms
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and pfizers blood thinner 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    eliquis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 drove sales of that product up 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    37
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 to 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    26 billion
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 covid19 could exacerbate an already tough sales environment for opdivo which is locked in a battle for market share with mercks pd1 blocker keytruda meanwhile 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bms
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has turned out impressive data from a trial combining opdivo with exelixis cabometyx in renal cell carcinoma the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 approved the drug in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    march
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 but 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bms
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 delayed the launch due to the pandemic during the conference call 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 analyst brought up a topic that was topofmind for politicians and patients long before the covid19 pandemic hit high drug prices</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2006
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 contag cofounded concentrx pronounced concentricks but the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 rebranded in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2016
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 to become bioeclipse therapeutics so contag set out to build concentrx in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2015
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 as an actual company anticipating that it would soon undergo a rebrand ie bioeclipse therapeutics its a mammalian oncolytic virus and its an immune cell when a virus infects your body this innate immune cell is 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 responders we thought of numerous names revolving around eclipse and what eclipse means and agreed on bioeclipse therapeutics as the rebranding contag states why startup ceos should always be looking for space i must have looked at 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    dozens
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of spaces for bioeclipse therapeutics contag shares</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">and rather than have her valley experience be her demise she instead opted to develop a novel solution over time she dropped the celebrity idea in favor of targeting emerging artists those upandcomers out to make a name for themselves republic records is a major recording label and 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    reverb nation
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 is a portal for emerging artists with 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    more than 4 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 subscribed artists worldwide she elaborates this represents a big opportunity for emerging artists as they can gain exposure to established bands fan bases while acknowledging the odds stacked against her jhaveri nonetheless remains optimistic and dogged in pursuing the sound affects dream</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr"> namely the company was broken and it had a broken business model what arrowhead did have was a majorityowned subsidiary calando pharmaceuticals an early pioneer in rna interference rnai when anzalone first spoke with arrowhead in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2007
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the companys stock 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nasdaq arwr
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 was trading over 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    70
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 share in fact he was in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    london
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 trying to raise money on 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the day
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the roche deal was supposed to close 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    four years later
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 arrowhead executed a similar deal with novartis acquiring the companys entire rnai rd portfolio and associated assets for 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    10 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 cash and 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    25 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 in arrowhead stock this was a big blow as just 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    a few months earlier
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the company had officially changed its name from arrowhead research company to arrowhead pharmaceuticals because its priorities were beginning to shift toward commercial aspirations</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">while complex legal obligations must be balanced the federal market presents a meaningful business opportunity regional market leaders will be uniformed personnel responsible for all healthcare delivered within their market including direct care and purchased care it remains to be seen what the future of the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    va
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 will look like with many speculating 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    va care
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 will be structured more like tricare although 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    only half
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    20 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 eligible veterans are enrolled in 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    va care
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 many anticipate 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    va benefit
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 enrollment will increase due to mission act accesstocare reforms this scenario represents just 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of many other unique considerations specific to federal market uptake</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">physician practices ambulatory surgery centers and the medical device manufacturers and other vendors that supply them are in free fall within 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    a span of a week
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the volume of procedures dropped by 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    more than 75 percent
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERCENT</span>
</mark>
 with no end in sight that provision provides loans that convert into grants for businesses with 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    up to 500
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 employees that are adversely impacted by the covid19 crisis for loan forgiveness the business must use the resources for payroll and other overhead expenses including rent contractors and health benefits he earned his master of public policy from duke university and bachelor of arts from 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    washington
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 and 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    lee university
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">what is your opinion regarding corporate culture and its link to company success or failure as such 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    obsidian
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 trains its leaders around aspects that contribute to a positive corporate culture helping new hires understand the core principles enables everyone to hold each other accountable to deliver on and that has a direct impact on a companys corporate culture what about the hiring process as it relates to corporate culture what are some tools you find useful in building a companys corporate culture</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">global public health is us health that is the profound meaning of a pandemic the public is trying to keep safe despite a faltered response in the worlds richest and most resourceful nation the foundation of a countrys public health is the robustness of its institutions the ability to deliver national priorities rests on the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    countrys
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 scientists and clinicians on public health infrastructure and on the programs in which we invest public health is an integral part of national security and covid19 has taught us that urban planning and global mobility are fundamental elements of public health policy</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">for example 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    lilly
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has a lot of entries in neurosciences eg alzheimers disease and so does biogen further the main theory around alzheimers disease seems to be flawed despite animal and biomarker studies providing data that looked good it seems like we keep going back to square one and there isnt a plethora of established alzheimers disease mechanisms given the high rate of failure in alzheimers drug development should we be looking at creating some type of international drug development consortium focused on the disease from my perspective alzheimers disease is a field ripe for small biotech startups interested in exploring different things</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">by 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    rob wright
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 chief editor life science leaderfollow me on twitter 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    rfwrightlslrob wright
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pamela contag phd cofounder
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and ceo of bioeclipse therapeutics jan 12 jpm 2020 one of the pitches received was for a littleknown company called bioeclipse therapeutics a long time ago i thought everybody could start and lead their own company says 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pamela contag phd cofounder
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and ceo of bioeclipse therapeutics this isnt to say there is a stereotype of a successful startup ceo or even a stereotypical startup company in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 you only get rich if the company you formed and the technology or therapeutics you developed actually works reminds pamela contag phd cofounder and ceo of bioeclipse therapeutics</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">there are a few things from my interview with 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    chris anzalone phd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 ceo of arrowhead pharmaceuticals that werent included in aprils printed article he was incredibly transparent in sharing the adversity arrowhead pharmaceuticals has overcome to get to where it is 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    today
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 that kind of transparency tends to make for a great interview and the better the interview the better the article similarly as a company that still believes in the power of producing a print publication life science leader plays a long game as the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 hold happened in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    november
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 arrowheads ceo recalled being in the office on 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the friday after thanksgiving
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    rob wright
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 chief editor of life science leader recently moderated a covid19 leadership roundtable with 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    five
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 biopharmaceutical ceos via zoom view in full here in this segment 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    paul wotton
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    phd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 ceo of 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    obsidian
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 therapeutics and caroline 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    loew phd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 ceo of 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    glympse bio
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 talk about best practices for physical distancing and working safely in a laboratory setting during the coronavirus pandemic</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    rob wright
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 chief editor of life science leader recently moderated a covid19 leadership roundtable with 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    five
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 biopharmaceutical ceos via zoom view in full here in this clip 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    five
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 ceos share insight gained from fundraising and meeting with investors during the coronavirus pandemic appearing in this video in order 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    areleen kawas phd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 pharmd ceo athira pharmacaroline 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    loew phd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 ceo 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    glympse biomike
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    clayman md
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 ceo flexion 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    therapeuticspaul wotton phd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 ceo 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    obsidian therapeuticsrachel leheny phd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 ceo calcimedica</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    rob wright
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 chief editor of life science leader recently conducted a covid19 leadership roundtable with 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    five
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 biopharmaceutical ceos via zoom view in full here in this portion rachel leheny phd ceo of calcimedica discusses how her company which had been studying an investigational compound cm4620ie for patients with acute pancreatitis pivoted and gained 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 approval to investigate if the compound could help patients suffering from covid19</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    rob wright
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 chief editor of life science leader recently moderated a covid19 leadership roundtable with 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    five
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 biopharmaceutical ceos via zoom view in full here in this section caroline 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    loew phd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 ceo of 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    glympse bio
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 shares best practices for working remotely during the coronavirus pandemic</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">covid19s market impact will be transient for life scienceskeith bliss iq capitalkeith bliss iq capitalas the covid19 outbreak has halted the world we are witnessing the life sciences industry come together and aggressively react to one of the gravest threats of our lifetime regardless of current uncertainties it is clear that 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    covid19s longterm
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">QUANTITY</span>
</mark>
 market impact on the life science sector will be transient as the industry remains on the forefront of value creation along with addressing a growing aging population life sciences companies innovations remain key in driving future global economic growth combined with increasing measures to create value for all stakeholders life sciences companies are well positioned to benefit from this investment approach advancements in medical devices and oncology will remain at the forefront of the life science impact thesis</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    paul wotton
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    phd obsidian
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 therapeuticsyeah i
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    m paul watton
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 im the ceo at 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    obsidian
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 therapeutics a company also in cambridge 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 im going to do this alphabetically once you get over that and make the decision to say im going to switch it on no matter what i have a high school senior whos not doing things youd normally expect we actually had a potential covid19 exposure from someone else in our facility not from our company who was diagnosed with covid19</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">collaborations trump competition during 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pandemicsby
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 suresh kumarfigures as of 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    april 27th
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 2020the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 was not unaware of covid19 it was unprepared while viruses endanger people presidential tweets that 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    incite
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 people to disregard public health protocols poisons the populace the role of government public health institutionsno one could have predicted the scale of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    covid19s
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 rapid spread and despite more frequent epidemic occurrences see my public health institutions have remained historically underresourced obama established 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the office of global health security 2014
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 within 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the national security council
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 to enable a white houselevel coordinated rapid response to keep 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    america
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 safe the 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    trump
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 administration dismantled or impaired these offices and initiatives even proposing 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    congress
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 take back 
<mark class="entity" style="background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    252mn
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FAC</span>
</mark>
 allocated to zika rather than repurposing this for pressing public health needs</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">the commercial manufacturing journey strategies for a successful launch bringing a biologic to market is not easy and there are several key considerations to how sponsor companies should approach commercialscale manufacturing that may aid the success of their products commercial launch in this article experts share how scaleup regulatory expectations demand forecasting and process validation play into the success of a biologics commercial manufacturing journey in this poster scientists at catalent biologics outline a method utilizing a highthroughput microwell plate platform to economically screen a monoclonal antibody mab in 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    96
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 formulations evolution of flexible commercial biologics manufacturing the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 industry is continuously evolving and needs new bioprocessing technologies to reduce cost increase efficiency improve pipelines and get to market faster are you achieving optimal flexibility in your biologics development and manufacturing by effectively leveraging the most advanced technologies</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">exclusive magazine content 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    5
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 execs reveal corporate culture best practices corporate culture will soon be the number 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 reason why an employee stays or leaves a company its a comment made to start off a roundtable discussion at the 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 jpm conference and we have the details of the discussion here how to create a lasting culture every interaction matters the best leaders are humble and check their egos at the door how you treat everyone around you every minute of every day is noticed when leaders fumble responsible public prepares to ward off a pandemic throughout this crisis the public has been the hero exercising abundant caution and behaving admirably and even inspirationally it is time for our leaders and politicians to learn and follow</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">because anticipating and readying for a pandemic is very different from actually living through one and im sure you can relate covid19 conflictedon 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the day of this writing
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    april 6 2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the united states
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 leads the world in the number of confirmed covid19 cases yes it would be great to take a break from all this misery and write about something other than covid19 theres the reality how every time she goes into work it increases our probability of catching the virus but perhaps this therapeutic writing session will help</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2006
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 contag cofounded concentrx pronounced concentricks but the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 rebranded in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2016
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 to become bioeclipse therapeutics so contag set out to build concentrx in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2015
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 as an actual company anticipating that it would soon undergo a rebrand ie bioeclipse therapeutics its a mammalian oncolytic virus and its an immune cell when a virus infects your body this innate immune cell is 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 responders we thought of numerous names revolving around eclipse and what eclipse means and agreed on bioeclipse therapeutics as the rebranding contag states why startup ceos should always be looking for space i must have looked at 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    dozens
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of spaces for bioeclipse therapeutics contag shares</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">and rather than have her valley experience be her demise she instead opted to develop a novel solution over time she dropped the celebrity idea in favor of targeting emerging artists those upandcomers out to make a name for themselves republic records is a major recording label and 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    reverb nation
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 is a portal for emerging artists with 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    more than 4 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 subscribed artists worldwide she elaborates this represents a big opportunity for emerging artists as they can gain exposure to established bands fan bases while acknowledging the odds stacked against her jhaveri nonetheless remains optimistic and dogged in pursuing the sound affects dream</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr"> namely the company was broken and it had a broken business model what arrowhead did have was a majorityowned subsidiary calando pharmaceuticals an early pioneer in rna interference rnai when anzalone first spoke with arrowhead in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2007
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the companys stock 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nasdaq arwr
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 was trading over 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    70
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 share in fact he was in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    london
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 trying to raise money on 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the day
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the roche deal was supposed to close 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    four years later
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 arrowhead executed a similar deal with novartis acquiring the companys entire rnai rd portfolio and associated assets for 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    10 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 cash and 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    25 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 in arrowhead stock this was a big blow as just 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    a few months earlier
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the company had officially changed its name from arrowhead research company to arrowhead pharmaceuticals because its priorities were beginning to shift toward commercial aspirations</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">while complex legal obligations must be balanced the federal market presents a meaningful business opportunity regional market leaders will be uniformed personnel responsible for all healthcare delivered within their market including direct care and purchased care it remains to be seen what the future of the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    va
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 will look like with many speculating 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    va care
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 will be structured more like tricare although 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    only half
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    20 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 eligible veterans are enrolled in 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    va care
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 many anticipate 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    va benefit
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 enrollment will increase due to mission act accesstocare reforms this scenario represents just 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of many other unique considerations specific to federal market uptake</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">physician practices ambulatory surgery centers and the medical device manufacturers and other vendors that supply them are in free fall within 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    a span of a week
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the volume of procedures dropped by 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    more than 75 percent
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERCENT</span>
</mark>
 with no end in sight that provision provides loans that convert into grants for businesses with 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    up to 500
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 employees that are adversely impacted by the covid19 crisis for loan forgiveness the business must use the resources for payroll and other overhead expenses including rent contractors and health benefits he earned his master of public policy from duke university and bachelor of arts from 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    washington
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 and 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    lee university
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">what is your opinion regarding corporate culture and its link to company success or failure as such 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    obsidian
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 trains its leaders around aspects that contribute to a positive corporate culture helping new hires understand the core principles enables everyone to hold each other accountable to deliver on and that has a direct impact on a companys corporate culture what about the hiring process as it relates to corporate culture what are some tools you find useful in building a companys corporate culture</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">global public health is us health that is the profound meaning of a pandemic the public is trying to keep safe despite a faltered response in the worlds richest and most resourceful nation the foundation of a countrys public health is the robustness of its institutions the ability to deliver national priorities rests on the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    countrys
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 scientists and clinicians on public health infrastructure and on the programs in which we invest public health is an integral part of national security and covid19 has taught us that urban planning and global mobility are fundamental elements of public health policy</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">for example 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    lilly
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has a lot of entries in neurosciences eg alzheimers disease and so does biogen further the main theory around alzheimers disease seems to be flawed despite animal and biomarker studies providing data that looked good it seems like we keep going back to square one and there isnt a plethora of established alzheimers disease mechanisms given the high rate of failure in alzheimers drug development should we be looking at creating some type of international drug development consortium focused on the disease from my perspective alzheimers disease is a field ripe for small biotech startups interested in exploring different things</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">by 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    rob wright
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 chief editor life science leaderfollow me on twitter 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    rfwrightlslrob wright
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pamela contag phd cofounder
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and ceo of bioeclipse therapeutics jan 12 jpm 2020 one of the pitches received was for a littleknown company called bioeclipse therapeutics a long time ago i thought everybody could start and lead their own company says 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pamela contag phd cofounder
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and ceo of bioeclipse therapeutics this isnt to say there is a stereotype of a successful startup ceo or even a stereotypical startup company in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 you only get rich if the company you formed and the technology or therapeutics you developed actually works reminds pamela contag phd cofounder and ceo of bioeclipse therapeutics</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">there are a few things from my interview with 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    chris anzalone phd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 ceo of arrowhead pharmaceuticals that werent included in aprils printed article he was incredibly transparent in sharing the adversity arrowhead pharmaceuticals has overcome to get to where it is 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    today
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 that kind of transparency tends to make for a great interview and the better the interview the better the article similarly as a company that still believes in the power of producing a print publication life science leader plays a long game as the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 hold happened in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    november
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 arrowheads ceo recalled being in the office on 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the friday after thanksgiving
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    rob wright
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 chief editor of life science leader recently moderated a covid19 leadership roundtable with 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    five
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 biopharmaceutical ceos via zoom view in full here in this segment 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    paul wotton
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    phd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 ceo of 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    obsidian
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 therapeutics and caroline 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    loew phd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 ceo of 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    glympse bio
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 talk about best practices for physical distancing and working safely in a laboratory setting during the coronavirus pandemic</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    rob wright
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 chief editor of life science leader recently moderated a covid19 leadership roundtable with 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    five
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 biopharmaceutical ceos via zoom view in full here in this clip 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    five
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 ceos share insight gained from fundraising and meeting with investors during the coronavirus pandemic appearing in this video in order 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    areleen kawas phd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 pharmd ceo athira pharmacaroline 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    loew phd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 ceo 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    glympse biomike
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    clayman md
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 ceo flexion 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    therapeuticspaul wotton phd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 ceo 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    obsidian therapeuticsrachel leheny phd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 ceo calcimedica</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    rob wright
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 chief editor of life science leader recently conducted a covid19 leadership roundtable with 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    five
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 biopharmaceutical ceos via zoom view in full here in this portion rachel leheny phd ceo of calcimedica discusses how her company which had been studying an investigational compound cm4620ie for patients with acute pancreatitis pivoted and gained 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 approval to investigate if the compound could help patients suffering from covid19</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    rob wright
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 chief editor of life science leader recently moderated a covid19 leadership roundtable with 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    five
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 biopharmaceutical ceos via zoom view in full here in this section caroline 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    loew phd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 ceo of 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    glympse bio
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 shares best practices for working remotely during the coronavirus pandemic</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">covid19s market impact will be transient for life scienceskeith bliss iq capitalkeith bliss iq capitalas the covid19 outbreak has halted the world we are witnessing the life sciences industry come together and aggressively react to one of the gravest threats of our lifetime regardless of current uncertainties it is clear that 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    covid19s longterm
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">QUANTITY</span>
</mark>
 market impact on the life science sector will be transient as the industry remains on the forefront of value creation along with addressing a growing aging population life sciences companies innovations remain key in driving future global economic growth combined with increasing measures to create value for all stakeholders life sciences companies are well positioned to benefit from this investment approach advancements in medical devices and oncology will remain at the forefront of the life science impact thesis</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    paul wotton
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    phd obsidian
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 therapeuticsyeah i
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    m paul watton
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 im the ceo at 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    obsidian
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 therapeutics a company also in cambridge 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 im going to do this alphabetically once you get over that and make the decision to say im going to switch it on no matter what i have a high school senior whos not doing things youd normally expect we actually had a potential covid19 exposure from someone else in our facility not from our company who was diagnosed with covid19</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">collaborations trump competition during 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pandemicsby
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 suresh kumarfigures as of 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    april 27th
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 2020the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 was not unaware of covid19 it was unprepared while viruses endanger people presidential tweets that 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    incite
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 people to disregard public health protocols poisons the populace the role of government public health institutionsno one could have predicted the scale of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    covid19s
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 rapid spread and despite more frequent epidemic occurrences see my public health institutions have remained historically underresourced obama established 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the office of global health security 2014
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 within 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the national security council
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 to enable a white houselevel coordinated rapid response to keep 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    america
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 safe the 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    trump
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 administration dismantled or impaired these offices and initiatives even proposing 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    congress
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 take back 
<mark class="entity" style="background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    252mn
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FAC</span>
</mark>
 allocated to zika rather than repurposing this for pressing public health needs</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">the commercial manufacturing journey strategies for a successful launch bringing a biologic to market is not easy and there are several key considerations to how sponsor companies should approach commercialscale manufacturing that may aid the success of their products commercial launch in this article experts share how scaleup regulatory expectations demand forecasting and process validation play into the success of a biologics commercial manufacturing journey in this poster scientists at catalent biologics outline a method utilizing a highthroughput microwell plate platform to economically screen a monoclonal antibody mab in 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    96
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 formulations evolution of flexible commercial biologics manufacturing the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 industry is continuously evolving and needs new bioprocessing technologies to reduce cost increase efficiency improve pipelines and get to market faster are you achieving optimal flexibility in your biologics development and manufacturing by effectively leveraging the most advanced technologies</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">exclusive magazine content 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    5
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 execs reveal corporate culture best practices corporate culture will soon be the number 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 reason why an employee stays or leaves a company its a comment made to start off a roundtable discussion at the 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 jpm conference and we have the details of the discussion here how to create a lasting culture every interaction matters the best leaders are humble and check their egos at the door how you treat everyone around you every minute of every day is noticed when leaders fumble responsible public prepares to ward off a pandemic throughout this crisis the public has been the hero exercising abundant caution and behaving admirably and even inspirationally it is time for our leaders and politicians to learn and follow</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">because anticipating and readying for a pandemic is very different from actually living through one and im sure you can relate covid19 conflictedon 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the day of this writing
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    april 6 2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the united states
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 leads the world in the number of confirmed covid19 cases yes it would be great to take a break from all this misery and write about something other than covid19 theres the reality how every time she goes into work it increases our probability of catching the virus but perhaps this therapeutic writing session will help</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">figure 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    3
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 acc20 virtual social engagementairfinity analysis90 not 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    3 days
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 is an opportunityalthough the virtual live portion of the conference only had limited science available all accs science has been made available for 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    90 days
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 for free the same structure has been applied to other virtual conferences eg sponsored sessions and exhibitions can be transformed to virtualthe virtual congresses we looked at offer both sponsored sessions and virtual exhibitions figure 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    4
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 virtual sponsored session novartis1288 viewsacc20a virtual control tower to lead the waywinning in virtual is no easy and there is no quick fix mckinsey and co 2020to drive this change we believe pharma needs to consider a new temporary structure at hq a virtual control tower a war room consisting of senior people from both medical and commercial divisions</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">eli lilly now has a 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    second
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 approved drug from its takeover of loxo oncology 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    last year
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 after getting the goahead from the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 for ret inhibitor retevmo the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 regulator says 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    retevmo selpercatinib
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 formerly loxo292 can be used to treat lung and thyroid cancers with a mutation or fusion in the ret gene specifically 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nonsmall
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 cell lung cancer nsclc and medullary thyroid cancer mtc as well as other types of 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    thyroid
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 cancers it is the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 therapy approved in the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 specifically for patients whose tumours have ret alterations according to the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 which has approved the drug 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    months ahead
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 of its review deadline according to the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 retevmo was approved on the strength of clinical data showing the drug had a 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    64
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 overall response rate in retpositive nsclc patients previously treated with chemotherapy and 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    84
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 in those who received it as firstline therapy patients received retevmo orally twice daily until disease progression or unacceptable toxicity in the phase 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    12
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 trial called libretto001</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">an attempt by pfizer to extend the uses of its pulmonary artery hypertension pah drug revatio into a new paediatric indication has had a major setback its drug failed on both those measures in the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 phase part a of the study missing its primary objectives it is also approved for the treatment of paediatric pah in the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    eu
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    japan
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 revatio extended the patent life of the franchise but generics of the product 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 appeared in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2012
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    earlier this year
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 approved the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 generic of an oral suspension formulation of the drug developed by novitium pharma</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">analysis of official data from the companies house register indicates that 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    3456
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 active companies are currently involved in biotechnology research and development rd activities findings follow record investment in the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    uk
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 biotech sector during 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2018
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 with figures from 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the uk bioindustry association bia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    informa pharma intelligence
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 revealing the sector raised an unprecedented 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    22bn
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 from investors in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2018
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 up 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    85
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 from 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2017
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 venture capital has contributed 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    51
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    uk
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 biotech funding from 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    20162018
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 increasing by 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    63
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 from 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    681 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2016
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 to 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    11 billion
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2018
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 under the terms of the agreement 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    regeneron
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 will make a 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    400 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 upfront payment to alnylam and purchase 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    400 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of alnylam equity nlrp3 drugs are of interest to pharma and biotech firms researching drugs for a range of diseases</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    merck co
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has announced a deal with 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    kings
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 college 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    london kcl
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    wellcome
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 to investigate a new class of painkillers that could provide an alternative to opioids and their dangerous sideeffects research conducted at 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    kcl
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 shows that blocking activity of hcn2 in animal models can deliver effective pain relief without side effects the deal is made possible through the work of professor 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    peter mcnaughton
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 from 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the institute of psychiatry psychology
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and neuroscience at kings dr 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    peter mcnaughtonsince
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2012
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    wellcome
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has provided 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    45m
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 in funding to develop professor mcnaughtons work towards candidate drug compounds for blocking hcn2 although the drug has hit endpoints in pain relief there are lingering doubts over its longterm safety</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">but theres more to creating a successful virtual meeting than just transferring content to zoom make sure your content works for a virtual meetingcreating a virtual meeting isnt always as simple as just taking content planned for a physical meeting online you might not even need a virtual meetingfinally 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    robertson
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 cautions against running headlong into virtual meetings and losing credibility as a result when there may be plenty of other more appropriate options they wont think about the structure they wont think about what they have to do to engage a virtual audience they wont think about timezones they wont think about the fact that not everybody will be on that some people might listen to it afterwards if they can</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">as all 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    healthcare
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 stakeholders adapt to the coronavirus pandemics digitalfirst reality 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    digital
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 health offers many ways to develop public utility projects and enhance healthcare communications a passion for medicine computer science and humantechnology interactions led to his lifelong commitment to the advancement of 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    digital
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 health 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    roberto
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 is currently ceo at 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    independent healthcare
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 consultancy healthware group which helps life sciences companies healthcare stakeholders and startups navigate the digital health transformation in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2015
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 she joined novartis newlyformed digital medicines unit to help accelerate the adoption of new digital health solutions to improve the lives of patients in addition to his current role 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    gerry
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 is also a lecturer at 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    johns hopkins university
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    carey business school
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    baltimore
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    maryland
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 teaching digital health innovation and its impact on health economics models</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">medicines discovery catapult retrogenix and peak proteins collaborate to identify target receptors for covid19today 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    27 april
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 medicines discovery catapult retrogenix and peak proteins announce a collaboration to advance understanding of the cellular mechanisms of infection by covid19 this collaboration aims to combine excellence in drug discovery and protein science with innovative cellular microarray technology to uncover any unknown cellular receptors or binding proteins of covid19 using the same technology we now have the perfect opportunity to search for new receptors for covid19 we are delighted to provide our protein production expertise and generate the tailored protein reagents needed for this project wwwpeakproteinscomabout medicines discovery catapultmedicines discovery catapult is a national facility connecting the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    uk
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 community to accelerate innovative drug discovery</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">personalised and precision medicines represent an evolution in healthcare in which traditional clinical information and new data points including genetic data and 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    healthcare
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 technology come together to match the right patient with the right treatment at the right time in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    november 2019
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 blue latitude health sponsored the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    15th
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 annual personalized medicine conference hosted by the personalized medicine coalition healthcare professionals patients payers providers and pharmaceutical executives joined together to discuss the challenges and opportunities for those operating in this space here we deep dive into 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    five
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of the key trends discussed to explore how the healthcare industry is changing and how pharmaceutical and biotech companies can position themselves as leaders at the forefront of innovation download the article to uncover our analysis of the following trends including reallife case studies innovative pricing models in precision and personalised healthcare novel approaches in tracking patient data in the long term the importance of taking an individualised approach to clinical trials a new regulatory landscape for laboratorydeveloped tests why the behaviour of healthcare professionals will need to change in this new era</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">figure 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    3
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 acc20 virtual social engagementairfinity analysis90 not 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    3 days
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 is an opportunityalthough the virtual live portion of the conference only had limited science available all accs science has been made available for 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    90 days
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 for free the same structure has been applied to other virtual conferences eg sponsored sessions and exhibitions can be transformed to virtualthe virtual congresses we looked at offer both sponsored sessions and virtual exhibitions figure 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    4
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 virtual sponsored session novartis1288 viewsacc20a virtual control tower to lead the waywinning in virtual is no easy and there is no quick fix mckinsey and co 2020to drive this change we believe pharma needs to consider a new temporary structure at hq a virtual control tower a war room consisting of senior people from both medical and commercial divisions</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">csl behring has signed a deal with 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 firm brightinsight to develop digital health products to help patients with rare diseases manage their conditions also getting involved in the alliance is mobiquity a digital consultancy that will work with brightinsight on the user interface and other design issues csl adds to a growing list of pharma companies that have turned to brightinsight for digital therapeutics that can sit alongside their drug or medical device products first launched in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2018
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 brightinsight was spun out of singaporeheadquartered electronics and medical device contract manufacturer and it giant flex 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    last september
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 brightinsight raised 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    25 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 in firstround financing from investors led by private equity groups new leaf venture partners and eclipse ventures</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">figure 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    3
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 acc20 virtual social engagementairfinity analysis90 not 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    3 days
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 is an opportunityalthough the virtual live portion of the conference only had limited science available all accs science has been made available for 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    90 days
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 for free the same structure has been applied to other virtual conferences eg sponsored sessions and exhibitions can be transformed to virtualthe virtual congresses we looked at offer both sponsored sessions and virtual exhibitions figure 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    4
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 virtual sponsored session novartis1288 viewsacc20a virtual control tower to lead the waywinning in virtual is no easy and there is no quick fix mckinsey and co 2020to drive this change we believe pharma needs to consider a new temporary structure at hq a virtual control tower a war room consisting of senior people from both medical and commercial divisions</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">being diagnosed with a rare disease is often a bolt from the blue and while each persons journey is different there are common challenges that bind patient communities together it was really really toughremembering the uncertainty he said i cant remember much in detail of how i handled that time when living with a rare disease they said the value of being able to talk to people who understand cannot be overestimated 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    portugal
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 does not have an lhon patient support organisation and disease education and information in its native tongue is thin on the ground we feel more loneliness because it is a rare disease and there is little information</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">by virtue of overseeing several different departments across the drug development process the role of coo of rd requires a breadth of skills uncommon in an industry that typically focuses on specialisation keresty though says this path was a conscious choice for her early on in my career i had to choose whether i wanted to be a deep expert taking every opportunity to hone my craft in 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 area or developing breadth by understanding the entire process she says ive focused my entire career on understanding the industry endtoend from discovery research through to product development and manufacturing as well as all the functions that support that such as quality and itnow keresty is in a role that requires understanding of how the entire complex pharma machine works</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    takedas georgia keresty
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 is 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of the only chief operating officers coos for rd in the industry she tells us what the role involves and why it has been important for takedas rd strategy in the wake of the shire acquisition by virtue of overseeing several different departments across the drug development process the role of coo of rd requires a breadth of skills uncommon in an industry that typically focuses on specialisation keresty though says this path was a conscious choice for her early on in my career i had to choose whether i wanted to be a deep expert taking every opportunity to hone my craft in 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 area or developing breadth by understanding the entire process she says</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    benjamin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 commented rare disease patients present unique healthcare challenges including delays in diagnosis lack of expertise about the disease limited data and poorly defined patient pathways the unique nature of these rare diseases means communications require innovative approaches to ensure the needs of the rare disease patient are met but he added communications are complex with a number of challenges that need to be overcome if patients are to access the lifechanging therapies that are coming to market now and in the future this complexity can be overcome to deliver better outcomes for patients and the pharmaceutical industry through the application of integrated communications and tools these can be used to connect 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    hcps
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and patients across broad geographic diagnostic and treatment pathways while enabling the patient advocacy community to be partners in positive change</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">open healths richard jones gemma allen and charlotte richards discuss how pharma can utilise tools channels and stakeholders to deliver change and enable better outcomes many innovative therapies are being launched in rare disease following 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    years
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 of research that has been driven by the emergence of new technology and regulatory incentives this brings high levels of hope and expectation to the rare disease community exploring the challenges in rare disease through better communication strategiesopen health recognises that there are multiple challenges in commercialising new therapies in rare disease and is leading future practice in communications by placing emphasis on a patient 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 approach this includes supporting 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    benjamin jamess
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 recent analysis on what the future could look like for outcomes driven communications in this space</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">overviewthis 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    april
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 webinar is part of iqvias 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    monthly
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 updates on the impact of covid19 and its implications for the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    healthcare
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 ecosystem he led on fundraising towards the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    25m william harvey heart centre
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">QUANTITY</span>
</mark>
 which created a translational clinical research centre dr 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    jonathan sheffield dhscnihr
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 covid19 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    uk
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 research system operations and 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    liaison directorjonathan
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 sheffield was chief executive officer of 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the national institute for health research clinical research network
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 until 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    march 2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 he is now leading the nihrs response to the global pandemic in the role of 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    dhscnihr covid19
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    uk
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 research system operations and 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    liaison
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 director 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    carol
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 also runs the 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    iqvia
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 clinical trial supplies business and provides clinical supply chain services for global clinical trials</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">the nhs globally unique health data ecosystem has the potential to improve health outcomes with around 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    363000
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 new cancer cases in the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    uk
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    every year
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 oncology data can further be leveraged to help researchers make more informed decisions about medicines discovery research and value to improve cancer outcomes and patient experience in addition to healthcare organisations which at the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    uk
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 level include the establishment of 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the national institute for health data science health data
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 research 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    uk
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 and 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nhsx information governance
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 is key as is alignment to 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    uk
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 and 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    eu
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 regulations such as the 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    july 2019
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 dhsc framework for the value of nhs research and gdpr this includes simulated data for generating realworld insights as well as datacan the health data research hub for cancer working in partnership with patients and the public to make highquality health data more accessible for cancer researchers clinicians and other health professionals his focus is to establish comprehensive and influential integrated oncology solutions that support health economics and outcomes research accelerate drug development and market access and improve cancer pathways</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">the pharmaceutical industry striving to meet these needs is dedicated to improving patient outcomes by providing access to new and innovative medicines for those in need on time and through the right distribution channels 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 way to do this is for pharmaceutical marketers to move out of the daytoday delivery mode and embrace new ways of working technologies and processes to ensure success the challenges are not inconsiderable but neither are they insurmountable and the solutions to them are clear working in this way not only delivers more efficient pharma marketing but also better patient outcomes ensuring everybody wins the whitepaper can be accessed here or by clicking on the buttons above or below</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    some 93
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of pharma companies now produce more content than they did 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    just two years ago
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 doing so requires pharma companies to develop a complete view of their promotional materials 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 way of achieving this is through a digital supply chain which brings together all pharma stakeholders from across the content development process how to do all of this and uncover the insights hidden in pharma company content is the subject of a new ebook from veeva veevas uncovering your contents hidden insights ebook can be downloaded here or by clicking on the button above or below</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">healthcare customer reference data is the fuel that powers pharmaceutical commercial operations but does the life sciences industry have the right data foundation to take full advantage of digital channels and artificial intelligence in its latest 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 customer reference data survey veeva will examine the current state of customer data and is seeking input from life sciences industry executives on their experiences and opinions the short 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    6minute
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 survey will build up a detailed picture of how customer reference data is perceived within pharma companies and what governance and quality challenges organisations face the goal of the research is to understand the priorities drivers barriers and progress towards accurate quality customer reference data and its role in digital transformation and advancing the business</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    digital
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has rapidly taken over the pharma industry but many still dont fully understand how to harness it</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    smi group
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 are delighted to announce that 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    bsi group
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 will lead a postconference workshop on 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    september 16th
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 at the inaugural conference in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    san francisco
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 bsi became the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 to issue a notified body opinion to a manufacturer under 
<mark class="entity" style="background: #ff8197; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    article 117 of the medical devices regulation
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">LAW</span>
</mark>
 the notified body then confirms the device is compliant with the relevant general safety and performance requirements and provides an opinion to the medicines competent authority to confirm compliance bsi has formed a dedicated medicinal and biologics team to provide guidance on 
<mark class="entity" style="background: #ff8197; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    article 117
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">LAW</span>
</mark>
 and focus our full attention on this challenging area of new 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    eu
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 regulation end about 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    smi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 groupestablished since 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    1993
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    smi group
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 is a global eventproduction company that specializes in businesstobusiness conferences workshops masterclasses and online communities</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">prescient hires 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    two
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 new senior members to support its fastgrowing advisory businesslondon 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    february 12
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 2020prescient a 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 product and portfolio strategy firm announces the recent appointment of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    two
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 new senior members 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    kevin baruzzi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and dr arun r shrivats to its advisory business after a very exciting and successful 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2019
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 for prescient advisory we are delighted to welcome 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    kevin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and arun to our rapidly growing team said dr 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    debasish
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 talukdar senior vice president and head of prescient advisory about prescientat prescient science is at the core of everything we do we are a 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 product and portfolio strategy partner that specializes in turning the science of molecules into 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    optimal
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 patient outcomes and client value prescient advisory a 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    prescient healthcare group
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 business helps biopharmaceutical clients create clinical and commercial strategies that deliver differentiated and valuable brands</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">prescient hires 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    three
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 new senior members to strengthen and grow its intelligence insight businesslondon 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    january 29
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 2020prescient a 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 product and portfolio strategy partner announces the recent appointment of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    three
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 new senior members to its intelligence insight business 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    jeanne penn
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ben kebble
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and dr 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    mladen tomich
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 they join the existing intelligence insight team shaping the competitive strategy of prescients clients through enhanced decision support 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    jeanne penn
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 joins prescient after spending 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    more than 25 years
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 providing strategic insight and planning support to the biopharmaceutical industry 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    jeanne ben
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    mladen
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 bring the deep subject matter expertise and industry knowledge that is critical to our clients businessesbiographies and contact information for the prescient intelligence insight team can be found on wwwprescienthgcom prescient intelligence insight a prescient 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    healthcare
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 group business offers bestinclass biopharmaceutical intelligence by providing impactful insight and decision support to product and portfolio teams from early clinical development through to loss of exclusivity</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">cadila pharmaceuticals 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of the largest privately held pharma companies in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    india
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 shut down its api manufacturing plant in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ahmedabad
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 after 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    26
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 employees tested positive for the novel coronavirus according to a 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    reuters
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 report the reported cited senior government official arun mahesh babu the district development officer of 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ahmedabad
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 who told 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    reuters
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 that 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    five
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 employees had tested positive for 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    covid19 six days
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 back while 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    21
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 others tested positive 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    this week
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 babu noted that the facility was ordered to be shut down on 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    thursday 95
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 employees had been quarantined and sanitization at the site had begun in a statement cadila pharmaceuticals told 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    reuters
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 recently 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    26
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of our employees from our dholka manufacturing facility tested positive for coid19 following this we have closed our operations on our own</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    astrazeneca
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    novartis
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 reported drug approvals for 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    two
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 significant indications 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    this week
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 novartis meanwhile notched a win on its quest to get its drug tabrecta approved for a new cancer indication the company announced 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    this week
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 that the drug has been given the goahead for patients with metex14 mutated 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nonsmall
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 cell lung cancer nsclc that has metastasized tabrecta is the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 drug to win approval for the indication beating out a rival from pfizer although nscls accounts for 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    about 85 percent
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERCENT</span>
</mark>
 of the new lung cancer diagnoses 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    each year
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    only about 40005000
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 patients have the metex14 mutation</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pharma manufacturing
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 presents funny pharm featuring drawings by awardwinning cartoonist 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    jerry king
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 the winning cartoon caption will be featured on 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the pharma manufacturing website
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and the winner will be mentioned in upcoming enewsletters the winner has a choice of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    two
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 prizes a coffee mug with the cartoon and winning caption printed on it or a 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    20
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 starbucks giftcard please submit your caption to cpalafoxputmannet with the subject funny pharm march 2020 thank you for your contributions contending submissionsplease note funny pharma caption contests are for entertainment purposes only</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr"> bill russopharmaceutical manufacturing presents funny pharm featuring drawings by awardwinning cartoonist 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    jerry king
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 the winning cartoon caption will be featured on 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the pharma manufacturing website
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and the winner will be mentioned in upcoming enewsletters the winner has a choice of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    two
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 prizes a coffee mug with the cartoon and winning caption printed on it or a 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    20
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 starbucks giftcard please submit your caption to cpalafoxputmannet with the subject funny pharm 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    april 2018
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 contending submissionsplease note funny pharma caption contests are for entertainment purposes only</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">the winning cartoon caption will be featured on the pharma manufacturing website and the winner will be mentioned in upcoming enewsletters please submit your caption to cpalafoxputmannet with the subject funny pharm 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    november 2019
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 contending submissionsplease note funny pharma caption contests are for entertainment purposes only 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ronald maytin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 we are cracking down on big pharma alex packardjustice delivers a crushing blow to 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the pharma industry alex packard
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 we are going to break up 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the pharma industry
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 alex packard im putting my foot down</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">covid19 has disrupted the supply chain to such an extent that governments around the world are asking questions about sources of active pharmaceutical ingredients api manufacturing in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the united states
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 the availability of critical pharmaceutical products has been reduced as countries of origin limit exports to protect their own populations president 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    trumps administration
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and lawmakers from both parties are now calling for a revamping of drug manufacturing operations within 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the united states
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 the onshoring of pharmaceutical and other manufacturing capacity would be expected to have many benefits to the welfare of 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    north american
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 communities a coordinated effortideally moving as much of the supply chain to 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the united states
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 as possible would result in fewer disruptions</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">the engineers that design fillfinish facilities for 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cmos
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and pharma have a few behindthescenes methods that help these projects in the very early stages performing 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    cfd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 during design helps predict the results of the air flow visualization ie environmental monitoring is key in fillfinish and understanding air flow is vital to ensure adherence to 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and emea regulations according to a zion market research study the global fillfinish manufacturing market is expected to reach 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    around 515 billion by 2024
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 facility design plays an important role identifying and addressing potential risks in producing and packaging biologics using a fillfinish production process</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">now in its 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    16th consecutive year
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 pharma manufacturings career and salary satisfaction survey queries readers for feedback on the financial and emotional health of their pharma industry careers satisfaction stays stableyear after 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    year
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 survey after survey the level of overall job satisfaction in pharma stays remarkably consistent to deal with rising drug development and operational costs many pharma companies have been restructuring their businesses show me the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    moneyof
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 course no career and salary satisfaction survey would be complete without a discussion about money 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    this year 71
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 of survey respondents were male and 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    29
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 female</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">overviewdigital technology is continuing to play a widening role in the pharma world at least for companies willing to begin the transformationhow well is pharma adopting 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    digital
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 tools what promise do they hold for modernizing operations in this ebook youll gain insights onrecharging the digital revolutionthe facility of the future todaymodernizing manufacturing through a connected shop floordownload now</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">overviewtheres no denying that 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 drugs will play a vital role in the future of medicine theres no denying that 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 drugs will play a vital role in the future of medicine as more new classes of therapeutics race towards commercialization the industry is grappling with the challenges of their highly complex and specific manufacturing processes this ebook will examinehow 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 is rethinking workforce trainingwhat the gene and cell therapy sector is doing to overcome commercialization challengeshow advances in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 characterization technologies are improving drug qualitydownload now</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stderr output_text">
<pre>/anaconda/envs/py37_default/lib/python3.7/runpy.py:193: UserWarning: [W006] No entities to visualize found in Doc object. If this is surprising to you, make sure the Doc was processed using a model that supports named entity recognition, and check the `doc.ents` property manually if necessary.
  &#34;__main__&#34;, mod_spec)
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">overviewas more pharma companies look to lower costs streamline operations and expand geographical presence contract manufacturers are increasingly becoming the unsung heroes of pharmaas more pharma companies look to lower costs streamline operations and expand geographical presence contract manufacturers are increasingly becoming the unsung heroes of pharma this ebook will explore</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">overviewa collection of the mostread feature articles of the 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    year
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 chosen by 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the pharma manufacturing digital audiencea collection
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 of the mostread feature articles of the year chosen by 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the pharma manufacturing digital
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 audience this ebook will explore</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">here at pharma manufacturing we understand and appreciate the investment pharmaceutical equipment vendors put into developing and improving their products the quartic platform delivers on this mission offering an aipowered smart manufacturing platform built specifically for ot users next up is another example of a company that used its expertise to develop a product specifically suited to fill a need in the pharma industry our largest and most diverse category brings several crosscompany collaborations resulting in targeted solutions to new industry packaging challenges and there you have it the 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2019
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 pharma innovation award winners the greatest things since 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    last years
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 winning technologies</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">the editors of pharmaceutical manufacturing have their own trophies to award in this issue as in the allstar game we showcase a variety of players from different ends of the country allstar innovators include recently introduced technologies systems and services that based on their applicational and technical merits were selected by pharmaceutical manufacturings editors and advisors to be on 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    this years
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 roster offering the worlds only plant digital twin the technology combines process and product data into a set of analytical models that mirror machines lines plants and supply chains although there are surely more great innovations out there in the pharma field these are the standout players that made 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    this years
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 allstar roster</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">watch this educational video to learn what needs to be monitored as well as the common challenges faced in lab monitoring safeguarding valuable scientific equipment and assets from deviations in ambient conditions 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    24 hours
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">TIME</span>
</mark>
 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    a day 7 days
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 a week is challenging topics covered how monitoring has adapted to recent trends and shifts towards biopharmaceuticals in the industry 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    three
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 areas of lab monitoring lab equipment lab environment general facility common monitoring challengeswatch nowthis fundamentals video is sponsored by xiltrix</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">informatics the science of computer information systems are playing an increasingly important role in the complex arena of biopharmaceutical product and process development this ondemand presentation includes 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 industry overview challenges and opportunities results of a research survey conducted to understand how informatics are impacting biopharmaceutical product and process development approaches to using informatics to add effectiveness and efficiency to these processes case study from a multinational biopharmaceutical manufacturerwatch now</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stderr output_text">
<pre>/anaconda/envs/py37_default/lib/python3.7/runpy.py:193: UserWarning: [W006] No entities to visualize found in Doc object. If this is surprising to you, make sure the Doc was processed using a model that supports named entity recognition, and check the `doc.ents` property manually if necessary.
  &#34;__main__&#34;, mod_spec)
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">raw material identification is a necessary step for ensuring cgmp compliance and for ensuring quality pharmaceutical products however where are we as an industry in conducting this necessary operation and quickly and accurately as possible at the lowest cost this ondemand presentation includes results of a research survey conducted to learn more about the industrys current raw material identification approaches the strengths and weaknesses of current approaches ideas for product quality and efficiency improvement and cost reductionwatch now</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stderr output_text">
<pre>/anaconda/envs/py37_default/lib/python3.7/runpy.py:193: UserWarning: [W006] No entities to visualize found in Doc object. If this is surprising to you, make sure the Doc was processed using a model that supports named entity recognition, and check the `doc.ents` property manually if necessary.
  &#34;__main__&#34;, mod_spec)
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">hear from insiders how modular construction new production platforms and singleuse technology are reducing the risk and time required for new biopharmaceutical manufacturing facility construction and startup learn true cost vs benefits and distinguish between myth and reality in terms of equipment and platform capabilities and versatility manufacturing floor issues will also be discussed in depth individual facility installations will be analyzed sharing best practices and lessons learned</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">join us for a review and moderated discussion of the issues and technologies driving new pharmaceutical manufacturing facility design and construction both in the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 and in growing 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    asian
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 markets among the questions in the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 are where are the facilities being built and how will that affect industry employment trends how are they being designed</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stderr output_text">
<pre>/anaconda/envs/py37_default/lib/python3.7/runpy.py:193: UserWarning: [W006] No entities to visualize found in Doc object. If this is surprising to you, make sure the Doc was processed using a model that supports named entity recognition, and check the `doc.ents` property manually if necessary.
  &#34;__main__&#34;, mod_spec)
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">biopharmaceutical manufacturers are reducing risk and cost by using modular construction disposable process equipment contained equipment and other innovations will they change the industrys approach to plant design and engineering</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">new details have emerged about the biogen company meeting in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    boston
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 that became what epidemiologists are calling a super spreader event according to 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the new york times
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 report officials now estimate that 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    about 100
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 biogen employees including 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    two
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 top executives fell ill because of the leadership meeting it is now believed that the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 cases of coronavirus in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    tennessee
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 and 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    indiana
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 along with some of the earliest cases in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    north carolina
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 can be traced back to the biogen meeting all of the biogen employees sickened from the meeting have reportedly recovered but it is unclear what the impact of the meeting has been on the wider public read the full 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    new york times
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 report</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">with more cell and gene therapies expected to be approved in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 and beyond we anticipate this sector of the pharmaceutical industry will continue to ramp up source evaluatepharma vantage 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 reportevaluatepharmas vantage 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 preview 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    andrew bulpin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 head of process solutions life science milliporesigmanew regions will emerge as leaders in the lowcost generic 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    marketin 2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 and beyond pharma will see accelerated consolidation of pharma companies and fast growth of emerging markets particularly in oncology and biologics this will be 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the african decade
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 where the smart money will be deployedemerging regional pharma companies in 
<mark class="entity" style="background: #ff9561; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    europe middle east
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">LOC</span>
</mark>
 and 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    north africa
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 mena and the wider 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    african
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 continent will purchase lowprofit generic assets branded 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 will continue to divest its less profitable assets and invest in oncology and biologics drug products</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">amidst rising demand for hydroxychloroquine an antiviral being studied as a treatment for 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    coronavirus india
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has halted exports of the drug although the drug is not in short supply in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    india
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the countrys commerce department
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 said there is not enough staff available at some manufacturing companies to run adequate operations 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    this week
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    india
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 issued a threeweek lockdown on its population of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    13 billion
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 people bringing everyday commerce and business operations to a standstill 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    india
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 has also banned the export of ventilators personal protection equipment and sanitizers as the country gears up to fight coronavirus on its own shores the country has also put restrictions on the export of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    26
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 other pharma medicines further weakening the global supply chain of drugs</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">its all about location but just how much cheaper is it to run a pharma plant in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    india
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 than in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    france
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 recently the boyd company which provides location counseling and costcomparative analysis for global corporate corporations released a report detailing their estimates for the price of doing pharma business around the world for the analysis boyd looked at a wide range of factors including labor costs utilities land acquisition construction and taxes to determine the final operating costs for each of the biomanufacturing hotspots included in the report boyd added up what it would take to run 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    a hypothetical 300000
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 squarefoot facility with 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    about 300
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 employees heres a look at what their results show are the most and least expensive places to run a pharma plant</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    last year
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the fdas center for drug evaluation and research cder issued 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    dozens
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 warning letters for manufacturing issues to pharma companies outside the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 one country in particular 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    india
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 received the highest amount of letters all told cders various divisions including 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the office of prescription drug promotion
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 letters 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the office of unapproved drugs
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and labeling compliance and others doled out over 90 warning letters throughout 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2019
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 but cders office of manufacturing quality letters issued 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    43
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 letters to companies outside of the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 of those letters 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    20
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 were aimed at facilities in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    india
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    china
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 received the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2nd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 most manufacturing quality warning letters 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    11
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 while the rest of the letters were distributed among plants in 
<mark class="entity" style="background: #ff9561; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    europe
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">LOC</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    costa rica
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    singapore
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    turkey
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 and others the agency also hit 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    dozens
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of us companies with warning letters in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2019
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stderr output_text">
<pre>/anaconda/envs/py37_default/lib/python3.7/runpy.py:193: UserWarning: [W006] No entities to visualize found in Doc object. If this is surprising to you, make sure the Doc was processed using a model that supports named entity recognition, and check the `doc.ents` property manually if necessary.
  &#34;__main__&#34;, mod_spec)
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">evolution of data analytics for process industriesthe eras of analyticsthere was a time in the not so distant past when pen and paper clipboards and slide rules were the best tools available for data analytics but these innovations opened new doors for data analytics with the recent advent of advanced analytics software applications data is once again directly at the fingertips of smes advanced analytics applicationswhy is sme connectivity to data and the corresponding use of advanced analytics crucial these and other challenges are being addressed with advanced analytics applications that directly connect the smes to the data</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">oral solid dose may be the backbone of 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 but recent innovations in drug delivery products are making it easier for patients and pharma companies to utilize alternatives there are also limitations on the amount of active ingredients that can be delivered due to the size of these dose formsheres a look at how innovations for injectables and chewables are improving the landscape of drug delivery options in pharma customizable componentsgetting the small details right for drug delivery can make a big difference when it comes to quickly bringing products to market the program enables generic drug manufacturers the possibility of offering delivery options and packaging for a variety of molecules leveraging a single formula 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    platform degrazio
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 says using 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    milliporesigmas synbiosys technology platform pharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 companies can encapsulate sensitive biological therapeutics and better control the drugs release</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">here are 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    three
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 ways advanced quality management systems improve supply chain management and safeguard patients1 with a cloudbased quality management system pharmaceutical companies are automatically alerted when these changes have been received viewed and implemented the quality management system also allows companies to manage each suppliers access privileges based on their individual needs 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    one
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 pharma company found that their supplier quality engineers were spending 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    up to four hours
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">QUANTITY</span>
</mark>
 per person each day on administrative tasks modernize links in the supply chainmodern technology is a key enabler to improving supplier quality management in the pharmaceutical industry</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">now as 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    covid19s
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 impacts have made their way around the world 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    us
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 manufacturers are scrambling to retool operations to produce critical supplies as weve seen with covid19 the response speed of supply chains is critical in helping slow down and even prevent the total number of casualties in a global health emergency supply chains play an important role in implementing response measures and building out a local healthcare systems capacity according to 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the world health organization
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 endtoend supply chain and logistics systems are the foundation of successful immunization programs in times of global health crises the urgency of strong and advanced supply chains becomes even more critical</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stderr output_text">
<pre>/anaconda/envs/py37_default/lib/python3.7/runpy.py:193: UserWarning: [W006] No entities to visualize found in Doc object. If this is surprising to you, make sure the Doc was processed using a model that supports named entity recognition, and check the `doc.ents` property manually if necessary.
  &#34;__main__&#34;, mod_spec)
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">the demands for pharmaceutical coldchain capacity and compliance are on the rise the problem of temperature excursions is widespread protecting pharma products in transitequipment malfunctions waits in exposed locations delays and human error can all cause temperature excursions for products that need refrigeration freezing or protection from freezing when temperature sensors are combined with location trackers the alerts can pinpoint problem links in the cold chain reducing coldchain equipment downtimewireless sensors that monitor the temperature and vibration of coldchain equipment can also reduce unplanned equipment downtime that causes product waste</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stderr output_text">
<pre>/anaconda/envs/py37_default/lib/python3.7/runpy.py:193: UserWarning: [W006] No entities to visualize found in Doc object. If this is surprising to you, make sure the Doc was processed using a model that supports named entity recognition, and check the `doc.ents` property manually if necessary.
  &#34;__main__&#34;, mod_spec)
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">with massive investing throughout the industry it is clear that in pharma oncology is king before all industry discussion was about treating a global pandemic oncology was the word on everyones lips the biggest therapeutic area in pharma oncology is exploding getting new information to doctors is complicated if they are unable to meet at conferences or with sales reps pfizer and jj are digging through their inventory of previously developed antiviral compounds to see what might prove effective as a covid19 treatment</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">the impact of the covid19 crisis may be greatest on the pharmaceutical industry long term savvy leaders in pharmaceutical manufacturing will accelerate innovation and speed new ways of doing business from 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    digital
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 to big data artificial intelligence the industrial internet of things 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    iiot
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 and machinelearning to improve processes and quality manage the swirlacknowledge people admit theres a lot you dont know and whatever you do now dont allow a vacuum to develop pharmaceutical manufacturing will very likely transform in ways large and small after we have navigated this pandemic smart pharmaceutical manufacturing leaders will be encouraging their teams to prepare now</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    alexion pharmaceuticals
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    portola pharmaceuticals
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 have entered into a definitive merger agreement for alexion to acquire the commercialstage biopharmaceutical company 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    portolas commercialized
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 medicine 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    andexxa
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 is the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    first
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 and only approved factor 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    xa inhibitor
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 reversal agent and has demonstrated value by rapidly reversing the anticoagulant effects of factor 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    xa
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 inhibitors rivaroxaban and apixaban in severe and uncontrolled bleeding the merger agreement has been unanimously approved by the boards of alexion and portola the acquisition of 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    portola
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 represents an important next step in our strategy to diversify beyond 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    c5
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 said 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ludwig hantson
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 ceo of alexion following completion of the offer alexion will acquire all remaining shares not tendered in the offer at the same price of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    18
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 per share through a merger</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    indias aurobindo pharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 stocks drop after the company announced 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    six
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 procedural observations on its formulation manufacturing facility in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    hyderabad
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 read morethe collaboration is focused on phase 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2b
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 clinical trial to evaluate use of 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    allergans
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 cenicriviroc and novartis lead fxr agonist to treat nonalcoholic steatohepatitis</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stderr output_text">
<pre>/anaconda/envs/py37_default/lib/python3.7/runpy.py:193: UserWarning: [W006] No entities to visualize found in Doc object. If this is surprising to you, make sure the Doc was processed using a model that supports named entity recognition, and check the `doc.ents` property manually if necessary.
  &#34;__main__&#34;, mod_spec)
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">this electron can be of any kinds we have encountered a electron a  electron or an n electron when light either visible or ultraviolet is absorbed by valence outer electrons ultraviolet visible spectroscopyor ultraviolet visible spectrophotometery uvvis or uvvis involves the spectroscopy of photons in the uvvisible region there is an interaction between uv visible light and sample which is in solution form as a result of this interaction some photons photons of uvvis emr are absorbed and this absorption of uv visible is measured by an instrument named uv visible spectrophotometer</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">scientific poster how to automate water content determination in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pharmaceuticals3
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 sharesposted 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    20 november 2019
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 metrohm 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    uk ltd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 the water content of pharmaceuticals strongly influences their quality shelflife and stability as well as the release of the active substances the determination of water content is therefore vital in pharmaceutical analysis this poster describes the water determination in pharmaceuticals using the 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    karl fischer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 oven technique substances that release water slowly at high temperatures or exhibit low solubility in alcohols are not suitable for a direct 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    karl fischer
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 titration only the water enters the 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    kf
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 cell and the sample itself does not come into contact with the 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    kf
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 reagent eliminating unwanted side reactions and matrix effects</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">ema to fasttrack development of covid19 vaccines and therapeutics10 sharesposted 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    7
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 may 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    victoria
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 rees 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 pharmaceutical review the ema has announced new regulatory changes that will help potential covid19 vaccines and therapeutics accelerate through development the 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 medicines agency ema has published an overview of how it will accelerate its regulatory procedures so that marketing authorisations of safe effective and highquality covid19 related medicines can be granted as soon as possible supporting the development and marketing authorisation of safe effective and highquality therapeutics and vaccines as soon as possible is one of 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    emas
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 top priorities in the covid19 public health emergency it will work closely with 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the emas human medicines committee
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 chmp for 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    optimal
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 and fast coordination of activities related to the development authorisation and safety monitoring of medicines and vaccines against covid19 applications for the marketing authorisation for covid19 products will be treated in an expedited manner</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">weak global market mood also weighed on the market sentiment back homeindias covid cases crossed 70000mark with 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    mumbai
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 and 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    delhi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 emerging as major hotbeds of the fastspreading virus broader market indices were faring in line with benchmark sensex as bse midcap index fell 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    176 per cent
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 while bse smallcap skid 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    143 per cent
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 bse 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    500
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 was down 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    182
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 per centin the 30share pack sensex 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    sun pharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 was the biggest gainer up 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    104 per cent
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 at rs 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    468
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 nifty private bank was the biggest loser down 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    224 per cent
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    chinese
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 shares dithered in early trade with the bluechip 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    csi300
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 index off a shade</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">lucknow in case all goes well uttar pradesh could emerge as a manufacturing hub for pharmaceuticals in the country it will further receive a boost once the upcoming 
<mark class="entity" style="background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    jewar airport
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FAC</span>
</mark>
 is completed which will make exports easy hence uttar pradesh should be allotted 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    four
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 bulk drugs or medical equipment parks 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    yogi adityanath
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 said in his 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    lettermsme
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 principal secretary dr navneet sehgal said the centre is considering the pharma hub proposal uttar pradesh is preparing a detailed report the centre will build solvent recovery plants common effluent treatment plants and drugs testing labs in such parks</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    new delhi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 fifatrol as an immunityboosting ayurvedic drug has found a mention among around 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    200
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 technologies and research activities evaluated by experts in a recently released compendium for combating coronavirus prime minister 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    narendra modi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 too recently highlighted the benefits of ayurveda and urged people to have a look at 
<mark class="entity" style="background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ayush ministry s protocol
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FAC</span>
</mark>
 to stay fit saying good health is the harbinger of happiness fifatrol acts as an immunity enhancer which is a multidrug combination of ayurvedic classical medicines and herbs researchers have suggested that fifatrol acts as a natural antibiotic and fights infection flu and ache it statedelaborating the salient features of the drug the compendium stated that fifatrol is a natural formulation providing fast relief from nasal congestion sore throat body ache and headache he has also been exhorting the citizens to fall back on traditional home remedies to boost their immunity amid the outbreak</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">the tata group patriarch ratan tata has penned down a note for entrepreneurs advising them to adapt and create to get over the covid19 pandemic he wrote about how the current crisis will drive businesses to find creative ways in order to survive instagramratan tata this crisis will force entrepreneurs to adapt and create tata wrote in an 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    instagram
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 post i hope that the ability to find another way to build a product run a company run operations a better way will emerge as an outcome of the current crisis tata wrote the chairman emeritus of tata sons reiterated that he is confident in the inventive nature and creativity of entrepreneurs to find ways to modify businesses amidst lockdown</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">the tata group patriarch ratan tata has penned down a note for entrepreneurs advising them to adapt and create to get over the covid19 pandemic he wrote about how the current crisis will drive businesses to find creative ways in order to survive instagramratan tata this crisis will force entrepreneurs to adapt and create tata wrote in an 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    instagram
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 post i hope that the ability to find another way to build a product run a company run operations a better way will emerge as an outcome of the current crisis tata wrote the chairman emeritus of tata sons reiterated that he is confident in the inventive nature and creativity of entrepreneurs to find ways to modify businesses amidst lockdown</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    new delhi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 warehousing space leasing fell 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    29 per cent
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 to 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    59 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 sq ft and new supply declined 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    14 per cent
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 to 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    9 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 sq ft in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the first quarter
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 of this calendar 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    year
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 across 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    eight
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 major cities in the country amid coronavirus outbreak according to jll indiathe absorption and new supply of warehousing space stood at 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    83 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 sq ft and 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    105 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 sq ft respectively across 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    eight
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 cities 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ahmedabad bengaluru
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 chennai 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    hyderabad
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 kolkata mumbai delhincr and puneproperty consultant 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    jll india
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 expects limited leasing activities during 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the second quarter of 2020 calendar year
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 new supply will also get deferred because of the lockdown to control the spread of covid19however it said that there can be gradual revival in the demand post lockdown as leases and active requests for proposals rfps that were in various stages of closure may be executed increased enquiries from ecommerce and 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    third
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 party logistics players are expected the report said adding that the gradea properties will be preferred due to adherence to additional safety norms the pent up demand and project closures might be pushed by 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    two quarters
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 and 
<mark class="entity" style="background: #bfeeb7; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    q4
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PRODUCT</span>
</mark>
 will be 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    an interesting quarter
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 to watch out for the fundamentals remain strong and there is opportunity for 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    india
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 to capture the pie of manufacturing demand in case companies replan their global supply chains from business continuity plan point of view the report saidas covid19 has significantly impacted businesses and the economy worldwide consumers have shifted consumption activity to online transactions the consultant said</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 things every emerging 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 needs to know about supply 
<mark class="entity" style="background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    chainby ray sison xcell
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FAC</span>
</mark>
 strategic consulting llcthere is an inside joke in drug product development we enter our careers with visions of 
<mark class="entity" style="background: #bfeeb7; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    discovery
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PRODUCT</span>
</mark>
 and worldchanging accomplishment with the worlds sudden focus on supply chain notably for 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    healthcare
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and the drug development industry supply chain professionals may yet have their moment in the opinion of some supply chain specialists outside the profession there is a fundamental lack of understanding of supply chain specifically there is a misunderstanding of the key difference between the supply chain sc and the activity of supply chain management 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    scm
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 a variation of the risk management supply chain it may inform and embed itself into the future of critical drug product scm</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">how military thinking can improve pharma decision making under stressful conditionsby stacey largent senior consultant valsource inc bruce t blythe chairman of the r3 continuum once said that decision making while in a crisis is located somewhere between analysis and intuition intuition equates to making the right decision without necessarily knowing the reason why this is the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    third
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    three
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 articles from valsource authors on some of the challenges of making decisions in difficult times prospect theoryin addition to the amount of information available the presence of stressful conditions during decision making can impact the actual decision being made a framework for military decision making under risks</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">econsent in clinical trials insights for implementation during covid19 and beyondby kelly roland and 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    hannah glenny
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 otsuka pharmaceuticalthe world has changed in the wake of covid19 clinical trial sites and sponsors are scrambling to adjust traditional clinical trial practices and processes to incorporate virtual interactions and data collection methods new mantras such as flattening the curve and social distancing require creative solutions and methods in relation to clinical trial models to adjust for these changes clinical trial sponsors must adapt their protocols and many are urgently doing so to provide virtual tools for clinical trial use her most recent work includes leading various transformation initiatives to deliver the next generation of clinical research while driving improved patient outcomes and operational efficiencies in the clinical trial process</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">how will covid19 impact biosimilar trends in the top 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    5
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 markets by 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    jose ignacio
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 diaz general manager emergpharmait is undeniable that covid19 will have a significant impact on biosimilar uptake particularly in 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 markets where governments are expected to cover all the pharmaceutical needs of their citizens and where the crisis will lead to an important reduction of available resources it seems reasonable to think that the need to balance the accounts will lead 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 countries to put into practice all possible savings measures to avoid a health system collapse sales of these approved biosimilars in top 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    5
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 markets were 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    around 14 billion
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 we still do not know the real impact the crisis caused by covid19 may have on the level of adoption of biosimilars and the erosion of prices in 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 markets</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">magazine articles becoming the ceo 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    two years ago
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 i was destined for retirement now im the ceo of a company that is developing an ultralonglasting dosage form that will allow people to take their medicine once a 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    week
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 or even once a month working with 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the us army
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 to achieve tech transfer success many pharmas or biotechs may not know the opportunities available from working with 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the us army
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 on license agreements or collaborative research and development agreements cradas heres what to know about the medical technology transfer 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    mtt
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 office</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 things every emerging 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 needs to know about supply 
<mark class="entity" style="background: #ddd; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    chainby ray sison xcell
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FAC</span>
</mark>
 strategic consulting llcthere is an inside joke in drug product development we enter our careers with visions of 
<mark class="entity" style="background: #bfeeb7; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    discovery
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PRODUCT</span>
</mark>
 and worldchanging accomplishment with the worlds sudden focus on supply chain notably for 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    healthcare
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and the drug development industry supply chain professionals may yet have their moment in the opinion of some supply chain specialists outside the profession there is a fundamental lack of understanding of supply chain specifically there is a misunderstanding of the key difference between the supply chain sc and the activity of supply chain management 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    scm
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 a variation of the risk management supply chain it may inform and embed itself into the future of critical drug product scm</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">how military thinking can improve pharma decision making under stressful conditionsby stacey largent senior consultant valsource inc bruce t blythe chairman of the r3 continuum once said that decision making while in a crisis is located somewhere between analysis and intuition intuition equates to making the right decision without necessarily knowing the reason why this is the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    third
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    three
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 articles from valsource authors on some of the challenges of making decisions in difficult times prospect theoryin addition to the amount of information available the presence of stressful conditions during decision making can impact the actual decision being made a framework for military decision making under risks</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">econsent in clinical trials insights for implementation during covid19 and beyondby kelly roland and 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    hannah glenny
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 otsuka pharmaceuticalthe world has changed in the wake of covid19 clinical trial sites and sponsors are scrambling to adjust traditional clinical trial practices and processes to incorporate virtual interactions and data collection methods new mantras such as flattening the curve and social distancing require creative solutions and methods in relation to clinical trial models to adjust for these changes clinical trial sponsors must adapt their protocols and many are urgently doing so to provide virtual tools for clinical trial use her most recent work includes leading various transformation initiatives to deliver the next generation of clinical research while driving improved patient outcomes and operational efficiencies in the clinical trial process</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">how will covid19 impact biosimilar trends in the top 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    5
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 markets by 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    jose ignacio
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 diaz general manager emergpharmait is undeniable that covid19 will have a significant impact on biosimilar uptake particularly in 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 markets where governments are expected to cover all the pharmaceutical needs of their citizens and where the crisis will lead to an important reduction of available resources it seems reasonable to think that the need to balance the accounts will lead 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 countries to put into practice all possible savings measures to avoid a health system collapse sales of these approved biosimilars in top 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    5
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 markets were 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    around 14 billion
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 we still do not know the real impact the crisis caused by covid19 may have on the level of adoption of biosimilars and the erosion of prices in 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    european
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 markets</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">magazine articles becoming the ceo 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    two years ago
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 i was destined for retirement now im the ceo of a company that is developing an ultralonglasting dosage form that will allow people to take their medicine once a 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    week
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 or even once a month working with 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the us army
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 to achieve tech transfer success many pharmas or biotechs may not know the opportunities available from working with 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the us army
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 on license agreements or collaborative research and development agreements cradas heres what to know about the medical technology transfer 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    mtt
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 office</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">all told forbes 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    annual
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 list counted 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2095
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 billionaires around the world and across all industries which is 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    58
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 fewer than 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    last year
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 in health care the list included 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    about 140
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 billionaires spread between 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the pharma biotech medical devices hospitals
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and medical equipment sectors in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 alone 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    about half
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of the worlds richest made their fortune in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    china
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 but he made his mark in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 by developing abraxane a blockbuster chemotherapy treatment used on a number of cancers although his yearly salary is comparable to other ceos in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 schleifer acquired 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nearly 4 percent
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERCENT</span>
</mark>
 of the companys stock after it went public in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    1991
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    oyster point pharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 a clinicalstage 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 focused on treating ocular surface diseases announced positive results of a phase 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    3
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 study testing a reformulation of the smokingcessation drug chantix as a nasal spray treatment for dry eye key secondary endpoints were met including an improvement in eye dryness score in the normal clinic environment as well as mean change in schirmers score in the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    12
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 mgml dose group in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2006
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 approved approved varenicline tartrate tablets marketed as chantix by pfizer for use as an aid to smoking cessation treatment oyster point says it plans to submit its new drug application for 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    oc01
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 to the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the second half of 2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 if approved the drug will launch in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the fourth quarter of 2021
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">all told forbes 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    annual
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 list counted 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2095
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 billionaires around the world and across all industries which is 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    58
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 fewer than 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    last year
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 in health care the list included 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    about 140
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 billionaires spread between 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the pharma biotech medical devices hospitals
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and medical equipment sectors in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 alone 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    about half
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 of the worlds richest made their fortune in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    china
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 but he made his mark in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 by developing abraxane a blockbuster chemotherapy treatment used on a number of cancers although his yearly salary is comparable to other ceos in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 schleifer acquired 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nearly 4 percent
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERCENT</span>
</mark>
 of the companys stock after it went public in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    1991
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    oyster point pharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 a clinicalstage 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biopharma
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 focused on treating ocular surface diseases announced positive results of a phase 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    3
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 study testing a reformulation of the smokingcessation drug chantix as a nasal spray treatment for dry eye key secondary endpoints were met including an improvement in eye dryness score in the normal clinic environment as well as mean change in schirmers score in the 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    12
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 mgml dose group in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2006
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 approved approved varenicline tartrate tablets marketed as chantix by pfizer for use as an aid to smoking cessation treatment oyster point says it plans to submit its new drug application for 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    oc01
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 to the 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    fda
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the second half of 2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 if approved the drug will launch in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the fourth quarter of 2021
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">by ptilondon 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    british
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 prime minister 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    boris johnson
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 has warned that a mass vaccine for the novel coronavirus may be over a year away and in the worstcase scenario may in fact never be found a mass vaccine or treatment may be 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    more than a year
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 away said 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    johnson
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 highlighting the work being done in the 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    uk
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 by scientists at 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    oxford university and imperial college
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    london
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 towards this mission read 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    uk
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pm boris johnson
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 launches new covid19 alert system as lockdown rules modifiedindeed in a worstcase scenario we may never find a vaccine under the step by step plan by 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the start of next month
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 nonessential shops will also reopen with some hairdressers pubs and cinemas to follow from 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    july
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 however as part of a covid19 alert system if infection rates are seen to be rising again restrictions would be tightened possibly at short notice</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">cleaning validation a beginners guide to increasing efficiency with toc14 sharesabout this webinarwhat are the consequences of not performing cleaning validation properly we answer these questions and more in our ondemand webinar which guides you through efficiency gains with toc for cleaning validation we call it a beginners guide but this webinar will benefit longtime toc users as well as those new to using toc for cleaning validation we cover stepbystep the what why and how for gaining efficiency and getting the most out of toc for cleaning validation most recently he served as the global product quality lead for several commercial products at shire formerly baxter in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    vienna
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">whitepaper an update for pharmaceutical stress testing enabled by modern informatics technologies6 sharesposted 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2 december 2019
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 acdlabs stress testing or forced degradation is well recognized as a fundamental part of the drug development process specifically related to purity through control of stability control strategies for stability require stabilityindicating analytical methods the development and validation of such methods is built on the foundation of welldesigned and conducted stress testing studies the complete regulatory definition of stress testing is found in q1ar21an excerpt of this definition is stress testing can help identify the likely degradation products which can in turn help establish the degradation pathways and the intrinsic stability of the molecule and validate the stability indicating power of the analytical procedures usedconditions for stressing include elevated heat and humidity susceptibility to hydrolysis across a wide ph range susceptibility to oxidative and photolytic degradation and in the case of biologics freezethaw cycles and shear when appropriate3</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the ministry of trade
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 plans to offer tax holiday to encourage companies to bring new investment that will support the government to boost the covid19 pandemic hit 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    economythe ministry of finance
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 is evaluating a proposal to give 10year tax exemption to companies making a fresh investment of over 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    500 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 as per the news agency bloomberg the report also said that under this proposal companies will need to start operations within 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    three years
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 from 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    june 1
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 and will cover sectors such as medical devices electronics telecom equipment and capital goodsit also points out to another program that includes a fouryear tax holiday this will be given to companies that invest 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    over 100 million
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 in labourintensive sectors like textiles food processing leather and footwear also a lower corporate tax rate of 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    10 per cent
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">MONEY</span>
</mark>
 for 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the next six years
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 has 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ben proposedthe ministry of finance
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has to take a decision on this and give approvalto make the proposal even more attractive for the investors and for the economy from wrecking the government is offering easy access to land for factories leaving 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    china
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 tax breaks for new plants while the thrust is on developing sectors such as 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    textiles pharma food processing
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 and gems and jewellery the ministry is also working on expanding the list to include services sectors such as tourism</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">what you need to know to integrate automation in your biomanufacturing environment integrating automation in a biomanufacturing environment successfully can become a daunting task without the right preparation and a clear implementation strategy through proper planning of your automation integration you can eliminate costly errors and missteps and focus on developing efficient futureproof automation strategies the top trends influencing automation in the life science industry the need for process optimization regulatory compliance and supply chain improvements is driving investment in automation technologies across the life science industry this article discusses the impact that multiproduct manufacturing facilities singleuse technologies continuous manufacturing and industry 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    40
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 will have on automation automation is an essential element in the acquisition and management of data at each phase from the supply chain to the boardroom</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">what you need to know to integrate automation in your biomanufacturing environment integrating automation in a biomanufacturing environment successfully can become a daunting task without the right preparation and a clear implementation strategy through proper planning of your automation integration you can eliminate costly errors and missteps and focus on developing efficient futureproof automation strategies the top trends influencing automation in the life science industry the need for process optimization regulatory compliance and supply chain improvements is driving investment in automation technologies across the life science industry this article discusses the impact that multiproduct manufacturing facilities singleuse technologies continuous manufacturing and industry 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    40
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 will have on automation automation is an essential element in the acquisition and management of data at each phase from the supply chain to the boardroom</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    smi
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 reports 
<mark class="entity" style="background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    julian dixon
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">PERSON</span>
</mark>
 from 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    team consulting ltd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 is interviewed for the injectable drug delivery conferencesmi groups 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    3rd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORDINAL</span>
</mark>
 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    annual
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 injectable drug delivery is set to take place on 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the 2nd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 and 3rd 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    september 2020
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    london
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 the twoday event will emphasise various elements of drug developments such as drug product formulation where top industry figures will assess evolving regulatory environment of injectable drug delivery with industry and regulatory representatives presenting updates on current guidelines as part of europes largest injectable conference series it will provide delegates the chance to meet and collaborate with top industry figures to discuss the dynamic injectable drug market register at wwwinjectabledrugdeliverycompharmapr8on the run up to the conference 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    julian
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 dixon director of human factors team consulting is interviewed by 
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    smi group
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 to discuss his presentation details insights of the injectable drug delivery market and his thoughts on the biggest growth area of the injectable drug delivery market snapshot of 
<mark class="entity" style="background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    julians
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">NORP</span>
</mark>
 interviewthe injectable drug delivery market has matured greatly over 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    recent years
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 what key differences have you noticed in 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    the last year
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 regarding significant developments</div></span>
</div>

</div>

<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>-----------------------------------------------
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt"></div>



<div class="output_html rendered_html output_subarea ">
<span class="tex2jax_ignore"><div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    genfit
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ORG</span>
</mark>
 has seen almost twothirds of the value wiped off its shares after its muchanticipated pivotal trial of nonalcoholic steatohepatitis nash drug elafibranor turned out to be a bust the phase 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    3
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 resolveit trial showed that elafibranor a ppar agonist was unable to improve on placebo on the main measure of resolving nash without an increase in fibrosis scarring elafibranor also failed to improve secondary measures relating to metabolic parameters so the study looks like a comprehensive fail a phase 
<mark class="entity" style="background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    3
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">CARDINAL</span>
</mark>
 trial of elafibranor in 
<mark class="entity" style="background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pbc
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">GPE</span>
</mark>
 is due to start 
<mark class="entity" style="background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    later this year
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DATE</span>
</mark>
 nash is a fastprogressing condition characterised by liver scarring and inflammation that can lead to liver failure and the need for a liver transplant</div></span>
</div>

</div>

</div>
</div>

</div>
    </div>
  </div>
</body>

 


</html>
